model,mri_category,mri_trait,protein,n,beta,pvalue
Primary analysis,Right ventricle,RV end diastolic volume,LEP;Leptin,4867,-0.267515997576868,1.5333013939189e-80
Primary analysis,Left ventricle,LV end diastolic volume,LEP;Leptin,4865,-0.253556220368186,3.03562075463009e-72
Primary analysis,Right ventricle,RV end diastolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4917,-0.249962916896561,6.27311913591428e-71
Primary analysis,Left ventricle,LV end diastolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4915,-0.234057131571381,3.79220971637306e-62
Primary analysis,Left ventricle,LV myocardial mass,LEP;Leptin,4866,-0.228005244773883,2.05069668201508e-58
Primary analysis,Right ventricle,RV end systolic volume,LEP;Leptin,4866,-0.214365809015648,1.09507802759352e-51
Primary analysis,Right ventricle,RV stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4917,-0.211331717132533,9.25317910449916e-51
Primary analysis,Left ventricle,LV myocardial mass,"FABP4;Fatty acid-binding protein, adipocyte",4916,-0.210643194034194,2.00506311875959e-50
Primary analysis,Left ventricle,LV stroke volume,LEP;Leptin,4867,-0.207554601618047,1.66133879183303e-48
Primary analysis,Right ventricle,RV stroke volume,LEP;Leptin,4867,-0.203202408797621,1.58968176904016e-46
Primary analysis,Left ventricle,LV cardiac output,LEP;Leptin,4865,-0.196036073137131,2.4090142784074e-43
Primary analysis,Left ventricle,LV stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4917,-0.192021594598917,4.71689405113058e-42
Primary analysis,Left ventricle,LV cardiac output,"FABP4;Fatty acid-binding protein, adipocyte",4915,-0.185422624952502,2.88722880286828e-39
Primary analysis,Right atrium,RA maximum volume,LEP;Leptin,4786,-0.187835377087817,2.96054829557141e-39
Primary analysis,Left ventricle,LV end systolic volume,LEP;Leptin,4856,-0.185223496373754,9.8250203877982e-39
Primary analysis,Right ventricle,RV end diastolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4832,-0.185593185486529,1.060665674582e-38
Primary analysis,Left ventricle,LV myocardial mass,REN;Renin,4866,-0.183593169302084,3.77854455096565e-38
Primary analysis,Right ventricle,RV end systolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4916,-0.178507096977478,1.76480781242044e-36
Primary analysis,Right ventricle,RV end diastolic volume,CLMP;CXADR-like membrane protein,4890,-0.175082611471118,5.83006927868197e-35
Primary analysis,Left ventricle,LV end diastolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4830,-0.175744752882724,8.33813361203602e-35
Primary analysis,Left ventricle,LV end systolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4906,-0.170034695124803,3.81469238090771e-33
Primary analysis,Right atrium,RA minimum volume,LEP;Leptin,4777,-0.172018916378981,4.77607457553132e-33
Primary analysis,Right ventricle,RV end diastolic volume,RTN4R;Reticulon-4 receptor,4890,-0.169893792493408,5.45501673856258e-33
Primary analysis,Ascending aorta,Ascending aorta maximum area,LEP;Leptin,4588,-0.17299216432306,3.74468395147949e-32
Primary analysis,Descending aorta,Descending aorta maximum area,LEP;Leptin,4586,-0.171796362436964,1.02955104270692e-31
Primary analysis,Descending aorta,Descending aorta minimum area,LEP;Leptin,4587,-0.171772711041569,1.03392981565382e-31
Primary analysis,Ascending aorta,Ascending aorta minimum area,LEP;Leptin,4588,-0.170639081419576,2.56448508449776e-31
Primary analysis,Right ventricle,RV end diastolic volume,ADM;Pro-adrenomedullin,4890,-0.163777083902304,9.56875118858246e-31
Primary analysis,Right ventricle,RV end diastolic volume,COLEC12;Collectin-12,4836,-0.162965164596897,3.89300559997084e-30
Primary analysis,Right ventricle,RV end diastolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4822,-0.162982781208511,4.63995421630132e-30
Primary analysis,Left ventricle,LV myocardial mass,CLMP;CXADR-like membrane protein,4889,-0.161550878050516,6.05505333791501e-30
Primary analysis,Right atrium,RA maximum volume,IL1RN;Interleukin-1 receptor antagonist protein,4749,-0.163011713515764,1.22035063913414e-29
Primary analysis,Right ventricle,RV stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4832,-0.161282238997134,1.60714935942595e-29
Primary analysis,Right ventricle,RV end diastolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4838,-0.159802459351019,4.87016286572706e-29
Primary analysis,Descending aorta,Descending aorta minimum area,REN;Renin,4587,-0.162980023039212,1.12714105771649e-28
Primary analysis,Right ventricle,RV end diastolic volume,AGRN;Agrin,4861,-0.158326964468613,1.17334148849532e-28
Primary analysis,Left atrium,LA maximum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4793,0.159301970930499,1.30063042982899e-28
Primary analysis,Right ventricle,RV end diastolic volume,TAFA5;Chemokine-like protein TAFA-5,4832,-0.158415617256454,1.58534852828542e-28
Primary analysis,Left ventricle,LV end diastolic volume,CLMP;CXADR-like membrane protein,4888,-0.157195077528569,2.04667353731768e-28
Primary analysis,Right atrium,RA maximum volume,RTN4R;Reticulon-4 receptor,4804,-0.158524390068574,2.08320136974913e-28
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,REN;Renin,4864,-0.157359426541004,2.43268925408986e-28
Primary analysis,Right atrium,RA maximum volume,"FABP4;Fatty acid-binding protein, adipocyte",4832,-0.156402546969617,7.71205144310572e-28
Primary analysis,Right ventricle,RV end diastolic volume,BTN2A1;Butyrophilin subfamily 2 member A1,4861,-0.0989424820148722,4.72669218919626e-12
Primary analysis,Left ventricle,LV stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4832,-0.155671271032454,1.36300925863522e-27
Primary analysis,Right ventricle,RV end diastolic volume,NPPC;C-type natriuretic peptide,4852,-0.152844241553487,9.45899788419494e-27
Primary analysis,Left ventricle,LV end diastolic volume,NPPC;C-type natriuretic peptide,4850,-0.151483287640354,2.73128726505566e-26
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4843,-0.150410217614417,6.66007508581051e-26
Primary analysis,Left ventricle,LV end diastolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4836,-0.150182205919937,8.56692891022848e-26
Primary analysis,Right ventricle,RV end diastolic volume,CST3;Cystatin-C,4859,-0.149615996503899,1.00608247928439e-25
Primary analysis,Ascending aorta,Ascending aorta minimum area,REN;Renin,4588,-0.150913568511276,8.83371270462248e-25
Primary analysis,Right ventricle,RV end diastolic volume,PLAT;Tissue-type plasminogen activator,4904,-0.147002504024547,4.27264915838423e-25
Primary analysis,Descending aorta,Descending aorta maximum area,REN;Renin,4586,-0.149489925706165,2.48776420286216e-24
Primary analysis,Right ventricle,RV end diastolic volume,SCARB2;Lysosome membrane protein 2,4724,-0.149095311123974,6.86943461871085e-25
Primary analysis,Left ventricle,LV cardiac output,IL1RN;Interleukin-1 receptor antagonist protein,4830,-0.147302602304326,7.75317771499978e-25
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,REN;Renin,4864,-0.149045301516262,1.45719844586753e-25
Primary analysis,Left ventricle,LV end diastolic volume,PLAT;Tissue-type plasminogen activator,4902,-0.146009774976011,9.10866964685637e-25
Primary analysis,Left ventricle,LV end diastolic volume,TAFA5;Chemokine-like protein TAFA-5,4830,-0.146737641217715,1.17253296938167e-24
Primary analysis,Left ventricle,LV end diastolic volume,ADM;Pro-adrenomedullin,4888,-0.145540744813654,1.49686675890161e-24
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,REN;Renin,4864,-0.147389488015747,4.99044026659147e-25
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4897,-0.144868941405876,2.22210682408772e-24
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,REN;Renin,4864,-0.145603995329638,1.85251594497179e-24
Primary analysis,Right atrium,RA maximum volume,PRSS8;Prostasin,4744,-0.145481751817231,7.40041685650596e-24
Primary analysis,Left ventricle,LV end diastolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4820,-0.144158704200312,8.43779480927193e-24
Primary analysis,Right ventricle,RV stroke volume,RTN4R;Reticulon-4 receptor,4890,-0.143063791393297,8.87183614086474e-24
Primary analysis,Left ventricle,LV end diastolic volume,IGSF9;Protein turtle homolog A,3454,-0.16950413374879,1.114457614784e-23
Primary analysis,Right ventricle,RV end diastolic volume,FSTL3;Follistatin-related protein 3,4829,-0.142875968681105,1.91706919072498e-23
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,REN;Renin,4864,-0.141615984803906,3.2687496482742e-23
Primary analysis,Right atrium,RA stroke volume,LEP;Leptin,4795,-0.142589257063297,3.3437019733152e-23
Primary analysis,Right ventricle,RV end diastolic volume,ASGR1;Asialoglycoprotein receptor 1,4829,-0.141460253399424,5.21808907497965e-23
Primary analysis,Left ventricle,LV end diastolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4830,-0.140562344300064,9.69746776126384e-23
Primary analysis,Descending aorta,Descending aorta maximum area,"FABP4;Fatty acid-binding protein, adipocyte",4630,-0.143449268413462,1.02973675631389e-22
Primary analysis,Left ventricle,LV end diastolic volume,COLEC12;Collectin-12,4834,-0.14029480165112,1.12302181389856e-22
Primary analysis,Left ventricle,LV end diastolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4830,-0.140315706041841,1.15211107048608e-22
Primary analysis,Left atrium,LA minimum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4759,0.141258189785119,1.22659640242923e-22
Primary analysis,Right atrium,RA maximum volume,BTN2A1;Butyrophilin subfamily 2 member A1,4777,-0.0935932503348704,9.0927250060297e-11
Primary analysis,Right atrium,RA stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4758,-0.141104116893562,1.37857566952993e-22
Primary analysis,Right ventricle,RV end diastolic volume,HNMT;Histamine N-methyltransferase,4815,-0.139548576255686,2.28097951330736e-22
Primary analysis,Right ventricle,RV end diastolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4832,-0.139229129059903,2.40437708466929e-22
Primary analysis,Right ventricle,RV stroke volume,AGRN;Agrin,4861,-0.138485391198286,3.02659196042686e-22
Primary analysis,Left ventricle,LV end diastolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4754,-0.139697347820665,3.77707645080744e-22
Primary analysis,Right ventricle,RV end diastolic volume,CPM;Carboxypeptidase M,4887,-0.137380991063115,5.05060770608206e-22
Primary analysis,Left ventricle,LV end diastolic volume,CPM;Carboxypeptidase M,4885,-0.137174237266268,5.9387139707813e-22
Primary analysis,Right ventricle,RV stroke volume,CLMP;CXADR-like membrane protein,4890,-0.136865712949798,7.00269592309001e-22
Primary analysis,Right ventricle,RV end diastolic volume,TGFBR2;TGF-beta receptor type-2,4872,-0.136483203986285,1.08100637000225e-21
Primary analysis,Right atrium,RA stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4841,-0.136750733216725,1.2096481268043e-21
Primary analysis,Left ventricle,LV end diastolic volume,CST3;Cystatin-C,4857,-0.136305521728556,1.40718886000225e-21
Primary analysis,Left ventricle,LV end diastolic volume,AGRN;Agrin,4859,-0.135931827227754,1.78077721851212e-21
Primary analysis,Right ventricle,RV end diastolic volume,RBP5;Retinol-binding protein 5,4832,-0.136140242556666,1.9947850961353e-21
Primary analysis,Right ventricle,RV stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4838,-0.135918859097663,2.18972852104606e-21
Primary analysis,Left ventricle,LV end diastolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4813,-0.136169499170835,2.34071386529819e-21
Primary analysis,Right ventricle,RV end systolic volume,CLMP;CXADR-like membrane protein,4889,-0.134923872095605,2.6674701376095e-21
Primary analysis,Left ventricle,LV end diastolic volume,LDLR;Low-density lipoprotein receptor,4864,-0.135074677436031,3.03854573742745e-21
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4829,-0.135504202192251,3.15289112741248e-21
Primary analysis,Right ventricle,RV end diastolic volume,"KRT18;Keratin, type I cytoskeletal 18",4832,-0.135128795022468,3.9466497108221e-21
Primary analysis,Left ventricle,LV end diastolic volume,SEZ6L;Seizure 6-like protein,4870,-0.133640758893739,7.54645451830222e-21
Primary analysis,Ascending aorta,Ascending aorta maximum area,REN;Renin,4588,-0.137502012308848,8.31276710972109e-21
Primary analysis,Right ventricle,RV end diastolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4815,-0.134154456992195,8.85845903267422e-21
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4896,-0.13272087310329,1.10380431848913e-20
Primary analysis,Right ventricle,RV end diastolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4825,-0.133514508429271,1.23646025452239e-20
Primary analysis,Left ventricle,LV end diastolic volume,RTN4R;Reticulon-4 receptor,4888,-0.131863377886596,2.09830309923274e-20
Primary analysis,Left ventricle,LV end diastolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3351,-0.158885127520457,2.1844965625473e-20
Primary analysis,Right ventricle,RV end diastolic volume,GFRA1;GDNF family receptor alpha-1,4886,-0.131510959348005,2.69702157815646e-20
Primary analysis,Right ventricle,RV end diastolic volume,CD83;CD83 antigen,4852,-0.131764328386633,3.08224265973799e-20
Primary analysis,Right ventricle,RV end diastolic volume,CD59;CD59 glycoprotein,4682,-0.133880592467731,3.58632958118834e-20
Primary analysis,Right ventricle,RV end diastolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4832,-0.131798452471741,3.59830832363466e-20
Primary analysis,Left ventricle,LV end diastolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4908,0.130629654459678,3.97977332303742e-20
Primary analysis,Right atrium,RA minimum volume,IL1RN;Interleukin-1 receptor antagonist protein,4740,-0.132592625900808,4.87344455742793e-20
Primary analysis,Right ventricle,RV end diastolic volume,IGSF9;Protein turtle homolog A,3456,-0.155018577915429,4.93854357226422e-20
Primary analysis,Right ventricle,RV end systolic volume,COLEC12;Collectin-12,4835,-0.131236173951531,5.06189842398503e-20
Primary analysis,Right ventricle,RV stroke volume,NPPC;C-type natriuretic peptide,4852,-0.130667301835929,6.32306415022242e-20
Primary analysis,Right ventricle,RV end diastolic volume,CFH;Complement factor H,3247,-0.159411475283959,6.32337935917831e-20
Primary analysis,Descending aorta,Descending aorta minimum area,"FABP4;Fatty acid-binding protein, adipocyte",4631,-0.133687689390482,6.4671920683538e-20
Primary analysis,Left atrium,LA maximum volume,NPPB;Natriuretic peptides B,4689,0.132861494616095,6.48277570118758e-20
Primary analysis,Right ventricle,RV end diastolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4756,-0.131797931682916,7.05999352587661e-20
Primary analysis,Right ventricle,RV end diastolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4867,-0.130247187946547,7.30042912140803e-20
Primary analysis,Right ventricle,RV end systolic volume,ADM;Pro-adrenomedullin,4889,-0.129891680979334,7.61451934687022e-20
Primary analysis,Descending aorta,Descending aorta maximum area,CLMP;CXADR-like membrane protein,4604,-0.133736453857856,8.0217044892017e-20
Primary analysis,Right ventricle,RV end diastolic volume,PALM;Paralemmin-1,3397,-0.155285503611476,8.82250246138754e-20
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4905,-0.129449758602151,8.85897875373206e-20
Primary analysis,Left ventricle,LV stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4838,-0.130137517723706,1.00745348951931e-19
Primary analysis,Right ventricle,RV end diastolic volume,THY1;Thy-1 membrane glycoprotein,4904,-0.128930469329903,1.25328116404107e-19
Primary analysis,Right ventricle,RV end systolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4821,-0.12978653705399,1.46310744462086e-19
Primary analysis,Right atrium,RA minimum volume,RTN4R;Reticulon-4 receptor,4795,-0.130033099356017,1.56210862447023e-19
Primary analysis,Right ventricle,RV end diastolic volume,PRSS8;Prostasin,4826,-0.129089750192184,2.1931468996042e-19
Primary analysis,Left ventricle,LV end diastolic volume,HNMT;Histamine N-methyltransferase,4813,-0.128823778044137,2.90287479398626e-19
Primary analysis,Left ventricle,LV end diastolic volume,PRAP1;Proline-rich acidic protein 1,3449,-0.151500628811215,3.69220363286733e-19
Primary analysis,Right atrium,RA maximum volume,ASGR1;Asialoglycoprotein receptor 1,4745,-0.12924858995441,3.95123022280021e-19
Primary analysis,Right atrium,RA maximum volume,HGF;Hepatocyte growth factor,4821,-0.128177877520168,4.09409077808722e-19
Primary analysis,Right ventricle,RV end diastolic volume,LDLR;Low-density lipoprotein receptor,4866,-0.127490463819843,4.35813812363587e-19
Primary analysis,Right atrium,RA maximum volume,LDLR;Low-density lipoprotein receptor,4782,-0.128581483393819,4.40022430851777e-19
Primary analysis,Right ventricle,RV end diastolic volume,CALB2;Calretinin,4751,-0.128955776267445,4.51612221911816e-19
Primary analysis,Right ventricle,RV end systolic volume,TAFA5;Chemokine-like protein TAFA-5,4831,-0.12762616829741,5.34593892551956e-19
Primary analysis,Left ventricle,LV cardiac output,IGFBP6;Insulin-like growth factor-binding protein 6,4836,-0.127523524229585,5.47344634486843e-19
Primary analysis,Right ventricle,RV end diastolic volume,HGF;Hepatocyte growth factor,4905,-0.126526808520901,5.84699712039142e-19
Primary analysis,Right ventricle,RV end systolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4831,-0.127148643842694,7.23255343252041e-19
Primary analysis,Right ventricle,RV stroke volume,ADM;Pro-adrenomedullin,4890,-0.126340239251139,7.44153638211654e-19
Primary analysis,Right atrium,RA maximum volume,AGRN;Agrin,4777,-0.127764473750052,7.67869203817633e-19
Primary analysis,Right ventricle,RV end diastolic volume,SEZ6L;Seizure 6-like protein,4872,-0.126502178466542,7.77662817557079e-19
Primary analysis,Left ventricle,LV end diastolic volume,AFM;Afamin,3442,-0.150228010066159,7.94510378634415e-19
Primary analysis,Right atrium,RA minimum volume,BTN2A1;Butyrophilin subfamily 2 member A1,4768,-0.0862040501587252,2.49184088452965e-09
Primary analysis,Left ventricle,LV end diastolic volume,SCARB2;Lysosome membrane protein 2,4722,-0.128287623489443,8.76989849462496e-19
Primary analysis,Right atrium,RA stroke volume,PRSS8;Prostasin,4753,-0.127732913642152,9.56512483006964e-19
Primary analysis,Right atrium,RA maximum volume,PLAT;Tissue-type plasminogen activator,4819,-0.126799734739897,9.9461242824671e-19
Primary analysis,Right atrium,RA maximum volume,F7;Coagulation factor VII,4773,-0.127250029869204,1.09554748038425e-18
Primary analysis,Right ventricle,RV end diastolic volume,COL6A3;Collagen alpha-3(VI) chain,4917,-0.12536571423125,1.1103189065113e-18
Primary analysis,Right ventricle,RV end systolic volume,SCARB2;Lysosome membrane protein 2,4723,-0.127765850886691,1.20314364869523e-18
Primary analysis,Right atrium,RA maximum volume,CPM;Carboxypeptidase M,4803,-0.126381343008454,1.47335158621227e-18
Primary analysis,Right ventricle,RV stroke volume,BTN2A1;Butyrophilin subfamily 2 member A1,4861,-0.0817249451047564,1.15651530368632e-08
Primary analysis,Left ventricle,LV end diastolic volume,CFH;Complement factor H,3245,-0.1531123265438,1.77989028459739e-18
Primary analysis,Right atrium,RA minimum volume,"FABP4;Fatty acid-binding protein, adipocyte",4823,-0.125801616386054,1.79873990801769e-18
Primary analysis,Right atrium,RA maximum volume,CST3;Cystatin-C,4776,-0.12632525536498,1.90117377752957e-18
Primary analysis,Left ventricle,LV end systolic volume,IGSF9;Protein turtle homolog A,3446,-0.148211330361623,2.21872660867892e-18
Primary analysis,Right ventricle,RV end diastolic volume,EFNA4;Ephrin-A4,4823,-0.125416465281765,2.28655937250782e-18
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 1,REN;Renin,4864,-0.124585754443593,2.76562917822088e-18
Primary analysis,Descending aorta,Descending aorta minimum area,CLMP;CXADR-like membrane protein,4605,-0.12791231803214,2.94355700491883e-18
Primary analysis,Left ventricle,LV end diastolic volume,GSTA3;Glutathione S-transferase A3,4754,-0.125689287949495,3.36542089368706e-18
Primary analysis,Left ventricle,LV myocardial mass,PALM;Paralemmin-1,3396,-0.148299422877342,3.71898352220364e-18
Primary analysis,Right ventricle,RV end systolic volume,FSTL3;Follistatin-related protein 3,4828,-0.124492040399638,3.89782101133441e-18
Primary analysis,Descending aorta,Descending aorta minimum area,CRLF1;Cytokine receptor-like factor 1,4579,-0.127634694385332,4.32327422469936e-18
Primary analysis,Ascending aorta,Ascending aorta minimum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4553,-0.127972918898953,4.38304149494007e-18
Primary analysis,Right ventricle,RV end diastolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4765,-0.125113197715792,4.38816392845076e-18
Primary analysis,Left ventricle,LV myocardial mass,CLEC4A;C-type lectin domain family 4 member A,4851,0.123897856720705,4.69535454347463e-18
Primary analysis,Right ventricle,RV end diastolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4910,0.123151674028572,4.70958130521664e-18
Primary analysis,Right atrium,RA minimum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4777,0.124283390333397,6.62869427858882e-18
Primary analysis,Right ventricle,RV stroke volume,PLAT;Tissue-type plasminogen activator,4904,-0.122642704039804,6.76259328317436e-18
Primary analysis,Right ventricle,RV stroke volume,SCG2;Secretogranin-2,4880,-0.122941261628563,6.76476609977374e-18
Primary analysis,Right ventricle,RV end diastolic volume,SCG2;Secretogranin-2,4880,-0.122836311165898,7.21698528564243e-18
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,REN;Renin,4864,-0.12302292966158,7.27860338750263e-18
Primary analysis,Right ventricle,RV stroke volume,CST3;Cystatin-C,4859,-0.123039832170701,7.48706520266115e-18
Primary analysis,Left ventricle,LV end diastolic volume,GHR;Growth hormone receptor,3375,-0.147271194078853,8.01050188985734e-18
Primary analysis,Right ventricle,RV end diastolic volume,PRAP1;Proline-rich acidic protein 1,3451,-0.145555586666358,8.44347113376255e-18
Primary analysis,Right ventricle,RV end diastolic volume,RARRES2;Retinoic acid receptor responder protein 2,4869,-0.12268512785215,8.61985985177558e-18
Primary analysis,Right ventricle,RV end diastolic volume,PRND;Prion-like protein doppel,3442,-0.145528642890616,9.44034318456469e-18
Primary analysis,Right atrium,RA maximum volume,IGFBP6;Insulin-like growth factor-binding protein 6,4755,-0.123917289307681,9.84625295202639e-18
Primary analysis,Left atrium,LA ejection fraction,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4782,-0.123514973476496,1.01777558043935e-17
Primary analysis,Right ventricle,RV stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4822,-0.122982529920261,1.03197972555005e-17
Primary analysis,Right atrium,RA maximum volume,IGFBP1;Insulin-like growth factor-binding protein 1,4826,0.122179603668859,1.63070672056002e-17
Primary analysis,Right ventricle,RV end diastolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3353,-0.146331848914139,1.65047609636379e-17
Primary analysis,Right ventricle,RV end diastolic volume,CXCL17;C-X-C motif chemokine 17,4905,-0.121099694795568,1.73218134963139e-17
Primary analysis,Right ventricle,RV end systolic volume,HNMT;Histamine N-methyltransferase,4814,-0.122145576486044,1.82402605950407e-17
Primary analysis,Right ventricle,RV end diastolic volume,LGALS1;Galectin-1,4867,-0.121441740037782,1.87070010570689e-17
Primary analysis,Left ventricle,LV end diastolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4888,-0.121153443169248,1.90395756622955e-17
Primary analysis,Left ventricle,LV stroke volume,AGRN;Agrin,4861,-0.12143097269902,1.96997811251327e-17
Primary analysis,Right atrium,RA stroke volume,RTN4R;Reticulon-4 receptor,4813,-0.121902475084298,2.12862270919927e-17
Primary analysis,Left ventricle,LV myocardial mass,IGFBP6;Insulin-like growth factor-binding protein 6,4837,-0.121473044385821,2.30086419966994e-17
Primary analysis,Right ventricle,RV stroke volume,COLEC12;Collectin-12,4836,-0.121331768245014,2.52464611561521e-17
Primary analysis,Right ventricle,RV end systolic volume,RBP5;Retinol-binding protein 5,4831,-0.121364694315549,2.5698178638284e-17
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4842,-0.121056353502818,2.84959756604531e-17
Primary analysis,Left ventricle,LV myocardial mass,ADM;Pro-adrenomedullin,4889,-0.120308589086122,3.15536145920934e-17
Primary analysis,Left ventricle,LV stroke volume,NPPC;C-type natriuretic peptide,4852,-0.120705026546484,3.26811760059735e-17
Primary analysis,Left ventricle,LV end systolic volume,PLAT;Tissue-type plasminogen activator,4893,-0.120122444784938,3.42843936647295e-17
Primary analysis,Right atrium,RA maximum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4785,-0.121430622062227,3.49177217421613e-17
Primary analysis,Left ventricle,LV end systolic volume,CLMP;CXADR-like membrane protein,4879,-0.120085491500038,3.88648033596042e-17
Primary analysis,Left ventricle,LV stroke volume,CLMP;CXADR-like membrane protein,4890,-0.119940911952204,3.9108033027583e-17
Primary analysis,Left ventricle,LV cardiac output,NPPC;C-type natriuretic peptide,4851,-0.120295549930806,4.21119188294307e-17
Primary analysis,Right ventricle,RV end diastolic volume,GSTA3;Glutathione S-transferase A3,4756,-0.121480350727759,4.21744155351754e-17
Primary analysis,Left ventricle,LV end diastolic volume,"KRT18;Keratin, type I cytoskeletal 18",4830,-0.120302151953823,4.89870108203396e-17
Primary analysis,Left ventricle,LV end diastolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4865,-0.119867205413502,4.91145732744343e-17
Primary analysis,Right atrium,RA minimum volume,HGF;Hepatocyte growth factor,4813,-0.120308859751889,5.53233142615809e-17
Primary analysis,Left ventricle,LV end diastolic volume,PALM;Paralemmin-1,3395,-0.142807913835757,6.23173921757899e-17
Primary analysis,Right ventricle,RV end diastolic volume,F7;Coagulation factor VII,4856,-0.119524875388642,6.43767481720078e-17
Primary analysis,Left atrium,LA minimum volume,NPPB;Natriuretic peptides B,4655,0.122030408244009,6.55205418207397e-17
Primary analysis,Left ventricle,LV longitudinal strain Segment 2,ANGPT2;Angiopoietin-2,4757,0.120512575358238,7.42273061653846e-17
Primary analysis,Right atrium,RA maximum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4786,0.120088017134473,7.69690632879833e-17
Primary analysis,Right atrium,RA maximum volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4759,-0.120409200377435,7.77300599471843e-17
Primary analysis,Left ventricle,LV myocardial mass,TAFA5;Chemokine-like protein TAFA-5,4831,-0.119461568328599,8.02145946579034e-17
Primary analysis,Right ventricle,RV end diastolic volume,PGF;Placenta growth factor,4905,-0.118443894671085,8.61291036012836e-17
Primary analysis,Right ventricle,RV end diastolic volume,GGH;Gamma-glutamyl hydrolase,4756,-0.120075116008855,9.67309420475993e-17
Primary analysis,Ascending aorta,Ascending aorta maximum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4553,-0.122602958917044,1.02535607302322e-16
Primary analysis,Right ventricle,RV end diastolic volume,GDF15;Growth/differentiation factor 15,4917,-0.117993940352004,1.03414022157567e-16
Primary analysis,Right atrium,RA maximum volume,PON3;Serum paraoxonase/lactonase 3,4777,0.119671208520077,1.05123953193887e-16
Primary analysis,Left ventricle,LV end diastolic volume,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3375,-0.103620533846599,1.60121353650478e-09
Primary analysis,Right ventricle,RV stroke volume,TAFA5;Chemokine-like protein TAFA-5,4832,-0.118798972117361,1.17869040016326e-16
Primary analysis,Left ventricle,LV end diastolic volume,KLK6;Kallikrein-6,4863,-0.118326714768167,1.24721313025389e-16
Primary analysis,Right ventricle,RV end systolic volume,AGER;Advanced glycosylation end product-specific receptor,4826,-0.118650615270552,1.34319092817767e-16
Primary analysis,Right ventricle,RV end diastolic volume,OXT;Oxytocin-neurophysin 1,4904,-0.117603417790691,1.43031644434007e-16
Primary analysis,Left ventricle,LV end diastolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4864,-0.117980213092592,1.51965545137002e-16
Primary analysis,Left ventricle,LV end diastolic volume,LPL;Lipoprotein lipase,4865,0.117788503402104,1.68945653192414e-16
Primary analysis,Right atrium,RA maximum volume,RARRES2;Retinoic acid receptor responder protein 2,4786,-0.118604256277935,1.83992069979472e-16
Primary analysis,Right ventricle,RV end systolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4866,-0.117530867421038,1.95221436960238e-16
Primary analysis,Right ventricle,RV end systolic volume,RTN4R;Reticulon-4 receptor,4889,-0.117158665082513,2.06724371541459e-16
Primary analysis,Right atrium,RA maximum volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4782,-0.118414205391995,2.11533770130583e-16
Primary analysis,Right ventricle,RV end diastolic volume,SNCG;Gamma-synuclein,4829,-0.117821156156132,2.13914118917019e-16
Primary analysis,Right ventricle,RV end diastolic volume,LGALS9;Galectin-9,4838,-0.117613548254345,2.26631547920183e-16
Primary analysis,Left ventricle,LV cardiac output,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3374,-0.0940446748545146,4.42977869647285e-08
Primary analysis,Left ventricle,LV stroke volume,LDLR;Low-density lipoprotein receptor,4866,-0.117117302850579,2.48852845903314e-16
Primary analysis,Left ventricle,LV end systolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4821,-0.117620982614112,2.54449952951339e-16
Primary analysis,Right ventricle,RV stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4756,-0.118402111589098,2.56624862643389e-16
Primary analysis,Right ventricle,RV end diastolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4872,-0.116969057152053,2.60273525564413e-16
Primary analysis,Left ventricle,LV end diastolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4823,-0.117428912698738,2.80593857159713e-16
Primary analysis,Right ventricle,RV end diastolic volume,CXCL16;C-X-C motif chemokine 16,4913,-0.0834663909293102,4.65299458034697e-09
Primary analysis,Left ventricle,LV cardiac output,AGRN;Agrin,4859,-0.116906129177625,2.95697627328015e-16
Primary analysis,Left ventricle,LV end diastolic volume,RBP5;Retinol-binding protein 5,4830,-0.11724100145249,2.98000947591253e-16
Primary analysis,Left ventricle,LV end diastolic volume,CALB2;Calretinin,4749,-0.117797170250332,3.82474637987074e-16
Primary analysis,Left ventricle,LV end diastolic volume,CLEC4A;C-type lectin domain family 4 member A,4850,0.116558196362326,3.85554546196512e-16
Primary analysis,Descending aorta,Descending aorta maximum area,IGFBP6;Insulin-like growth factor-binding protein 6,4559,-0.120105677481548,4.05779195604058e-16
Primary analysis,Left ventricle,LV end diastolic volume,GSTA1;Glutathione S-transferase A1,4838,-0.116547123328021,4.21736333928842e-16
Primary analysis,Right ventricle,RV end systolic volume,ASGR1;Asialoglycoprotein receptor 1,4828,-0.11665726268878,4.24120652797418e-16
Primary analysis,Right ventricle,RV end diastolic volume,CALB1;Calbindin,4832,-0.116443654865327,4.66797418756001e-16
Primary analysis,Right atrium,RA maximum volume,IGFBP2;Insulin-like growth factor-binding protein 2,4825,0.116513985511,4.7047438523986e-16
Primary analysis,Right ventricle,RV end diastolic volume,OGN;Mimecan,4843,-0.116205415572585,4.96554679973202e-16
Primary analysis,Right ventricle,RV end systolic volume,TGFBR2;TGF-beta receptor type-2,4871,-0.11585229428067,5.02564730197526e-16
Primary analysis,Left ventricle,LV stroke volume,ADM;Pro-adrenomedullin,4890,-0.115611362859956,5.07567125185503e-16
Primary analysis,Descending aorta,Descending aorta minimum area,STC2;Stanniocalcin-2,4552,-0.119693675031426,5.38503877051931e-16
Primary analysis,Right ventricle,RV end systolic volume,GFRA1;GDNF family receptor alpha-1,4885,-0.115393700014921,5.95867668445542e-16
Primary analysis,Left ventricle,LV end diastolic volume,CD59;CD59 glycoprotein,4680,-0.117760424667127,6.36949909845429e-16
Primary analysis,Left ventricle,LV end diastolic volume,APCS;Serum amyloid P-component,3417,-0.137477433587652,6.93428592065123e-16
Primary analysis,Left ventricle,LV end diastolic volume,SERPINF1;Pigment epithelium-derived factor,3405,-0.137439314260647,7.93368328252358e-16
Primary analysis,Right ventricle,RV end diastolic volume,SOST;Sclerostin,4866,-0.115104215436168,8.01241206710142e-16
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,REN;Renin,4863,-0.114701105229864,1.03074885426077e-15
Primary analysis,Left ventricle,LV stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4910,0.114531438287117,8.29060976033781e-16
Primary analysis,Right ventricle,RV end diastolic volume,PON3;Serum paraoxonase/lactonase 3,4861,0.115092117016083,8.34609954387905e-16
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,REN;Renin,4862,-0.111872899480079,5.14804072990423e-15
Primary analysis,Left ventricle,LV stroke volume,RTN4R;Reticulon-4 receptor,4890,-0.114324766760345,1.06763693507967e-15
Primary analysis,Right atrium,RA maximum volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4745,-0.115987873737104,1.10440506211957e-15
Primary analysis,Descending aorta,Descending aorta minimum area,IGFBP6;Insulin-like growth factor-binding protein 6,4560,-0.118247138572145,1.13876534752477e-15
Primary analysis,Left ventricle,LV myocardial mass,COLEC12;Collectin-12,4835,-0.114648773783012,1.28188872299122e-15
Primary analysis,Right ventricle,RV end diastolic volume,VWC2;Brorin,4819,-0.114829671708252,1.28781904462848e-15
Primary analysis,Left ventricle,LV end diastolic volume,COL6A3;Collagen alpha-3(VI) chain,4915,-0.113621373404157,1.35466824384998e-15
Primary analysis,Right atrium,RA stroke volume,PLAT;Tissue-type plasminogen activator,4828,-0.114576049075493,1.40035430840234e-15
Primary analysis,Right ventricle,RV end diastolic volume,CLEC4A;C-type lectin domain family 4 member A,4852,0.114237776207444,1.44599804788499e-15
Primary analysis,Left ventricle,LV end systolic volume,ADM;Pro-adrenomedullin,4879,-0.113814526209651,1.53855165740063e-15
Primary analysis,Right ventricle,RV end diastolic volume,FGF21;Fibroblast growth factor 21,4886,-0.113732684068947,1.53923069388154e-15
Primary analysis,Right ventricle,RV stroke volume,CPM;Carboxypeptidase M,4887,-0.113720702050755,1.53959555497345e-15
Primary analysis,Right atrium,RA maximum volume,ADIPOQ;Adiponectin,3382,0.136471903774438,1.57518832318118e-15
Primary analysis,Descending aorta,Descending aorta maximum area,CRLF1;Cytokine receptor-like factor 1,4578,-0.117398547147637,1.60361095395588e-15
Primary analysis,Left ventricle,LV cardiac output,LDLR;Low-density lipoprotein receptor,4864,-0.113827213816408,1.68691761563074e-15
Primary analysis,Left ventricle,LV end diastolic volume,CFD;Complement factor D,3442,-0.135089283984705,1.73263024114382e-15
Primary analysis,Left ventricle,LV end diastolic volume,SOST;Sclerostin,4864,-0.113647879586114,1.86806513877511e-15
Primary analysis,Right atrium,RA maximum volume,PRAP1;Proline-rich acidic protein 1,3387,-0.135871026313812,1.99998610502064e-15
Primary analysis,Right ventricle,RV end diastolic volume,TREM2;Triggering receptor expressed on myeloid cells 2,4836,-0.113794040422185,2.06898357502958e-15
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4843,-0.113474334947825,2.36703691044397e-15
Primary analysis,Right ventricle,RV end diastolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4843,-0.113416308400271,2.44591229148894e-15
Primary analysis,Left atrium,LA stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4846,-0.113338705842377,2.50561925509067e-15
Primary analysis,Right ventricle,RV end diastolic volume,XG;Glycoprotein Xg,4897,-0.112641114076784,2.66598774269132e-15
Primary analysis,Right ventricle,RV end diastolic volume,GSTA1;Glutathione S-transferase A1,4840,-0.113189325291523,2.83523087764724e-15
Primary analysis,Right ventricle,RV stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4869,-0.112838346276991,2.85997882615864e-15
Primary analysis,Left ventricle,LV cardiac output,CLMP;CXADR-like membrane protein,4888,-0.112505966292997,3.0507379380223e-15
Primary analysis,Left ventricle,LV end diastolic volume,NPY;Pro-neuropeptide Y,4888,-0.112487702751285,3.08239960441759e-15
Primary analysis,Left ventricle,LV end diastolic volume,CDHR5;Cadherin-related family member 5,4865,-0.11269183832201,3.18826909029329e-15
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4828,-0.113105991464502,3.21396323440528e-15
Primary analysis,Right ventricle,RV stroke volume,PRSS8;Prostasin,4826,-0.113077921363076,3.30796881518968e-15
Primary analysis,Left ventricle,LV end diastolic volume,COL15A1;Collagen alpha-1(XV) chain,3449,-0.133555753698191,3.38161729665656e-15
Primary analysis,Right ventricle,RV end diastolic volume,EPHA1;Ephrin type-A receptor 1,4852,-0.112720745999667,3.41302163064699e-15
Primary analysis,Left ventricle,LV myocardial mass,IL1RN;Interleukin-1 receptor antagonist protein,4831,-0.112953144988154,3.43393884554011e-15
Primary analysis,Right atrium,RA maximum volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4821,-0.113002809340117,3.56477439171445e-15
Primary analysis,Left ventricle,LV stroke volume,PLAT;Tissue-type plasminogen activator,4904,-0.112039400468329,3.58220563294732e-15
Primary analysis,Right atrium,RA stroke volume,CPM;Carboxypeptidase M,4811,-0.113036468560322,3.73425376263845e-15
Primary analysis,Right ventricle,RV end diastolic volume,CES1;Liver carboxylesterase 1,4880,-0.112214079535405,3.78739297645017e-15
Primary analysis,Descending aorta,Descending aorta minimum area,MFAP5;Microfibrillar-associated protein 5,4631,-0.114955939805708,4.26679894038022e-15
Primary analysis,Right atrium,RA stroke volume,AGRN;Agrin,4786,-0.112914504957986,4.70505696479522e-15
Primary analysis,Right atrium,RA maximum volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4682,-0.114131493000725,4.76423064942989e-15
Primary analysis,Left ventricle,LV end diastolic volume,F7;Coagulation factor VII,4854,-0.112009055932514,5.02147531205132e-15
Primary analysis,Right ventricle,RV stroke volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4815,-0.112424696059568,5.1186526352791e-15
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,REN;Renin,4863,-0.101640468020404,1.20756907840534e-12
Primary analysis,Left ventricle,LV stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4756,-0.11309019147192,5.19166260243057e-15
Primary analysis,Left ventricle,LV end systolic volume,TAFA5;Chemokine-like protein TAFA-5,4821,-0.11224509775827,5.44198666440131e-15
Primary analysis,Left ventricle,LV stroke volume,COLEC12;Collectin-12,4836,-0.112024999225798,5.5860571767005e-15
Primary analysis,Left ventricle,LV end diastolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3431,-0.13278370498875,5.73971949762348e-15
Primary analysis,Right ventricle,RV end diastolic volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4865,-0.11137661467881,6.66275574735931e-15
Primary analysis,Right ventricle,RV stroke volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4843,-0.111564638919513,6.9009700375237e-15
Primary analysis,Left ventricle,LV end systolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4811,-0.111918382754396,6.95674763878617e-15
Primary analysis,Left ventricle,LV myocardial mass,NPDC1;Neural proliferation differentiation and control protein 1,4866,-0.11119576133937,7.3220493865815e-15
Primary analysis,Left ventricle,LV cardiac output,SORCS2;VPS10 domain-containing receptor SorCS2,4754,-0.112423614718107,7.59602812596856e-15
Primary analysis,Descending aorta,Descending aorta minimum area,CCN5;CCN family member 5,4562,-0.114657339730194,7.98871146806391e-15
Primary analysis,Right ventricle,RV end diastolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4829,-0.111454358590015,8.0189242037647e-15
Primary analysis,Right atrium,RA maximum volume,"KRT18;Keratin, type I cytoskeletal 18",4748,-0.112373704727665,8.11563088464089e-15
Primary analysis,Right ventricle,RV stroke volume,SEZ6L;Seizure 6-like protein,4872,-0.110862927615304,8.48319292138157e-15
Primary analysis,Right ventricle,RV end diastolic volume,AGER;Advanced glycosylation end product-specific receptor,4827,-0.111351570706233,8.59640361296786e-15
Primary analysis,Left ventricle,LV cardiac output,ADM;Pro-adrenomedullin,4888,-0.110614253492424,8.81063570257997e-15
Primary analysis,Right ventricle,RV end diastolic volume,GHR;Growth hormone receptor,3376,-0.132878735632732,9.02855659293589e-15
Primary analysis,Right atrium,RA stroke volume,ASGR1;Asialoglycoprotein receptor 1,4754,-0.112035429652619,9.3993729149414e-15
Primary analysis,Left ventricle,LV end diastolic volume,FSTL3;Follistatin-related protein 3,4827,-0.111177921494757,9.46166906480471e-15
Primary analysis,Right ventricle,RV end systolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4824,-0.111207168783768,9.48843645288555e-15
Primary analysis,Left ventricle,LV end diastolic volume,CES1;Liver carboxylesterase 1,4878,-0.110532174408766,9.81613822066348e-15
Primary analysis,Right atrium,RA maximum volume,COLEC12;Collectin-12,4754,-0.111937473584236,9.91730115005543e-15
Primary analysis,Left ventricle,LV end systolic volume,NPPC;C-type natriuretic peptide,4841,-0.110927213298173,9.94806382503576e-15
Primary analysis,Left ventricle,LV cardiac output,HNMT;Histamine N-methyltransferase,4813,-0.111207130065456,1.01720594519885e-14
Primary analysis,Right atrium,RA maximum volume,TAFA5;Chemokine-like protein TAFA-5,4748,-0.111821283704685,1.09814028298994e-14
Primary analysis,Right ventricle,RV end diastolic volume,CYTL1;Cytokine-like protein 1,3451,-0.130846452207727,1.19085062450283e-14
Primary analysis,Left ventricle,LV end diastolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4841,-0.110597273188216,1.19329225542785e-14
Primary analysis,Right ventricle,RV end diastolic volume,SERPINF1;Pigment epithelium-derived factor,3407,-0.131596452449193,1.23898610967129e-14
Primary analysis,Left ventricle,LV cardiac output,IGFBP2;Insulin-like growth factor-binding protein 2,4908,0.109736637601077,1.26642937252118e-14
Primary analysis,Left ventricle,LV stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4832,-0.110558948851901,1.28924683061914e-14
Primary analysis,Right ventricle,RV end diastolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4890,-0.109849296769705,1.32953198874769e-14
Primary analysis,Descending aorta,Descending aorta maximum area,CCN5;CCN family member 5,4561,-0.113658829294695,1.37324307599452e-14
Primary analysis,Left ventricle,LV myocardial mass,CALB2;Calretinin,4750,-0.111322985702336,1.42255638447348e-14
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,LEP;Leptin,4864,-0.110003026963433,1.43434999971272e-14
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4890,-0.109665690481432,1.4713085684665e-14
Primary analysis,Left ventricle,LV cardiac output,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4830,-0.110304478865273,1.50101072253321e-14
Primary analysis,Left ventricle,LV end diastolic volume,PON3;Serum paraoxonase/lactonase 3,4859,0.109965513240809,1.51022963080687e-14
Primary analysis,Left ventricle,LV stroke volume,CST3;Cystatin-C,4859,-0.10995835673066,1.51617954373312e-14
Primary analysis,Right ventricle,RV stroke volume,CFH;Complement factor H,3247,-0.134283502817651,1.54582271770358e-14
Primary analysis,Right ventricle,RV stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4832,-0.110140975383654,1.62133329385084e-14
Primary analysis,Right ventricle,RV stroke volume,LDLR;Low-density lipoprotein receptor,4866,-0.10975285142231,1.62560913494789e-14
Primary analysis,Right ventricle,RV end diastolic volume,CD302;CD302 antigen,4832,-0.110062477525973,1.69248186351345e-14
Primary analysis,Right ventricle,RV end diastolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4890,-0.109368149097318,1.73324679473422e-14
Primary analysis,Left ventricle,LV stroke volume,SEZ6L;Seizure 6-like protein,4872,-0.109563130475351,1.73873033634286e-14
Primary analysis,Left ventricle,LV end diastolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4763,-0.110743122377157,1.79587202404961e-14
Primary analysis,Right ventricle,RV end diastolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4866,-0.109557376151478,1.80965633659213e-14
Primary analysis,Right ventricle,RV end diastolic volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4836,-0.109858707952884,1.84569043396501e-14
Primary analysis,Right atrium,RA maximum volume,PTGDS;Prostaglandin-H2 D-isomerase,4739,-0.110853311923289,1.96698453162937e-14
Primary analysis,Left ventricle,LV end diastolic volume,PGF;Placenta growth factor,4903,-0.108919530687071,2.04897104125024e-14
Primary analysis,Right ventricle,RV end systolic volume,CST3;Cystatin-C,4858,-0.109368439160904,2.10761059680348e-14
Primary analysis,Right ventricle,RV end diastolic volume,FURIN;Furin,4872,-0.118351538484028,1.15240110902866e-16
Primary analysis,Left ventricle,LV end diastolic volume,TGFBR2;TGF-beta receptor type-2,4870,-0.108978664351482,2.42361946262882e-14
Primary analysis,Right ventricle,RV end systolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4831,-0.109387058676461,2.46105316174306e-14
Primary analysis,Right ventricle,RV stroke volume,TREM2;Triggering receptor expressed on myeloid cells 2,4836,-0.109278040314272,2.5326700291373e-14
Primary analysis,Left ventricle,LV cardiac output,PLAT;Tissue-type plasminogen activator,4902,-0.108535927721779,2.5437384621949e-14
Primary analysis,Left ventricle,LV myocardial mass,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4831,-0.109307229946613,2.57013577883265e-14
Primary analysis,Right atrium,RA maximum volume,NPC2;NPC intracellular cholesterol transporter 2,3328,-0.131516189430977,2.59096514674873e-14
Primary analysis,Left ventricle,LV cardiac output,CST3;Cystatin-C,4857,-0.108991789519785,2.60405585256718e-14
Primary analysis,Left ventricle,LV stroke volume,TAFA5;Chemokine-like protein TAFA-5,4832,-0.109260327134271,2.62038269403971e-14
Primary analysis,Left ventricle,LV cardiac output,TAFA5;Chemokine-like protein TAFA-5,4830,-0.109260776331148,2.65192749212458e-14
Primary analysis,Left ventricle,LV end diastolic volume,DPT;Dermatopontin,4915,-0.108201138155283,2.82549233487259e-14
Primary analysis,Right ventricle,RV end diastolic volume,CDHR2;Cadherin-related family member 2,4832,-0.109101961068259,2.855495608019e-14
Primary analysis,Descending aorta,Descending aorta maximum area,MFAP5;Microfibrillar-associated protein 5,4630,-0.111425207481814,2.88298631033125e-14
Primary analysis,Left ventricle,LV end diastolic volume,OXT;Oxytocin-neurophysin 1,4902,-0.108295243320444,2.90131685120748e-14
Primary analysis,Left ventricle,LV end diastolic volume,PRSS8;Prostasin,4824,-0.109095780574394,3.00804949165969e-14
Primary analysis,Left ventricle,LV end systolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4821,-0.109113180545775,3.03478327232746e-14
Primary analysis,Right ventricle,RV end systolic volume,PRND;Prion-like protein doppel,3441,-0.128986832373361,3.06911834995319e-14
Primary analysis,Left ventricle,LV stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3353,-0.130592582441097,3.15765740661157e-14
Primary analysis,Right ventricle,RV end diastolic volume,CFI;Complement factor I,3444,-0.12870768456787,3.40004368906117e-14
Primary analysis,Right ventricle,RV end diastolic volume,SEMA3F;Semaphorin-3F,4867,-0.108349626874686,3.47501704335412e-14
Primary analysis,Right ventricle,RV end diastolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4843,-0.108482948042131,3.73484776707916e-14
Primary analysis,Right atrium,RA stroke volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4754,-0.10947494488628,3.76138672282508e-14
Primary analysis,Right atrium,RA maximum volume,OXT;Oxytocin-neurophysin 1,4820,-0.108702334593295,3.81158599074506e-14
Primary analysis,Left ventricle,LV end diastolic volume,SCG2;Secretogranin-2,4878,-0.107964742243083,4.00835345325193e-14
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,LEP;Leptin,4864,-0.1080931570096,4.06515238773583e-14
Primary analysis,Left ventricle,LV myocardial mass,PRND;Prion-like protein doppel,3441,-0.128297753023081,4.20616933331643e-14
Primary analysis,Left ventricle,LV end diastolic volume,CFI;Complement factor I,3442,-0.128246786146872,4.26892944943196e-14
Primary analysis,Right atrium,RA maximum volume,ACP5;Tartrate-resistant acid phosphatase type 5,4781,-0.10888477587533,4.37607426792946e-14
Primary analysis,Left ventricle,LV stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4832,-0.108290179999441,4.42714368022769e-14
Primary analysis,Right atrium,RA maximum volume,LPL;Lipoprotein lipase,4786,0.108781982749017,4.48574525499886e-14
Primary analysis,Right ventricle,RV end systolic volume,IGSF9;Protein turtle homolog A,3455,-0.127897276759586,4.48852381966215e-14
Primary analysis,Left ventricle,LV end systolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4856,-0.107942652580511,4.62488583115444e-14
Primary analysis,Right ventricle,RV end diastolic volume,AFM;Afamin,3444,-0.128004793666442,4.68716038368604e-14
Primary analysis,Right ventricle,RV end systolic volume,NPPC;C-type natriuretic peptide,4851,-0.107924717103923,4.81101792765951e-14
Primary analysis,Right atrium,RA maximum volume,CD83;CD83 antigen,4769,-0.108807276809663,4.90527752806967e-14
Primary analysis,Right ventricle,RV end diastolic volume,LPL;Lipoprotein lipase,4867,0.107677599828621,4.99745413033767e-14
Primary analysis,Right atrium,RA maximum volume,PRCP;Lysosomal Pro-X carboxypeptidase,4788,-0.108547970874675,5.0230559529189e-14
Primary analysis,Right ventricle,RV end diastolic volume,WFDC2;WAP four-disulfide core domain protein 2,4564,-0.111156707711284,5.04511474629044e-14
Primary analysis,Right atrium,RA minimum volume,PRSS8;Prostasin,4735,-0.108990174246,5.46964856468175e-14
Primary analysis,Right ventricle,RV end diastolic volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4832,-0.107884081373587,5.5063574532355e-14
Primary analysis,Left ventricle,LV end diastolic volume,MIA;Melanoma-derived growth regulatory protein,4870,-0.1074575199538,5.52734447313897e-14
Primary analysis,Right ventricle,RV end diastolic volume,RTBDN;Retbindin,4832,-0.107839334007358,5.640039746372e-14
Primary analysis,Right ventricle,RV end systolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4837,-0.107724175101567,5.82347880091449e-14
Primary analysis,Right atrium,RA stroke volume,PRAP1;Proline-rich acidic protein 1,3393,-0.128420894982529,5.96710820734617e-14
Primary analysis,Left ventricle,LV stroke volume,CPM;Carboxypeptidase M,4887,-0.10703891486056,6.26473822590192e-14
Primary analysis,Right ventricle,RV end diastolic volume,NECTIN4;Nectin-4,4872,-0.107108953908133,6.58814800719227e-14
Primary analysis,Right atrium,RA stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4835,0.107489037322709,6.68323718212018e-14
Primary analysis,Right ventricle,RV stroke volume,GGH;Gamma-glutamyl hydrolase,4756,-0.108281681386877,7.01590776727225e-14
Primary analysis,Right ventricle,RV end systolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4764,-0.108117659467336,7.29485164356993e-14
Primary analysis,Right ventricle,RV end diastolic volume,DPT;Dermatopontin,4917,-0.106394107212208,7.44149442632941e-14
Primary analysis,Left ventricle,LV cardiac output,SEZ6L;Seizure 6-like protein,4870,-0.106884136616413,7.51946921497303e-14
Primary analysis,Left ventricle,LV end diastolic volume,CYTL1;Cytokine-like protein 1,3449,-0.126845752028615,7.60733546354814e-14
Primary analysis,Right ventricle,RV end diastolic volume,EFNA1;Ephrin-A1,4838,-0.107208301234713,7.62810334718284e-14
Primary analysis,Right ventricle,RV end diastolic volume,C19orf12;Protein C19orf12,4751,-0.108095460172626,7.97769920966547e-14
Primary analysis,Left ventricle,LV cardiac output,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4813,-0.107383995815342,8.04873161722007e-14
Primary analysis,Right atrium,RA stroke volume,FURIN;Furin,4796,-0.107558537763941,8.11134706205605e-14
Primary analysis,Right ventricle,RV end systolic volume,AGRN;Agrin,4860,-0.106758417486829,8.5255802311605e-14
Primary analysis,Left ventricle,LV end systolic volume,RBP5;Retinol-binding protein 5,4821,-0.107150076161027,8.69502753965064e-14
Primary analysis,Descending aorta,Descending aorta minimum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4552,-0.110222020851031,8.83780309684166e-14
Primary analysis,Right ventricle,RV end systolic volume,COL6A3;Collagen alpha-3(VI) chain,4916,-0.106066702742634,8.92363236949551e-14
Primary analysis,Right ventricle,RV stroke volume,PGF;Placenta growth factor,4905,-0.106065050069607,9.51526492696972e-14
Primary analysis,Right ventricle,RV end diastolic volume,ACP5;Tartrate-resistant acid phosphatase type 5,4865,-0.106493420562833,9.53821210020256e-14
Primary analysis,Left ventricle,LV end diastolic volume,RTBDN;Retbindin,4830,-0.10681675194063,9.8459245574549e-14
Primary analysis,Left ventricle,LV cardiac output,AHNAK;Neuroblast differentiation-associated protein AHNAK,3351,-0.128081899179574,9.89571066750925e-14
Primary analysis,Left ventricle,LV end diastolic volume,IGFBP1;Insulin-like growth factor-binding protein 1,4909,0.105926998108137,1.00117033926465e-13
Primary analysis,Right atrium,RA maximum volume,PLTP;Phospholipid transfer protein,4821,0.106863482027718,1.01232913610519e-13
Primary analysis,Right atrium,RA maximum volume,LGALS9;Galectin-9,4755,-0.107530363891682,1.04937872448399e-13
Primary analysis,Descending aorta,Descending aorta maximum area,STC2;Stanniocalcin-2,4551,-0.109886624615239,1.05716140495735e-13
Primary analysis,Right ventricle,RV end diastolic volume,CD300E;CMRF35-like molecule 2,4874,-0.106181355236307,1.06914663390983e-13
Primary analysis,Right ventricle,RV end systolic volume,PLAT;Tissue-type plasminogen activator,4903,-0.105802832052889,1.1072722577248e-13
Primary analysis,Right ventricle,RV stroke volume,FURIN;Furin,4872,-0.106124288979245,1.11488893153963e-13
Primary analysis,Right ventricle,RV stroke volume,F7;Coagulation factor VII,4856,-0.106092639636847,1.24325183307637e-13
Primary analysis,Left ventricle,LV end diastolic volume,PRND;Prion-like protein doppel,3440,-0.12583183512133,1.29185957796037e-13
Primary analysis,Left atrium,LA ejection fraction,NPPB;Natriuretic peptides B,4678,-0.107924937455833,1.34880594187063e-13
Primary analysis,Left ventricle,LV cardiac output,RTN4R;Reticulon-4 receptor,4888,-0.105522767790908,1.40016974045286e-13
Primary analysis,Right ventricle,RV end diastolic volume,STC1;Stanniocalcin-1,4904,-0.105323770861211,1.42084490078601e-13
Primary analysis,Right ventricle,RV end diastolic volume,IGFBP1;Insulin-like growth factor-binding protein 1,4911,0.105198378618552,1.45963989914801e-13
Primary analysis,Right atrium,RA stroke volume,CST3;Cystatin-C,4785,-0.106549617601143,1.47328386836368e-13
Primary analysis,Left ventricle,LV stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4822,-0.106126379986481,1.48556949301431e-13
Primary analysis,Right atrium,RA minimum volume,IL10RB;Interleukin-10 receptor subunit beta,4768,-0.106610378895714,1.57537842332151e-13
Primary analysis,Right ventricle,RV end diastolic volume,CFB;Complement factor B,3391,-0.126283253910042,1.57558153340498e-13
Primary analysis,Right ventricle,RV stroke volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4872,-0.105462422677932,1.58353918164944e-13
Primary analysis,Right atrium,RA stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4834,0.1058615205316,1.5939943075669e-13
Primary analysis,Left ventricle,LV stroke volume,HNMT;Histamine N-methyltransferase,4815,-0.105999183167503,1.65362972196904e-13
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4904,-0.105029862098257,1.66059996268671e-13
Primary analysis,Right atrium,RA maximum volume,IGSF9;Protein turtle homolog A,3393,-0.126125896503665,1.66179838039862e-13
Primary analysis,Left ventricle,LV longitudinal strain Segment 2,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4737,0.106757534724471,1.74770389247839e-13
Primary analysis,Right atrium,RA maximum volume,GSTA3;Glutathione S-transferase A3,4673,-0.107462274261574,1.76587278659714e-13
Primary analysis,Left ventricle,LV cardiac output,CPM;Carboxypeptidase M,4885,-0.105089274508715,1.79152862767243e-13
Primary analysis,Left ventricle,LV end diastolic volume,HGF;Hepatocyte growth factor,4903,-0.104876823165641,1.81090862935668e-13
Primary analysis,Right ventricle,RV end diastolic volume,KLK6;Kallikrein-6,4865,-0.105248060226438,1.84509117830988e-13
Primary analysis,Left ventricle,LV end diastolic volume,CNTN3;Contactin-3,4841,-0.105463753003003,1.88779725628097e-13
Primary analysis,Right ventricle,RV stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4832,-0.105525890982995,1.92332431029459e-13
Primary analysis,Right ventricle,RV stroke volume,PRAP1;Proline-rich acidic protein 1,3451,-0.124692164747537,1.96553658585992e-13
Primary analysis,Left ventricle,LV cardiac output,COLEC12;Collectin-12,4834,-0.105437954415773,1.99129799687981e-13
Primary analysis,Left ventricle,LV end diastolic volume,SEMA3F;Semaphorin-3F,4865,-0.105078030235126,2.01781932301029e-13
Primary analysis,Left ventricle,LV end diastolic volume,NPC2;NPC intracellular cholesterol transporter 2,3388,-0.125749944571194,2.04313366509461e-13
Primary analysis,Right atrium,RA minimum volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4813,-0.105559770527456,2.10567276080167e-13
Primary analysis,Left ventricle,LV stroke volume,PRAP1;Proline-rich acidic protein 1,3451,-0.124490577402484,2.14967977001031e-13
Primary analysis,Left ventricle,LV end diastolic volume,MFAP5;Microfibrillar-associated protein 5,4915,-0.104407587858993,2.16956319956113e-13
Primary analysis,Left ventricle,LV end diastolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4903,-0.104531000473051,2.17373304514529e-13
Primary analysis,Right ventricle,RV end diastolic volume,CD4;T-cell surface glycoprotein CD4,4849,-0.105086518624595,2.1989542430224e-13
Primary analysis,Left atrium,LA stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4762,-0.105952201478677,2.29826248118863e-13
Primary analysis,Right atrium,RA maximum volume,CNTN3;Contactin-3,4759,-0.10593871811656,2.35463875669149e-13
Primary analysis,Right ventricle,RV end systolic volume,EFNA4;Ephrin-A4,4822,-0.105183041378107,2.43572831694072e-13
Primary analysis,Left ventricle,LV stroke volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4815,-0.105137793971059,2.59466788943206e-13
Primary analysis,Left atrium,LA stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4763,-0.105706462026203,2.59573177380217e-13
Primary analysis,Right atrium,RA minimum volume,RARRES2;Retinoic acid receptor responder protein 2,4777,-0.105536003956669,2.61768521135021e-13
Primary analysis,Right ventricle,RV end diastolic volume,NPC2;NPC intracellular cholesterol transporter 2,3390,-0.125122787199998,2.64819092937433e-13
Primary analysis,Right ventricle,RV end diastolic volume,PLIN1;Perilipin-1,4751,-0.105747487844706,2.72182106203227e-13
Primary analysis,Left ventricle,LV end diastolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4735,-0.105921537877525,2.72681813362559e-13
Primary analysis,Left ventricle,LV end diastolic volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3426,-0.124383535077563,2.74897638970488e-13
Primary analysis,Right ventricle,RV end diastolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3433,-0.124116008603437,2.92584496730056e-13
Primary analysis,Right ventricle,RV stroke volume,SCARB2;Lysosome membrane protein 2,4724,-0.105838439476911,3.03159601604255e-13
Primary analysis,Right atrium,RA maximum volume,SMOC1;SPARC-related modular calcium-binding protein 1,4804,-0.10493600868773,3.06628450672642e-13
Primary analysis,Right ventricle,RV end diastolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4872,-0.10418804681445,3.09317565066903e-13
Primary analysis,Ascending aorta,Ascending aorta maximum area,"FABP4;Fatty acid-binding protein, adipocyte",4632,-0.106727110030338,3.27528575411394e-13
Primary analysis,Left ventricle,LV stroke volume,CFH;Complement factor H,3247,-0.127257316213753,3.38178359475104e-13
Primary analysis,Right atrium,RA maximum volume,FURIN;Furin,4787,-0.104928956440628,3.38698925904203e-13
Primary analysis,Right ventricle,RV end diastolic volume,SORD;Sorbitol dehydrogenase,4879,-0.103938857885465,3.38877252536698e-13
Primary analysis,Right ventricle,RV end systolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3352,-0.125159843239635,3.53624896182435e-13
Primary analysis,Right ventricle,RV end systolic volume,CD59;CD59 glycoprotein,4681,-0.105991317990153,3.58833068967832e-13
Primary analysis,Left atrium,LA maximum volume,LEP;Leptin,4793,-0.104600219687365,3.88057935661923e-13
Primary analysis,Right ventricle,RV end diastolic volume,APCS;Serum amyloid P-component,3419,-0.123692428975503,3.93401619795991e-13
Primary analysis,Right ventricle,RV stroke volume,CXCL17;C-X-C motif chemokine 17,4905,-0.103257239756817,4.1913476864036e-13
Primary analysis,Right ventricle,RV end diastolic volume,CDHR5;Cadherin-related family member 5,4867,-0.103529537713333,4.47924480084896e-13
Primary analysis,Left ventricle,LV end diastolic volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4863,-0.103508747965183,4.62822052624437e-13
Primary analysis,Left ventricle,LV stroke volume,NPY;Pro-neuropeptide Y,4890,-0.103218431703999,4.64157160497818e-13
Primary analysis,Right atrium,RA maximum volume,GFRA1;GDNF family receptor alpha-1,4800,-0.104157370328304,4.68841494550452e-13
Primary analysis,Right ventricle,RV end systolic volume,CD83;CD83 antigen,4851,-0.103606279809056,4.700087586752e-13
Primary analysis,Right ventricle,RV end systolic volume,"KRT18;Keratin, type I cytoskeletal 18",4831,-0.103810754786227,4.7212804613888e-13
Primary analysis,Left ventricle,LV end diastolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4888,-0.103188848292584,4.76508981214679e-13
Primary analysis,Right ventricle,RV end diastolic volume,FAS;Tumor necrosis factor receptor superfamily member 6,4904,-0.102998024773147,4.82280469704098e-13
Primary analysis,Right atrium,RA maximum volume,FSTL3;Follistatin-related protein 3,4747,-0.10461449321827,4.98473362650043e-13
Primary analysis,Right ventricle,RV end systolic volume,PALM;Paralemmin-1,3396,-0.123409580818682,5.32750172570612e-13
Primary analysis,Left ventricle,LV end diastolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4827,-0.103607015242289,5.36075170945829e-13
Primary analysis,Left ventricle,LV end diastolic volume,ELOA;Elongin-A,4830,-0.103572006216646,5.3689945839044e-13
Primary analysis,Right ventricle,RV end systolic volume,SEMA3F;Semaphorin-3F,4866,-0.103041787943346,5.79604683981974e-13
Primary analysis,Left ventricle,LV cardiac output,NPY;Pro-neuropeptide Y,4888,-0.102784557086346,5.87508588200668e-13
Primary analysis,Right atrium,RA maximum volume,CRHBP;Corticotropin-releasing factor-binding protein,4754,-0.104197652740291,5.93041180135181e-13
Primary analysis,Right atrium,RA minimum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4776,-0.103940097657912,5.98664734757478e-13
Primary analysis,Right atrium,RA stroke volume,LDLR;Low-density lipoprotein receptor,4791,-0.103749124695076,6.07591724574835e-13
Primary analysis,Left ventricle,LV end systolic volume,PON3;Serum paraoxonase/lactonase 3,4850,0.103089663660185,6.1689831378633e-13
Primary analysis,Left ventricle,LV stroke volume,PALM;Paralemmin-1,3397,-0.122892062402867,6.61159300111136e-13
Primary analysis,Right ventricle,RV stroke volume,ASGR1;Asialoglycoprotein receptor 1,4829,-0.10309756647978,6.88788974809737e-13
Primary analysis,Left ventricle,LV end diastolic volume,C19orf12;Protein C19orf12,4749,-0.103877178157636,7.17689381448673e-13
Primary analysis,Right atrium,RA maximum volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4748,-0.103874365290479,7.22697679323661e-13
Primary analysis,Left ventricle,LV end diastolic volume,LGALS9;Galectin-9,4836,-0.102838663722133,7.57110252487918e-13
Primary analysis,Right atrium,RA minimum volume,ASGR1;Asialoglycoprotein receptor 1,4736,-0.103874031258883,7.72376522192685e-13
Primary analysis,Left ventricle,LV end systolic volume,CPM;Carboxypeptidase M,4876,-0.102368060726214,7.76783974034077e-13
Primary analysis,Right ventricle,RV end diastolic volume,SHISA5;Protein shisa-5,3451,-0.121479262093426,8.05174777115351e-13
Primary analysis,Left ventricle,LV end diastolic volume,FGF21;Fibroblast growth factor 21,4884,-0.102189236430935,8.15787893711984e-13
Primary analysis,Left ventricle,LV myocardial mass,MEGF10;Multiple epidermal growth factor-like domains protein 10,4835,0.102647482116402,8.39380575573113e-13
Primary analysis,Left ventricle,LV stroke volume,SCG2;Secretogranin-2,4880,-0.102084734304641,8.79317005952462e-13
Primary analysis,Left ventricle,LV end systolic volume,COLEC12;Collectin-12,4825,-0.102634027256803,8.92014937459825e-13
Primary analysis,Right ventricle,RV stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4832,-0.102449837820671,9.43546642765531e-13
Primary analysis,Left ventricle,LV end systolic volume,CLEC4A;C-type lectin domain family 4 member A,4841,0.102345444554293,9.48161400631158e-13
Primary analysis,Right ventricle,RV stroke volume,CALB2;Calretinin,4751,-0.103241641492889,9.79310597371095e-13
Primary analysis,Left ventricle,LV end diastolic volume,RNASE4;Ribonuclease 4,3321,-0.12330272034243,1.00185413420889e-12
Primary analysis,Left ventricle,LV end systolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4821,-0.102441431116286,1.00531006701226e-12
Primary analysis,Right ventricle,RV end diastolic volume,MFAP5;Microfibrillar-associated protein 5,4917,-0.101440551546484,1.00562752474316e-12
Primary analysis,Right atrium,RA maximum volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3288,-0.123833442257568,1.03715082386185e-12
Primary analysis,Right ventricle,RV end systolic volume,THY1;Thy-1 membrane glycoprotein,4903,-0.101492145003844,1.05440599111161e-12
Primary analysis,Left ventricle,LV end diastolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4827,-0.1022114908959,1.09411023889354e-12
Primary analysis,Right atrium,RA maximum volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4749,-0.103042411117792,1.09468812542217e-12
Primary analysis,Right ventricle,RV end diastolic volume,CD5;T-cell surface glycoprotein CD5,4888,-0.10154621990082,1.11015054078442e-12
Primary analysis,Right atrium,RA maximum volume,PALM;Paralemmin-1,3335,-0.1227627578312,1.12934197480651e-12
Primary analysis,Left ventricle,LV end diastolic volume,FURIN;Furin,4870,-0.10166373129957,1.14994895924687e-12
Primary analysis,Left ventricle,LV cardiac output,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4830,-0.102050371775345,1.16846663267659e-12
Primary analysis,Left ventricle,LV end diastolic volume,CKB;Creatine kinase B-type,3449,0.12065071044454,1.168772650232e-12
Primary analysis,Left ventricle,LV end diastolic volume,SLC39A5;Zinc transporter ZIP5,4850,-0.10183013343001,1.17477788886548e-12
Primary analysis,Left ventricle,LV stroke volume,IGSF9;Protein turtle homolog A,3456,-0.120502572632712,1.18227799545635e-12
Primary analysis,Right ventricle,RV end diastolic volume,CKB;Creatine kinase B-type,3451,0.120552197070248,1.20127079155961e-12
Primary analysis,Right ventricle,RV end diastolic volume,REN;Renin,4867,-0.0996347316947878,3.25013941821369e-12
Primary analysis,Right atrium,RA stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4757,-0.102592670385084,1.31442767292894e-12
Primary analysis,Right ventricle,RV end diastolic volume,COL15A1;Collagen alpha-1(XV) chain,3451,-0.120249204849636,1.36817335961597e-12
Primary analysis,Right atrium,RA maximum volume,TGFBR2;TGF-beta receptor type-2,4787,-0.10214660675406,1.40027205839572e-12
Primary analysis,Right atrium,RA maximum volume,IL10RB;Interleukin-10 receptor subunit beta,4777,-0.102188715924027,1.4462320229815601e-12
Primary analysis,Right ventricle,RV end diastolic volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4832,-0.101606950060884,1.44714679230215e-12
Primary analysis,Right atrium,RA maximum volume,SERPINF1;Pigment epithelium-derived factor,3347,-0.121949770466643,1.45207042917406e-12
Primary analysis,Left ventricle,LV end diastolic volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4830,-0.101546146849169,1.50814016184539e-12
Primary analysis,Left ventricle,LV end systolic volume,GHR;Growth hormone receptor,3368,-0.121456726623825,1.52434483910465e-12
Primary analysis,Left ventricle,LV end systolic volume,GSTA3;Glutathione S-transferase A3,4746,-0.102398486845544,1.53719654017535e-12
Primary analysis,Right atrium,RA maximum volume,PAMR1;Inactive serine protease PAMR1,4759,-0.102119594005084,1.64848024561515e-12
Primary analysis,Left ventricle,LV stroke volume,FURIN;Furin,4872,-0.088603566809933,5.82466995476004e-10
Primary analysis,Right ventricle,RV end systolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4831,-0.10116492428092,1.81800958429378e-12
Primary analysis,Right ventricle,RV stroke volume,CD59;CD59 glycoprotein,4682,-0.102751348707477,1.82084987478159e-12
Primary analysis,Left ventricle,LV cardiac output,FURIN;Furin,4870,-0.0845755908409519,3.39586847636053e-09
Primary analysis,Right atrium,RA maximum volume,EFNA4;Ephrin-A4,4739,-0.102074244329308,1.876308849945e-12
Primary analysis,Left ventricle,LV end systolic volume,LPL;Lipoprotein lipase,4856,0.100824846722738,1.89334195374108e-12
Primary analysis,Left ventricle,LV end diastolic volume,ASGR1;Asialoglycoprotein receptor 1,4827,-0.101121982373754,1.89704503931142e-12
Primary analysis,Left ventricle,LV end diastolic volume,NRCAM;Neuronal cell adhesion molecule,4865,-0.100662183143506,1.96115817953815e-12
Primary analysis,Left ventricle,LV cardiac output,CFH;Complement factor H,3245,-0.123037360645416,2.02362525138045e-12
Primary analysis,Left ventricle,LV cardiac output,PTGDS;Prostaglandin-H2 D-isomerase,4820,-0.101033625426032,2.05707663535497e-12
Primary analysis,Right ventricle,RV end diastolic volume,AMBP;Protein AMBP,4888,-0.100322852839806,2.06618715299589e-12
Primary analysis,Right ventricle,RV stroke volume,HGF;Hepatocyte growth factor,4905,-0.100128725797288,2.08814792302309e-12
Primary analysis,Right ventricle,RV end diastolic volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4817,-0.10103285189094,2.09041742267176e-12
Primary analysis,Left atrium,LA maximum volume,"FABP4;Fatty acid-binding protein, adipocyte",4839,-0.100761674816607,2.13528840146523e-12
Primary analysis,Left ventricle,LV end systolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4804,-0.101095465888044,2.16855061610935e-12
Primary analysis,Left ventricle,LV end diastolic volume,DLK1;Protein delta homolog 1,4915,-0.0999395823651788,2.18285276294577e-12
Primary analysis,Right ventricle,RV stroke volume,CD83;CD83 antigen,4852,-0.100526875692315,2.24567981826796e-12
Primary analysis,Right ventricle,RV end diastolic volume,IGFBP4;Insulin-like growth factor-binding protein 4,4784,-0.101208219080559,2.2764585446125e-12
Primary analysis,Right ventricle,RV stroke volume,SNCG;Gamma-synuclein,4829,-0.100725520395207,2.29040732960729e-12
Primary analysis,Left ventricle,LV end diastolic volume,C1RL;Complement C1r subcomponent-like protein,3435,-0.119279837637479,2.32656192986634e-12
Primary analysis,Left ventricle,LV end diastolic volume,SORD;Sorbitol dehydrogenase,4877,-0.100142700901629,2.39427114063539e-12
Primary analysis,Left ventricle,LV cardiac output,SCG2;Secretogranin-2,4878,-0.100122800651622,2.40595397209271e-12
Primary analysis,Ascending aorta,Ascending aorta minimum area,"FABP4;Fatty acid-binding protein, adipocyte",4632,-0.102714956992446,2.42944079651957e-12
Primary analysis,Right atrium,RA minimum volume,CST3;Cystatin-C,4767,-0.101241119613699,2.44857168297197e-12
Primary analysis,Right atrium,RA minimum volume,LDLR;Low-density lipoprotein receptor,4773,-0.101126077819732,2.51229348064277e-12
Primary analysis,Left ventricle,LV end diastolic volume,THY1;Thy-1 membrane glycoprotein,4902,-0.0996751857924121,2.6652886445571e-12
Primary analysis,Right ventricle,RV end diastolic volume,CHRDL1;Chordin-like protein 1,4851,-0.100150147504524,2.72633596133846e-12
Primary analysis,Right ventricle,RV stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4911,0.0995085042390183,2.76880150757173e-12
Primary analysis,Left ventricle,LV end diastolic volume,TREM2;Triggering receptor expressed on myeloid cells 2,4834,-0.100207534229125,2.8913493655109e-12
Primary analysis,Descending aorta,Descending aorta maximum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4551,-0.103249257690335,2.90879607813782e-12
Primary analysis,Right ventricle,RV end diastolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4737,-0.101207752234507,2.91410019281524e-12
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,4829,-0.100224294919774,2.94203452387266e-12
Primary analysis,Right atrium,RA minimum volume,AGRN;Agrin,4768,-0.100855246401389,2.949631384367e-12
Primary analysis,Left atrium,LA stroke volume,CXCL17;C-X-C motif chemokine 17,4835,-0.100078036424053,3.06832757387954e-12
Primary analysis,Right atrium,RA maximum volume,CCL22;C-C motif chemokine 22,4692,-0.1015338631513,3.1457906934477e-12
Primary analysis,Right atrium,RA minimum volume,F7;Coagulation factor VII,4764,-0.100739341761223,3.18943440986835e-12
Primary analysis,Left ventricle,LV end diastolic volume,VGF;Neurosecretory protein VGF,3442,-0.118412125177383,3.19029391117216e-12
Primary analysis,Left ventricle,LV end diastolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3440,-0.118417032244389,3.22988854604062e-12
Primary analysis,Left ventricle,LV end diastolic volume,REN;Renin,4865,-0.0971375380355261,1.12429666260077e-11
Primary analysis,Left ventricle,LV end diastolic volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4759,-0.100637084975701,3.44287568521092e-12
Primary analysis,Left ventricle,LV end diastolic volume,CALB1;Calbindin,4830,-0.0998947990584292,3.44839139607184e-12
Primary analysis,Right ventricle,RV end diastolic volume,NPY;Pro-neuropeptide Y,4890,-0.0992182653402145,3.56138259285973e-12
Primary analysis,Right ventricle,RV end systolic volume,HGF;Hepatocyte growth factor,4904,-0.0990687093225073,3.57647832494791e-12
Primary analysis,Right atrium,RA minimum volume,CPM;Carboxypeptidase M,4794,-0.100189773806691,3.58355404552101e-12
Primary analysis,Left ventricle,LV end diastolic volume,LGALS1;Galectin-1,4865,-0.0994539533700201,3.59307253982719e-12
Primary analysis,Left ventricle,LV end diastolic volume,PENK;Proenkephalin-A,3375,-0.11925250770666,3.64789017500334e-12
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,IGFBP2;Insulin-like growth factor-binding protein 2,4906,-0.0989945749753736,3.67443547605114e-12
Primary analysis,Left ventricle,LV end diastolic volume,ACY1;Aminoacylase-1,4865,-0.0993854964182093,3.7176734002921e-12
Primary analysis,Right atrium,RA maximum volume,PLAUR;Urokinase plasminogen activator surface receptor,4729,-0.100786795695112,3.73822442174058e-12
Primary analysis,Right ventricle,RV end diastolic volume,CFD;Complement factor D,3444,-0.11798478799127,3.76411220151082e-12
Primary analysis,Right ventricle,RV stroke volume,PALM;Paralemmin-1,3397,-0.118769834490546,3.80071425561765e-12
Primary analysis,Right ventricle,RV stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4910,0.0988699500654379,3.83294548099062e-12
Primary analysis,Right atrium,RA stroke volume,PALM;Paralemmin-1,3341,-0.119716309171695,3.86154663583418e-12
Primary analysis,Right atrium,RA maximum volume,CLMP;CXADR-like membrane protein,4804,-0.0999347945815189,3.86173447731612e-12
Primary analysis,Right atrium,RA maximum volume,CFH;Complement factor H,3187,-0.122529661209735,3.90206197490187e-12
Primary analysis,Right ventricle,RV end systolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4822,-0.0997199215655143,3.91761526599454e-12
Primary analysis,Left ventricle,LV myocardial mass,SEZ6L;Seizure 6-like protein,4871,-0.0991839304017347,3.98719799346666e-12
Primary analysis,Left ventricle,LV end diastolic volume,SHISA5;Protein shisa-5,3449,-0.117677659654363,4.13206093269409e-12
Primary analysis,Right atrium,RA minimum volume,IGFBP6;Insulin-like growth factor-binding protein 6,4746,-0.100396798371312,4.14474386197888e-12
Primary analysis,Right ventricle,RV stroke volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4829,-0.0994913447801276,4.23343703166209e-12
Primary analysis,Right ventricle,RV stroke volume,THY1;Thy-1 membrane glycoprotein,4904,-0.0987040698329023,4.29060323626828e-12
Primary analysis,Left ventricle,LV stroke volume,PRSS8;Prostasin,4826,-0.0994447029649807,4.3986165479175e-12
Primary analysis,Right ventricle,RV stroke volume,FSTL3;Follistatin-related protein 3,4829,-0.0994122950367153,4.40220696207526e-12
Primary analysis,Left ventricle,LV end diastolic volume,EFNA4;Ephrin-A4,4821,-0.0994577252522691,4.48261170114576e-12
Primary analysis,Right atrium,RA stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4764,-0.100046846363186,4.48578394180866e-12
Primary analysis,Left ventricle,LV myocardial mass,SCGB1A1;Uteroglobin,4847,-0.0991412661710717,4.5961319534456e-12
Primary analysis,Right ventricle,RV end systolic volume,FURIN;Furin,4871,-0.0782957620436057,4.46345829348768e-08
Primary analysis,Right ventricle,RV end diastolic volume,CRHBP;Corticotropin-releasing factor-binding protein,4836,-0.0991783495667135,4.76989183606354e-12
Primary analysis,Right atrium,RA maximum volume,BPIFB2;BPI fold-containing family B member 2,3386,-0.118400312542751,4.7984151691788e-12
Primary analysis,Right atrium,RA stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4691,-0.100673598988077,4.81423448447015e-12
Primary analysis,Left ventricle,LV myocardial mass,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4896,-0.0985078274510402,4.92301074670309e-12
Primary analysis,Left ventricle,LV end systolic volume,SCARB2;Lysosome membrane protein 2,4713,-0.100383673839568,4.94684972262545e-12
Primary analysis,Right atrium,RA maximum volume,SLC39A5;Zinc transporter ZIP5,4769,-0.0996815430755371,5.23011047537252e-12
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,ADAMTSL2;ADAMTS-like protein 2,3451,0.117021764706624,5.36073365347586e-12
Primary analysis,Right atrium,RA maximum volume,NTRK3;NT-3 growth factor receptor,4820,0.0990469605596952,5.51591389235468e-12
Primary analysis,Right atrium,RA maximum volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4759,-0.0996571180918734,5.56949990071188e-12
Primary analysis,Right ventricle,RV end diastolic volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3428,-0.117318869904638,5.57072569059288e-12
Primary analysis,Right ventricle,RV end diastolic volume,OCLN;Occludin,3444,-0.116935743663401,5.83667672753676e-12
Primary analysis,Right atrium,RA stroke volume,F7;Coagulation factor VII,4782,-0.0993122554425332,5.86597861007678e-12
Primary analysis,Left ventricle,LV end diastolic volume,CBLN4;Cerebellin-4,4888,-0.0981800440688611,6.02524194628391e-12
Primary analysis,Right ventricle,RV end diastolic volume,CDCP1;CUB domain-containing protein 1,4829,-0.0986089540183667,6.53809205940737e-12
Primary analysis,Left ventricle,LV stroke volume,CALB2;Calretinin,4751,-0.0993823201233606,6.63174529061474e-12
Primary analysis,Right atrium,RA maximum volume,PGF;Placenta growth factor,4821,-0.098640513521542,6.69977415903655e-12
Primary analysis,Right ventricle,RV end systolic volume,CPM;Carboxypeptidase M,4886,-0.0979359826336291,6.86374254728364e-12
Primary analysis,Left ventricle,LV end systolic volume,CBLN4;Cerebellin-4,4879,-0.0979764827413399,6.96391229873035e-12
Primary analysis,Left ventricle,LV stroke volume,AFM;Afamin,3444,-0.116501296493769,6.99144486708629e-12
Primary analysis,Right ventricle,RV end diastolic volume,ACY1;Aminoacylase-1,4867,-0.0980775547716663,7.02967315810415e-12
Primary analysis,Left ventricle,LV cardiac output,"KRT18;Keratin, type I cytoskeletal 18",4830,-0.0984315782706063,7.09639940980352e-12
Primary analysis,Left ventricle,LV end diastolic volume,OGN;Mimecan,4841,-0.0982981187305732,7.17351108105366e-12
Primary analysis,Right ventricle,RV end diastolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4887,-0.0978062382737184,7.28079846540583e-12
Primary analysis,Right ventricle,RV end systolic volume,CALB2;Calretinin,4750,-0.0991388737189744,7.50196529168929e-12
Primary analysis,Left ventricle,LV stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4832,-0.0982493905099319,7.68149705898722e-12
Primary analysis,Right atrium,RA maximum volume,CES1;Liver carboxylesterase 1,4798,-0.0985764544772537,7.75263784100724e-12
Primary analysis,Right atrium,RA stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4791,-0.0984454153996677,8.55585958309791e-12
Primary analysis,Right ventricle,RV end diastolic volume,EPHB6;Ephrin type-B receptor 6,4825,-0.0980113195165404,8.93130700831383e-12
Primary analysis,Left ventricle,LV cardiac output,IGSF9;Protein turtle homolog A,3454,-0.115726148694283,8.99190651335609e-12
Primary analysis,Right ventricle,RV stroke volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4905,-0.0971378402798984,9.26319092700044e-12
Primary analysis,Right ventricle,RV end diastolic volume,CD99L2;CD99 antigen-like protein 2,4843,-0.0977512743922283,9.28002250207996e-12
Primary analysis,Left ventricle,LV end diastolic volume,CD4;T-cell surface glycoprotein CD4,4847,-0.0976926597680527,9.36388512615128e-12
Primary analysis,Left ventricle,LV cardiac output,CALB2;Calretinin,4749,-0.0986906329499456,9.36622148123072e-12
Primary analysis,Right ventricle,RV stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4825,-0.0979007236663218,9.42535938760942e-12
Primary analysis,Left ventricle,LV cardiac output,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4863,-0.0975138678566736,9.44950213685793e-12
Primary analysis,Right ventricle,RV end diastolic volume,BPIFB2;BPI fold-containing family B member 2,3449,-0.115671259555632,9.51978583882314e-12
Primary analysis,Right ventricle,RV stroke volume,CALB1;Calbindin,4832,-0.0977987118724606,9.57043956504143e-12
Primary analysis,Left ventricle,LV end systolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4855,-0.0975380182567966,9.7103607571865e-12
Primary analysis,Right atrium,RA stroke volume,PON3;Serum paraoxonase/lactonase 3,4786,0.0982219099426361,9.77491135325919e-12
Primary analysis,Left ventricle,LV stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4865,-0.0973585177836798,1.00951700629762e-11
Primary analysis,Right atrium,RA maximum volume,CDHR5;Cadherin-related family member 5,4786,-0.098118901985207,1.02746040439378e-11
Primary analysis,Left ventricle,LV end systolic volume,HGF;Hepatocyte growth factor,4894,-0.0970033882079959,1.04338576404456e-11
Primary analysis,Left ventricle,LV stroke volume,TREM2;Triggering receptor expressed on myeloid cells 2,4836,-0.097511037928654,1.07940819810227e-11
Primary analysis,Right atrium,RA minimum volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4773,-0.0981381246292882,1.08545911629352e-11
Primary analysis,Right ventricle,RV end diastolic volume,TFF3;Trefoil factor 3,4835,-0.0974692305129691,1.10692798155733e-11
Primary analysis,Left ventricle,LV end diastolic volume,KYNU;Kynureninase,4903,-0.0967931057098031,1.10731469384651e-11
Primary analysis,Right ventricle,RV end systolic volume,ROBO2;Roundabout homolog 2,4903,-0.0967825433246071,1.11304603640735e-11
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,REN;Renin,4864,-0.09473371618047,3.58835970216733e-11
Primary analysis,Right atrium,RA maximum volume,VWC2;Brorin,4735,-0.0984561910959416,1.12433660123454e-11
Primary analysis,Left ventricle,LV end diastolic volume,CFP;Properdin,3442,-0.11538249755518,1.12481705169117e-11
Primary analysis,Left atrium,LA stroke volume,AGRN;Agrin,4791,-0.0978766200936324,1.12703061089636e-11
Primary analysis,Right ventricle,RV stroke volume,FAS;Tumor necrosis factor receptor superfamily member 6,4904,-0.0966522276849365,1.18052378333763e-11
Primary analysis,Right atrium,RA stroke volume,LPL;Lipoprotein lipase,4795,0.0976606897347779,1.22656445912335e-11
Primary analysis,Right ventricle,RV stroke volume,IL18R1;Interleukin-18 receptor 1,4905,-0.0935959714811777,5.10605733175501e-11
Primary analysis,Right ventricle,RV stroke volume,STC1;Stanniocalcin-1,4904,-0.0965377852468972,1.24831661458095e-11
Primary analysis,Right ventricle,RV stroke volume,IGSF9;Protein turtle homolog A,3456,-0.114872310016215,1.26075229729324e-11
Primary analysis,Right atrium,RA minimum volume,PLAT;Tissue-type plasminogen activator,4810,-0.0974446985164491,1.26522207433337e-11
Primary analysis,Right ventricle,RV stroke volume,TGFBR2;TGF-beta receptor type-2,4872,-0.0967984742611237,1.28181947681547e-11
Primary analysis,Right ventricle,RV end diastolic volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4765,-0.0978249917226266,1.31277197510203e-11
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,LEP;Leptin,4864,-0.0967908048145861,1.33702393573354e-11
Primary analysis,Right atrium,RA maximum volume,HAVCR2;Hepatitis A virus cellular receptor 2,4759,-0.0977897338035411,1.37506740503665e-11
Primary analysis,Right ventricle,RV end diastolic volume,ADIPOQ;Adiponectin,3444,0.114725855538626,1.45200960075865e-11
Primary analysis,Right atrium,RA stroke volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4768,-0.0975472991780474,1.47797931683597e-11
Primary analysis,Right ventricle,RV end diastolic volume,ELOA;Elongin-A,4832,-0.0968898318099181,1.4865828938496e-11
Primary analysis,Left ventricle,LV stroke volume,GPD1;Glycerol-3-phosphate dehydrogenase,3433,-0.114787847096366,1.52516876827484e-11
Primary analysis,Left ventricle,LV end diastolic volume,CXCL17;C-X-C motif chemokine 17,4903,-0.0961324376652623,1.52773860955151e-11
Primary analysis,Left ventricle,LV end diastolic volume,PLIN1;Perilipin-1,4749,-0.097657476066983,1.53849096778346e-11
Primary analysis,Right ventricle,RV stroke volume,OGN;Mimecan,4843,-0.0966168937451387,1.60844477580291e-11
Primary analysis,Right atrium,RA minimum volume,CRHBP;Corticotropin-releasing factor-binding protein,4745,-0.097548737811136,1.65245868728421e-11
Primary analysis,Right atrium,RA maximum volume,WFDC2;WAP four-disulfide core domain protein 2,4483,-0.100274947347172,1.70805894866776e-11
Primary analysis,Right ventricle,RV end diastolic volume,NRCAM;Neuronal cell adhesion molecule,4867,-0.0962081149861057,1.74709553371156e-11
Primary analysis,Left ventricle,LV end systolic volume,SEZ6L;Seizure 6-like protein,4861,-0.0962060723258344,1.79935561750174e-11
Primary analysis,Left ventricle,LV cardiac output,PRAP1;Proline-rich acidic protein 1,3449,-0.114098574433495,1.81313679783047e-11
Primary analysis,Right ventricle,RV end diastolic volume,F9;Coagulation factor IX,4864,-0.0960430518936075,1.9188216902595e-11
Primary analysis,Descending aorta,Descending aorta maximum area,GFRA1;GDNF family receptor alpha-1,4600,-0.0987363158120932,1.93021725928315e-11
Primary analysis,Left ventricle,LV end systolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4827,-0.0963827658859934,1.9430372223306e-11
Primary analysis,Right ventricle,RV end diastolic volume,SLC39A5;Zinc transporter ZIP5,4852,-0.0961252308267153,1.95233513664331e-11
Primary analysis,Left ventricle,LV myocardial mass,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4814,-0.0964995647187424,1.95489720493166e-11
Primary analysis,Left ventricle,LV myocardial mass,CFD;Complement factor D,3443,-0.113987410517117,1.97454882208281e-11
Primary analysis,Left ventricle,LV end systolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4746,-0.0971589741838493,1.9797259106917e-11
Primary analysis,Right atrium,RA maximum volume,HNMT;Histamine N-methyltransferase,4731,-0.097285064147937,2.00540177057002e-11
Primary analysis,Left ventricle,LV end systolic volume,PRAP1;Proline-rich acidic protein 1,3441,-0.113931048401872,2.04735986033182e-11
Primary analysis,Right ventricle,RV stroke volume,MOG;Myelin-oligodendrocyte glycoprotein,4890,-0.0955856629865236,2.11585515009295e-11
Primary analysis,Left ventricle,LV stroke volume,APCS;Serum amyloid P-component,3419,-0.11420183324083,2.12577747026034e-11
Primary analysis,Right ventricle,RV end systolic volume,CDHR2;Cadherin-related family member 2,4831,-0.0961513081753216,2.1299546797466e-11
Primary analysis,Right ventricle,RV end diastolic volume,CNTN3;Contactin-3,4843,-0.0960280181484663,2.13463913675382e-11
Primary analysis,Left atrium,LA stroke volume,NPPC;C-type natriuretic peptide,4783,-0.096503814321244,2.26241487457182e-11
Primary analysis,Descending aorta,Descending aorta maximum area,DKK4;Dickkopf-related protein 4,4540,-0.0989950121588292,2.3120065879785e-11
Primary analysis,Left ventricle,LV end systolic volume,COL6A3;Collagen alpha-3(VI) chain,4906,-0.0952230847727638,2.33801771616475e-11
Primary analysis,Right ventricle,RV stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4865,-0.0955743761550955,2.39183323460703e-11
Primary analysis,Right ventricle,RV stroke volume,CDCP1;CUB domain-containing protein 1,4829,-0.0959023137786948,2.4219273661352e-11
Primary analysis,Left atrium,LA stroke volume,CST3;Cystatin-C,4790,-0.0962115379149325,2.51431656386656e-11
Primary analysis,Right atrium,RA stroke volume,TAFA5;Chemokine-like protein TAFA-5,4757,-0.096528691359112,2.53175745213458e-11
Primary analysis,Right ventricle,RV end diastolic volume,CTSD;Cathepsin D,4545,-0.0986966436416518,2.58873293625475e-11
Primary analysis,Right ventricle,RV stroke volume,CYTL1;Cytokine-like protein 1,3451,-0.113150019715687,2.62814067039334e-11
Primary analysis,Right atrium,RA stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3333,-0.115102071769867,2.6510308306123e-11
Primary analysis,Right ventricle,RV stroke volume,NPY;Pro-neuropeptide Y,4890,-0.0951040247773185,2.66666817754014e-11
Primary analysis,Left ventricle,LV end diastolic volume,GPR37;Prosaposin receptor GPR37,4763,-0.0963487948292498,2.67884991970175e-11
Primary analysis,Left ventricle,LV end diastolic volume,CD302;CD302 antigen,4830,-0.0956593749125912,2.7065092099953e-11
Primary analysis,Left ventricle,LV cardiac output,PALM;Paralemmin-1,3395,-0.113990849667526,2.71714795121998e-11
Primary analysis,Right atrium,RA maximum volume,NPY;Pro-neuropeptide Y,4804,-0.095889616901093,2.74170641877739e-11
Primary analysis,Right atrium,RA stroke volume,ADIPOQ;Adiponectin,3387,0.114100788018266,2.74314906926186e-11
Primary analysis,Left ventricle,LV cardiac output,HSPB6;Heat shock protein beta-6,4888,-0.0950554214845015,2.75491739142782e-11
Primary analysis,Left ventricle,LV myocardial mass,TGFBR2;TGF-beta receptor type-2,4871,-0.0952188448342194,2.75707443143421e-11
Primary analysis,Left ventricle,LV end diastolic volume,UPB1;Beta-ureidopropionase,3454,-0.112973912462534,2.76667948395649e-11
Primary analysis,Descending aorta,Descending aorta minimum area,PTGDS;Prostaglandin-H2 D-isomerase,4545,-0.098528706083404,2.79764032753742e-11
Primary analysis,Left ventricle,LV end diastolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4870,-0.0951738687784214,2.83009135852951e-11
Primary analysis,Right ventricle,RV end systolic volume,CFB;Complement factor B,3390,-0.113957701877572,2.84691259562381e-11
Primary analysis,Right ventricle,RV end diastolic volume,CD74;HLA class II histocompatibility antigen gamma chain,4904,-0.0947986856110128,2.89317391434582e-11
Primary analysis,Right ventricle,RV end diastolic volume,PALM2;Paralemmin-2,3442,-0.113056562795849,2.89545014866536e-11
Primary analysis,Right atrium,RA minimum volume,PON3;Serum paraoxonase/lactonase 3,4768,0.0960772548057861,2.97413458927282e-11
Primary analysis,Descending aorta,Descending aorta maximum area,PTGDS;Prostaglandin-H2 D-isomerase,4544,-0.0984015214876558,2.98152752259898e-11
Primary analysis,Left ventricle,LV stroke volume,SCARB2;Lysosome membrane protein 2,4724,-0.0964727735553019,3.04345777857185e-11
Primary analysis,Left ventricle,LV end diastolic volume,CFB;Complement factor B,3389,-0.113776689727669,3.08072331238874e-11
Primary analysis,Right atrium,RA stroke volume,COLEC12;Collectin-12,4762,-0.0960425139027746,3.11042150317897e-11
Primary analysis,Left ventricle,LV cardiac output,DPT;Dermatopontin,4915,-0.0945235362827853,3.13784543459038e-11
Primary analysis,Right ventricle,RV end diastolic volume,LY6D;Lymphocyte antigen 6D,4821,-0.0954029536011,3.18875659435831e-11
Primary analysis,Left ventricle,LV end diastolic volume,GGH;Gamma-glutamyl hydrolase,4754,-0.0960542650842181,3.21266904675219e-11
Primary analysis,Right ventricle,RV end diastolic volume,RGMB;RGM domain family member B,4904,-0.0945729570148528,3.22315252472412e-11
Primary analysis,Left ventricle,LV stroke volume,HSPB6;Heat shock protein beta-6,4890,-0.094673444494898,3.27627144557145e-11
Primary analysis,Right ventricle,RV stroke volume,HNMT;Histamine N-methyltransferase,4815,-0.0954031596170855,3.27907434349526e-11
Primary analysis,Left ventricle,LV stroke volume,FSTL3;Follistatin-related protein 3,4829,-0.0952505063058031,3.30219068815855e-11
Primary analysis,Right atrium,RA minimum volume,NPPB;Natriuretic peptides B,4675,0.0967816695223403,3.33085008186737e-11
Primary analysis,Right ventricle,RV end diastolic volume,ROBO2;Roundabout homolog 2,4904,-0.0944839507865425,3.36315038129412e-11
Primary analysis,Right ventricle,RV end systolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4814,-0.0953307007413012,3.40933747613331e-11
Primary analysis,Left ventricle,LV end diastolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4870,-0.0947647838064393,3.43935893206121e-11
Primary analysis,Left ventricle,LV stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4911,0.0943676073847546,3.44320996916271e-11
Primary analysis,Left ventricle,LV end diastolic volume,XG;Glycoprotein Xg,4895,-0.0944504551072786,3.56111668635516e-11
Primary analysis,Left ventricle,LV end diastolic volume,NCAN;Neurocan core protein,4902,-0.0943788442642218,3.56862388928218e-11
Primary analysis,Left ventricle,LV end systolic volume,REN;Renin,4856,-0.0936802301555691,6.11847198674132e-11
Primary analysis,Right ventricle,RV end systolic volume,CFI;Complement factor I,3443,-0.112494888405806,3.60425868662396e-11
Primary analysis,Left ventricle,LV end diastolic volume,CDHR2;Cadherin-related family member 2,4830,-0.0950179857073399,3.66946898423929e-11
Primary analysis,Right atrium,RA minimum volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4750,-0.095809426375558,3.67314154924767e-11
Primary analysis,Right atrium,RA maximum volume,EPHA1;Ephrin type-A receptor 1,4768,-0.0955891104629395,3.74289338316135e-11
Primary analysis,Left atrium,LA stroke volume,LEP;Leptin,4800,-0.0952601077118095,3.76257831893219e-11
Primary analysis,Left ventricle,LV stroke volume,CXCL17;C-X-C motif chemokine 17,4905,-0.09422148164812,3.79420677222453e-11
Primary analysis,Right atrium,RA maximum volume,CKB;Creatine kinase B-type,3387,0.113230118258668,3.87998786160443e-11
Primary analysis,Right atrium,RA maximum volume,NPPC;C-type natriuretic peptide,4769,-0.0954944104503245,3.89481840996025e-11
Primary analysis,Right ventricle,RV end diastolic volume,SCLY;Selenocysteine lyase,4884,-0.0943413590482507,3.9443100872115e-11
Primary analysis,Right atrium,RA maximum volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4748,-0.0956389596585094,4.01620942825862e-11
Primary analysis,Left ventricle,LV end diastolic volume,SCLY;Selenocysteine lyase,4882,-0.0943187706622697,4.02341733111361e-11
Primary analysis,Right ventricle,RV end diastolic volume,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4832,-0.0947996365201422,4.03089077250404e-11
Primary analysis,Right atrium,RA stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4795,-0.0951511132307511,4.05391372266338e-11
Primary analysis,Right ventricle,RV stroke volume,CDHR5;Cadherin-related family member 5,4867,-0.094425172312414,4.09700179961665e-11
Primary analysis,Right ventricle,RV end diastolic volume,ITGA5;Integrin alpha-5,4843,-0.0946216482461236,4.16781344982445e-11
Primary analysis,Right atrium,RA maximum volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3393,-0.112948811391631,4.17005828989453e-11
Primary analysis,Right atrium,RA maximum volume,NPPB;Natriuretic peptides B,4682,0.0961223332997718,4.37777535287067e-11
Primary analysis,Right ventricle,RV stroke volume,CES1;Liver carboxylesterase 1,4880,-0.0941045779099027,4.49407452761698e-11
Primary analysis,Right atrium,RA maximum volume,F9;Coagulation factor IX,4781,-0.0950411109621583,4.55536907807268e-11
Primary analysis,Right ventricle,RV end diastolic volume,IL18BP;Interleukin-18-binding protein,4865,-0.0942162968260098,4.56399469051845e-11
Primary analysis,Right atrium,RA maximum volume,RBP5;Retinol-binding protein 5,4748,-0.095351201114476,4.59442892070445e-11
Primary analysis,Right ventricle,RV end diastolic volume,KYNU;Kynureninase,4905,-0.0938125451852873,4.60816958711158e-11
Primary analysis,Left ventricle,LV end systolic volume,OXT;Oxytocin-neurophysin 1,4893,-0.0939201383865561,4.6233063472654e-11
Primary analysis,Right atrium,RA maximum volume,GHR;Growth hormone receptor,3311,-0.11404627020115,4.66120194336964e-11
Primary analysis,Right atrium,RA stroke volume,GSTA3;Glutathione S-transferase A3,4682,-0.0959651137549402,4.70880903353896e-11
Primary analysis,Right ventricle,RV end diastolic volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3442,-0.111829246105474,4.73230693112035e-11
Primary analysis,Left ventricle,LV cardiac output,TREM2;Triggering receptor expressed on myeloid cells 2,4834,-0.0944179455970988,4.78120901544214e-11
Primary analysis,Right ventricle,RV stroke volume,OXT;Oxytocin-neurophysin 1,4904,-0.093717733912549,4.84178049395187e-11
Primary analysis,Right atrium,RA stroke volume,OCLN;Occludin,3387,-0.112619196202192,4.94094920809247e-11
Primary analysis,Left ventricle,LV stroke volume,CDCP1;CUB domain-containing protein 1,4829,-0.0943710997988158,5.00075406200429e-11
Primary analysis,Right atrium,RA minimum volume,COLEC12;Collectin-12,4745,-0.0951864754946628,5.03100138270121e-11
Primary analysis,Right atrium,RA maximum volume,CRIP2;Cysteine-rich protein 2,4745,-0.095184802030782,5.03492338415426e-11
Primary analysis,Right atrium,RA minimum volume,TGFBR2;TGF-beta receptor type-2,4778,-0.0948558823975683,5.03718791198751e-11
Primary analysis,Right atrium,RA stroke volume,CXCL17;C-X-C motif chemokine 17,4830,-0.0943369698728036,5.05840068111021e-11
Primary analysis,Right ventricle,RV end systolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4889,-0.0937640312399431,5.06849598442713e-11
Primary analysis,Left ventricle,LV end diastolic volume,IL18R1;Interleukin-18 receptor 1,4903,-0.0876920500610633,7.71865193196759e-10
Primary analysis,Right ventricle,RV end diastolic volume,ICAM1;Intercellular adhesion molecule 1,4836,-0.0942508850840798,5.12485845358533e-11
Primary analysis,Left ventricle,LV end diastolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4841,-0.0941898882452528,5.1550664202833e-11
Primary analysis,Right ventricle,RV stroke volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4897,-0.0936123542803734,5.25229285831474e-11
Primary analysis,Right ventricle,RV stroke volume,GDF15;Growth/differentiation factor 15,4917,-0.0933495147702823,5.43692807495758e-11
Primary analysis,Descending aorta,Descending aorta maximum area,COL6A3;Collagen alpha-3(VI) chain,4630,-0.0961762294481945,5.46571702221241e-11
Primary analysis,Right atrium,RA minimum volume,ACP5;Tartrate-resistant acid phosphatase type 5,4772,-0.0947346319858271,5.48004934434571e-11
Primary analysis,Right ventricle,RV end systolic volume,GSTA3;Glutathione S-transferase A3,4755,-0.0948828676442319,5.53200939686041e-11
Primary analysis,Right atrium,RA maximum volume,HIP1R;Huntingtin-interacting protein 1-related protein,3372,-0.112573170425703,5.54833189066964e-11
Primary analysis,Right atrium,RA maximum volume,APCS;Serum amyloid P-component,3357,-0.112771711690319,5.66089951016144e-11
Primary analysis,Right ventricle,RV stroke volume,NECTIN4;Nectin-4,4872,-0.0936803396137302,5.6925975326829e-11
Primary analysis,Descending aorta,Descending aorta minimum area,COL6A3;Collagen alpha-3(VI) chain,4631,-0.0960648989530781,5.72505628999012e-11
Primary analysis,Left ventricle,LV end diastolic volume,EPHA1;Ephrin type-A receptor 1,4850,-0.0938771398926392,5.73174934688705e-11
Primary analysis,Left ventricle,LV end systolic volume,FGF21;Fibroblast growth factor 21,4875,-0.0936073367207886,5.81246125404096e-11
Primary analysis,Right atrium,RA maximum volume,GPD1;Glycerol-3-phosphate dehydrogenase,3373,-0.11242597183152,5.84022962204406e-11
Primary analysis,Left ventricle,LV end systolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3343,-0.112913121998946,5.87072914094083e-11
Primary analysis,Right ventricle,RV stroke volume,LGALS1;Galectin-1,4867,-0.0936168917060925,5.99848660141293e-11
Primary analysis,Left ventricle,LV end systolic volume,CST3;Cystatin-C,4848,-0.0937964281610551,6.00698298404397e-11
Primary analysis,Right ventricle,RV end systolic volume,LGALS9;Galectin-9,4837,-0.0938658153500403,6.11133993500049e-11
Primary analysis,Right ventricle,RV stroke volume,REN;Renin,4867,-0.0837853093878096,4.79939175836707e-09
Primary analysis,Right ventricle,RV end diastolic volume,MIA;Melanoma-derived growth regulatory protein,4872,-0.0934444389742146,6.35993799830209e-11
Primary analysis,Right atrium,RA stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4794,-0.0941945773061419,6.3718435990483e-11
Primary analysis,Right atrium,RA maximum volume,SHISA5;Protein shisa-5,3387,-0.111961239824622,6.40100004958129e-11
Primary analysis,Right atrium,RA maximum volume,GCG;Pro-glucagon,4673,-0.0953532319884725,6.51460676187676e-11
Primary analysis,Right atrium,RA maximum volume,CFI;Complement factor I,3382,-0.111983238020509,6.55402419206285e-11
Primary analysis,Left ventricle,LV stroke volume,GSTA3;Glutathione S-transferase A3,4756,-0.0944890285747926,6.61141479055481e-11
Primary analysis,Right ventricle,RV end systolic volume,ACP5;Tartrate-resistant acid phosphatase type 5,4864,-0.0934379771854305,6.61218832765656e-11
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,CLMP;CXADR-like membrane protein,4887,-0.0931940260321475,6.68921163961579e-11
Primary analysis,Right atrium,RA stroke volume,PRCP;Lysosomal Pro-X carboxypeptidase,4797,-0.0940446388676749,6.73972331082668e-11
Primary analysis,Descending aorta,Descending aorta maximum area,COLEC12;Collectin-12,4555,-0.0964855640649843,6.78549535230187e-11
Primary analysis,Left ventricle,LV stroke volume,CFD;Complement factor D,3444,-0.110876933305088,6.81634705104754e-11
Primary analysis,Right ventricle,RV end diastolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4823,-0.0937562708783786,6.85230333552567e-11
Primary analysis,Right ventricle,RV stroke volume,TFF3;Trefoil factor 3,4835,-0.0934942288137424,7.33545747327189e-11
Primary analysis,Left ventricle,LV cardiac output,GPD1;Glycerol-3-phosphate dehydrogenase,3431,-0.110881396891788,7.38745601441011e-11
Primary analysis,Left ventricle,LV end diastolic volume,CD83;CD83 antigen,4850,-0.0933070575729249,7.48428660002211e-11
Primary analysis,Left ventricle,LV cardiac output,CXCL17;C-X-C motif chemokine 17,4903,-0.0927866529626011,7.54298597239329e-11
Primary analysis,Descending aorta,Descending aorta maximum area,NPDC1;Neural proliferation differentiation and control protein 1,4586,-0.0959228020002923,7.5584229816243e-11
Primary analysis,Left ventricle,LV cardiac output,GSTA3;Glutathione S-transferase A3,4754,-0.0941877645198738,7.66982161113447e-11
Primary analysis,Right atrium,RA maximum volume,GDF15;Growth/differentiation factor 15,4832,-0.0933799526010492,7.8411428800623e-11
Primary analysis,Right ventricle,RV end diastolic volume,XCL1;Lymphotactin,4890,-0.0927830014328892,8.00287732973794e-11
Primary analysis,Right atrium,RA maximum volume,APOF;Apolipoprotein F,3389,0.111328403236767,8.09547703498143e-11
Primary analysis,Right ventricle,RV end diastolic volume,LAYN;Layilin,4825,-0.0932932592716436,8.42320449291601e-11
Primary analysis,Right atrium,RA maximum volume,LEPR;Leptin receptor,4786,0.0936655606153927,8.44492655234555e-11
Primary analysis,Right atrium,RA minimum volume,SMOC1;SPARC-related modular calcium-binding protein 1,4795,-0.0935775259966073,8.4466108322968e-11
Primary analysis,Right ventricle,RV end systolic volume,PAMR1;Inactive serine protease PAMR1,4842,-0.0931040815963283,8.52519895258882e-11
Primary analysis,Right atrium,RA maximum volume,COL6A3;Collagen alpha-3(VI) chain,4832,-0.0931884905133815,8.57089576546833e-11
Primary analysis,Right ventricle,RV stroke volume,CLEC4A;C-type lectin domain family 4 member A,4852,0.0929187787527402,8.88829250685736e-11
Primary analysis,Right ventricle,RV end diastolic volume,RNASE4;Ribonuclease 4,3323,-0.112169415594553,8.92646012217171e-11
Primary analysis,Left ventricle,LV stroke volume,IL18R1;Interleukin-18 receptor 1,4905,-0.0855845532553274,1.93151575906194e-09
Primary analysis,Right ventricle,RV stroke volume,AFM;Afamin,3444,-0.110141877118632,9.10426826592374e-11
Primary analysis,Right ventricle,RV end systolic volume,LGALS1;Galectin-1,4866,-0.0927150266327125,9.18472722519718e-11
Primary analysis,Right atrium,RA maximum volume,GSTA1;Glutathione S-transferase A1,4760,-0.0937262860347102,9.23312999124408e-11
Primary analysis,Left ventricle,LV cardiac output,MOG;Myelin-oligodendrocyte glycoprotein,4888,-0.0924912277817379,9.25223244936932e-11
Primary analysis,Right atrium,RA maximum volume,COL4A1;Collagen alpha-1(IV) chain,4786,0.093455638028265,9.30454617707258e-11
Primary analysis,Right atrium,RA maximum volume,CCL7;C-C motif chemokine 7,4769,-0.0935180605074643,9.75781726740633e-11
Primary analysis,Left ventricle,LV end systolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4899,0.0922499696302125,9.86610075099014e-11
Primary analysis,Right ventricle,RV stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3390,-0.110801734774364,9.87613260084658e-11
Primary analysis,Right ventricle,RV stroke volume,WFDC2;WAP four-disulfide core domain protein 2,4564,-0.0955532815701578,9.9068352130873e-11
Primary analysis,Right ventricle,RV end diastolic volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3346,-0.111505697255025,9.94578759073261e-11
Primary analysis,Left ventricle,LV cardiac output,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4830,-0.0928755480020394,9.99714685586562e-11
Primary analysis,Left ventricle,LV cardiac output,MIA;Melanoma-derived growth regulatory protein,4870,-0.0924704961605653,1.01105812488725e-10
Primary analysis,Right ventricle,RV stroke volume,GSTA3;Glutathione S-transferase A3,4756,-0.093541604914034,1.02335363458357e-10
Primary analysis,Right ventricle,RV end diastolic volume,NOMO1;Nodal modulator 1,4843,-0.0926996225457532,1.02392153366853e-10
Primary analysis,Left ventricle,LV cardiac output,AFM;Afamin,3442,-0.109869572966771,1.02564118376861e-10
Primary analysis,Descending aorta,Descending aorta maximum area,MIA;Melanoma-derived growth regulatory protein,4589,-0.0951429369706402,1.06035454758434e-10
Primary analysis,Left ventricle,LV end diastolic volume,EGLN1;Egl nine homolog 1,4850,-0.0925567402795785,1.06070766020567e-10
Primary analysis,Left ventricle,LV stroke volume,MIA;Melanoma-derived growth regulatory protein,4872,-0.0923283838951546,1.07056226601801e-10
Primary analysis,Right ventricle,RV stroke volume,EPHA1;Ephrin type-A receptor 1,4852,-0.0925112313680938,1.07380255086126e-10
Primary analysis,Right atrium,RA maximum volume,KYNU;Kynureninase,4821,-0.0927723872664777,1.09111756694346e-10
Primary analysis,Right ventricle,RV end diastolic volume,NTRK3;NT-3 growth factor receptor,4904,0.0918961696739756,1.13813590389057e-10
Primary analysis,Left ventricle,LV end diastolic volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4850,0.092403254741589,1.13875081727047e-10
Primary analysis,Left ventricle,LV end systolic volume,RTN4R;Reticulon-4 receptor,4879,-0.092085640915551,1.16200567882264e-10
Primary analysis,Right ventricle,RV end diastolic volume,ISM1;Isthmin-1,4852,-0.0923105051259647,1.17824146760903e-10
Primary analysis,Left ventricle,LV cardiac output,KLK6;Kallikrein-6,4863,-0.0921612364523189,1.20312193458404e-10
Primary analysis,Left ventricle,LV stroke volume,NRCAM;Neuronal cell adhesion molecule,4867,-0.0920891654461501,1.22237120233367e-10
Primary analysis,Right ventricle,RV end diastolic volume,HAVCR2;Hepatitis A virus cellular receptor 2,4843,-0.092304447236387,1.22901687272108e-10
Primary analysis,Right ventricle,RV end diastolic volume,DCXR;L-xylulose reductase,4872,-0.0920270081041505,1.23091806810317e-10
Primary analysis,Right atrium,RA maximum volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3292,-0.111850245454088,1.2324690688964e-10
Primary analysis,Descending aorta,Descending aorta maximum area,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4548,-0.0951663920351948,1.26977436403211e-10
Primary analysis,Right ventricle,RV end systolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4909,0.0915998301113841,1.27805389034625e-10
Primary analysis,Descending aorta,Descending aorta maximum area,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4604,-0.0945712867898865,1.27943080278303e-10
Primary analysis,Right atrium,RA maximum volume,CD5;T-cell surface glycoprotein CD5,4802,-0.0925984836133564,1.28536585882093e-10
Primary analysis,Right atrium,RA maximum volume,GLA;Alpha-galactosidase A,3304,-0.111536838335993,1.28591888930657e-10
Primary analysis,Right ventricle,RV end diastolic volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3428,-0.10949265324575,1.29554126573422e-10
Primary analysis,Left ventricle,LV stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3428,-0.109477343951096,1.30326729505018e-10
Primary analysis,Right atrium,RA maximum volume,CD4;T-cell surface glycoprotein CD4,4766,-0.0929097420039643,1.30696621271445e-10
Primary analysis,Left ventricle,LV cardiac output,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3426,-0.109481242093082,1.31745048058741e-10
Primary analysis,Right atrium,RA stroke volume,CTSD;Cathepsin D,4471,-0.0958881778397615,1.32190955713537e-10
Primary analysis,Right ventricle,RV stroke volume,CTSD;Cathepsin D,4545,-0.0950719793211735,1.34302139888565e-10
Primary analysis,Right ventricle,RV end diastolic volume,CCN5;CCN family member 5,4843,-0.0920731439632065,1.36714746665778e-10
Primary analysis,Left ventricle,LV end diastolic volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3426,-0.109383432117446,1.36840573228399e-10
Primary analysis,Right atrium,RA maximum volume,SELE;E-selectin,4832,-0.092164617970585,1.37525810751287e-10
Primary analysis,Right atrium,RA minimum volume,IGFBP1;Insulin-like growth factor-binding protein 1,4817,0.0922495793426642,1.41224843885192e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,"FABP4;Fatty acid-binding protein, adipocyte",4914,-0.0912889980667583,1.44460014951797e-10
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4842,-0.0919594436317245,1.44677001034799e-10
Primary analysis,Right ventricle,RV stroke volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4843,-0.0919445998912134,1.45035257888233e-10
Primary analysis,Right ventricle,RV stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4866,-0.0917202843142123,1.45541541425188e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,LAMP2;Lysosome-associated membrane glycoprotein 2,4713,0.0931908560758562,1.45588187169774e-10
Primary analysis,Left ventricle,LV end diastolic volume,SNCG;Gamma-synuclein,4827,-0.0920821814715633,1.4597646873697e-10
Primary analysis,Right ventricle,RV stroke volume,GFRA1;GDNF family receptor alpha-1,4886,-0.0915238311465184,1.4616277807695e-10
Primary analysis,Right ventricle,RV end systolic volume,CD300E;CMRF35-like molecule 2,4873,-0.0916306962134231,1.47154680803394e-10
Primary analysis,Right atrium,RA stroke volume,CNTN3;Contactin-3,4768,-0.0926255232758649,1.47479728045369e-10
Primary analysis,Left ventricle,LV end systolic volume,PGF;Placenta growth factor,4894,-0.0914013310871939,1.49432454964023e-10
Primary analysis,Right atrium,RA maximum volume,SNCG;Gamma-synuclein,4745,-0.0928164606341841,1.49669148538842e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,CLMP;CXADR-like membrane protein,4887,-0.0914569498484324,1.50093682757672e-10
Primary analysis,Right ventricle,RV stroke volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3442,-0.108852563069282,1.52416183905916e-10
Primary analysis,Right ventricle,RV end systolic volume,CFH;Complement factor H,3247,-0.112027323818388,1.54066976688792e-10
Primary analysis,Left ventricle,LV stroke volume,F7;Coagulation factor VII,4856,-0.0916761435198685,1.55083048091554e-10
Primary analysis,Right ventricle,RV end diastolic volume,CCL7;C-C motif chemokine 7,4852,-0.0917053863217766,1.55682019013691e-10
Primary analysis,Left ventricle,LV stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4832,-0.0918815901565393,1.56589017803094e-10
Primary analysis,Left ventricle,LV cardiac output,AGR3;Anterior gradient protein 3,4745,-0.092683201917149,1.59004367959186e-10
Primary analysis,Descending aorta,Descending aorta maximum area,SEMA3F;Semaphorin-3F,4586,-0.0942051786375409,1.63670336210562e-10
Primary analysis,Right ventricle,RV end systolic volume,PON3;Serum paraoxonase/lactonase 3,4860,0.0915107662884796,1.64452531764154e-10
Primary analysis,Right ventricle,RV stroke volume,RBP5;Retinol-binding protein 5,4832,-0.0917626715585596,1.65347897423195e-10
Primary analysis,Left ventricle,LV stroke volume,DPT;Dermatopontin,4917,-0.0909440528422215,1.67260102296476e-10
Primary analysis,Left ventricle,LV stroke volume,KLK6;Kallikrein-6,4865,-0.0914228530081387,1.67579731276652e-10
Primary analysis,Right atrium,RA stroke volume,GCG;Pro-glucagon,4682,-0.09318012173465,1.68000947633987e-10
Primary analysis,Right ventricle,RV end diastolic volume,FTCD;Formimidoyltransferase-cyclodeaminase,3432,-0.108732164838895,1.69716367853876e-10
Primary analysis,Right ventricle,RV stroke volume,GUSB;Beta-glucuronidase,4865,-0.0913294033473224,1.74917065671548e-10
Primary analysis,Descending aorta,Descending aorta maximum area,FSTL3;Follistatin-related protein 3,4548,-0.0944422471888759,1.75253841421843e-10
Primary analysis,Right ventricle,RV end diastolic volume,CFC1;Cryptic protein,4756,-0.0923386533358286,1.7711048902872e-10
Primary analysis,Right atrium,RA stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3293,-0.110878062157258,1.77128437696187e-10
Primary analysis,Right ventricle,RV end systolic volume,SERPINF1;Pigment epithelium-derived factor,3406,-0.109029350444377,1.77381175303138e-10
Primary analysis,Left ventricle,LV end diastolic volume,RARRES2;Retinoic acid receptor responder protein 2,4867,-0.0912706253339696,1.78159968646701e-10
Primary analysis,Left ventricle,LV cardiac output,PRSS8;Prostasin,4824,-0.0916646485596692,1.79003929868947e-10
Primary analysis,Right ventricle,RV end diastolic volume,FGFR2;Fibroblast growth factor receptor 2,4872,-0.0912054106397777,1.7968062301845e-10
Primary analysis,Left ventricle,LV myocardial mass,CYTL1;Cytokine-like protein 1,3450,-0.108245236384331,1.8367944400149e-10
Primary analysis,Right ventricle,RV end systolic volume,XG;Glycoprotein Xg,4896,-0.0909223194039967,1.84709227978582e-10
Primary analysis,Right ventricle,RV end diastolic volume,ALDH1A1;Retinal dehydrogenase 1,4843,-0.0914068442526523,1.8553885896949e-10
Primary analysis,Right atrium,RA minimum volume,PTGDS;Prostaglandin-H2 D-isomerase,4730,-0.0924868438201964,1.85652244104777e-10
Primary analysis,Right ventricle,RV end diastolic volume,CCL16;C-C motif chemokine 16,4917,-0.0907088714232987,1.86398376702415e-10
Primary analysis,Right atrium,RA maximum volume,CD302;CD302 antigen,4748,-0.0923007567710595,1.86600549349695e-10
Primary analysis,Right ventricle,RV end diastolic volume,NCAN;Neurocan core protein,4904,-0.0908208685624407,1.87060485262296e-10
Primary analysis,Right atrium,RA maximum volume,BCHE;Cholinesterase,3325,-0.110142426916441,1.91363108785865e-10
Primary analysis,Left ventricle,LV cardiac output,NRCAM;Neuronal cell adhesion molecule,4865,-0.0911245354629215,1.9211765126684e-10
Primary analysis,Right ventricle,RV end diastolic volume,PENK;Proenkephalin-A,3376,-0.109267136687564,1.94650464089702e-10
Primary analysis,Right atrium,RA stroke volume,F9;Coagulation factor IX,4790,-0.0918001584876661,1.94961022767053e-10
Primary analysis,Right atrium,RA maximum volume,CDHR2;Cadherin-related family member 2,4748,-0.0922019927498923,1.95118270608219e-10
Primary analysis,Left ventricle,LV end diastolic volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3345,-0.10974057372113,1.96810980191768e-10
Primary analysis,Left ventricle,LV end diastolic volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3375,-0.109244072106384,1.97582628182948e-10
Primary analysis,Right atrium,RA stroke volume,PLAUR;Urokinase plasminogen activator surface receptor,4737,-0.0922719039863328,1.98373573835448e-10
Primary analysis,Descending aorta,Descending aorta maximum area,SEZ6L;Seizure 6-like protein,4589,-0.093733618415299,1.99145857067623e-10
Primary analysis,Right atrium,RA maximum volume,IL16;Pro-interleukin-16,4821,-0.0914504542348575,1.9991709228059e-10
Primary analysis,Descending aorta,Descending aorta maximum area,COL15A1;Collagen alpha-1(XV) chain,3253,-0.111156523469133,2.05607880468389e-10
Primary analysis,Right atrium,RA minimum volume,TAFA5;Chemokine-like protein TAFA-5,4740,-0.0921547953695678,2.06405225481142e-10
Primary analysis,Right ventricle,RV end systolic volume,GSTA1;Glutathione S-transferase A1,4839,-0.0911648976042706,2.10756202001539e-10
Primary analysis,Descending aorta,Descending aorta minimum area,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4549,-0.0939908677181086,2.13008715803147e-10
Primary analysis,Right ventricle,RV end diastolic volume,DLK1;Protein delta homolog 1,4917,-0.0904097471107273,2.13851840263393e-10
Primary analysis,Left ventricle,LV stroke volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4843,-0.0910779874165146,2.15548403012194e-10
Primary analysis,Right ventricle,RV stroke volume,CD4;T-cell surface glycoprotein CD4,4849,-0.091012760717057,2.16440056776143e-10
Primary analysis,Right ventricle,RV stroke volume,PLIN1;Perilipin-1,4751,-0.0919319347569337,2.17540750417785e-10
Primary analysis,Right atrium,RA stroke volume,OXT;Oxytocin-neurophysin 1,4828,-0.091165700359218,2.20815421233574e-10
Primary analysis,Left ventricle,LV stroke volume,CDHR5;Cadherin-related family member 5,4867,-0.0907935239114082,2.21572577022695e-10
Primary analysis,Left ventricle,LV end diastolic volume,DCXR;L-xylulose reductase,4870,-0.0907577489173829,2.22372939329951e-10
Primary analysis,Left ventricle,LV cardiac output,GSTA1;Glutathione S-transferase A1,4838,-0.0910005358771772,2.2808099700985e-10
Primary analysis,Right ventricle,RV stroke volume,SOST;Sclerostin,4866,-0.0907142430200083,2.30697924455767e-10
Primary analysis,Right ventricle,RV stroke volume,CCL7;C-C motif chemokine 7,4852,-0.0908200660350428,2.33280590192982e-10
Primary analysis,Right ventricle,RV stroke volume,EFNA4;Ephrin-A4,4823,-0.0910862289581676,2.33860779963613e-10
Primary analysis,Right ventricle,RV stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3428,-0.107958982359941,2.340885841218e-10
Primary analysis,Right atrium,RA maximum volume,OCLN;Occludin,3381,-0.108697951289103,2.34529811747828e-10
Primary analysis,Left ventricle,LV stroke volume,GSTA1;Glutathione S-transferase A1,4840,-0.0908287952206899,2.44486742869437e-10
Primary analysis,Descending aorta,Descending aorta minimum area,THY1;Thy-1 membrane glycoprotein,4617,-0.0929279997783186,2.5110605695342e-10
Primary analysis,Left ventricle,LV end diastolic volume,CDCP1;CUB domain-containing protein 1,4827,-0.0908391138235157,2.57140992111258e-10
Primary analysis,Left ventricle,LV end systolic volume,AFM;Afamin,3434,-0.107606903081956,2.58418815583533e-10
Primary analysis,Right ventricle,RV end systolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4828,-0.0907943203584734,2.61294741630923e-10
Primary analysis,Left ventricle,LV end diastolic volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4815,-0.0908849143237365,2.65032462806174e-10
Primary analysis,Right atrium,RA maximum volume,ITGA5;Integrin alpha-5,4759,-0.0914105759148449,2.65694238857872e-10
Primary analysis,Left ventricle,LV stroke volume,SERPINF1;Pigment epithelium-derived factor,3407,-0.107949003930955,2.66542622028694e-10
Primary analysis,Right atrium,RA stroke volume,PAMR1;Inactive serine protease PAMR1,4768,-0.0912495406211992,2.74802487571048e-10
Primary analysis,Descending aorta,Descending aorta minimum area,FSTL3;Follistatin-related protein 3,4549,-0.0933857186028196,2.77988474277998e-10
Primary analysis,Right atrium,RA maximum volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4813,-0.0907677657831,2.81798596989543e-10
Primary analysis,Right atrium,RA stroke volume,SLC39A5;Zinc transporter ZIP5,4778,-0.0910980519470221,2.81842838739574e-10
Primary analysis,Left ventricle,LV end systolic volume,CD59;CD59 glycoprotein,4671,-0.0921101138782753,2.84559105732231e-10
Primary analysis,Right atrium,RA maximum volume,STC1;Stanniocalcin-1,4820,-0.0906688559701291,2.860522479582e-10
Primary analysis,Left ventricle,LV cardiac output,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4823,-0.0906237619626676,2.8825329935338e-10
Primary analysis,Right atrium,RA stroke volume,SCARA5;Scavenger receptor class A member 5,4828,-0.0905568760200935,2.90881764490183e-10
Primary analysis,Right ventricle,RV end systolic volume,VWC2;Brorin,4818,-0.090648740808501,2.91108127438581e-10
Primary analysis,Right ventricle,RV end diastolic volume,GUSB;Beta-glucuronidase,4865,-0.0901818996613091,2.95019720329328e-10
Primary analysis,Left ventricle,LV stroke volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4872,-0.0900985651690734,2.97537130211876e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,"FABP4;Fatty acid-binding protein, adipocyte",4914,-0.0896854223138852,3.01438845174919e-10
Primary analysis,Left ventricle,LV end diastolic volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3426,-0.1073200055506,3.02363935729032e-10
Primary analysis,Descending aorta,Descending aorta minimum area,MIA;Melanoma-derived growth regulatory protein,4590,-0.0927569608950981,3.052141398645e-10
Primary analysis,Left ventricle,LV end systolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4879,-0.0899533239875424,3.08633830046503e-10
Primary analysis,Left ventricle,LV end systolic volume,GSTA1;Glutathione S-transferase A1,4829,-0.0904120151888732,3.09210499206856e-10
Primary analysis,Left ventricle,LV end diastolic volume,LCAT;Phosphatidylcholine-sterol acyltransferase,3450,-0.106781925156154,3.2214299346605e-10
Primary analysis,Right atrium,RA maximum volume,FTCD;Formimidoyltransferase-cyclodeaminase,3370,-0.107979428525353,3.29025619600625e-10
Primary analysis,Right ventricle,RV stroke volume,COL6A3;Collagen alpha-3(VI) chain,4917,-0.0894576083068633,3.3019873620846e-10
Primary analysis,Left ventricle,LV end systolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4814,-0.0903870958870643,3.33039204925255e-10
Primary analysis,Right ventricle,RV end diastolic volume,HIP1R;Huntingtin-interacting protein 1-related protein,3434,-0.106928811926233,3.34674244275573e-10
Primary analysis,Right atrium,RA stroke volume,FSTL3;Follistatin-related protein 3,4755,-0.0909097021682962,3.38192481875599e-10
Primary analysis,Right atrium,RA maximum volume,SCARB2;Lysosome membrane protein 2,4642,-0.0919924649328323,3.40141776906458e-10
Primary analysis,Right atrium,RA stroke volume,CFH;Complement factor H,3191,-0.110834673930948,3.43331757395831e-10
Primary analysis,Left ventricle,LV stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3390,-0.107497626625171,3.50103347044009e-10
Primary analysis,Right atrium,RA minimum volume,WFDC2;WAP four-disulfide core domain protein 2,4475,-0.0935970993867604,3.53600651017271e-10
Primary analysis,Right atrium,RA maximum volume,CFC1;Cryptic protein,4673,-0.0915854924686297,3.55902752083983e-10
Primary analysis,Right ventricle,RV end diastolic volume,PSPN;Persephin,4852,-0.0898594575888745,3.60231635638792e-10
Primary analysis,Left ventricle,LV cardiac output,SCARB2;Lysosome membrane protein 2,4722,-0.0910830893130137,3.6030920589067e-10
Primary analysis,Right atrium,RA maximum volume,SHBG;Sex hormone-binding globulin,3389,0.107430100752975,3.61277278589767e-10
Primary analysis,Left ventricle,LV stroke volume,LGALS9;Galectin-9,4838,-0.0899715584198565,3.63052513953832e-10
Primary analysis,Right atrium,RA maximum volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4677,-0.09147831820015,3.66782297170345e-10
Primary analysis,Right ventricle,RV end diastolic volume,HAO1;Hydroxyacid oxidase 1,4890,-0.0894592751379958,3.68721807572249e-10
Primary analysis,Right ventricle,RV end diastolic volume,CSF1;Macrophage colony-stimulating factor 1,4861,-0.0897197872217741,3.69553267379743e-10
Primary analysis,Left ventricle,LV end diastolic volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4763,-0.0906309487885435,3.70189124434888e-10
Primary analysis,Right atrium,RA stroke volume,HGF;Hepatocyte growth factor,4830,-0.0899582439067483,3.77594420977759e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.106223267758291,3.8476533900304e-10
Primary analysis,Right atrium,RA minimum volume,LGALS9;Galectin-9,4746,-0.0906979250102571,3.86092668897309e-10
Primary analysis,Left ventricle,LV cardiac output,APCS;Serum amyloid P-component,3417,-0.106806778840008,3.87383744170773e-10
Primary analysis,Right ventricle,RV stroke volume,PON3;Serum paraoxonase/lactonase 3,4861,0.0895845404995199,3.92732249454887e-10
Primary analysis,Right ventricle,RV end diastolic volume,CRIP2;Cysteine-rich protein 2,4829,-0.0898010562084062,4.06832776248397e-10
Primary analysis,Left ventricle,LV end diastolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4841,-0.0896559934453952,4.13094062142834e-10
Primary analysis,Right atrium,RA stroke volume,PLTP;Phospholipid transfer protein,4830,0.0897181533023869,4.20462264047843e-10
Primary analysis,Left ventricle,LV end diastolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4888,-0.0891851503127896,4.2064931134783e-10
Primary analysis,Right atrium,RA maximum volume,AMBP;Protein AMBP,4802,-0.0899551720146321,4.2484400325646e-10
Primary analysis,Left ventricle,LV stroke volume,CLEC4A;C-type lectin domain family 4 member A,4852,0.0894258120452707,4.37652552710971e-10
Primary analysis,Right ventricle,RV end diastolic volume,PAMR1;Inactive serine protease PAMR1,4843,-0.0894997770477845,4.39378833430901e-10
Primary analysis,Left atrium,LA maximum volume,LDLR;Low-density lipoprotein receptor,4789,-0.0899997590159924,4.3965641350013e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,LEP;Leptin,4864,-0.0892831879287779,4.44102233142894e-10
Primary analysis,Left ventricle,LV cardiac output,FSTL3;Follistatin-related protein 3,4827,-0.0896013817927607,4.48515149280753e-10
Primary analysis,Right ventricle,RV end diastolic volume,CKAP4;Cytoskeleton-associated protein 4,4884,-0.0890709239410972,4.50106896425221e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,ADAMTSL2;ADAMTS-like protein 2,3451,0.105842735766403,4.57539669429708e-10
Primary analysis,Right ventricle,RV end diastolic volume,PLAUR;Urokinase plasminogen activator surface receptor,4810,-0.0897125984506507,4.57890118964101e-10
Primary analysis,Right ventricle,RV end systolic volume,GHR;Growth hormone receptor,3375,-0.107014554291928,4.58799556369e-10
Primary analysis,Left ventricle,LV end diastolic volume,GUSB;Beta-glucuronidase,4863,-0.0891041421274342,4.83147026510254e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,ACE2;Angiotensin-converting enzyme 2,4761,0.0900201772607671,4.89615007180713e-10
Primary analysis,Right ventricle,RV end systolic volume,FTCD;Formimidoyltransferase-cyclodeaminase,3431,-0.105932451273075,4.96480939635602e-10
Primary analysis,Descending aorta,Descending aorta minimum area,GFRA1;GDNF family receptor alpha-1,4601,-0.0915184996921259,4.99922059097651e-10
Primary analysis,Right ventricle,RV stroke volume,KLK6;Kallikrein-6,4865,-0.089005298281014,5.00877216193689e-10
Primary analysis,Right atrium,RA minimum volume,CLMP;CXADR-like membrane protein,4795,-0.0896252063773674,5.06498030803232e-10
Primary analysis,Right ventricle,RV end diastolic volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4761,-0.0899392248016187,5.0746377750819e-10
Primary analysis,Descending aorta,Descending aorta maximum area,PRELP;Prolargin,4555,-0.0919340514218091,5.09463514820476e-10
Primary analysis,Right ventricle,RV stroke volume,AGR3;Anterior gradient protein 3,4747,-0.090028179108572,5.17210751716905e-10
Primary analysis,Left ventricle,LV end diastolic volume,C1R;Complement C1r subcomponent,3442,-0.105606115704867,5.26878927016528e-10
Primary analysis,Right atrium,RA maximum volume,SEMA3F;Semaphorin-3F,4786,-0.0896107904062696,5.29055840312989e-10
Primary analysis,Right atrium,RA minimum volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4740,-0.0900283636562519,5.32486008849228e-10
Primary analysis,Right atrium,RA minimum volume,GFRA1;GDNF family receptor alpha-1,4791,-0.0895452309370954,5.33516080522767e-10
Primary analysis,Left ventricle,LV stroke volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4829,-0.0891238170010706,5.50286174157487e-10
Primary analysis,Left ventricle,LV cardiac output,SOST;Sclerostin,4864,-0.0887359241431909,5.67162871312132e-10
Primary analysis,Left ventricle,LV cardiac output,CES1;Liver carboxylesterase 1,4878,-0.0886061512892282,5.67867100804956e-10
Primary analysis,Left ventricle,LV end diastolic volume,CRIP2;Cysteine-rich protein 2,4827,-0.0890498787438747,5.73316782674081e-10
Primary analysis,Descending aorta,Descending aorta minimum area,SEMA3F;Semaphorin-3F,4587,-0.0913234283397452,5.77826519894813e-10
Primary analysis,Right ventricle,RV end diastolic volume,IL18R1;Interleukin-18 receptor 1,4905,-0.081441353291351,1.11762035687466e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,DNER;Delta and Notch-like epidermal growth factor-related receptor,4828,0.0890033116152357,5.82905229941643e-10
Primary analysis,Left ventricle,LV end diastolic volume,STC1;Stanniocalcin-1,4902,-0.0882724851399828,5.98420570602583e-10
Primary analysis,Left ventricle,LV myocardial mass,MOG;Myelin-oligodendrocyte glycoprotein,4889,-0.0883882531238576,5.987181674187e-10
Primary analysis,Right ventricle,RV end systolic volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4764,-0.0895175545118274,6.03689138434079e-10
Primary analysis,Left ventricle,LV cardiac output,CDCP1;CUB domain-containing protein 1,4827,-0.0889056222042898,6.11191444266251e-10
Primary analysis,Right ventricle,RV end diastolic volume,MEGF10;Multiple epidermal growth factor-like domains protein 10,4836,0.08880867016425,6.15126148706419e-10
Primary analysis,Right atrium,RA maximum volume,CSTB;Cystatin-B,4731,-0.0897745916973642,6.18034998432438e-10
Primary analysis,Left atrium,LA stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4769,-0.0894118176530845,6.19572589646834e-10
Primary analysis,Descending aorta,Descending aorta minimum area,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4605,-0.0909811009301868,6.20450844217149e-10
Primary analysis,Right ventricle,RV end diastolic volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4852,0.0886267658576562,6.24999836786827e-10
Primary analysis,Right ventricle,RV end diastolic volume,C1RL;Complement C1r subcomponent-like protein,3437,-0.10522344279182,6.2596004836203e-10
Primary analysis,Right atrium,RA minimum volume,CD83;CD83 antigen,4760,-0.0894544258067491,6.31008598530135e-10
Primary analysis,Left ventricle,LV stroke volume,AGR3;Anterior gradient protein 3,4747,-0.0895584686691353,6.35997087222885e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.104844454348848,6.47650648684349e-10
Primary analysis,Descending aorta,Descending aorta maximum area,CHRDL1;Chordin-like protein 1,4569,-0.0912310348869602,6.49581104881045e-10
Primary analysis,Right ventricle,RV stroke volume,LGALS9;Galectin-9,4838,-0.0886292552282982,6.60652115934193e-10
Primary analysis,Right ventricle,RV stroke volume,CD302;CD302 antigen,4832,-0.0886804704181944,6.61706993296522e-10
Primary analysis,Right ventricle,RV stroke volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3428,-0.105176395076401,6.70626154982613e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,MVK;Mevalonate kinase,4756,0.0893362875105806,6.75639878511508e-10
Primary analysis,Left atrium,LA maximum volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4755,-0.0893415967262152,6.76841935689916e-10
Primary analysis,Right atrium,RA maximum volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4754,-0.08934597622265,6.78323286952758e-10
Primary analysis,Left ventricle,LV end systolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4818,-0.0887300339293533,6.85123803165903e-10
Primary analysis,Left ventricle,LV stroke volume,MOG;Myelin-oligodendrocyte glycoprotein,4890,-0.0880765840752054,6.85131183133912e-10
Primary analysis,Left ventricle,LV end diastolic volume,CRLF1;Cytokine receptor-like factor 1,4859,-0.0883453869733173,6.88406386980406e-10
Primary analysis,Left ventricle,LV end diastolic volume,PSPN;Persephin,4850,-0.0884151871112699,6.92029130959409e-10
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,4828,-0.0885928470756249,6.99054871104956e-10
Primary analysis,Right ventricle,RV stroke volume,NRCAM;Neuronal cell adhesion molecule,4867,-0.0882370335446775,6.99474838041851e-10
Primary analysis,Right ventricle,RV end diastolic volume,CCL3;C-C motif chemokine 3,4852,-0.0883680854566508,7.00954379918129e-10
Primary analysis,Descending aorta,Descending aorta minimum area,COLEC12;Collectin-12,4556,-0.0911785387506232,7.02432086407879e-10
Primary analysis,Left ventricle,LV stroke volume,GHR;Growth hormone receptor,3376,-0.105845623529797,7.04685130013214e-10
Primary analysis,Left ventricle,LV stroke volume,SOST;Sclerostin,4866,-0.0882175678179529,7.08369045413613e-10
Primary analysis,Left ventricle,LV end diastolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4895,-0.0878968665278525,7.27472193675956e-10
Primary analysis,Left atrium,LA stroke volume,CLEC4A;C-type lectin domain family 4 member A,4783,0.0888455712007018,7.50488598783305e-10
Primary analysis,Right ventricle,RV end systolic volume,CHRDL1;Chordin-like protein 1,4850,-0.0881899254873289,7.645208792857e-10
Primary analysis,Left ventricle,LV cardiac output,IL18R1;Interleukin-18 receptor 1,4903,-0.0783330554747684,3.9733133493623e-08
Primary analysis,Right ventricle,RV stroke volume,FGF21;Fibroblast growth factor 21,4886,-0.0878297964749085,7.7672570679133e-10
Primary analysis,Right ventricle,RV end diastolic volume,CSTB;Cystatin-B,4814,-0.0884791176776544,7.77692401592391e-10
Primary analysis,Left ventricle,LV end systolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4754,-0.0890163208579803,7.8365654587229e-10
Primary analysis,Right ventricle,RV end diastolic volume,CCL22;C-C motif chemokine 22,4774,-0.088798325212163,7.94708934541638e-10
Primary analysis,Right ventricle,RV end systolic volume,GDF15;Growth/differentiation factor 15,4916,-0.0875024285512269,7.97663525988532e-10
Primary analysis,Left ventricle,LV stroke volume,CES1;Liver carboxylesterase 1,4880,-0.0877869550635178,8.10671292852383e-10
Primary analysis,Left atrium,LA stroke volume,COLEC12;Collectin-12,4767,-0.0888028329508468,8.15998005066464e-10
Primary analysis,Right atrium,RA stroke volume,KYNU;Kynureninase,4830,-0.0882158072103126,8.18857753937349e-10
Primary analysis,Right ventricle,RV end diastolic volume,HSPB6;Heat shock protein beta-6,4890,-0.0876741405543922,8.19081090903912e-10
Primary analysis,Descending aorta,Descending aorta minimum area,SEZ6L;Seizure 6-like protein,4590,-0.0904499211193013,8.31170802383143e-10
Primary analysis,Left ventricle,LV stroke volume,CKB;Creatine kinase B-type,3451,0.104227781353365,8.38899537169218e-10
Primary analysis,Right ventricle,RV stroke volume,RTBDN;Retbindin,4832,-0.088092504122316,8.57606029903675e-10
Primary analysis,Right ventricle,RV end systolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4871,-0.0877148600998607,8.67296857842432e-10
Primary analysis,Right atrium,RA ejection fraction,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4791,-0.0884333433502809,8.70470037943889e-10
Primary analysis,Left ventricle,LV end diastolic volume,PARP1;Poly [ADP-ribose] polymerase 1,4850,-0.0878770294536193,8.77624015726002e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,ACY1;Aminoacylase-1,4864,0.0877352588079125,8.83693331735714e-10
Primary analysis,Right atrium,RA maximum volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3301,-0.106411920899892,8.84785258707054e-10
Primary analysis,Descending aorta,Descending aorta maximum area,NPPC;C-type natriuretic peptide,4570,-0.0905001385475276,8.85020470986978e-10
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,GGT1;Glutathione hydrolase 1 proenzyme,4835,0.0879694316424093,8.94500516235042e-10
Primary analysis,Left ventricle,LV end systolic volume,PRND;Prion-like protein doppel,3432,-0.104332766381663,8.97458782122852e-10
Primary analysis,Right ventricle,RV end diastolic volume,PRSS2;Trypsin-2,4865,-0.087674194754022,9.04206604278288e-10
Primary analysis,Right atrium,RA maximum volume,SCLY;Selenocysteine lyase,4798,-0.0882491940479069,9.17340553444566e-10
Primary analysis,Descending aorta,Descending aorta maximum area,THY1;Thy-1 membrane glycoprotein,4616,-0.0899630582078835,9.18546295168778e-10
Primary analysis,Right ventricle,RV end diastolic volume,CTSZ;Cathepsin Z,4855,-0.0877183246424197,9.22617451475076e-10
Primary analysis,Left ventricle,LV cardiac output,CKB;Creatine kinase B-type,3449,0.10399153111637,9.26267208179862e-10
Primary analysis,Right atrium,RA maximum volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4748,-0.0886806853597473,9.29542975065535e-10
Primary analysis,Right atrium,RA maximum volume,LAMP3;Lysosome-associated membrane glycoprotein 3,4813,-0.0880584605475158,9.39116080144515e-10
Primary analysis,Left atrium,LA stroke volume,TREM2;Triggering receptor expressed on myeloid cells 2,4767,-0.0884537569916262,9.50274044618872e-10
Primary analysis,Left ventricle,LV stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4825,-0.0878996149944472,9.59768864776626e-10
Primary analysis,Left ventricle,LV end diastolic volume,SELE;E-selectin,4915,-0.0870911355149172,9.60898280043972e-10
Primary analysis,Right atrium,RA stroke volume,STC1;Stanniocalcin-1,4828,-0.0878636706937736,9.63444169218263e-10
Primary analysis,Descending aorta,Descending aorta maximum area,TAFA5;Chemokine-like protein TAFA-5,4551,-0.0904835356923348,9.65638921161698e-10
Primary analysis,Left ventricle,LV end diastolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4870,-0.0874715363075838,9.69269982732819e-10
Primary analysis,Left ventricle,LV end diastolic volume,RNASE1;Ribonuclease pancreatic,3450,-0.103817599395039,9.82573840734978e-10
Primary analysis,Left ventricle,LV cardiac output,CFD;Complement factor D,3442,-0.103858761391746,1.01169998747666e-09
Primary analysis,Left ventricle,LV end systolic volume,"KRT18;Keratin, type I cytoskeletal 18",4821,-0.0878021167939315,1.01765318104495e-09
Primary analysis,Right ventricle,RV end systolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4842,-0.0875775991014263,1.03317226126568e-09
Primary analysis,Right ventricle,RV end diastolic volume,SERPIND1;Heparin cofactor 2,3442,-0.103784619272971,1.0398538348357e-09
Primary analysis,Right ventricle,RV end diastolic volume,CBLN4;Cerebellin-4,4890,-0.0871325083158526,1.04030256565723e-09
Primary analysis,Left ventricle,LV myocardial mass,SORCS2;VPS10 domain-containing receptor SorCS2,4755,-0.0883410567502365,1.04735027647e-09
Primary analysis,Left ventricle,LV end diastolic volume,CALCB;Calcitonin gene-related peptide 2,3440,-0.103755901474278,1.06269404306158e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,ADAMTSL2;ADAMTS-like protein 2,3450,0.103593102020343,1.06783046511203e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,HEG1;Protein HEG homolog 1,3376,0.104711887385873,1.06981093572043e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,IGFBP2;Insulin-like growth factor-binding protein 2,4907,-0.0869076382381891,1.07492867428591e-09
Primary analysis,Left ventricle,LV end diastolic volume,ALDH1A1;Retinal dehydrogenase 1,4841,-0.0874942935984486,1.07578188285225e-09
Primary analysis,Right atrium,RA stroke volume,LGALS9;Galectin-9,4764,-0.0881745201875674,1.08593876555704e-09
Primary analysis,Right ventricle,RV end diastolic volume,FAM3C;Protein FAM3C,4866,-0.087233507284268,1.09313259208532e-09
Primary analysis,Right ventricle,RV end diastolic volume,EPHA2;Ephrin type-A receptor 2,4620,-0.0894994645426224,1.10181001602858e-09
Primary analysis,Right ventricle,RV end diastolic volume,REG1A;Lithostathine-1-alpha,4827,-0.0875601557280107,1.10459012975091e-09
Primary analysis,Descending aorta,Descending aorta maximum area,TGFBR2;TGF-beta receptor type-2,4589,-0.0897838305164028,1.10951630255953e-09
Primary analysis,Right ventricle,RV end diastolic volume,PRRT3;Proline-rich transmembrane protein 3,3353,-0.104934507600398,1.1234895467295e-09
Primary analysis,Left ventricle,LV cardiac output,NPC2;NPC intracellular cholesterol transporter 2,3388,-0.104388038753433,1.12580770064131e-09
Primary analysis,Left ventricle,LV end diastolic volume,FTCD;Formimidoyltransferase-cyclodeaminase,3430,-0.103742433567452,1.12893892802997e-09
Primary analysis,Right atrium,RA minimum volume,OXT;Oxytocin-neurophysin 1,4811,-0.08763522716543,1.13876195200674e-09
Primary analysis,Right ventricle,RV end systolic volume,CBLN4;Cerebellin-4,4889,-0.0868982046438972,1.15763548557796e-09
Primary analysis,Left ventricle,LV end diastolic volume,IL16;Pro-interleukin-16,4903,-0.0867573905091697,1.16635019629465e-09
Primary analysis,Right ventricle,RV end systolic volume,OXT;Oxytocin-neurophysin 1,4903,-0.0867133132793595,1.18915376942767e-09
Primary analysis,Left ventricle,LV stroke volume,MFAP5;Microfibrillar-associated protein 5,4917,-0.0865841744214095,1.19229834664123e-09
Primary analysis,Left atrium,LA stroke volume,CYTL1;Cytokine-like protein 1,3396,-0.10410479764655,1.19417062960081e-09
Primary analysis,Right atrium,RA maximum volume,SCG2;Secretogranin-2,4794,-0.0876743288881639,1.19743637033385e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,DSG2;Desmoglein-2,4840,-0.0872433258327713,1.2051700528791e-09
Primary analysis,Right atrium,RA maximum volume,CTSD;Cathepsin D,4462,-0.090787758771165,1.23748942936461e-09
Primary analysis,Right ventricle,RV stroke volume,CTSZ;Cathepsin Z,4855,-0.0869649724214614,1.28331796271962e-09
Primary analysis,Left ventricle,LV cardiac output,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4870,-0.086807102165961,1.29699841674444e-09
Primary analysis,Left ventricle,LV end systolic volume,CALB2;Calretinin,4740,-0.0879811647126542,1.29942525707269e-09
Primary analysis,Left ventricle,LV cardiac output,CDHR5;Cadherin-related family member 5,4865,-0.086830702948152,1.30885564695106e-09
Primary analysis,Right atrium,RA stroke volume,HIP1R;Huntingtin-interacting protein 1-related protein,3378,-0.104117444331143,1.3144872251062e-09
Primary analysis,Left ventricle,LV myocardial mass,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4831,-0.0871213493605968,1.31648690306469e-09
Primary analysis,Descending aorta,Descending aorta minimum area,DKK4;Dickkopf-related protein 4,4541,-0.0898333691200774,1.32617670417218e-09
Primary analysis,Right ventricle,RV end diastolic volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3376,-0.104117207631966,1.3293825195468e-09
Primary analysis,Right ventricle,RV end systolic volume,CXCL17;C-X-C motif chemokine 17,4904,-0.0864358332294833,1.33785839232758e-09
Primary analysis,Left ventricle,LV cardiac output,CFP;Properdin,3442,-0.103074067504496,1.35143227657507e-09
Primary analysis,Right atrium,RA minimum volume,CCL7;C-C motif chemokine 7,4760,-0.0876811126609292,1.36591825135306e-09
Primary analysis,Right ventricle,RV end diastolic volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3456,-0.102791429954346,1.38907625860431e-09
Primary analysis,Left ventricle,LV myocardial mass,CD83;CD83 antigen,4851,-0.0868048625206841,1.39758596295762e-09
Primary analysis,Right ventricle,RV stroke volume,GCG;Pro-glucagon,4756,-0.0876021896773302,1.43570647639048e-09
Primary analysis,Right atrium,RA maximum volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4769,0.0874548071225303,1.45332667564204e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,DSG2;Desmoglein-2,4840,-0.0867379545368292,1.50149568420345e-09
Primary analysis,Left ventricle,LV myocardial mass,THY1;Thy-1 membrane glycoprotein,4903,-0.0861772492505721,1.50375667390466e-09
Primary analysis,Right ventricle,RV stroke volume,VWC2;Brorin,4819,-0.0869084846695269,1.51300243682391e-09
Primary analysis,Right ventricle,RV stroke volume,LY6D;Lymphocyte antigen 6D,4821,-0.0868905059641091,1.51300812831026e-09
Primary analysis,Right atrium,RA maximum volume,CCL27;C-C motif chemokine 27,4786,-0.0872033213662904,1.5151492394302e-09
Primary analysis,Right ventricle,RV end systolic volume,SEZ6L;Seizure 6-like protein,4871,-0.0864213810366335,1.52853228071004e-09
Primary analysis,Right ventricle,RV end systolic volume,FGF21;Fibroblast growth factor 21,4885,-0.08629628453698,1.52957734791986e-09
Primary analysis,Right atrium,RA maximum volume,FGF21;Fibroblast growth factor 21,4800,-0.0870438451338924,1.53664971975414e-09
Primary analysis,Right atrium,RA stroke volume,CD4;T-cell surface glycoprotein CD4,4775,-0.0872180606037895,1.57184522085691e-09
Primary analysis,Right ventricle,RV end systolic volume,OGN;Mimecan,4842,-0.0865802499461284,1.5953463921383e-09
Primary analysis,Right ventricle,RV end diastolic volume,INHBC;Inhibin beta C chain,4843,-0.155611199632482,1.2465932196288e-27
Primary analysis,Right atrium,RA minimum volume,FSTL3;Follistatin-related protein 3,4738,-0.0874955433749038,1.61367621698733e-09
Primary analysis,Right atrium,RA stroke volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3399,-0.103222440184986,1.62073195763448e-09
Primary analysis,Right ventricle,RV end diastolic volume,PLTP;Phospholipid transfer protein,4906,0.0859418542862917,1.64737360697331e-09
Primary analysis,Left ventricle,LV cardiac output,LGALS9;Galectin-9,4836,-0.0865437409122388,1.65872210753627e-09
Primary analysis,Right atrium,RA stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4757,-0.0872509475420374,1.66307390778661e-09
Primary analysis,Left ventricle,LV end diastolic volume,EFNA1;Ephrin-A1,4836,-0.0864877584116171,1.69936105285472e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,IGFBP2;Insulin-like growth factor-binding protein 2,4907,-0.085857010409861,1.70289808489544e-09
Primary analysis,Right ventricle,RV stroke volume,ADGRG1;Adhesion G-protein coupled receptor G1,4832,-0.0864895551069046,1.7244128622718e-09
Primary analysis,Right ventricle,RV stroke volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4890,-0.0859739351337821,1.72652313214163e-09
Primary analysis,Left ventricle,LV cardiac output,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4841,-0.086382584418646,1.74450066243176e-09
Primary analysis,Left ventricle,LV cardiac output,ELOA;Elongin-A,4830,-0.0864519801572404,1.76616481635009e-09
Primary analysis,Left ventricle,LV end systolic volume,CFH;Complement factor H,3239,-0.105482947813156,1.76863265607636e-09
Primary analysis,Right atrium,RA stroke volume,CD83;CD83 antigen,4778,-0.0868816436504208,1.79518159471593e-09
Primary analysis,Right ventricle,RV end diastolic volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3352,-0.103647932488154,1.80091606424681e-09
Primary analysis,Right ventricle,RV stroke volume,F9;Coagulation factor IX,4864,-0.0860800003442133,1.82070994139569e-09
Primary analysis,Right ventricle,RV stroke volume,APCS;Serum amyloid P-component,3419,-0.102601825178071,1.82079961446678e-09
Primary analysis,Right ventricle,RV stroke volume,CCL15;C-C motif chemokine 15,4917,-0.0856030877067396,1.83120052031262e-09
Primary analysis,Right ventricle,RV stroke volume,EFNA1;Ephrin-A1,4838,-0.0862690296672275,1.85337980432735e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,CPM;Carboxypeptidase M,4884,0.0858478871493647,1.86564286134039e-09
Primary analysis,Left atrium,LA maximum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4792,-0.08665300886118,1.87559389224754e-09
Primary analysis,Left ventricle,LV stroke volume,CD59;CD59 glycoprotein,4682,-0.0876469272122245,1.88737103567876e-09
Primary analysis,Right atrium,RA stroke volume,IGSF9;Protein turtle homolog A,3399,-0.102783638407144,1.90049163582465e-09
Primary analysis,Descending aorta,Descending aorta maximum area,CALB2;Calretinin,4473,-0.0896248564761933,1.9184467818641e-09
Primary analysis,Left ventricle,LV end diastolic volume,ADIPOQ;Adiponectin,3442,0.102115261682856,1.919453670451e-09
Primary analysis,Left ventricle,LV end diastolic volume,LY6D;Lymphocyte antigen 6D,4819,-0.0863432031716843,1.93085791035251e-09
Primary analysis,Left ventricle,LV end diastolic volume,INHBC;Inhibin beta C chain,4841,-0.140054210726703,1.23847910329347e-22
Primary analysis,Left ventricle,LV cardiac output,LPL;Lipoprotein lipase,4865,0.0859320221598257,1.93362924825331e-09
Primary analysis,Right atrium,RA stroke volume,CKB;Creatine kinase B-type,3393,0.102812982664987,1.94294644488603e-09
Primary analysis,Left ventricle,LV stroke volume,CFP;Properdin,3444,-0.102050174950617,1.94448730487387e-09
Primary analysis,Right atrium,RA minimum volume,COL6A3;Collagen alpha-3(VI) chain,4823,-0.0862825197846678,1.95172335867984e-09
Primary analysis,Right ventricle,RV stroke volume,NPDC1;Neural proliferation differentiation and control protein 1,4867,-0.0858794637479286,1.96305560737136e-09
Primary analysis,Left atrium,LA maximum volume,COL4A1;Collagen alpha-1(IV) chain,4793,0.0865289499426089,1.97047630376495e-09
Primary analysis,Left ventricle,LV end systolic volume,HNMT;Histamine N-methyltransferase,4804,-0.0864271554138548,1.97300849125694e-09
Primary analysis,Right ventricle,RV end diastolic volume,SFRP1;Secreted frizzled-related protein 1,4813,-0.0863430291763594,1.97601273206603e-09
Primary analysis,Right atrium,RA maximum volume,LGALS1;Galectin-1,4786,-0.0865774850855085,1.98276583303361e-09
Primary analysis,Left atrium,LA stroke volume,WFDC2;WAP four-disulfide core domain protein 2,4496,-0.0892905286233972,2.004456130886e-09
Primary analysis,Left ventricle,LV end systolic volume,CYTL1;Cytokine-like protein 1,3441,-0.102005288758317,2.00862319629941e-09
Primary analysis,Right ventricle,RV end systolic volume,SOST;Sclerostin,4865,-0.0858056893293438,2.04202780248283e-09
Primary analysis,Left ventricle,LV end diastolic volume,SKAP1;Src kinase-associated phosphoprotein 1,4823,-0.0861380122381672,2.07677494997982e-09
Primary analysis,Left ventricle,LV end diastolic volume,ITGA5;Integrin alpha-5,4841,-0.0859655507027635,2.08813690919682e-09
Primary analysis,Right ventricle,RV end diastolic volume,SLITRK2;SLIT and NTRK-like protein 2,4890,-0.0855271574848378,2.09534239625215e-09
Primary analysis,Left ventricle,LV stroke volume,C1RL;Complement C1r subcomponent-like protein,3437,-0.101914455919453,2.12105924937219e-09
Primary analysis,Right ventricle,RV stroke volume,SHISA5;Protein shisa-5,3451,-0.101677447777597,2.14511286225385e-09
Primary analysis,Right atrium,RA maximum volume,FAS;Tumor necrosis factor receptor superfamily member 6,4819,-0.0860832194016566,2.15891990609706e-09
Primary analysis,Right atrium,RA stroke volume,SCLY;Selenocysteine lyase,4807,-0.086186569020303,2.16233132438188e-09
Primary analysis,Right ventricle,RV stroke volume,LPL;Lipoprotein lipase,4867,0.085616781238029,2.19857154374781e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.101497278619514,2.23018876675361e-09
Primary analysis,Right atrium,RA minimum volume,BPIFB2;BPI fold-containing family B member 2,3378,-0.102642315446475,2.24210122581277e-09
Primary analysis,Right atrium,RA minimum volume,PRCP;Lysosomal Pro-X carboxypeptidase,4779,-0.086317042668342,2.27674766543764e-09
Primary analysis,Left ventricle,LV end diastolic volume,PLTP;Phospholipid transfer protein,4904,0.0852100273522321,2.28001417289138e-09
Primary analysis,Left ventricle,LV end diastolic volume,PALM2;Paralemmin-2,3440,-0.101666655089081,2.28366183491654e-09
Primary analysis,Ascending aorta,Ascending aorta minimum area,CRLF1;Cytokine receptor-like factor 1,4580,-0.0881450843049113,2.29688690369644e-09
Primary analysis,Left ventricle,LV end systolic volume,SLC39A5;Zinc transporter ZIP5,4841,-0.0856850482640094,2.35546484546138e-09
Primary analysis,Right atrium,RA maximum volume,MXRA8;Matrix remodeling-associated protein 8,3311,0.103492393834771,2.38901678310283e-09
Primary analysis,Left ventricle,LV myocardial mass,AHNAK;Neuroblast differentiation-associated protein AHNAK,3352,-0.102841964369195,2.40483105697546e-09
Primary analysis,Left ventricle,LV end diastolic volume,LSP1;Lymphocyte-specific protein 1,4850,-0.0855207299532924,2.44296976884625e-09
Primary analysis,Descending aorta,Descending aorta maximum area,OGN;Mimecan,4561,-0.0881755145817468,2.44727687110723e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,ADAMTSL2;ADAMTS-like protein 2,3451,0.101272456703657,2.48482219553932e-09
Primary analysis,Right ventricle,RV stroke volume,INHBC;Inhibin beta C chain,4843,-0.126740446132656,8.47980339724864e-19
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,GLA;Alpha-galactosidase A,3369,0.102481928516749,2.49379059904313e-09
Primary analysis,Right atrium,RA minimum volume,VWC2;Brorin,4726,-0.0865823750042817,2.49462975725057e-09
Primary analysis,Left ventricle,LV end diastolic volume,CD5;T-cell surface glycoprotein CD5,4886,-0.0851306358440196,2.52355058377209e-09
Primary analysis,Right atrium,RA stroke volume,GSTA1;Glutathione S-transferase A1,4769,-0.0861611799795892,2.52795201638577e-09
Primary analysis,Right ventricle,RV stroke volume,ICAM1;Intercellular adhesion molecule 1,4836,-0.0855447579927419,2.54899340014855e-09
Primary analysis,Right ventricle,RV end systolic volume,DPT;Dermatopontin,4916,-0.0848144491892865,2.58615872071484e-09
Primary analysis,Right atrium,RA minimum volume,IGFBP2;Insulin-like growth factor-binding protein 2,4816,0.0856858542969056,2.58821496319335e-09
Primary analysis,Right atrium,RA maximum volume,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,4745,-0.0862983013906241,2.61486720070033e-09
Primary analysis,Left ventricle,LV end systolic volume,SHISA5;Protein shisa-5,3441,-0.101261056780886,2.63068541949237e-09
Primary analysis,Ascending aorta,Ascending aorta maximum area,CLMP;CXADR-like membrane protein,4606,-0.0875561726305414,2.64820111505246e-09
Primary analysis,Left ventricle,LV end diastolic volume,VNN1;Pantetheinase,3450,-0.101099593433829,2.65926680333658e-09
Primary analysis,Right atrium,RA stroke volume,GLA;Alpha-galactosidase A,3309,-0.103217866560736,2.66260894519114e-09
Primary analysis,Right atrium,RA maximum volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4733,-0.086315520922724,2.71826880255093e-09
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4889,-0.0848947788551882,2.76157779173854e-09
Primary analysis,Right ventricle,RV stroke volume,MIA;Melanoma-derived growth regulatory protein,4872,-0.0850349661595215,2.77026907688176e-09
Primary analysis,Left ventricle,LV myocardial mass,NTRK3;NT-3 growth factor receptor,4903,0.0847586334915267,2.77970793046259e-09
Primary analysis,Right ventricle,RV stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4765,-0.0859707965048949,2.78274946982015e-09
Primary analysis,Right atrium,RA maximum volume,NOTCH3;Neurogenic locus notch homolog protein 3,4832,0.0853534042037514,2.80797927375595e-09
Primary analysis,Right ventricle,RV stroke volume,C19orf12;Protein C19orf12,4751,-0.086066479860345,2.8188586018559e-09
Primary analysis,Descending aorta,Descending aorta maximum area,CD59;CD59 glycoprotein,4409,-0.0893221011801963,2.82924149879524e-09
Primary analysis,Left ventricle,LV end systolic volume,AGRN;Agrin,4850,-0.0851733141069522,2.83455221063946e-09
Primary analysis,Right atrium,RA maximum volume,XG;Glycoprotein Xg,4812,-0.0854855563369317,2.86162427207175e-09
Primary analysis,Descending aorta,Descending aorta maximum area,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4550,-0.0878806556093559,2.88984876595407e-09
Primary analysis,Right ventricle,RV end diastolic volume,BCHE;Cholinesterase,3387,-0.101785144904224,2.90420867024356e-09
Primary analysis,Right ventricle,RV stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3353,-0.102294518146055,2.90738133681385e-09
Primary analysis,Right ventricle,RV end diastolic volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3366,-0.102096407826834,2.90869715450435e-09
Primary analysis,Left ventricle,LV end systolic volume,SOST;Sclerostin,4855,-0.0850542738963301,2.92720949179279e-09
Primary analysis,Right atrium,RA stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4748,-0.0859915106471544,2.94306079467252e-09
Primary analysis,Descending aorta,Descending aorta maximum area,NCAN;Neurocan core protein,4616,-0.0871951788998161,2.95929440237477e-09
Primary analysis,Right ventricle,RV stroke volume,MFAP5;Microfibrillar-associated protein 5,4917,-0.0844912012823194,2.96109321565472e-09
Primary analysis,Descending aorta,Descending aorta minimum area,NPPC;C-type natriuretic peptide,4571,-0.0875760477595062,3.01605700308521e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,ACY1;Aminoacylase-1,4863,0.0849128407931586,3.01819040608675e-09
Primary analysis,Right ventricle,RV end systolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4842,-0.0850889741933886,3.02750189735733e-09
Primary analysis,Descending aorta,Descending aorta minimum area,ACVRL1;Serine/threonine-protein kinase receptor R3,4545,-0.0878103694886157,3.03477444479712e-09
Primary analysis,Left atrium,LA maximum volume,NOTCH3;Neurogenic locus notch homolog protein 3,4839,0.0850963616176704,3.05196848932853e-09
Primary analysis,Right atrium,RA minimum volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4750,-0.0858717870643108,3.07210245542212e-09
Primary analysis,Right ventricle,RV end systolic volume,PRSS8;Prostasin,4825,-0.0851966921047456,3.08149811395941e-09
Primary analysis,Right atrium,RA maximum volume,ANG;Angiogenin,4759,-0.0857697486709447,3.09953536297378e-09
Primary analysis,Left atrium,LA ejection fraction,ANGPT2;Angiopoietin-2,4799,-0.0853682250896958,3.15847467326843e-09
Primary analysis,Left ventricle,LV end systolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4821,0.0851732686909111,3.15922484788297e-09
Primary analysis,Descending aorta,Descending aorta maximum area,ACVRL1;Serine/threonine-protein kinase receptor R3,4544,-0.0877159061293181,3.16793933330259e-09
Primary analysis,Left ventricle,LV stroke volume,LPL;Lipoprotein lipase,4867,0.0847300536368223,3.21496169042927e-09
Primary analysis,Right atrium,RA minimum volume,PGF;Placenta growth factor,4813,-0.0851986614292788,3.22029719512147e-09
Primary analysis,Right ventricle,RV end diastolic volume,SCGB1A1;Uteroglobin,4848,-0.0848813617496583,3.23424191950174e-09
Primary analysis,Right ventricle,RV end diastolic volume,B2M;Beta-2-microglobulin,3444,-0.10063731849182,3.24202440194592e-09
Primary analysis,Right ventricle,RV end diastolic volume,KHK;Ketohexokinase,3353,-0.101971384911103,3.26093628269677e-09
Primary analysis,Left ventricle,LV cardiac output,GHR;Growth hormone receptor,3374,-0.101648413909351,3.26854591443062e-09
Primary analysis,Right atrium,RA maximum volume,"NOS3;Nitric oxide synthase, endothelial",4669,-0.0864261100710745,3.31892297559615e-09
Primary analysis,Right ventricle,RV stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4832,-0.0849494749262857,3.33446393478954e-09
Primary analysis,Left ventricle,LV end diastolic volume,GPKOW;G-patch domain and KOW motifs-containing protein,4749,-0.0856616572019415,3.36919658792132e-09
Primary analysis,Right atrium,RA maximum volume,INHBC;Inhibin beta C chain,4759,-0.126877145922494,1.55101838730059e-18
Primary analysis,Left ventricle,LV cardiac output,C19orf12;Protein C19orf12,4749,-0.0856346357841975,3.40771225820271e-09
Primary analysis,Ascending aorta,Ascending aorta minimum area,CLMP;CXADR-like membrane protein,4606,-0.0869481769893377,3.40964869163949e-09
Primary analysis,Right atrium,RA maximum volume,RNASE6;Ribonuclease K6,3361,-0.101719608030779,3.41594422671994e-09
Primary analysis,Descending aorta,Descending aorta maximum area,NOTCH1;Neurogenic locus notch homolog protein 1,4630,-0.0866948333528671,3.45014194802892e-09
Primary analysis,Left ventricle,LV cardiac output,MFAP5;Microfibrillar-associated protein 5,4915,-0.0841512301061587,3.45075516403245e-09
Primary analysis,Left ventricle,LV end diastolic volume,B2M;Beta-2-microglobulin,3442,-0.100465289850001,3.48472637642034e-09
Primary analysis,Left atrium,LA maximum volume,APCS;Serum amyloid P-component,3359,-0.101679936624881,3.50150698087368e-09
Primary analysis,Descending aorta,Descending aorta maximum area,GFRA3;GDNF family receptor alpha-3,4541,-0.0874883453651396,3.52059833514514e-09
Primary analysis,Left ventricle,LV end systolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4894,-0.0842760244155843,3.53269332195274e-09
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF12A;Tumor necrosis factor receptor superfamily member 12A,4872,-0.0844540748124636,3.54991974689121e-09
Primary analysis,Descending aorta,Descending aorta maximum area,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4561,-0.0872649381668415,3.56731448345176e-09
Primary analysis,Right ventricle,RV end diastolic volume,GPKOW;G-patch domain and KOW motifs-containing protein,4751,-0.0854905436395634,3.59326514697988e-09
Primary analysis,Right ventricle,RV end systolic volume,C19orf12;Protein C19orf12,4750,-0.085442525204447,3.68028926183214e-09
Primary analysis,Right atrium,RA maximum volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4759,-0.0853570439539807,3.68787941941531e-09
Primary analysis,Descending aorta,Descending aorta minimum area,NPDC1;Neural proliferation differentiation and control protein 1,4587,-0.0869004445556703,3.74475100216797e-09
Primary analysis,Right atrium,RA stroke volume,ITGA5;Integrin alpha-5,4768,-0.0852347814822372,3.75344854067976e-09
Primary analysis,Right atrium,RA maximum volume,ACY1;Aminoacylase-1,4786,-0.0850699844053165,3.76114188201783e-09
Primary analysis,Left ventricle,LV end diastolic volume,SFRP1;Secreted frizzled-related protein 1,4811,-0.0848481338521992,3.76307586261718e-09
Primary analysis,Right ventricle,RV end diastolic volume,CCDC80;Coiled-coil domain-containing protein 80,4867,-0.0843577198201312,3.76686084773462e-09
Primary analysis,Right ventricle,RV stroke volume,CFD;Complement factor D,3444,-0.100212679557787,3.77533485871819e-09
Primary analysis,Left ventricle,LV cardiac output,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3374,-0.101174437064398,3.86726142814759e-09
Primary analysis,Right ventricle,RV end systolic volume,CD302;CD302 antigen,4831,-0.0846081241279373,3.867519012437e-09
Primary analysis,Right atrium,RA minimum volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4675,-0.0859890922673731,3.89120893092649e-09
Primary analysis,Right ventricle,RV end systolic volume,PRAP1;Proline-rich acidic protein 1,3450,-0.100029648042139,3.90767550589835e-09
Primary analysis,Left ventricle,LV stroke volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4761,-0.0851603937346326,3.97531109169449e-09
Primary analysis,Left atrium,LA stroke volume,PRSS8;Prostasin,4758,-0.0851859529306971,3.97731248091872e-09
Primary analysis,Right ventricle,RV stroke volume,CFC1;Cryptic protein,4756,-0.0851712317377593,4.0319810708672e-09
Primary analysis,Right atrium,RA minimum volume,IGSF9;Protein turtle homolog A,3385,-0.100833616223614,4.11760108606873e-09
Primary analysis,Left atrium,LA maximum volume,IL1RN;Interleukin-1 receptor antagonist protein,4756,-0.0850902996952787,4.17098911170967e-09
Primary analysis,Right ventricle,RV end diastolic volume,PARP1;Poly [ADP-ribose] polymerase 1,4852,-0.0842370019491784,4.18847616381222e-09
Primary analysis,Right atrium,RA minimum volume,NPC2;NPC intracellular cholesterol transporter 2,3320,-0.101762678120206,4.18876846817292e-09
Primary analysis,Descending aorta,Descending aorta minimum area,COL15A1;Collagen alpha-1(XV) chain,3253,-0.102780364936853,4.21828201650075e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,ERBB2;Receptor tyrosine-protein kinase erbB-2,4869,0.08407195969786,4.22106530261038e-09
Primary analysis,Right ventricle,RV end systolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4831,0.0843870723514712,4.24585027487353e-09
Primary analysis,Right ventricle,RV end systolic volume,CLEC4A;C-type lectin domain family 4 member A,4851,0.0842116455523244,4.2491149643742e-09
Primary analysis,Ascending aorta,Ascending aorta minimum area,MFAP5;Microfibrillar-associated protein 5,4632,-0.0861723441199106,4.25064463513142e-09
Primary analysis,Right atrium,RA maximum volume,IGFBP4;Insulin-like growth factor-binding protein 4,4702,-0.0855132984869184,4.28122489380896e-09
Primary analysis,Left ventricle,LV end diastolic volume,GFRA1;GDNF family receptor alpha-1,4884,-0.0839065805377306,4.28701067492835e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,KYNU;Kynureninase,4900,0.0837543362277598,4.31541097699615e-09
Primary analysis,Left ventricle,LV stroke volume,CRLF1;Cytokine receptor-like factor 1,4861,-0.0840815504438401,4.3283514734559e-09
Primary analysis,Right atrium,RA maximum volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3311,-0.101773762618009,4.37831531262804e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,ADAMTSL2;ADAMTS-like protein 2,3451,0.0996961447757552,4.3796563490962e-09
Primary analysis,Left ventricle,LV end systolic volume,SERPINF1;Pigment epithelium-derived factor,3397,-0.100478997061384,4.38434309853562e-09
Primary analysis,Right ventricle,RV end diastolic volume,GPR37;Prosaposin receptor GPR37,4765,-0.0848895782116444,4.38697976965867e-09
Primary analysis,Left ventricle,LV stroke volume,TGFBR2;TGF-beta receptor type-2,4872,-0.0839399128466337,4.41519590086313e-09
Primary analysis,Right atrium,RA maximum volume,LCAT;Phosphatidylcholine-sterol acyltransferase,3389,-0.100557324945412,4.44629035527439e-09
Primary analysis,Right ventricle,RV end systolic volume,ACY1;Aminoacylase-1,4866,-0.0839702601909845,4.45499634232054e-09
Primary analysis,Right ventricle,RV stroke volume,XG;Glycoprotein Xg,4897,-0.0837007943253235,4.46267398833921e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,CLMP;CXADR-like membrane protein,4887,-0.083744088101514,4.54282383297317e-09
Primary analysis,Descending aorta,Descending aorta maximum area,NRCAM;Neuronal cell adhesion molecule,4586,-0.0864232544229982,4.57440110402534e-09
Primary analysis,Descending aorta,Descending aorta minimum area,CHRDL1;Chordin-like protein 1,4570,-0.0865557307407357,4.6085997564008e-09
Primary analysis,Left ventricle,LV stroke volume,C19orf12;Protein C19orf12,4751,-0.0848910055983943,4.61849303271671e-09
Primary analysis,Left ventricle,LV cardiac output,F7;Coagulation factor VII,4854,-0.083984788525917,4.62524005691054e-09
Primary analysis,Descending aorta,Descending aorta maximum area,SMOC2;SPARC-related modular calcium-binding protein 2,4578,-0.0864650611362832,4.6374835082355e-09
Primary analysis,Right ventricle,RV end systolic volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4835,-0.0841360448562,4.65080698711468e-09
Primary analysis,Right ventricle,RV end systolic volume,INHBC;Inhibin beta C chain,4842,-0.117509541890647,2.34143301772519e-16
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 15,ACE2;Angiotensin-converting enzyme 2,4761,0.0847189374311851,4.7816218238547e-09
Primary analysis,Right ventricle,RV end diastolic volume,IL6;Interleukin-6,4832,-0.0840908496276864,4.79221766919197e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 14,REN;Renin,4864,-0.0831722501067793,6.27694255257814e-09
Primary analysis,Left ventricle,LV stroke volume,SORD;Sorbitol dehydrogenase,4879,-0.0836803528356397,4.80378538374206e-09
Primary analysis,Left ventricle,LV stroke volume,STC1;Stanniocalcin-1,4904,-0.0834554434181023,4.82820883326092e-09
Primary analysis,Left ventricle,LV end systolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4861,-0.0838217246329305,4.83008206410295e-09
Primary analysis,Right atrium,RA minimum volume,GSTA3;Glutathione S-transferase A3,4664,-0.0855644836547605,4.83755526383645e-09
Primary analysis,Right ventricle,RV end diastolic volume,OSM;Oncostatin-M,4820,-0.0841720356898552,4.83892910247617e-09
Primary analysis,Right ventricle,RV stroke volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4843,-0.0839491878347886,4.88667680938054e-09
Primary analysis,Descending aorta,Descending aorta minimum area,PRELP;Prolargin,4556,-0.0865442928157536,4.88753758978262e-09
Primary analysis,Right atrium,RA maximum volume,COL18A1;Collagen alpha-1(XVIII) chain,4802,-0.0842906544870641,4.91761256890054e-09
Primary analysis,Left ventricle,LV myocardial mass,EPHB6;Ephrin type-B receptor 6,4824,-0.0840808179611933,4.9548891656786e-09
Primary analysis,Left ventricle,LV end diastolic volume,CD300E;CMRF35-like molecule 2,4872,-0.0836458363181744,4.99898067018511e-09
Primary analysis,Right ventricle,RV end diastolic volume,SFTPD;Pulmonary surfactant-associated protein D,4867,-0.0836731802155808,5.03169465184507e-09
Primary analysis,Right atrium,RA maximum volume,CYTL1;Cytokine-like protein 1,3387,-0.100179907290934,5.13259703605908e-09
Primary analysis,Right ventricle,RV stroke volume,SERPINF1;Pigment epithelium-derived factor,3407,-0.0998606331682283,5.18003049103853e-09
Primary analysis,Left ventricle,LV end diastolic volume,PRRT3;Proline-rich transmembrane protein 3,3351,-0.100667265453034,5.21774247104265e-09
Primary analysis,Right atrium,RA minimum volume,"KRT18;Keratin, type I cytoskeletal 18",4740,-0.0846911968433128,5.22803351037104e-09
Primary analysis,Left ventricle,LV stroke volume,CFI;Complement factor I,3444,-0.0992974469818984,5.23100184069451e-09
Primary analysis,Right atrium,RA maximum volume,XCL1;Lymphotactin,4804,-0.0840909276936046,5.30721864135722e-09
Primary analysis,Descending aorta,Descending aorta minimum area,CALB2;Calretinin,4474,-0.0871245433566247,5.31310019850666e-09
Primary analysis,Right atrium,RA stroke volume,HNMT;Histamine N-methyltransferase,4740,-0.0846490378057539,5.32036712427793e-09
Primary analysis,Left ventricle,LV radial strain AHA 6,CXCL17;C-X-C motif chemokine 17,4895,-0.0833004016223662,5.32417067341305e-09
Primary analysis,Right atrium,RA minimum volume,CCL22;C-C motif chemokine 22,4683,-0.0851215378701764,5.40781640900795e-09
Primary analysis,Right atrium,RA minimum volume,NPPC;C-type natriuretic peptide,4760,-0.0844268482138344,5.42023529546101e-09
Primary analysis,Right ventricle,RV stroke volume,PRSS2;Trypsin-2,4865,-0.0834929371633302,5.46738496700145e-09
Primary analysis,Right atrium,RA maximum volume,FGFR2;Fibroblast growth factor receptor 2,4787,-0.0841568253657707,5.49375196233344e-09
Primary analysis,Descending aorta,Descending aorta minimum area,MEPE;Matrix extracellular phosphoglycoprotein,4556,-0.0862568508489977,5.49475183452133e-09
Primary analysis,Left ventricle,LV cardiac output,SORD;Sorbitol dehydrogenase,4877,-0.0833774107370495,5.49748668085988e-09
Primary analysis,Right ventricle,RV end diastolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4872,-0.0834115134565034,5.51726859168707e-09
Primary analysis,Right atrium,RA maximum volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4745,-0.084512323349064,5.52806042990057e-09
Primary analysis,Right ventricle,RV stroke volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4761,-0.0843705436971918,5.52825688810445e-09
Primary analysis,Right atrium,RA stroke volume,SHISA5;Protein shisa-5,3393,-0.0998596430068941,5.56929496443414e-09
Primary analysis,Right atrium,RA minimum volume,PLAUR;Urokinase plasminogen activator surface receptor,4720,-0.0847085390507742,5.58928500816719e-09
Primary analysis,Left ventricle,LV end diastolic volume,RBKS;Ribokinase,4748,-0.0844456865595157,5.62062198793799e-09
Primary analysis,Left ventricle,LV stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4866,-0.0833913035464286,5.68538310568401e-09
Primary analysis,Right ventricle,RV end diastolic volume,RNASE1;Ribonuclease pancreatic,3452,-0.0989454079477081,5.6905928558036e-09
Primary analysis,Left ventricle,LV end diastolic volume,"ATRN;Attractin, Isoform 2",3442,-0.0990740584977554,5.71960609953357e-09
Primary analysis,Left ventricle,LV end systolic volume,CDHR2;Cadherin-related family member 2,4821,-0.0837558457247154,5.7392910201875e-09
Primary analysis,Right ventricle,RV stroke volume,CKB;Creatine kinase B-type,3451,0.0989232916280977,5.7644184016988e-09
Primary analysis,Left ventricle,LV stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4765,-0.0842255836034812,5.78597307813258e-09
Primary analysis,Right ventricle,RV end diastolic volume,IL16;Pro-interleukin-16,4905,-0.0829696728479682,5.90613616546201e-09
Primary analysis,Right ventricle,RV stroke volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4836,-0.0835233634849086,5.99159062334723e-09
Primary analysis,Left ventricle,LV end systolic volume,SEMA3F;Semaphorin-3F,4856,-0.0833464510115092,6.00476897733198e-09
Primary analysis,Right atrium,RA stroke volume,CFC1;Cryptic protein,4682,-0.0848611555768086,6.04245475758874e-09
Primary analysis,Left ventricle,LV cardiac output,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4827,-0.0835773209671966,6.05101571462407e-09
Primary analysis,Right atrium,RA maximum volume,SCARA5;Scavenger receptor class A member 5,4820,-0.0836363706397414,6.05464134474307e-09
Primary analysis,Descending aorta,Descending aorta maximum area,AGRN;Agrin,4578,-0.0857342867947639,6.2481760055782e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 2,REN;Renin,4864,-0.0830219540053287,6.68416781868631e-09
Primary analysis,Right ventricle,RV end diastolic volume,YAP1;Transcriptional coactivator YAP1,3442,-0.098798297408935,6.3048695589556e-09
Primary analysis,Right atrium,RA maximum volume,ALDH1A1;Retinal dehydrogenase 1,4759,-0.0840499473097949,6.36089465301232e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,LEP;Leptin,4863,-0.0831483016164476,6.36282651295881e-09
Primary analysis,Left ventricle,LV end systolic volume,TGFBR2;TGF-beta receptor type-2,4861,-0.0831564055484596,6.38668890003043e-09
Primary analysis,Right atrium,RA stroke volume,ACY1;Aminoacylase-1,4795,-0.0837229643050185,6.39221099689678e-09
Primary analysis,Left ventricle,LV cardiac output,KYNU;Kynureninase,4903,-0.0827954936593206,6.40018764453375e-09
Primary analysis,Left ventricle,LV stroke volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3428,-0.0989537016034383,6.4062019506498e-09
Primary analysis,Left ventricle,LV end systolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4726,-0.0842956971886391,6.48351339081187e-09
Primary analysis,Left ventricle,LV end diastolic volume,CFC1;Cryptic protein,4754,-0.0840404603374695,6.50332809501848e-09
Primary analysis,Right atrium,RA minimum volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4740,-0.084156155546129,6.52470532660721e-09
Primary analysis,Right ventricle,RV end diastolic volume,UPB1;Beta-ureidopropionase,3456,-0.0984994903153202,6.53007343319406e-09
Primary analysis,Right atrium,RA maximum volume,CCL18;C-C motif chemokine 18,4695,-0.084551914895278,6.53908470326222e-09
Primary analysis,Left ventricle,LV stroke volume,NELL2;Protein kinase C-binding protein NELL2,4861,-0.0830992728777486,6.5410966584019e-09
Primary analysis,Descending aorta,Descending aorta minimum area,NOTCH1;Neurogenic locus notch homolog protein 1,4631,-0.0851212902770782,6.56870133458113e-09
Primary analysis,Left ventricle,LV myocardial mass,MYOM3;Myomesin-3,3376,0.0996320081615935,6.58227267287439e-09
Primary analysis,Left ventricle,LV end systolic volume,ACY1;Aminoacylase-1,4856,-0.0831193513123968,6.60304727390865e-09
Primary analysis,Left ventricle,LV end diastolic volume,F9;Coagulation factor IX,4862,-0.0830667248529678,6.60711791961928e-09
Primary analysis,Right atrium,RA maximum volume,SOST;Sclerostin,4785,-0.0837154762055076,6.64819679566908e-09
Primary analysis,Left ventricle,LV radial strain AHA 2,REN;Renin,4859,0.0758278594429517,1.21014490200334e-07
Primary analysis,Left ventricle,LV end diastolic volume,CXCL10;C-X-C motif chemokine 10,4859,-0.0830585680396358,6.70083985456e-09
Primary analysis,Left ventricle,LV myocardial mass,INHBB;Inhibin beta B chain,3376,-0.0995739325785949,6.71702302679963e-09
Primary analysis,Right ventricle,RV stroke volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4832,-0.0832684321588395,6.76020937907891e-09
Primary analysis,Left ventricle,LV cardiac output,CD59;CD59 glycoprotein,4680,-0.0845994305700047,6.77783445992718e-09
Primary analysis,Left ventricle,LV end systolic volume,COL15A1;Collagen alpha-1(XV) chain,3441,-0.0985760522403977,6.8528678007495e-09
Primary analysis,Left ventricle,LV stroke volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3346,-0.0999535337488146,6.86768962947403e-09
Primary analysis,Left ventricle,LV end diastolic volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3350,-0.0998940854279612,6.86771659080799e-09
Primary analysis,Left atrium,LA stroke volume,PLAT;Tissue-type plasminogen activator,4833,-0.0832211413156692,6.87001417863052e-09
Primary analysis,Descending aorta,Descending aorta minimum area,TGFBR2;TGF-beta receptor type-2,4590,-0.0853842623059263,6.88313422466644e-09
Primary analysis,Left ventricle,LV end diastolic volume,GDF15;Growth/differentiation factor 15,4915,-0.082517208679751,6.89552705090648e-09
Primary analysis,Left ventricle,LV end diastolic volume,NOMO1;Nodal modulator 1,4841,-0.0831423830179609,6.89917733915487e-09
Primary analysis,Right atrium,RA minimum volume,EFNA4;Ephrin-A4,4730,-0.0840940733301797,6.94278220943992e-09
Primary analysis,Left ventricle,LV stroke volume,EPHA1;Ephrin type-A receptor 1,4852,-0.0830232589870141,6.97176168767557e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,IGFBP2;Insulin-like growth factor-binding protein 2,4907,-0.0825519072755328,6.98966735260121e-09
Primary analysis,Right ventricle,RV end diastolic volume,COL4A1;Collagen alpha-1(IV) chain,4867,0.0828532795845375,7.09600420260579e-09
Primary analysis,Right ventricle,RV end systolic volume,LPL;Lipoprotein lipase,4866,0.0828359567651439,7.17282884194722e-09
Primary analysis,Left ventricle,LV stroke volume,ELOA;Elongin-A,4832,-0.0830948356864481,7.26641200585331e-09
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,4829,-0.0831174030714493,7.27596814512401e-09
Primary analysis,Left ventricle,LV end diastolic volume,COL4A1;Collagen alpha-1(IV) chain,4865,0.0827976940607842,7.31402893160191e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,KHK;Ketohexokinase,3353,0.0996493284500547,7.36207287582655e-09
Primary analysis,Left atrium,LA stroke volume,LDLR;Low-density lipoprotein receptor,4796,-0.0833302819186909,7.4952103726176e-09
Primary analysis,Right ventricle,RV end diastolic volume,GM2A;Ganglioside GM2 activator,3364,-0.099426325226901,7.5187280582602e-09
Primary analysis,Left ventricle,LV stroke volume,KYNU;Kynureninase,4905,-0.0823776076075252,7.57174128493877e-09
Primary analysis,Left ventricle,LV myocardial mass,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4842,-0.0828995669652461,7.60535672538163e-09
Primary analysis,Left ventricle,LV end diastolic volume,ZHX2;Zinc fingers and homeoboxes protein 2,3440,-0.098279611766601,7.64334966451952e-09
Primary analysis,Right ventricle,RV end systolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4755,-0.0836177769094305,7.71412962085644e-09
Primary analysis,Right atrium,RA maximum volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4748,0.083642341913567,7.83195899353333e-09
Primary analysis,Right ventricle,RV end diastolic volume,SELE;E-selectin,4917,-0.0821960287299732,7.83372704356533e-09
Primary analysis,Left ventricle,LV end systolic volume,BPIFB2;BPI fold-containing family B member 2,3439,-0.0982048378170312,7.88562688622923e-09
Primary analysis,Right atrium,RA minimum volume,CD302;CD302 antigen,4740,-0.0836593082326173,8.00551370132244e-09
Primary analysis,Right atrium,RA maximum volume,ICAM1;Intercellular adhesion molecule 1,4753,-0.0835437661723978,8.01010715304885e-09
Primary analysis,Right atrium,RA maximum volume,SORD;Sorbitol dehydrogenase,4794,-0.0831648707697505,8.08296605419579e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,ADAMTSL2;ADAMTS-like protein 2,3451,0.0979541267647605,8.1116303651656e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,DSG2;Desmoglein-2,4840,-0.0827610709056902,8.1125467993962e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,MVK;Mevalonate kinase,4758,0.0834661247449599,8.12242048584949e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 3,CBLN4;Cerebellin-4,4885,0.0823743775712543,8.13191776463191e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,SHBG;Sex hormone-binding globulin,3452,-0.0979247264621448,8.1551977398536e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,ACE2;Angiotensin-converting enzyme 2,4760,0.0834342403789195,8.170651067462e-09
Primary analysis,Right ventricle,RV end systolic volume,SLITRK2;SLIT and NTRK-like protein 2,4889,-0.0823214677709251,8.19757358579076e-09
Primary analysis,Right atrium,RA stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4757,-0.0834489452640385,8.20943078752212e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,IGFBP2;Insulin-like growth factor-binding protein 2,4907,-0.0821649723881298,8.21745450452286e-09
Primary analysis,Right ventricle,RV stroke volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4843,-0.0826665156324618,8.34793209555789e-09
Primary analysis,Left ventricle,LV myocardial mass,MFAP5;Microfibrillar-associated protein 5,4916,-0.0820486316683285,8.36043235045598e-09
Primary analysis,Left ventricle,LV end diastolic volume,CSTB;Cystatin-B,4812,-0.0829182212591599,8.39415328857001e-09
Primary analysis,Left ventricle,LV stroke volume,OXT;Oxytocin-neurophysin 1,4904,-0.082108192619784,8.50269051072233e-09
Primary analysis,Left ventricle,LV end systolic volume,RTBDN;Retbindin,4821,-0.0827976167805358,8.54606971476746e-09
Primary analysis,Right ventricle,RV end systolic volume,CRHBP;Corticotropin-releasing factor-binding protein,4835,-0.0826409125527622,8.67822744883111e-09
Primary analysis,Left ventricle,LV cardiac output,LGALS1;Galectin-1,4865,-0.0823616857274038,8.76785198838752e-09
Primary analysis,Left ventricle,LV cardiac output,CALB1;Calbindin,4830,-0.0826531865852425,8.78783161665179e-09
Primary analysis,Left ventricle,LV stroke volume,NECTIN4;Nectin-4,4872,-0.0822808327370293,8.84766149472174e-09
Primary analysis,Left ventricle,LV myocardial mass,XG;Glycoprotein Xg,4896,-0.0820793639599764,8.8481470926925e-09
Primary analysis,Left ventricle,LV stroke volume,PGF;Placenta growth factor,4905,-0.0820007665347141,8.86096239814842e-09
Primary analysis,Descending aorta,Descending aorta maximum area,SCARB2;Lysosome membrane protein 2,4453,-0.0860400045668428,8.8941691303491e-09
Primary analysis,Right atrium,RA stroke volume,CCL22;C-C motif chemokine 22,4700,-0.0837194639101606,9.02606771933494e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,GGT5;Glutathione hydrolase 5 proenzyme,4825,0.0826147826050698,9.08702089470069e-09
Primary analysis,Left ventricle,LV stroke volume,SNCG;Gamma-synuclein,4829,-0.082556496840314,9.1781000182163e-09
Primary analysis,Left ventricle,LV stroke volume,LGALS1;Galectin-1,4867,-0.0822227490968504,9.2229221712667e-09
Primary analysis,Right ventricle,RV end systolic volume,LDLR;Low-density lipoprotein receptor,4865,-0.0822344054497067,9.24278376507946e-09
Primary analysis,Right atrium,RA minimum volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4736,-0.0833412472037323,9.25157500959764e-09
Primary analysis,Right ventricle,RV end systolic volume,EPHB6;Ephrin type-B receptor 6,4824,-0.0825601362701593,9.32694674062131e-09
Primary analysis,Right atrium,RA stroke volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3306,-0.099634041804941,9.41949818910101e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,MVK;Mevalonate kinase,4758,0.0831024466124677,9.42930351605015e-09
Primary analysis,Right ventricle,RV stroke volume,CCL3;C-C motif chemokine 3,4852,-0.0822856884073772,9.46903145306633e-09
Primary analysis,Left atrium,LA stroke volume,LPL;Lipoprotein lipase,4800,0.0827246315942862,9.48570687074092e-09
Primary analysis,Left ventricle,LV myocardial mass,AGRN;Agrin,4860,-0.0822121987183009,9.49229316466323e-09
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF10A;Tumor necrosis factor receptor superfamily member 10A,4829,-0.0824636966833175,9.5362322763675e-09
Primary analysis,Right atrium,RA maximum volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4740,-0.0832189891541517,9.58712788634863e-09
Primary analysis,Left ventricle,LV end diastolic volume,HSPB6;Heat shock protein beta-6,4888,-0.0819398570177907,9.63990631997314e-09
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,ERBB2;Receptor tyrosine-protein kinase erbB-2,4869,0.0820903441748091,9.67497046064814e-09
Primary analysis,Left ventricle,LV end diastolic volume,CRHBP;Corticotropin-releasing factor-binding protein,4834,-0.0823597650877078,9.78072279624324e-09
Primary analysis,Right ventricle,RV stroke volume,SORD;Sorbitol dehydrogenase,4879,-0.0819584170671441,9.86918662746646e-09
Primary analysis,Right ventricle,RV stroke volume,CKAP4;Cytoskeleton-associated protein 4,4884,-0.0818984473666378,9.94354936310336e-09
Primary analysis,Right atrium,RA maximum volume,CA6;Carbonic anhydrase 6,4755,0.0829936609134166,9.96416214793802e-09
Primary analysis,Left ventricle,LV end diastolic volume,EPHB6;Ephrin type-B receptor 6,4823,-0.0823420875066176,1.0238918734221e-08
Primary analysis,Right atrium,RA maximum volume,SORCS2;VPS10 domain-containing receptor SorCS2,4673,-0.0836452946225224,1.02557090451345e-08
Primary analysis,Left ventricle,LV stroke volume,COL15A1;Collagen alpha-1(XV) chain,3451,-0.0972341792791573,1.04327414972346e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,TTR;Transthyretin,3409,0.0978220568720412,1.04574893402727e-08
Primary analysis,Right atrium,RA minimum volume,ADIPOQ;Adiponectin,3374,0.0983116241620683,1.05095660429903e-08
Primary analysis,Descending aorta,Descending aorta maximum area,DLL1;Delta-like protein 1,4589,-0.0843390602891717,1.05308263731625e-08
Primary analysis,Left atrium,LA maximum volume,NPPC;C-type natriuretic peptide,4776,-0.0826731605169877,1.05445893865147e-08
Primary analysis,Right ventricle,RV end systolic volume,BPIFB2;BPI fold-containing family B member 2,3448,-0.0972315919457574,1.05963603434339e-08
Primary analysis,Right atrium,RA minimum volume,LPL;Lipoprotein lipase,4777,0.0826508322580009,1.06038172957933e-08
Primary analysis,Right ventricle,RV end systolic volume,EPHA1;Ephrin type-A receptor 1,4851,-0.0819945302793846,1.07148608815306e-08
Primary analysis,Left ventricle,LV end diastolic volume,CD74;HLA class II histocompatibility antigen gamma chain,4902,-0.0815634636204733,1.07354205038213e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,KHK;Ketohexokinase,3353,0.0985345995780205,1.08137336806326e-08
Primary analysis,Right ventricle,RV stroke volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4829,-0.0821376246078228,1.09055189278429e-08
Primary analysis,Left ventricle,LV stroke volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3376,-0.0981653214950498,1.09426483512231e-08
Primary analysis,Right atrium,RA maximum volume,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,4763,-0.082690704810903,1.09608291998823e-08
Primary analysis,Left ventricle,LV cardiac output,IGFBP1;Insulin-like growth factor-binding protein 1,4909,0.0814457720728926,1.10040373738543e-08
Primary analysis,Right atrium,RA stroke volume,RBP5;Retinol-binding protein 5,4757,-0.0827134661506221,1.10921265041658e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,LEP;Leptin,4864,-0.0817989002275937,1.11028245538901e-08
Primary analysis,Left atrium,LA minimum volume,LEP;Leptin,4759,-0.0826911803239061,1.11145429978647e-08
Primary analysis,Right atrium,RA minimum volume,SERPINF1;Pigment epithelium-derived factor,3339,-0.0986542127219414,1.11362546534525e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,KHK;Ketohexokinase,3352,0.098456544963307,1.11628750610777e-08
Primary analysis,Left ventricle,LV end systolic volume,INHBC;Inhibin beta C chain,4832,-0.117251340704956,2.92081280309622e-16
Primary analysis,Right ventricle,RV end diastolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4832,0.0820524792131532,1.11762730739259e-08
Primary analysis,Right ventricle,RV end diastolic volume,CFP;Properdin,3444,-0.097088929377204,1.13544787436683e-08
Primary analysis,Left ventricle,LV longitudinal strain Segment 2,THBS2;Thrombospondin-2,4711,0.0830472352986292,1.14016212676197e-08
Primary analysis,Left atrium,LA maximum volume,CST3;Cystatin-C,4783,-0.0824094957275273,1.14581573056621e-08
Primary analysis,Descending aorta,Descending aorta minimum area,TAFA5;Chemokine-like protein TAFA-5,4552,-0.0844575210476309,1.15081696065822e-08
Primary analysis,Right atrium,RA stroke volume,INHBC;Inhibin beta C chain,4768,-0.110350688892856,2.15305561430029e-14
Primary analysis,Right ventricle,RV stroke volume,SFRP1;Secreted frizzled-related protein 1,4813,-0.0821063329532618,1.16791282350765e-08
Primary analysis,Left ventricle,LV cardiac output,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4864,-0.0816452762064638,1.1827513302145e-08
Primary analysis,Right ventricle,RV end systolic volume,SNCG;Gamma-synuclein,4828,-0.0819401465148814,1.18668003955655e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,KYNU;Kynureninase,4902,0.0812991469980053,1.19746244132054e-08
Primary analysis,Left ventricle,LV myocardial mass,FSTL3;Follistatin-related protein 3,4828,-0.0819010389838463,1.20584037547244e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,ACE2;Angiotensin-converting enzyme 2,4762,0.0824337841016829,1.22125496427915e-08
Primary analysis,Right ventricle,RV end diastolic volume,CCL20;C-C motif chemokine 20,4905,-0.0812021249309609,1.23368449549893e-08
Primary analysis,Right atrium,RA maximum volume,NOMO1;Nodal modulator 1,4759,-0.0824233711860592,1.23941008201533e-08
Primary analysis,Right ventricle,RV stroke volume,NOMO1;Nodal modulator 1,4843,-0.0817039130651457,1.24122539968406e-08
Primary analysis,Left ventricle,LV end diastolic volume,CTSO;Cathepsin O,4903,-0.0811949192133042,1.24580809002854e-08
Primary analysis,Right ventricle,RV end diastolic volume,IL10RB;Interleukin-10 receptor subunit beta,4861,-0.0815430868916908,1.24624961451182e-08
Primary analysis,Left ventricle,LV myocardial mass,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,3352,-0.0981296814021374,1.24836488481774e-08
Primary analysis,Left ventricle,LV end diastolic volume,BCAN;Brevican core protein,4827,-0.0818191695537289,1.25124691153334e-08
Primary analysis,Descending aorta,Descending aorta maximum area,RGMB;RGM domain family member B,4616,-0.0836516729000292,1.25685274817224e-08
Primary analysis,Right ventricle,RV stroke volume,DPT;Dermatopontin,4917,-0.0810507933207634,1.26069195234279e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,CNTN3;Contactin-3,4840,0.0816897113921798,1.26144086145232e-08
Primary analysis,Right ventricle,RV stroke volume,ISM1;Isthmin-1,4852,-0.0815579076085488,1.27757588117204e-08
Primary analysis,Descending aorta,Descending aorta minimum area,AGRN;Agrin,4579,-0.0839324215914228,1.28496088967734e-08
Primary analysis,Descending aorta,Descending aorta minimum area,SMOC2;SPARC-related modular calcium-binding protein 2,4579,-0.0839154546211655,1.29366992243496e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 3,ADAMTS13;A disintegrin and metalloproteinase with thrombospondin motifs 13,4912,0.0810138032187397,1.30195338364241e-08
Primary analysis,Descending aorta,Descending aorta minimum area,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4551,-0.0841516644577535,1.30437437129577e-08
Primary analysis,Left ventricle,LV myocardial mass,CCN5;CCN family member 5,4842,-0.0815689885650363,1.31623868452153e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,IGFBP2;Insulin-like growth factor-binding protein 2,4907,-0.0810061392091473,1.32838614091703e-08
Primary analysis,Right atrium,RA stroke volume,AGR3;Anterior gradient protein 3,4674,-0.0829910396076495,1.33045930226705e-08
Primary analysis,Descending aorta,Descending aorta minimum area,PRND;Prion-like protein doppel,3243,-0.0995684847205631,1.33051559816099e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,ACY1;Aminoacylase-1,4864,0.0813328865908839,1.34455839038348e-08
Primary analysis,Left ventricle,LV stroke volume,PLIN1;Perilipin-1,4751,-0.0822795456593927,1.351186599626e-08
Primary analysis,Right ventricle,RV stroke volume,GPD1;Glycerol-3-phosphate dehydrogenase,3433,-0.0967152857627746,1.36299214220776e-08
Primary analysis,Right atrium,RA minimum volume,CD5;T-cell surface glycoprotein CD5,4793,-0.0818912302209902,1.36668704197877e-08
Primary analysis,Left ventricle,LV end diastolic volume,MXRA8;Matrix remodeling-associated protein 8,3375,0.0974998373225734,1.38157439336273e-08
Primary analysis,Left atrium,LA maximum volume,WFDC2;WAP four-disulfide core domain protein 2,4489,-0.0845088904758387,1.42244480281319e-08
Primary analysis,Left ventricle,LV myocardial mass,NECTIN4;Nectin-4,4871,-0.0811237921046847,1.43023124420275e-08
Primary analysis,Right ventricle,RV end systolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4886,-0.0809911975660142,1.43511701601447e-08
Primary analysis,Right ventricle,RV stroke volume,GSTA1;Glutathione S-transferase A1,4840,-0.081365774267235,1.43999280997955e-08
Primary analysis,Right ventricle,RV end diastolic volume,MXRA8;Matrix remodeling-associated protein 8,3376,0.0973436163390617,1.45014831639118e-08
Primary analysis,Right atrium,RA stroke volume,EPHA1;Ephrin type-A receptor 1,4777,-0.0818811617918774,1.45046094362233e-08
Primary analysis,Descending aorta,Descending aorta minimum area,OGN;Mimecan,4562,-0.083718525828433,1.48784924083484e-08
Primary analysis,Left ventricle,LV stroke volume,CYTL1;Cytokine-like protein 1,3451,-0.0961729151148176,1.50689260380878e-08
Primary analysis,Right ventricle,RV end systolic volume,COL15A1;Collagen alpha-1(XV) chain,3450,-0.0961727471103226,1.51420536133754e-08
Primary analysis,Left ventricle,LV end diastolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4885,-0.0808414400617223,1.53103645280532e-08
Primary analysis,Left ventricle,LV end diastolic volume,SNRPB2;U2 small nuclear ribonucleoprotein B'',3440,-0.0962696525014456,1.53636094160441e-08
Primary analysis,Left ventricle,LV end systolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3423,-0.0965031533937555,1.53863915537221e-08
Primary analysis,Right atrium,RA stroke volume,SERPINF1;Pigment epithelium-derived factor,3352,-0.0974903233943912,1.55198263420234e-08
Primary analysis,Right ventricle,RV end diastolic volume,OPTC;Opticin,4832,-0.0812346622966948,1.56102479526817e-08
Primary analysis,Right ventricle,RV end diastolic volume,EGLN1;Egl nine homolog 1,4852,-0.0810366615007723,1.58077861061277e-08
Primary analysis,Right atrium,RA stroke volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3298,-0.0981982213560183,1.59635532044274e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,CPM;Carboxypeptidase M,4884,0.0807268784239303,1.60984713630813e-08
Primary analysis,Right atrium,RA maximum volume,CXCL17;C-X-C motif chemokine 17,4821,-0.081231787782954,1.62255454256671e-08
Primary analysis,Right atrium,RA stroke volume,CCL18;C-C motif chemokine 18,4703,-0.082227859532793,1.6315548038384e-08
Primary analysis,Left ventricle,LV myocardial mass,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4871,-0.0807586052535584,1.66025546130182e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,ERBB2;Receptor tyrosine-protein kinase erbB-2,4869,0.0807717243163524,1.66257021604492e-08
Primary analysis,Right atrium,RA stroke volume,LGALS1;Galectin-1,4795,-0.0813858921808179,1.66592027068429e-08
Primary analysis,Right ventricle,RV stroke volume,AMBP;Protein AMBP,4888,-0.0805902683851698,1.67945074589828e-08
Primary analysis,Left ventricle,LV end diastolic volume,SMOC2;SPARC-related modular calcium-binding protein 2,4859,-0.0808249725120154,1.68271306360619e-08
Primary analysis,Right atrium,RA maximum volume,CXCL13;C-X-C motif chemokine 13,4820,-0.0811453408272569,1.68616376007491e-08
Primary analysis,Left ventricle,LV end diastolic volume,PROS1;Vitamin K-dependent protein S,3442,-0.0959645967635593,1.68984240593922e-08
Primary analysis,Ascending aorta,Ascending aorta distensibility,PTPRB;Receptor-type tyrosine-protein phosphatase beta,2935,-0.103869593509004,1.69985224107345e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,TIMP4;Metalloproteinase inhibitor 4,4840,-0.0809571875476786,1.70045540713493e-08
Primary analysis,Descending aorta,Descending aorta minimum area,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4590,-0.083120828361532,1.70420891259822e-08
Primary analysis,Right atrium,RA maximum volume,IL18BP;Interleukin-18-binding protein,4782,-0.0814286333869636,1.71192692358773e-08
Primary analysis,Right ventricle,RV stroke volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3346,-0.0972577011718887,1.72937330041289e-08
Primary analysis,Right ventricle,RV stroke volume,PRND;Prion-like protein doppel,3442,-0.09586123949234,1.7507984087792e-08
Primary analysis,Right ventricle,RV stroke volume,SLC39A5;Zinc transporter ZIP5,4852,-0.0807686598171326,1.76279222574473e-08
Primary analysis,Left ventricle,LV myocardial mass,LGALS9;Galectin-9,4837,-0.080874896120386,1.77610140683869e-08
Primary analysis,Right atrium,RA maximum volume,IGSF8;Immunoglobulin superfamily member 8,4786,-0.0813001747343411,1.77845708238674e-08
Primary analysis,Left ventricle,LV end diastolic volume,NECTIN4;Nectin-4,4870,-0.0805977763684126,1.77855646459141e-08
Primary analysis,Left ventricle,LV myocardial mass,VSIG4;V-set and immunoglobulin domain-containing protein 4,4831,-0.0809163986110515,1.78227378510993e-08
Primary analysis,Left ventricle,LV end systolic volume,ASGR1;Asialoglycoprotein receptor 1,4818,-0.0810192572274036,1.78655381141937e-08
Primary analysis,Left ventricle,LV end systolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4879,-0.0805003021785289,1.79550589378294e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,ACE2;Angiotensin-converting enzyme 2,4762,0.0814688165386494,1.80395079530976e-08
Primary analysis,Right atrium,RA minimum volume,SEMA3F;Semaphorin-3F,4777,-0.0813395932733362,1.80509336310741e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,GGT1;Glutathione hydrolase 1 proenzyme,4835,0.0808481623924317,1.80761318611162e-08
Primary analysis,Left ventricle,LV cardiac output,COL15A1;Collagen alpha-1(XV) chain,3449,-0.0956680868296112,1.80950866350703e-08
Primary analysis,Left ventricle,LV stroke volume,CALB1;Calbindin,4832,-0.0808374644490497,1.83394114878307e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,IL1R2;Interleukin-1 receptor type 2,4824,0.0809035662292982,1.83447130758332e-08
Primary analysis,Left ventricle,LV stroke volume,PON3;Serum paraoxonase/lactonase 3,4861,0.0805921169019516,1.83730729363226e-08
Primary analysis,Right ventricle,RV end systolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3432,-0.0958544861176876,1.8402743595334e-08
Primary analysis,Descending aorta,Descending aorta maximum area,CSF1;Macrophage colony-stimulating factor 1,4578,-0.0830341310910017,1.84063614007086e-08
Primary analysis,Left ventricle,LV end systolic volume,LDLR;Low-density lipoprotein receptor,4855,-0.0806366196263303,1.84114539718803e-08
Primary analysis,Right atrium,RA minimum volume,SELE;E-selectin,4823,-0.0808899893248061,1.85081534254591e-08
Primary analysis,Right atrium,RA minimum volume,GDF15;Growth/differentiation factor 15,4823,-0.0808600218010415,1.87336740338755e-08
Primary analysis,Left ventricle,LV end diastolic volume,CHRDL1;Chordin-like protein 1,4849,-0.0806433529565386,1.87351251688e-08
Primary analysis,Left ventricle,LV end diastolic volume,NELL2;Protein kinase C-binding protein NELL2,4859,-0.0805602534046015,1.87374113121418e-08
Primary analysis,Right ventricle,RV end diastolic volume,SMAD5;Mothers against decapentaplegic homolog 5,4832,-0.0807146021590323,1.9273646156905e-08
Primary analysis,Right atrium,RA stroke volume,CES1;Liver carboxylesterase 1,4807,-0.080917700119941,1.93198431445453e-08
Primary analysis,Left ventricle,LV cardiac output,PON3;Serum paraoxonase/lactonase 3,4859,0.080462157687026,1.94974378891738e-08
Primary analysis,Left ventricle,LV cardiac output,CNTN3;Contactin-3,4841,-0.0806070252914091,1.95303645446094e-08
Primary analysis,Left ventricle,LV end systolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4861,-0.0804221131928141,1.96842271401608e-08
Primary analysis,Left ventricle,LV cardiac output,CYTL1;Cytokine-like protein 1,3449,-0.0954049098920909,1.98005350597817e-08
Primary analysis,Right atrium,RA stroke volume,FTCD;Formimidoyltransferase-cyclodeaminase,3376,-0.0964140976079088,1.98862273229092e-08
Primary analysis,Right atrium,RA maximum volume,CD300E;CMRF35-like molecule 2,4789,-0.0809945820112022,1.9908374900215e-08
Primary analysis,Left atrium,LA maximum volume,AGRN;Agrin,4784,-0.0810360590063448,1.9914138579392e-08
Primary analysis,Right atrium,RA maximum volume,THY1;Thy-1 membrane glycoprotein,4820,-0.0807310518727881,1.99354344089953e-08
Primary analysis,Left ventricle,LV end diastolic volume,RBP7;Retinoid-binding protein 7,3426,-0.0956904165323168,2.00241183825075e-08
Primary analysis,Left ventricle,LV end diastolic volume,CTSD;Cathepsin D,4543,-0.0831334468304399,2.00562077327333e-08
Primary analysis,Left ventricle,LV end diastolic volume,MUC13;Mucin-13,4749,-0.0813142607366777,2.00664451142334e-08
Primary analysis,Right atrium,RA stroke volume,NTRK3;NT-3 growth factor receptor,4828,0.0806406782949505,2.01265290042769e-08
Primary analysis,Right atrium,RA minimum volume,AMBP;Protein AMBP,4793,-0.0809163020157798,2.02682891185102e-08
Primary analysis,Left ventricle,LV end systolic volume,CDHR5;Cadherin-related family member 5,4856,-0.0803833489081553,2.03322522713066e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,CLMP;CXADR-like membrane protein,4887,-0.080126085316543,2.03537135578682e-08
Primary analysis,Right ventricle,RV end diastolic volume,PI3;Elafin,4791,-0.0809178047841895,2.03935780806758e-08
Primary analysis,Left ventricle,LV myocardial mass,ITGAM;Integrin alpha-M,4842,0.0804827359183442,2.04675359505639e-08
Primary analysis,Descending aorta,Descending aorta maximum area,PRND;Prion-like protein doppel,3243,-0.0982635101639708,2.05551369950481e-08
Primary analysis,Right atrium,RA maximum volume,CD300LG;CMRF35-like molecule 9,4759,0.0811563660652434,2.06588228850063e-08
Primary analysis,Right ventricle,RV stroke volume,SELE;E-selectin,4917,-0.0798092199638964,2.09647613524172e-08
Primary analysis,Right ventricle,RV end systolic volume,IGFBP4;Insulin-like growth factor-binding protein 4,4783,-0.0809132384587381,2.09915115156625e-08
Primary analysis,Descending aorta,Descending aorta minimum area,CSF1;Macrophage colony-stimulating factor 1,4579,-0.0826825201234843,2.10607245501132e-08
Primary analysis,Right ventricle,RV stroke volume,REG1A;Lithostathine-1-alpha,4827,-0.0805341618847478,2.1080218533415e-08
Primary analysis,Right atrium,RA maximum volume,GGH;Gamma-glutamyl hydrolase,4672,-0.081852537470879,2.11046989282138e-08
Primary analysis,Descending aorta,Descending aorta minimum area,GFRA3;GDNF family receptor alpha-3,4542,-0.0830064273828068,2.11531988844341e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,4862,-0.0802356421972708,2.11563346302874e-08
Primary analysis,Left ventricle,LV cardiac output,SERPINF1;Pigment epithelium-derived factor,3405,-0.0957757298874146,2.14889609615889e-08
Primary analysis,Right ventricle,RV end systolic volume,UPB1;Beta-ureidopropionase,3455,-0.0950745412571248,2.15499277185339e-08
Primary analysis,Right atrium,RA stroke volume,GPD1;Glycerol-3-phosphate dehydrogenase,3379,-0.0961271446796029,2.15974773513889e-08
Primary analysis,Left atrium,LA minimum volume,ANGPT2;Angiopoietin-2,4776,0.0808958952972211,2.16443626239368e-08
Primary analysis,Left ventricle,LV end systolic volume,CFB;Complement factor B,3381,-0.0960907910733449,2.16560883766838e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,TCTN3;Tectonic-3,3456,0.0950371867189507,2.17245467504434e-08
Primary analysis,Right ventricle,RV stroke volume,CCL16;C-C motif chemokine 16,4917,-0.0797138799292865,2.17929621020244e-08
Primary analysis,Right atrium,RA minimum volume,IL16;Pro-interleukin-16,4813,-0.0805148346690523,2.22650583171277e-08
Primary analysis,Left ventricle,LV end diastolic volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4865,0.0800695455404937,2.24003599762751e-08
Primary analysis,Left ventricle,LV stroke volume,CNTN3;Contactin-3,4843,-0.0802220265993608,2.26606156253278e-08
Primary analysis,Left ventricle,LV end diastolic volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3365,-0.0961826057577001,2.2666224484354e-08
Primary analysis,Right ventricle,RV stroke volume,CD5;T-cell surface glycoprotein CD5,4888,-0.0798372149002691,2.28048107850794e-08
Primary analysis,Left ventricle,LV cardiac output,CRLF1;Cytokine receptor-like factor 1,4859,-0.0800639906068153,2.29013306845928e-08
Primary analysis,Right atrium,RA minimum volume,EPHA1;Ephrin type-A receptor 1,4759,-0.0808516027015852,2.33338971880908e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,DNER;Delta and Notch-like epidermal growth factor-related receptor,4827,0.0802616328263505,2.35221623983324e-08
Primary analysis,Descending aorta,Descending aorta maximum area,IL1RN;Interleukin-1 receptor antagonist protein,4552,-0.0826349020139598,2.36033472253625e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,KYNU;Kynureninase,4901,0.0796381143201823,2.36836287634608e-08
Primary analysis,Left ventricle,LV myocardial mass,CST3;Cystatin-C,4858,-0.0799874982935067,2.3696491245399e-08
Primary analysis,Right ventricle,RV end systolic volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4816,-0.0803271581912498,2.37671220592038e-08
Primary analysis,Right ventricle,RV stroke volume,GHR;Growth hormone receptor,3376,-0.0958781301316892,2.38260493888108e-08
Primary analysis,Left ventricle,LV cardiac output,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4763,-0.0807649655594586,2.38302640028626e-08
Primary analysis,Right atrium,RA stroke volume,ICAM1;Intercellular adhesion molecule 1,4762,-0.0807631804145797,2.39277619356679e-08
Primary analysis,Right ventricle,RV end systolic volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4831,-0.0801486991346808,2.42879206647124e-08
Primary analysis,Descending aorta,Descending aorta maximum area,MEPE;Matrix extracellular phosphoglycoprotein,4555,-0.0825337579872638,2.4294440295421e-08
Primary analysis,Right ventricle,RV end diastolic volume,ANG;Angiogenin,4842,-0.0800078323287164,2.47808170647825e-08
Primary analysis,Right atrium,RA maximum volume,VMO1;Vitelline membrane outer layer protein 1 homolog,4748,-0.080753044608871,2.51854685505581e-08
Primary analysis,Right atrium,RA maximum volume,UPB1;Beta-ureidopropionase,3393,-0.0954598759762853,2.53043217361385e-08
Primary analysis,Left ventricle,LV myocardial mass,MIA;Melanoma-derived growth regulatory protein,4871,-0.0796362994415123,2.61500206633216e-08
Primary analysis,Right atrium,RA maximum volume,OSM;Oncostatin-M,4737,-0.0807341362211983,2.63335368014511e-08
Primary analysis,Descending aorta,Descending aorta maximum area,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4613,-0.0817993612655579,2.64332164420212e-08
Primary analysis,Left ventricle,LV cardiac output,CFI;Complement factor I,3442,-0.0946117611600261,2.67929388431087e-08
Primary analysis,Left ventricle,LV end systolic volume,KLK6;Kallikrein-6,4854,-0.0796865721824251,2.70971353412284e-08
Primary analysis,Right ventricle,RV end diastolic volume,VGF;Neurosecretory protein VGF,3444,-0.0945421922492138,2.71782733236761e-08
Primary analysis,Right ventricle,RV end diastolic volume,CCL15;C-C motif chemokine 15,4917,-0.079168187569076,2.7180277385091e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,HAVCR1;Hepatitis A virus cellular receptor 1,4885,0.0794237821576422,2.72087049892852e-08
Primary analysis,Right atrium,RA stroke volume,CFI;Complement factor I,3387,-0.09530929499906,2.73804553532412e-08
Primary analysis,Right ventricle,RV stroke volume,PRCP;Lysosomal Pro-X carboxypeptidase,4872,-0.0794990642353945,2.75421156568794e-08
Primary analysis,Right atrium,RA stroke volume,ACP5;Tartrate-resistant acid phosphatase type 5,4790,-0.0801661996896339,2.76368717524804e-08
Primary analysis,Left ventricle,LV cardiac output,SELE;E-selectin,4915,-0.0791247358314911,2.78404951454626e-08
Primary analysis,Descending aorta,Descending aorta minimum area,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4614,-0.0816449418145905,2.79813353177388e-08
Primary analysis,Right atrium,RA minimum volume,HAVCR2;Hepatitis A virus cellular receptor 2,4750,-0.0804635629727725,2.80624484550271e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,THBS2;Thrombospondin-2,4839,0.079711967894925,2.81771758475566e-08
Primary analysis,Right atrium,RA minimum volume,CES1;Liver carboxylesterase 1,4789,-0.0801219476592337,2.82214147293597e-08
Primary analysis,Right ventricle,RV end diastolic volume,CXCL10;C-X-C motif chemokine 10,4861,-0.0795207009075907,2.83034945359918e-08
Primary analysis,Left ventricle,LV end diastolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4830,0.079770138322013,2.8356285961049e-08
Primary analysis,Left atrium,LA maximum volume,CXCL17;C-X-C motif chemokine 17,4828,-0.0797553012310391,2.87130361117914e-08
Primary analysis,Right ventricle,RV end systolic volume,AFM;Afamin,3443,-0.0943855085776086,2.87891251143227e-08
Primary analysis,Left ventricle,LV end systolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4812,-0.0798781249766168,2.88197124911956e-08
Primary analysis,Descending aorta,Descending aorta minimum area,NRCAM;Neuronal cell adhesion molecule,4587,-0.0817881478419435,2.90474313789825e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,PRND;Prion-like protein doppel,3442,-0.0943460021562654,2.93104411189868e-08
Primary analysis,Descending aorta,Descending aorta minimum area,DLL1;Delta-like protein 1,4590,-0.081717954579006,2.95436612981878e-08
Primary analysis,Descending aorta,Descending aorta maximum area,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4561,-0.0819447312055414,2.99109966892671e-08
Primary analysis,Left ventricle,LV myocardial mass,DPT;Dermatopontin,4916,-0.0789320146386369,2.99901458997842e-08
Primary analysis,Left ventricle,LV end systolic volume,IDUA;Alpha-L-iduronidase,4879,-0.0792260857281152,3.00366865424121e-08
Primary analysis,Left ventricle,LV stroke volume,PALM2;Paralemmin-2,3442,-0.0942648229974075,3.01241593966262e-08
Primary analysis,Right atrium,RA stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4749,-0.0802865385730982,3.01998937630589e-08
Primary analysis,Right ventricle,RV stroke volume,HSPB6;Heat shock protein beta-6,4890,-0.0791223601986488,3.02155516185673e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,ACE2;Angiotensin-converting enzyme 2,4761,0.0801558678330187,3.05569656339711e-08
Primary analysis,Right ventricle,RV end diastolic volume,BSG;Basigin,4897,-0.0790322737040018,3.06265274118956e-08
Primary analysis,Left ventricle,LV end diastolic volume,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,3285,-0.0964299677369038,3.06502557812472e-08
Primary analysis,Right ventricle,RV end diastolic volume,VSNL1;Visinin-like protein 1,3442,-0.0942111033053459,3.06746314001446e-08
Primary analysis,Left ventricle,LV stroke volume,SMOC2;SPARC-related modular calcium-binding protein 2,4861,-0.0793073984284731,3.08257120800217e-08
Primary analysis,Right ventricle,RV stroke volume,C1RL;Complement C1r subcomponent-like protein,3437,-0.0942525464002618,3.09527248658465e-08
Primary analysis,Left ventricle,LV myocardial mass,SCARB2;Lysosome membrane protein 2,4723,-0.0804350693325999,3.10636393086135e-08
Primary analysis,Right atrium,RA maximum volume,CHRDL1;Chordin-like protein 1,4768,-0.0800511410572099,3.11188148889668e-08
Primary analysis,Descending aorta,Descending aorta maximum area,ADM;Pro-adrenomedullin,4604,-0.0814358999308942,3.14182562040075e-08
Primary analysis,Right ventricle,RV end diastolic volume,SERPINB8;Serpin B8,4905,-0.0788974831208003,3.15053411238297e-08
Primary analysis,Left ventricle,LV end systolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4832,-0.0794654019758422,3.18111034590986e-08
Primary analysis,Left ventricle,LV cardiac output,NECTIN4;Nectin-4,4870,-0.0791537631062066,3.18342541309756e-08
Primary analysis,Right ventricle,RV end diastolic volume,FOLR1;Folate receptor alpha,4840,-0.0793891244765836,3.19476480769365e-08
Primary analysis,Right atrium,RA maximum volume,CANT1;Soluble calcium-activated nucleotidase 1,4743,-0.0801634165246634,3.23435734345784e-08
Primary analysis,Left ventricle,LV stroke volume,RNASE4;Ribonuclease 4,3323,-0.0957087384888892,3.24285311428473e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,CDA;Cytidine deaminase,3449,0.0939447248163512,3.24953804944323e-08
Primary analysis,Right ventricle,RV stroke volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4737,-0.0801934725162005,3.26066230457077e-08
Primary analysis,Left ventricle,LV end diastolic volume,VSNL1;Visinin-like protein 1,3440,-0.0940556924540788,3.26200798156557e-08
Primary analysis,Right ventricle,RV end diastolic volume,SKAP1;Src kinase-associated phosphoprotein 1,4825,-0.0794419480784553,3.28513990516376e-08
Primary analysis,Descending aorta,Descending aorta minimum area,CD59;CD59 glycoprotein,4410,-0.0830739412959148,3.29959371016937e-08
Primary analysis,Left ventricle,LV end diastolic volume,SYT1;Synaptotagmin-1,3440,-0.0940131566682181,3.3089919123458e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,ACY1;Aminoacylase-1,4862,0.0791185477894068,3.31322678364802e-08
Primary analysis,Left ventricle,LV end diastolic volume,RGMB;RGM domain family member B,4902,-0.0787868407692001,3.32530704143589e-08
Primary analysis,Left ventricle,LV end diastolic volume,CCL15;C-C motif chemokine 15,4915,-0.0786792108774785,3.33016032076263e-08
Primary analysis,Right atrium,RA maximum volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3366,-0.0949761052591837,3.37675371596687e-08
Primary analysis,Left ventricle,LV myocardial mass,CHRDL1;Chordin-like protein 1,4850,-0.0791492729422863,3.40259096093814e-08
Primary analysis,Right ventricle,RV end systolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4865,-0.0790217306196187,3.41039865924086e-08
Primary analysis,Right atrium,RA maximum volume,IGSF3;Immunoglobulin superfamily member 3,4748,-0.0799797674024178,3.41992731195416e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,MFGE8;Lactadherin,4840,0.0791982819499292,3.44684004960483e-08
Primary analysis,Right atrium,RA minimum volume,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,4754,-0.079899658736139,3.46025855740358e-08
Primary analysis,Left ventricle,LV stroke volume,SELE;E-selectin,4917,-0.0785515088298643,3.48267527453807e-08
Primary analysis,Left ventricle,LV cardiac output,EFNA4;Ephrin-A4,4821,-0.0793170779973129,3.49738421289218e-08
Primary analysis,Right ventricle,RV end systolic volume,CRIP2;Cysteine-rich protein 2,4828,-0.0792474716331697,3.51440715154844e-08
Primary analysis,Left ventricle,LV end systolic volume,CFD;Complement factor D,3434,-0.093911593818923,3.51895259651659e-08
Primary analysis,Right ventricle,RV end diastolic volume,IGSF8;Immunoglobulin superfamily member 8,4867,-0.0789266403559187,3.51932928271936e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,"GSR;Glutathione reductase, mitochondrial",3427,0.0940002437289524,3.5270433304349e-08
Primary analysis,Left ventricle,LV cardiac output,SMNDC1;Survival of motor neuron-related-splicing factor 30,3426,-0.0940123437092601,3.5288940301342e-08
Primary analysis,Right ventricle,RV end diastolic volume,TGFA;Protransforming growth factor alpha,4852,-0.0790405471213021,3.53009711524283e-08
Primary analysis,Right ventricle,RV stroke volume,NELL2;Protein kinase C-binding protein NELL2,4861,-0.0789524489250308,3.55135561440927e-08
Primary analysis,Descending aorta,Descending aorta minimum area,NCAN;Neurocan core protein,4617,-0.0809992139300325,3.56106092801747e-08
Primary analysis,Right atrium,RA stroke volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4759,-0.0797740629335145,3.57628594917131e-08
Primary analysis,Right atrium,RA stroke volume,PIGR;Polymeric immunoglobulin receptor,4724,-0.0800277093162095,3.63360256899326e-08
Primary analysis,Right atrium,RA stroke volume,GDF15;Growth/differentiation factor 15,4841,-0.0790555398290507,3.63611122767969e-08
Primary analysis,Right atrium,RA minimum volume,LEPR;Leptin receptor,4777,0.0795721670857316,3.65017320037481e-08
Primary analysis,Right atrium,RA minimum volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3280,-0.0959413479654879,3.68554704850903e-08
Primary analysis,Left ventricle,LV stroke volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4737,-0.0798817601991447,3.68583161971647e-08
Primary analysis,Left ventricle,LV end systolic volume,PALM;Paralemmin-1,3387,-0.0944084717841731,3.69905913535874e-08
Primary analysis,Right ventricle,RV end diastolic volume,MSR1;Macrophage scavenger receptor types I and II,4904,-0.078477587684242,3.7389158641298e-08
Primary analysis,Right ventricle,RV end systolic volume,GGH;Gamma-glutamyl hydrolase,4755,-0.079692446886428,3.74186060068588e-08
Primary analysis,Left ventricle,LV cardiac output,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3426,-0.0938106944361704,3.77509836653649e-08
Primary analysis,Right atrium,RA maximum volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4682,-0.0802834298504444,3.78031326170556e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,ERBB2;Receptor tyrosine-protein kinase erbB-2,4867,0.0787027612439414,3.84713034432497e-08
Primary analysis,Left ventricle,LV end diastolic volume,CSF1;Macrophage colony-stimulating factor 1,4859,-0.0787180631640714,3.92312009541767e-08
Primary analysis,Right atrium,RA minimum volume,APOF;Apolipoprotein F,3381,0.0943042886116982,3.93664723912149e-08
Primary analysis,Right atrium,RA stroke volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4830,-0.0789413847720263,3.94182589444205e-08
Primary analysis,Left ventricle,LV stroke volume,TFF3;Trefoil factor 3,4835,-0.0789004113350276,3.94221820365629e-08
Primary analysis,Left ventricle,LV end systolic volume,C19orf12;Protein C19orf12,4740,-0.0796725657524534,3.96159033116006e-08
Primary analysis,Right atrium,RA minimum volume,INHBC;Inhibin beta C chain,4750,-0.10216612216172,1.68994965416127e-12
Primary analysis,Left atrium,LA maximum volume,CLEC4A;C-type lectin domain family 4 member A,4776,0.0793571780136437,3.98555603792815e-08
Primary analysis,Left ventricle,LV end systolic volume,APCS;Serum amyloid P-component,3409,-0.0938700300802847,3.99951382019385e-08
Primary analysis,Left ventricle,LV end diastolic volume,AGR3;Anterior gradient protein 3,4746,-0.0795684994463184,4.04602782587974e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,BLMH;Bleomycin hydrolase,4914,0.0781948159868944,4.05449913035832e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,MVK;Mevalonate kinase,4757,0.0794707327700453,4.05549595890313e-08
Primary analysis,Descending aorta,Descending aorta minimum area,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4562,-0.0811135977972014,4.10760850658536e-08
Primary analysis,Descending aorta,Descending aorta maximum area,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4589,-0.0808731415693577,4.11099032993908e-08
Primary analysis,Left ventricle,LV cardiac output,CLEC4A;C-type lectin domain family 4 member A,4851,0.0786232134990715,4.17899868752646e-08
Primary analysis,Right ventricle,RV end systolic volume,MEGF10;Multiple epidermal growth factor-like domains protein 10,4835,0.0787523073333208,4.1799102279877e-08
Primary analysis,Left ventricle,LV end diastolic volume,VWC2;Brorin,4817,-0.0788943824439921,4.18740615375538e-08
Primary analysis,Right ventricle,RV end systolic volume,CYTL1;Cytokine-like protein 1,3450,-0.0931656805645341,4.20096643894609e-08
Primary analysis,Right atrium,RA minimum volume,APCS;Serum amyloid P-component,3349,-0.0945412684620896,4.21990043949722e-08
Primary analysis,Left ventricle,LV cardiac output,C1RL;Complement C1r subcomponent-like protein,3435,-0.0933483083648641,4.2288316526283e-08
Primary analysis,Left ventricle,LV end diastolic volume,KIAA0319;Dyslexia-associated protein KIAA0319,3440,-0.0932670377136776,4.24813546676111e-08
Primary analysis,Left atrium,LA maximum volume,IGFBP6;Insulin-like growth factor-binding protein 6,4762,-0.0792920248301849,4.27940461958519e-08
Primary analysis,Left ventricle,LV stroke volume,PRND;Prion-like protein doppel,3442,-0.0932156056158036,4.28290074660273e-08
Primary analysis,Right atrium,RA maximum volume,CCN1;CCN family member 1,4745,-0.0794240877766674,4.29529043844914e-08
Primary analysis,Right atrium,RA minimum volume,COL18A1;Collagen alpha-1(XVIII) chain,4793,-0.0790233777143708,4.3004438754113e-08
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,4903,-0.0780699582076791,4.41155415512882e-08
Primary analysis,Left ventricle,LV stroke volume,INHBC;Inhibin beta C chain,4843,-0.100994201132947,1.86051367023732e-12
Primary analysis,Left ventricle,LV cardiac output,EPHA1;Ephrin type-A receptor 1,4850,-0.0784828921428946,4.43142847942177e-08
Primary analysis,Left ventricle,LV end diastolic volume,AGER;Advanced glycosylation end product-specific receptor,4825,-0.0786831159902335,4.43546651406479e-08
Primary analysis,Left ventricle,LV cardiac output,INHBC;Inhibin beta C chain,4841,-0.097161863670885,1.24796605717685e-11
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,TTR;Transthyretin,3409,0.0935379907346715,4.46582407490447e-08
Primary analysis,Right ventricle,RV end diastolic volume,MMP12;Macrophage metalloelastase,4858,-0.0783923095351517,4.47736394494343e-08
Primary analysis,Left ventricle,LV cardiac output,NELL2;Protein kinase C-binding protein NELL2,4859,-0.0783409859192191,4.55455621531331e-08
Primary analysis,Left ventricle,LV cardiac output,PLIN1;Perilipin-1,4749,-0.0792349974786722,4.5647751783662e-08
Primary analysis,Ascending aorta,Ascending aorta maximum area,MFAP5;Microfibrillar-associated protein 5,4632,-0.0802224773874694,4.57239418503512e-08
Primary analysis,Left ventricle,LV end diastolic volume,FGFR2;Fibroblast growth factor receptor 2,4870,-0.0782387678803714,4.57968431143571e-08
Primary analysis,Left ventricle,LV stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4869,-0.0782448323333056,4.58321317740166e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 13,ACY1;Aminoacylase-1,4863,0.0782824907842169,4.60220884736949e-08
Primary analysis,Right atrium,RA stroke volume,MSR1;Macrophage scavenger receptor types I and II,4828,-0.0785589889366784,4.61310666223842e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,KYNU;Kynureninase,4902,0.0779527593008268,4.63608122514017e-08
Primary analysis,Right ventricle,RV end systolic volume,"FABP1;Fatty acid-binding protein, liver",4835,-0.0784542012945457,4.70118240244359e-08
Primary analysis,Right ventricle,RV stroke volume,MMP12;Macrophage metalloelastase,4858,-0.0782659780734238,4.70630251930993e-08
Primary analysis,Right ventricle,RV stroke volume,CCL22;C-C motif chemokine 22,4774,-0.0789120118667829,4.77626681281146e-08
Primary analysis,Left ventricle,LV end diastolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4821,-0.0785224041981831,4.78566073643633e-08
Primary analysis,Right ventricle,RV end systolic volume,HAO1;Hydroxyacid oxidase 1,4889,-0.077958442758605,4.81864307572558e-08
Primary analysis,Right ventricle,RV end systolic volume,CALB1;Calbindin,4831,-0.0784002088606639,4.86358330045957e-08
Primary analysis,Right ventricle,RV end systolic volume,PGF;Placenta growth factor,4904,-0.0778096005948087,4.87588223711323e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,CDA;Cytidine deaminase,3450,0.0927121847478801,4.88662206696983e-08
Primary analysis,Right atrium,RA maximum volume,DCXR;L-xylulose reductase,4787,-0.0787464090654999,4.88714914257016e-08
Primary analysis,Right atrium,RA maximum volume,EPHB6;Ephrin type-B receptor 6,4741,-0.0791113281669972,4.91612455607184e-08
Primary analysis,Left ventricle,LV cardiac output,EFNA1;Ephrin-A1,4836,-0.0783198570743217,4.94048994885638e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 14,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.0925825994209388,4.96755708327651e-08
Primary analysis,Right ventricle,RV end systolic volume,SORD;Sorbitol dehydrogenase,4878,-0.0779249315542993,5.05460913250036e-08
Primary analysis,Right ventricle,RV end systolic volume,EPHA2;Ephrin type-A receptor 2,4619,-0.0800398473007815,5.12165801540555e-08
Primary analysis,Left ventricle,LV myocardial mass,COL6A3;Collagen alpha-3(VI) chain,4916,-0.0775904148772056,5.12211211394059e-08
Primary analysis,Left ventricle,LV cardiac output,SIT1;Signaling threshold-regulating transmembrane adapter 1,4759,-0.0788464855580784,5.14237459048731e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,PRSS8;Prostasin,4823,0.0783080822387939,5.17242262282687e-08
Primary analysis,Left ventricle,LV myocardial mass,HAVCR2;Hepatitis A virus cellular receptor 2,4842,-0.0781533565084519,5.17511663000661e-08
Primary analysis,Right ventricle,RV end systolic volume,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4831,-0.0782328532516125,5.19382611036218e-08
Primary analysis,Right atrium,RA maximum volume,SERPIND1;Heparin cofactor 2,3380,-0.0934687068136309,5.21051590070403e-08
Primary analysis,Left ventricle,LV stroke volume,LY6D;Lymphocyte antigen 6D,4821,-0.0783019364571385,5.21789954467624e-08
Primary analysis,Left ventricle,LV stroke volume,COL6A3;Collagen alpha-3(VI) chain,4917,-0.0775210577575672,5.24823499540893e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,ADAMTSL2;ADAMTS-like protein 2,3450,0.0924825786849534,5.27393963689789e-08
Primary analysis,Right ventricle,RV stroke volume,CES2;Cocaine esterase,4832,-0.0781783447613367,5.28924826990554e-08
Primary analysis,Right atrium,RA stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4757,-0.0787779110881384,5.31550181136108e-08
Primary analysis,Right atrium,RA stroke volume,CLMP;CXADR-like membrane protein,4813,-0.0783158966871823,5.32289775071159e-08
Primary analysis,Left ventricle,LV end diastolic volume,BPIFB2;BPI fold-containing family B member 2,3447,-0.092486924161653,5.33682853419888e-08
Primary analysis,Right ventricle,RV end systolic volume,SERPIND1;Heparin cofactor 2,3441,-0.0925654971379414,5.33990164056753e-08
Primary analysis,Right ventricle,RV end systolic volume,CES1;Liver carboxylesterase 1,4879,-0.0777751857550771,5.34505068617979e-08
Primary analysis,Left ventricle,LV end diastolic volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4834,-0.0781190288386265,5.37953186957065e-08
Primary analysis,Right atrium,RA minimum volume,NTRK3;NT-3 growth factor receptor,4811,0.0782998790441758,5.39044343788669e-08
Primary analysis,Left ventricle,LV stroke volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4905,-0.0775475604032364,5.39110837234309e-08
Primary analysis,Right atrium,RA maximum volume,MSR1;Macrophage scavenger receptor types I and II,4820,-0.0782239998924105,5.39662618954426e-08
Primary analysis,Left ventricle,LV end diastolic volume,MEGF10;Multiple epidermal growth factor-like domains protein 10,4834,0.0781084478882601,5.40188048661609e-08
Primary analysis,Right ventricle,RV end diastolic volume,LCAT;Phosphatidylcholine-sterol acyltransferase,3452,-0.0923832678623236,5.40253727182069e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,SELE;E-selectin,4914,0.0774496458897876,5.44900249417218e-08
Primary analysis,Left ventricle,LV radial strain AHA 16,LEP;Leptin,4859,-0.0778687436466579,5.48528464826819e-08
Primary analysis,Right ventricle,RV end diastolic volume,REG1B;Lithostathine-1-beta,4917,-0.0773956992642549,5.51476202024189e-08
Primary analysis,Left ventricle,LV stroke volume,CD4;T-cell surface glycoprotein CD4,4849,-0.0779243028041517,5.5382174933672e-08
Primary analysis,Ascending aorta,Ascending aorta maximum area,CKB;Creatine kinase B-type,3254,0.095062750651541,5.54242608925341e-08
Primary analysis,Left ventricle,LV myocardial mass,SOST;Sclerostin,4865,-0.0777826922952996,5.56807056052969e-08
Primary analysis,Right ventricle,RV end diastolic volume,CRLF1;Cytokine receptor-like factor 1,4861,-0.0778108910688509,5.57619919488757e-08
Primary analysis,Left ventricle,LV end systolic volume,THY1;Thy-1 membrane glycoprotein,4893,-0.0775444065778762,5.6031957727055e-08
Primary analysis,Left ventricle,LV end systolic volume,RNASE1;Ribonuclease pancreatic,3442,-0.0924036095587722,5.60895120565997e-08
Primary analysis,Left ventricle,LV longitudinal strain Segment 2,VEGFD;Vascular endothelial growth factor D,4764,0.0785783431922643,5.61684989682083e-08
Primary analysis,Right ventricle,RV end diastolic volume,IDUA;Alpha-L-iduronidase,4890,-0.0775585829764655,5.6242884254083e-08
Primary analysis,Descending aorta,Descending aorta maximum area,CFD;Complement factor D,3249,-0.0950855784449471,5.63228064008762e-08
Primary analysis,Right atrium,RA minimum volume,TGFA;Protransforming growth factor alpha,4760,-0.0785875586428415,5.66879497230592e-08
Primary analysis,Left ventricle,LV end systolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4886,-0.077550290607068,5.713360834004e-08
Primary analysis,Left ventricle,LV end systolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4832,-0.0779660202443397,5.74765772399001e-08
Primary analysis,Right atrium,RA minimum volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4745,-0.0786637121190422,5.77442750777139e-08
Primary analysis,Right atrium,RA minimum volume,CRIP2;Cysteine-rich protein 2,4736,-0.0787267516778652,5.80013020968102e-08
Primary analysis,Left ventricle,LV stroke volume,ITGA5;Integrin alpha-5,4843,-0.0778403106222285,5.83225497082466e-08
Primary analysis,Right atrium,RA stroke volume,SORD;Sorbitol dehydrogenase,4803,-0.0781616360831129,5.83524157503907e-08
Primary analysis,Left ventricle,LV stroke volume,EFNA4;Ephrin-A4,4823,-0.0779975277959771,5.84046251938454e-08
Primary analysis,Descending aorta,Descending aorta distensibility,REN;Renin,4151,0.0840465941055014,5.86262814332023e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,LAMP2;Lysosome-associated membrane glycoprotein 2,4712,0.078880621981298,5.90366424181755e-08
Primary analysis,Left ventricle,LV myocardial mass,PLAT;Tissue-type plasminogen activator,4903,-0.0773290950803869,5.91235165464933e-08
Primary analysis,Right atrium,RA stroke volume,SHBG;Sex hormone-binding globulin,3395,0.0928372116578864,5.99247975036312e-08
Primary analysis,Left ventricle,LV myocardial mass,INHBC;Inhibin beta C chain,4842,-0.0777781607582077,5.99448240687559e-08
Primary analysis,Right ventricle,RV stroke volume,FAM3C;Protein FAM3C,4866,-0.0775657056092654,6.0437432666934e-08
Primary analysis,Left ventricle,LV stroke volume,C1R;Complement C1r subcomponent,3444,-0.092105022395755,6.13609146043743e-08
Primary analysis,Right atrium,RA minimum volume,PRAP1;Proline-rich acidic protein 1,3379,-0.0929680492902231,6.16722129811203e-08
Primary analysis,Right ventricle,RV stroke volume,CXCL10;C-X-C motif chemokine 10,4861,-0.0775398551842309,6.20098366792708e-08
Primary analysis,Left ventricle,LV end diastolic volume,LGALS3BP;Galectin-3-binding protein,3442,-0.0920818637902436,6.23773468643483e-08
Primary analysis,Right atrium,RA maximum volume,THOP1;Thimet oligopeptidase,4775,-0.0782114439638308,6.25361092258061e-08
Primary analysis,Right ventricle,RV end diastolic volume,KIAA0319;Dyslexia-associated protein KIAA0319,3442,-0.0920695319229608,6.26314525395337e-08
Primary analysis,Right atrium,RA stroke volume,EFNA4;Ephrin-A4,4748,-0.0784005249069282,6.33244615458609e-08
Primary analysis,Right ventricle,RV end diastolic volume,DPY30;Protein dpy-30 homolog,4879,-0.0773122947769456,6.41029120796495e-08
Primary analysis,Right ventricle,RV end diastolic volume,RETN;Resistin,4837,-0.0776294440621028,6.45276189391979e-08
Primary analysis,Left ventricle,LV end systolic volume,CES1;Liver carboxylesterase 1,4869,-0.0773727228139201,6.45740488251782e-08
Primary analysis,Descending aorta,Descending aorta maximum area,FLT3LG;Fms-related tyrosine kinase 3 ligand,4621,-0.079410397792597,6.47245955140359e-08
Primary analysis,Right ventricle,RV end diastolic volume,"FABP1;Fatty acid-binding protein, liver",4836,-0.0776239256374117,6.48685656375913e-08
Primary analysis,Right atrium,RA stroke volume,SNCG;Gamma-synuclein,4754,-0.0782767313654324,6.51723746782132e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,HEG1;Protein HEG homolog 1,3375,0.092836562409068,6.55389996723772e-08
Primary analysis,Left ventricle,LV end diastolic volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3440,-0.0919342055084844,6.60629085525671e-08
Primary analysis,Left ventricle,LV stroke volume,OGN;Mimecan,4843,-0.0775174755723022,6.6157380599459e-08
Primary analysis,Right atrium,RA maximum volume,FUOM;Fucose mutarotase,3311,-0.0936745910175236,6.66414995846546e-08
Primary analysis,Right atrium,RA minimum volume,NPY;Pro-neuropeptide Y,4795,-0.0778764523573435,6.68554717042674e-08
Primary analysis,Left ventricle,LV myocardial mass,PRRT3;Proline-rich transmembrane protein 3,3352,-0.0930894895974018,6.69130860017866e-08
Primary analysis,Left ventricle,LV myocardial mass,RSPO3;R-spondin-3,4889,-0.0771233631548566,6.69252127582125e-08
Primary analysis,Right atrium,RA stroke volume,CDHR5;Cadherin-related family member 5,4795,-0.0778680403911136,6.70738076371939e-08
Primary analysis,Right ventricle,RV end systolic volume,RTBDN;Retbindin,4831,-0.0775777681935002,6.70823166850866e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,"FABP4;Fatty acid-binding protein, adipocyte",4914,-0.0769164925664171,6.72125701771818e-08
Primary analysis,Left ventricle,LV end systolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4876,-0.0771819282725582,6.80836848818747e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,GNPDA2;Glucosamine-6-phosphate isomerase 2,3376,0.092678132000864,6.87033330528082e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,IGSF3;Immunoglobulin superfamily member 3,4829,0.0775321177236838,6.87102620436113e-08
Primary analysis,Right ventricle,RV stroke volume,GPR37;Prosaposin receptor GPR37,4765,-0.078037433819806,6.9037747754662e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,DNER;Delta and Notch-like epidermal growth factor-related receptor,4828,0.0775227667348616,6.91753076327498e-08
Primary analysis,Right atrium,RA maximum volume,RNASE4;Ribonuclease 4,3265,-0.0942063356621911,6.93286459145229e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,"FABP4;Fatty acid-binding protein, adipocyte",4914,-0.0768350607241838,6.93932269341696e-08
Primary analysis,Left atrium,LA stroke volume,SOST;Sclerostin,4799,-0.0777424176466554,6.95418038360936e-08
Primary analysis,Right ventricle,RV end systolic volume,RGMB;RGM domain family member B,4903,-0.0768945597514387,7.01148531894268e-08
Primary analysis,Left ventricle,LV stroke volume,CFC1;Cryptic protein,4756,-0.0780674165454802,7.02089856297733e-08
Primary analysis,Left atrium,LA stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3375,-0.0926192695932296,7.0344307671312e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,IGSF3;Immunoglobulin superfamily member 3,4829,0.0774382351277309,7.1262077108252e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,ERBB2;Receptor tyrosine-protein kinase erbB-2,4868,0.0771172904142352,7.15651944350673e-08
Primary analysis,Left ventricle,LV cardiac output,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3350,-0.0929034231104861,7.1714880759634e-08
Primary analysis,Right ventricle,RV end systolic volume,PSPN;Persephin,4851,-0.0772317889431571,7.21290219185105e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,CPM;Carboxypeptidase M,4882,0.0769852787291803,7.21717841834505e-08
Primary analysis,Right atrium,RA stroke volume,FGF21;Fibroblast growth factor 21,4809,-0.0775521845323757,7.25573215099185e-08
Primary analysis,Right atrium,RA maximum volume,TGFA;Protransforming growth factor alpha,4769,-0.0778732041081176,7.26334863522746e-08
Primary analysis,Right atrium,RA maximum volume,CD6;T-cell differentiation antigen CD6,4813,-0.0775138043575698,7.27325495292789e-08
Primary analysis,Left atrium,LA stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4687,-0.0785461381796636,7.27331574456812e-08
Primary analysis,Right ventricle,RV end diastolic volume,LCN2;Neutrophil gelatinase-associated lipocalin,4712,-0.0783313120774512,7.29205326124424e-08
Primary analysis,Descending aorta,Descending aorta maximum area,SCG2;Secretogranin-2,4593,-0.079318944590282,7.3418994934457e-08
Primary analysis,Right ventricle,RV end systolic volume,CD99L2;CD99 antigen-like protein 2,4842,-0.0772512213104129,7.3604566019767e-08
Primary analysis,Right atrium,RA minimum volume,HNMT;Histamine N-methyltransferase,4722,-0.0781913237280186,7.45381278605697e-08
Primary analysis,Right ventricle,RV end diastolic volume,LTBP3;Latent-transforming growth factor beta-binding protein 3,4756,-0.0778941648645378,7.50524050374886e-08
Primary analysis,Descending aorta,Descending aorta maximum area,MOG;Myelin-oligodendrocyte glycoprotein,4604,-0.0791627954975113,7.51510266019102e-08
Primary analysis,Left ventricle,LV end systolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3432,-0.0916430385523144,7.52703515895272e-08
Primary analysis,Left ventricle,LV cardiac output,RARRES2;Retinoic acid receptor responder protein 2,4867,-0.0769917897595854,7.53803802465196e-08
Primary analysis,Right atrium,RA maximum volume,PROC;Vitamin K-dependent protein C,4781,-0.0776702717041597,7.56474866043528e-08
Primary analysis,Right ventricle,RV stroke volume,MXRA8;Matrix remodeling-associated protein 8,3376,0.0923668185354162,7.60190436951354e-08
Primary analysis,Left ventricle,LV myocardial mass,KLK6;Kallikrein-6,4864,-0.0769828461504428,7.63426738923202e-08
Primary analysis,Right ventricle,RV stroke volume,ELOA;Elongin-A,4832,-0.0772218364033589,7.6783788279763e-08
Primary analysis,Right ventricle,RV end systolic volume,CCN5;CCN family member 5,4842,-0.0771378097272132,7.69161245984808e-08
Primary analysis,Right atrium,RA maximum volume,CCL3;C-C motif chemokine 3,4769,-0.0777189007309601,7.70815192353129e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,HEPH;Hephaestin,3455,0.0912636294102779,7.71442759846062e-08
Primary analysis,Left atrium,LA maximum volume,CYTL1;Cytokine-like protein 1,3390,-0.0921288645873114,7.72071047792361e-08
Primary analysis,Right ventricle,RV end diastolic volume,C1R;Complement C1r subcomponent,3444,-0.0913940953699415,7.7515584698854e-08
Primary analysis,Left ventricle,LV end diastolic volume,SPON1;Spondin-1,4843,-0.0770834226341896,7.83135976625442e-08
Primary analysis,Left ventricle,LV cardiac output,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3344,-0.0926964483246961,7.87590067902204e-08
Primary analysis,Left ventricle,LV myocardial mass,NCAN;Neurocan core protein,4903,-0.0765877716736683,7.90407077715041e-08
Primary analysis,Left ventricle,LV stroke volume,EFNA1;Ephrin-A1,4838,-0.0770921535598064,7.92593429901871e-08
Primary analysis,Right atrium,RA minimum volume,GHR;Growth hormone receptor,3303,-0.0932053022199136,8.03561094295878e-08
Primary analysis,Left ventricle,LV end diastolic volume,PXN;Paxillin,4749,-0.0777358004489196,8.15281238762671e-08
Primary analysis,Right atrium,RA stroke volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4768,-0.0775785619061496,8.1609147904524e-08
Primary analysis,Left ventricle,LV end diastolic volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3454,-0.0910991519957371,8.17688102865104e-08
Primary analysis,Right ventricle,RV stroke volume,OCLN;Occludin,3444,-0.0912218542810862,8.20098729106685e-08
Primary analysis,Right ventricle,RV stroke volume,APOF;Apolipoprotein F,3452,0.0911157897344127,8.20277031999731e-08
Primary analysis,Right ventricle,RV stroke volume,COL15A1;Collagen alpha-1(XV) chain,3451,-0.0911109710123759,8.25115571518836e-08
Primary analysis,Descending aorta,Descending aorta maximum area,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4555,-0.0793368257845001,8.25410630811878e-08
Primary analysis,Left ventricle,LV cardiac output,SNCG;Gamma-synuclein,4827,-0.0770728896855133,8.26011422145314e-08
Primary analysis,Left ventricle,LV cardiac output,SFRP1;Secreted frizzled-related protein 1,4811,-0.0771974856081282,8.27013266185689e-08
Primary analysis,Left ventricle,LV cardiac output,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4903,-0.0764479311353662,8.34653849361914e-08
Primary analysis,Left ventricle,LV cardiac output,TFF3;Trefoil factor 3,4833,-0.0769979792432647,8.34731009363046e-08
Primary analysis,Right atrium,RA minimum volume,PAMR1;Inactive serine protease PAMR1,4750,-0.0776653107492288,8.3498973530532e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,HEG1;Protein HEG homolog 1,3376,0.0920743322113498,8.3575771228982e-08
Primary analysis,Left ventricle,LV myocardial mass,PODXL2;Podocalyxin-like protein 2,4871,-0.0766909896355965,8.36933920957754e-08
Primary analysis,Right atrium,RA stroke volume,CDHR2;Cadherin-related family member 2,4757,-0.0776022008688618,8.36940976325505e-08
Primary analysis,Left ventricle,LV cardiac output,RBP5;Retinol-binding protein 5,4830,-0.0770057761509439,8.39922786636463e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,TCTN3;Tectonic-3,3455,0.0910020278889107,8.40478524573551e-08
Primary analysis,Right atrium,RA minimum volume,OSM;Oncostatin-M,4728,-0.0778258973024204,8.41217848471474e-08
Primary analysis,Left ventricle,LV cardiac output,OXT;Oxytocin-neurophysin 1,4902,-0.076411824136768,8.49025754488528e-08
Primary analysis,Right ventricle,RV end diastolic volume,EPS8L2;Epidermal growth factor receptor kinase substrate 8-like protein 2,4883,-0.076559869583427,8.4906247944457e-08
Primary analysis,Left atrium,LA stroke volume,RTN4R;Reticulon-4 receptor,4818,-0.0770721648323247,8.49439347251856e-08
Primary analysis,Right ventricle,RV end diastolic volume,INHBB;Inhibin beta B chain,3376,-0.0920193103360126,8.50763756673878e-08
Primary analysis,Left ventricle,LV cardiac output,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4735,-0.0777320142290452,8.53032124010771e-08
Primary analysis,Right ventricle,RV end systolic volume,VSNL1;Visinin-like protein 1,3441,-0.0911224807946375,8.581786170441e-08
Primary analysis,Right ventricle,RV end systolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4736,-0.077681596488543,8.66911532429177e-08
Primary analysis,Descending aorta,Descending aorta maximum area,SOST;Sclerostin,4585,-0.0789280926829727,8.73145221316252e-08
Primary analysis,Right atrium,RA stroke volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4686,-0.0780436061154084,8.8363394313708e-08
Primary analysis,Right ventricle,RV stroke volume,KYNU;Kynureninase,4905,-0.0762682442100732,8.89662245951042e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,CDA;Cytidine deaminase,3450,0.0908829857888142,8.92754457822338e-08
Primary analysis,Right atrium,RA stroke volume,HAVCR2;Hepatitis A virus cellular receptor 2,4768,-0.0772989983087048,9.08433123790685e-08
Primary analysis,Left atrium,LA stroke volume,INHBC;Inhibin beta C chain,4773,-0.0772585203635011,9.08460844003505e-08
Primary analysis,Left ventricle,LV stroke volume,ASGR1;Asialoglycoprotein receptor 1,4829,-0.0768091146518395,9.08891485876843e-08
Primary analysis,Left ventricle,LV end diastolic volume,IGSF3;Immunoglobulin superfamily member 3,4830,-0.0767801871618964,9.16271450953565e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,TIMP4;Metalloproteinase inhibitor 4,4840,-0.0766948675030719,9.18447608815672e-08
Primary analysis,Right atrium,RA maximum volume,DPT;Dermatopontin,4832,-0.0767578805084043,9.18552101379429e-08
Primary analysis,Ascending aorta,Ascending aorta maximum area,CRLF1;Cytokine receptor-like factor 1,4580,-0.0788260988358674,9.21970563001137e-08
Primary analysis,Descending aorta,Descending aorta minimum area,RGMB;RGM domain family member B,4617,-0.0785082696734646,9.22717672908382e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,MEGF10;Multiple epidermal growth factor-like domains protein 10,4833,0.0767336611192776,9.24336344349847e-08
Primary analysis,Right ventricle,RV end diastolic volume,"NOS3;Nitric oxide synthase, endothelial",4751,-0.0773815519902986,9.27817500205716e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,"FABP4;Fatty acid-binding protein, adipocyte",4914,-0.0760846206789178,9.299230469235e-08
Primary analysis,Right atrium,RA stroke volume,GFRA1;GDNF family receptor alpha-1,4809,-0.0768882369491613,9.37276420978506e-08
Primary analysis,Left atrium,LA stroke volume,OGN;Mimecan,4773,-0.0771739717789819,9.38342487754779e-08
Primary analysis,Right atrium,RA maximum volume,HEG1;Protein HEG homolog 1,3311,-0.0925566636082219,9.54002736811395e-08
Primary analysis,Left ventricle,LV end systolic volume,CFI;Complement factor I,3434,-0.090880719658323,9.56791655766656e-08
Primary analysis,Right ventricle,RV end systolic volume,EFNA1;Ephrin-A1,4837,-0.0766104503709682,9.57505495389528e-08
Primary analysis,Left atrium,LA stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3296,-0.092748290933479,9.59483723929073e-08
Primary analysis,Left ventricle,LV cardiac output,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,3284,-0.0928937802076577,9.66583600835331e-08
Primary analysis,Right atrium,RA maximum volume,DPY30;Protein dpy-30 homolog,4793,-0.076919619403236,9.72591971740691e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 1,LEP;Leptin,4864,-0.0763386025865039,9.79713449064808e-08
Primary analysis,Left ventricle,LV end diastolic volume,ICAM1;Intercellular adhesion molecule 1,4834,-0.0765701885530912,9.8135549816151e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,GGT1;Glutathione hydrolase 1 proenzyme,4835,0.076544880953924,9.87945009892995e-08
Primary analysis,Right atrium,RA maximum volume,CD163;Scavenger receptor cysteine-rich type 1 protein M130,4782,-0.0769596549941492,9.90670766150202e-08
Primary analysis,Left ventricle,LV stroke volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3442,-0.0906672508181724,9.91023647833733e-08
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,CLEC4A;C-type lectin domain family 4 member A,4849,0.0764252166241579,9.91507630390092e-08
Primary analysis,Right atrium,RA stroke volume,CYTL1;Cytokine-like protein 1,3393,-0.0913105813775682,9.9318919156853e-08
Primary analysis,Left atrium,LA stroke volume,CD4;T-cell surface glycoprotein CD4,4780,-0.0769522696643239,9.9958594451624e-08
Primary analysis,Left ventricle,LV end diastolic volume,CCL7;C-C motif chemokine 7,4850,-0.0763950379365897,1.00006140697456e-07
Primary analysis,Left ventricle,LV end diastolic volume,FUOM;Fucose mutarotase,3375,-0.0914975749276302,1.01102141908279e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,HEG1;Protein HEG homolog 1,3376,0.0914826461808173,1.0114842560353e-07
Primary analysis,Right ventricle,RV end diastolic volume,APOF;Apolipoprotein F,3452,0.0904640692309239,1.01456839256262e-07
Primary analysis,Right ventricle,RV end diastolic volume,CLEC7A;C-type lectin domain family 7 member A,4905,-0.075925368289243,1.01612132288032e-07
Primary analysis,Left ventricle,LV cardiac output,ITGA5;Integrin alpha-5,4841,-0.0764003010877688,1.02557383454029e-07
Primary analysis,Right ventricle,RV stroke volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3352,-0.0917610046947997,1.02696707201061e-07
Primary analysis,Right ventricle,RV stroke volume,ITGA5;Integrin alpha-5,4843,-0.0763623292236858,1.03437143585009e-07
Primary analysis,Right ventricle,RV end diastolic volume,SNRPB2;U2 small nuclear ribonucleoprotein B'',3442,-0.0905261718967213,1.03746175868359e-07
Primary analysis,Right atrium,RA maximum volume,CD74;HLA class II histocompatibility antigen gamma chain,4820,-0.0765279585010201,1.04069554263342e-07
Primary analysis,Left ventricle,LV cardiac output,SMOC2;SPARC-related modular calcium-binding protein 2,4859,-0.0762203972551784,1.04092052556782e-07
Primary analysis,Right ventricle,RV end diastolic volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3428,-0.0906758134957086,1.04907613647065e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,ADM;Pro-adrenomedullin,4887,-0.0759411629704777,1.06573459000706e-07
Primary analysis,Right atrium,RA minimum volume,CA6;Carbonic anhydrase 6,4746,0.0770431452362443,1.07187182820887e-07
Primary analysis,Descending aorta,Descending aorta maximum area,EPHB6;Ephrin type-B receptor 6,4547,-0.078703465834977,1.07319230434494e-07
Primary analysis,Left ventricle,LV stroke volume,CD83;CD83 antigen,4852,-0.0761900430765023,1.07555189758606e-07
Primary analysis,Left ventricle,LV myocardial mass,CD59;CD59 glycoprotein,4681,-0.0775576116650805,1.07888108727884e-07
Primary analysis,Right atrium,RA minimum volume,EPHB6;Ephrin type-B receptor 6,4732,-0.0771133199829898,1.08967088828779e-07
Primary analysis,Descending aorta,Descending aorta minimum area,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4562,-0.078528474796971,1.09166228764353e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,4862,-0.0760678677755285,1.09388011896013e-07
Primary analysis,Left ventricle,LV stroke volume,CCER2;Coiled-coil domain-containing glutamate-rich protein 2,3353,-0.0915276849798154,1.10174122306757e-07
Primary analysis,Left ventricle,LV end diastolic volume,ANGPTL4;Angiopoietin-related protein 4,4849,-0.0761278764976343,1.11149497188139e-07
Primary analysis,Left ventricle,LV cardiac output,NT5C1A;Cytosolic 5'-nucleotidase 1A,3440,-0.0903306038846346,1.11472938818394e-07
Primary analysis,Right ventricle,RV end systolic volume,F7;Coagulation factor VII,4855,-0.0760666440930999,1.11760543992829e-07
Primary analysis,Left ventricle,LV end diastolic volume,FAM3C;Protein FAM3C,4864,-0.0759861214428434,1.12202714357269e-07
Primary analysis,Descending aorta,Descending aorta maximum area,PALM;Paralemmin-1,3200,-0.0936076422878876,1.12778076917353e-07
Primary analysis,Left ventricle,LV end systolic volume,PENK;Proenkephalin-A,3368,-0.0912234266361128,1.13791162534752e-07
Primary analysis,Right ventricle,RV end diastolic volume,NECTIN2;Nectin-2,4866,-0.075927874039229,1.14055830192579e-07
Primary analysis,Left ventricle,LV end diastolic volume,PLAUR;Urokinase plasminogen activator surface receptor,4808,-0.0763745338264425,1.14441171712215e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.0900270856311081,1.14953859216775e-07
Primary analysis,Left ventricle,LV end diastolic volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4830,-0.0761770590218417,1.15485258356839e-07
Primary analysis,Ascending aorta,Ascending aorta minimum area,GGH;Gamma-glutamyl hydrolase,4484,-0.0790261837547697,1.16682910802616e-07
Primary analysis,Left ventricle,LV end diastolic volume,HAO1;Hydroxyacid oxidase 1,4888,-0.0756949925737874,1.16817790161036e-07
Primary analysis,Descending aorta,Descending aorta maximum area,LGALS3;Galectin-3,4591,-0.0780985834075921,1.16839639234252e-07
Primary analysis,Right atrium,RA maximum volume,CSF1;Macrophage colony-stimulating factor 1,4777,-0.0765585293787638,1.17206891072529e-07
Primary analysis,Right atrium,RA stroke volume,GUSB;Beta-glucuronidase,4790,-0.0764338433062924,1.18145997109352e-07
Primary analysis,Right ventricle,RV end diastolic volume,FUOM;Fucose mutarotase,3376,-0.0909840805887926,1.18685494971061e-07
Primary analysis,Left ventricle,LV end systolic volume,PRSS8;Prostasin,4815,-0.0762202170186525,1.18842683972423e-07
Primary analysis,Left ventricle,LV stroke volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3428,-0.0902850254519948,1.1901786854237e-07
Primary analysis,Right ventricle,RV end systolic volume,RARRES2;Retinoic acid receptor responder protein 2,4868,-0.0757949839110355,1.19306642980268e-07
Primary analysis,Right atrium,RA maximum volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4787,-0.0764316646460136,1.19322810418414e-07
Primary analysis,Left ventricle,LV cardiac output,STC1;Stanniocalcin-1,4902,-0.0755269997682379,1.195497241606e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3456,0.0898942501710079,1.20004444085273e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,ITIH3;Inter-alpha-trypsin inhibitor heavy chain H3,4862,-0.0758091109228443,1.20801800897962e-07
Primary analysis,Ascending aorta,Ascending aorta distensibility,REN;Renin,4150,0.12452221031188,8.23105047482151e-16
Primary analysis,Right atrium,RA stroke volume,IGSF3;Immunoglobulin superfamily member 3,4757,-0.0766288523586515,1.21276238112e-07
Primary analysis,Right atrium,RA minimum volume,PLTP;Phospholipid transfer protein,4812,0.0761798221895361,1.21780797521076e-07
Primary analysis,Left ventricle,LV myocardial mass,ANGPTL4;Angiopoietin-related protein 4,4850,-0.0758717626809175,1.22235466018564e-07
Primary analysis,Right ventricle,RV end diastolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3442,-0.0900143447167384,1.2242683235919e-07
Primary analysis,Right ventricle,RV stroke volume,CD74;HLA class II histocompatibility antigen gamma chain,4904,-0.075448943774358,1.22466832462351e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,IL1R2;Interleukin-1 receptor type 2,4823,0.0760679995416679,1.22952117065911e-07
Primary analysis,Left ventricle,LV end diastolic volume,SCG3;Secretogranin-3,4843,-0.075908264309976,1.23087360921833e-07
Primary analysis,Left ventricle,LV myocardial mass,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4904,-0.0754153824854698,1.24056702460502e-07
Primary analysis,Left ventricle,LV stroke volume,SFRP1;Secreted frizzled-related protein 1,4813,-0.0761217566632468,1.24129785354936e-07
Primary analysis,Right ventricle,RV end systolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4871,-0.0756499413802394,1.25004262254425e-07
Primary analysis,Right ventricle,RV end systolic volume,SCLY;Selenocysteine lyase,4883,-0.0755466287312048,1.25509299980542e-07
Primary analysis,Right ventricle,RV stroke volume,AREG;Amphiregulin,4832,-0.0759326756409404,1.26019916277517e-07
Primary analysis,Right atrium,RA maximum volume,CD80;T-lymphocyte activation antigen CD80,3393,-0.0905606591235945,1.26375110789334e-07
Primary analysis,Right ventricle,RV stroke volume,RNASE4;Ribonuclease 4,3323,-0.0915012413597773,1.26576790438876e-07
Primary analysis,Left ventricle,LV end diastolic volume,CES2;Cocaine esterase,4830,-0.0759113485696898,1.27809799031856e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,DNER;Delta and Notch-like epidermal growth factor-related receptor,4826,0.0759382290181654,1.28028902977599e-07
Primary analysis,Right ventricle,RV stroke volume,IGFBP4;Insulin-like growth factor-binding protein 4,4784,-0.0762549090753706,1.28765808744082e-07
Primary analysis,Right atrium,RA stroke volume,NPPC;C-type natriuretic peptide,4778,-0.076288254414524,1.29470333142933e-07
Primary analysis,Right ventricle,RV end diastolic volume,RSPO3;R-spondin-3,4890,-0.0753966730617631,1.30213499176572e-07
Primary analysis,Left ventricle,LV stroke volume,IGSF3;Immunoglobulin superfamily member 3,4832,-0.0758406963141878,1.30514725561993e-07
Primary analysis,Left ventricle,LV stroke volume,RBP5;Retinol-binding protein 5,4832,-0.0758289798100076,1.31098297225111e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,VWA1;von Willebrand factor A domain-containing protein 1,4883,0.075429345235385,1.31275660579283e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 13,PTPRB;Receptor-type tyrosine-protein phosphatase beta,3455,0.0896039325536049,1.32351087409388e-07
Primary analysis,Right atrium,RA stroke volume,NPY;Pro-neuropeptide Y,4813,-0.0759384811402914,1.33089014371939e-07
Primary analysis,Left ventricle,LV stroke volume,SEMA3F;Semaphorin-3F,4867,-0.075510112696837,1.33440844574302e-07
Primary analysis,Right ventricle,RV end systolic volume,TNFRSF9;Tumor necrosis factor receptor superfamily member 9,4828,-0.0758122037224281,1.33519975738576e-07
Primary analysis,Left ventricle,LV stroke volume,DCXR;L-xylulose reductase,4872,-0.0754625875597265,1.33893264719458e-07
Primary analysis,Right atrium,RA maximum volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3366,-0.0907362722766377,1.34070591262944e-07
Primary analysis,Left ventricle,LV end systolic volume,PSPN;Persephin,4841,-0.0756968231112006,1.34221470382346e-07
Primary analysis,Right ventricle,RV stroke volume,C1R;Complement C1r subcomponent,3444,-0.0896867239371369,1.34918786961656e-07
Primary analysis,Right ventricle,RV stroke volume,CFI;Complement factor I,3444,-0.0896587923725445,1.36136259789028e-07
Primary analysis,Left ventricle,LV cardiac output,IL16;Pro-interleukin-16,4903,-0.075170070729784,1.36699088531695e-07
Primary analysis,Right atrium,RA maximum volume,CLEC7A;C-type lectin domain family 7 member A,4821,-0.0758011179519505,1.36909049686992e-07
Primary analysis,Right ventricle,RV end diastolic volume,GCG;Pro-glucagon,4756,-0.0763128952490994,1.37075364647634e-07
Primary analysis,Left ventricle,LV end systolic volume,OGN;Mimecan,4832,-0.0757060613887716,1.37374682389008e-07
Primary analysis,Descending aorta,Descending aorta minimum area,IL1RN;Interleukin-1 receptor antagonist protein,4553,-0.077985159508906,1.37392775714877e-07
Primary analysis,Left ventricle,LV stroke volume,CSF1;Macrophage colony-stimulating factor 1,4861,-0.0754771551557658,1.37546232093056e-07
Primary analysis,Right atrium,RA minimum volume,SCARB2;Lysosome membrane protein 2,4633,-0.0773023904735609,1.37813045827056e-07
Primary analysis,Right ventricle,RV end diastolic volume,BAIAP2;Brain-specific angiogenesis inhibitor 1-associated protein 2,4756,-0.0762804256266931,1.3876422589714e-07
Primary analysis,Left ventricle,LV myocardial mass,CNTN4;Contactin-4,4842,0.0756003692636513,1.3882803173861e-07
Primary analysis,Right atrium,RA stroke volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4822,-0.0757561916423606,1.3885062569164e-07
Primary analysis,Left ventricle,LV end systolic volume,IGFBP1;Insulin-like growth factor-binding protein 1,4900,0.0751428473867514,1.39349799143716e-07
Primary analysis,Right ventricle,RV stroke volume,RETN;Resistin,4837,-0.0756255283696816,1.39559013750981e-07
Primary analysis,Left ventricle,LV stroke volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3352,-0.0907677717287593,1.40922743418383e-07
Primary analysis,Left ventricle,LV end diastolic volume,NEFL;Neurofilament light polypeptide,4740,-0.0763444446107697,1.42162928288668e-07
Primary analysis,Descending aorta,Descending aorta maximum area,DPT;Dermatopontin,4630,-0.077218230198071,1.43521861835097e-07
Primary analysis,Right atrium,RA stroke volume,HEPH;Hephaestin,3399,-0.0900778829915929,1.43749962089201e-07
Primary analysis,Right atrium,RA maximum volume,RBKS;Ribokinase,4667,-0.0769058696567661,1.43865244533253e-07
Primary analysis,Right atrium,RA stroke volume,IL16;Pro-interleukin-16,4830,-0.0755876969723943,1.44546361056538e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness global,LAMP2;Lysosome-associated membrane glycoprotein 2,4713,0.0765130809964105,1.44810287027199e-07
Primary analysis,Right atrium,RA stroke volume,BCHE;Cholinesterase,3331,-0.0909616935041242,1.45020989854586e-07
Primary analysis,Right ventricle,RV stroke volume,CD99L2;CD99 antigen-like protein 2,4843,-0.0754493457544885,1.46596247479707e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,GFER;FAD-linked sulfhydryl oxidase ALR,4751,0.0761734001209182,1.46664259639659e-07
Primary analysis,Left ventricle,LV cardiac output,DCXR;L-xylulose reductase,4870,-0.0752326459700863,1.47029261837197e-07
Primary analysis,Right atrium,RA maximum volume,CD28;T-cell-specific surface glycoprotein CD28,4673,-0.0767978307779442,1.4705550487127e-07
Primary analysis,Right atrium,RA maximum volume,AFM;Afamin,3382,-0.0902286591086785,1.47199726768304e-07
Primary analysis,Left atrium,LA maximum volume,MIA;Melanoma-derived growth regulatory protein,4794,-0.0758205470743129,1.47290288224857e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,PRSS8;Prostasin,4823,0.0755897092308332,1.47462371917366e-07
Primary analysis,Left ventricle,LV end systolic volume,MFAP5;Microfibrillar-associated protein 5,4906,-0.074947456729784,1.47552350876685e-07
Primary analysis,Left ventricle,LV cardiac output,COL6A3;Collagen alpha-3(VI) chain,4915,-0.0748676773244688,1.48190660873648e-07
Primary analysis,Left ventricle,LV end diastolic volume,SCGB1A1;Uteroglobin,4846,-0.0753878664257144,1.48737262374728e-07
Primary analysis,Ascending aorta,Ascending aorta maximum area,DPT;Dermatopontin,4632,-0.0771002268188546,1.49029971414687e-07
Primary analysis,Left ventricle,LV myocardial mass,COL5A1;Collagen alpha-1(V) chain,3376,0.0902581694379015,1.4957255623586e-07
Primary analysis,Right atrium,RA maximum volume,PRND;Prion-like protein doppel,3380,-0.0901857789482527,1.50484778042721e-07
Primary analysis,Right ventricle,RV end diastolic volume,CDH2;Cadherin-2,4867,-0.0751730438788524,1.51730854849122e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,ERBB2;Receptor tyrosine-protein kinase erbB-2,4869,0.0751469397240597,1.52349529393489e-07
Primary analysis,Right atrium,RA minimum volume,CDHR5;Cadherin-related family member 5,4777,-0.0758653342066546,1.52354561149028e-07
Primary analysis,Right atrium,RA stroke volume,PGF;Placenta growth factor,4830,-0.0754447976509919,1.52592934997508e-07
Primary analysis,Right ventricle,RV stroke volume,GPKOW;G-patch domain and KOW motifs-containing protein,4751,-0.076067620890413,1.52613855695319e-07
Primary analysis,Right atrium,RA stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4682,-0.0766168267235615,1.53065247263304e-07
Primary analysis,Right atrium,RA maximum volume,CFB;Complement factor B,3329,-0.0908166514586055,1.53115061061906e-07
Primary analysis,Descending aorta,Descending aorta minimum area,FLT3LG;Fms-related tyrosine kinase 3 ligand,4622,-0.0770814801854878,1.5476645118652e-07
Primary analysis,Right atrium,RA stroke volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4796,-0.0756306329298879,1.57297362654108e-07
Primary analysis,Right ventricle,RV end systolic volume,IL16;Pro-interleukin-16,4904,-0.0747887780149199,1.57678592657692e-07
Primary analysis,Right atrium,RA maximum volume,C19orf12;Protein C19orf12,4669,-0.07662134058239,1.58976800583309e-07
Primary analysis,Left ventricle,LV end diastolic volume,MEP1A;Meprin A subunit alpha,3426,-0.0894068713007644,1.59054739755813e-07
Primary analysis,Left atrium,LA stroke volume,CPM;Carboxypeptidase M,4816,-0.0754438221343989,1.59088618996383e-07
Primary analysis,Right ventricle,RV end diastolic volume,ITGA11;Integrin alpha-11,4852,0.0751633390656897,1.59132673975155e-07
Primary analysis,Left ventricle,LV cardiac output,TGFBR2;TGF-beta receptor type-2,4870,-0.0750223252791125,1.59271782494897e-07
Primary analysis,Right ventricle,RV stroke volume,IL18BP;Interleukin-18-binding protein,4865,-0.0750590933619362,1.59373688052643e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,NFASC;Neurofascin,4901,0.0747739270151509,1.59958902852432e-07
Primary analysis,Right ventricle,RV stroke volume,SMOC1;SPARC-related modular calcium-binding protein 1,4890,-0.0748481995933392,1.60543533917653e-07
Primary analysis,Right ventricle,RV end diastolic volume,IFNLR1;Interferon lambda receptor 1,4852,-0.075127175987025,1.6132873609841e-07
Primary analysis,Right atrium,RA maximum volume,GM2A;Ganglioside GM2 activator,3303,-0.0910019684687973,1.61506692639071e-07
Primary analysis,Right ventricle,RV end diastolic volume,S100A11;Protein S100-A11,4812,-0.0754347879484426,1.61527670854901e-07
Primary analysis,Left ventricle,LV end diastolic volume,NPTXR;Neuronal pentraxin receptor,4865,-0.0750132932611507,1.62167715019657e-07
Primary analysis,Right ventricle,RV stroke volume,IGSF3;Immunoglobulin superfamily member 3,4832,-0.0752632598017334,1.62484096179701e-07
Primary analysis,Left ventricle,LV stroke volume,HGF;Hepatocyte growth factor,4905,-0.0746992525088281,1.62678240834887e-07
Primary analysis,Left ventricle,LV end diastolic volume,VWC2L;von Willebrand factor C domain-containing protein 2-like,3442,-0.0891149402842808,1.6341323724862e-07
Primary analysis,Left ventricle,LV end diastolic volume,WFDC2;WAP four-disulfide core domain protein 2,4562,-0.0774318457304818,1.63759990337185e-07
Primary analysis,Right ventricle,RV end systolic volume,XCL1;Lymphotactin,4889,-0.0747937391119358,1.64379547551375e-07
Primary analysis,Left ventricle,LV stroke volume,ANGPTL7;Angiopoietin-related protein 7,4890,-0.0747766174127701,1.64973671999803e-07
Primary analysis,Right ventricle,RV end diastolic volume,IL12A_IL12B;Interleukin-12,4832,-0.0751808045013321,1.67626126686258e-07
Primary analysis,Right atrium,RA minimum volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4805,-0.0753850754933192,1.6801598787904e-07
Primary analysis,Right atrium,RA maximum volume,IL6;Interleukin-6,4748,-0.0758307562429196,1.68293625412747e-07
Primary analysis,Right atrium,RA minimum volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4740,0.0758809613700109,1.69152378077831e-07
Primary analysis,Right atrium,RA stroke volume,WFDC2;WAP four-disulfide core domain protein 2,4491,-0.0779263697513559,1.70680114429992e-07
Primary analysis,Left ventricle,LV myocardial mass,SUSD2;Sushi domain-containing protein 2,4842,0.0750478008984008,1.7117963759998e-07
Primary analysis,Left ventricle,LV cardiac output,PALM2;Paralemmin-2,3440,-0.0889940732802593,1.71246118659403e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 1,GNPDA2;Glucosamine-6-phosphate isomerase 2,3376,0.0898231632506594,1.71664959840485e-07
Primary analysis,Left atrium,LA stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4799,-0.0753683071674816,1.72095369731166e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,TTR;Transthyretin,3409,0.089380486839456,1.72117583270028e-07
Primary analysis,Right atrium,RA stroke volume,COL6A3;Collagen alpha-3(VI) chain,4841,-0.0750281160626141,1.72961412815859e-07
Primary analysis,Left ventricle,LV end diastolic volume,ISM1;Isthmin-1,4850,-0.0749553462308841,1.73176228732853e-07
Primary analysis,Descending aorta,Descending aorta maximum area,RELT;Tumor necrosis factor receptor superfamily member 19L,4561,-0.0772735376577023,1.74093669904733e-07
Primary analysis,Right ventricle,RV end diastolic volume,TNFRSF14;Tumor necrosis factor receptor superfamily member 14,4845,-0.0749702577761424,1.74731100596968e-07
Primary analysis,Right atrium,RA minimum volume,RBP5;Retinol-binding protein 5,4740,-0.0757847826464529,1.75343206611068e-07
Primary analysis,Right atrium,RA maximum volume,CCL20;C-C motif chemokine 20,4821,-0.0751423788256736,1.75643458056675e-07
Primary analysis,Right ventricle,RV end diastolic volume,ADGRG1;Adhesion G-protein coupled receptor G1,4832,-0.0750296668130346,1.7746256377254e-07
Primary analysis,Right atrium,RA stroke volume,APOF;Apolipoprotein F,3395,0.0894666298166376,1.77505984922625e-07
Primary analysis,Left ventricle,LV end diastolic volume,MNDA;Myeloid cell nuclear differentiation antigen,4838,-0.0749799970468207,1.77679370371246e-07
Primary analysis,Right ventricle,RV end diastolic volume,ADH1B;All-trans-retinol dehydrogenase,3376,-0.0897129892782085,1.77742374194071e-07
Primary analysis,Left ventricle,LV end systolic volume,NPC2;NPC intracellular cholesterol transporter 2,3380,-0.0896425931586978,1.78725573522577e-07
Primary analysis,Left ventricle,LV end systolic volume,RNASE4;Ribonuclease 4,3314,-0.0905199168020866,1.79170202128164e-07
Primary analysis,Left ventricle,LV cardiac output,PRSS2;Trypsin-2,4863,-0.0747526881810268,1.80030387109994e-07
Primary analysis,Left atrium,LA ejection fraction,ACE2;Angiotensin-converting enzyme 2,4678,-0.0762105300847672,1.80197068381216e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,MFGE8;Lactadherin,4839,0.0749273945587851,1.80711405438631e-07
Primary analysis,Left ventricle,LV cardiac output,PGF;Placenta growth factor,4903,-0.0744303320693434,1.81229803664361e-07
Primary analysis,Right ventricle,RV end systolic volume,AMBP;Protein AMBP,4887,-0.0745491396790303,1.81412386207706e-07
Primary analysis,Descending aorta,Descending aorta maximum area,RTN4R;Reticulon-4 receptor,4604,-0.0767999530355285,1.8146955803108e-07
Primary analysis,Right ventricle,RV end systolic volume,BCHE;Cholinesterase,3386,-0.0894890540871718,1.82972137938828e-07
Primary analysis,Descending aorta,Descending aorta maximum area,TMPRSS5;Transmembrane protease serine 5,4526,-0.0774192331159588,1.8400479958987e-07
Primary analysis,Right ventricle,RV end systolic volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4864,-0.0746845279953105,1.84192726212289e-07
Primary analysis,Left ventricle,LV stroke volume,CXCL10;C-X-C motif chemokine 10,4861,-0.0746744369139848,1.86507388649498e-07
Primary analysis,Left ventricle,LV end systolic volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4841,0.0748220186641341,1.86940672998813e-07
Primary analysis,Right ventricle,RV stroke volume,DCXR;L-xylulose reductase,4872,-0.0745624802225578,1.88476553762104e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 11,CNTN3;Contactin-3,4840,0.0747553272285236,1.92250115414756e-07
Primary analysis,Right ventricle,RV end diastolic volume,CCL27;C-C motif chemokine 27,4867,-0.0745462664065336,1.92387225665284e-07
Primary analysis,Right atrium,RA stroke volume,SELE;E-selectin,4841,-0.0747389855139446,1.92875944371739e-07
Primary analysis,Right atrium,RA maximum volume,IFNLR1;Interferon lambda receptor 1,4769,-0.0752975728058362,1.93033571011008e-07
Primary analysis,Left ventricle,LV stroke volume,CHRDL1;Chordin-like protein 1,4851,-0.0746454240668309,1.94090001702342e-07
Primary analysis,Right atrium,RA maximum volume,DDT;D-dopachrome decarboxylase,3387,-0.0892816441224075,1.94534674905498e-07
Primary analysis,Left ventricle,LV cardiac output,RTBDN;Retbindin,4830,-0.0748009993677669,1.94539064630484e-07
Primary analysis,Descending aorta,Descending aorta minimum area,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4556,-0.0770096215970091,1.94718655879685e-07
Primary analysis,Left ventricle,LV end diastolic volume,ACP5;Tartrate-resistant acid phosphatase type 5,4863,-0.0745214339829046,1.96448483172358e-07
Primary analysis,Right atrium,RA stroke volume,VMO1;Vitelline membrane outer layer protein 1 homolog,4757,-0.0753385394104038,1.9693924972192e-07
Primary analysis,Right ventricle,RV stroke volume,CXCL13;C-X-C motif chemokine 13,4904,-0.074201226557287,1.97099128803351e-07
Primary analysis,Right atrium,RA stroke volume,THOP1;Thimet oligopeptidase,4784,-0.0751160306064074,1.97684149970534e-07
Primary analysis,Left atrium,LA stroke volume,SCG2;Secretogranin-2,4808,-0.0749270813188148,1.97807738585272e-07
Primary analysis,Left ventricle,LV mean myocardial wall thickness AHA 12,TCTN3;Tectonic-3,3456,0.0883334565519094,1.97988407320386e-07
Primary analysis,Right ventricle,RV stroke volume,CCL27;C-C motif chemokine 27,4867,-0.0744538978089518,1.99205473833586e-07
Primary analysis,Descending aorta,Descending aorta maximum area,SPINK5;Serine protease inhibitor Kazal-type 5,4561,-0.0768795058310606,2.01073501039165e-07
Primary analysis,Right atrium,RA stroke volume,IFNLR1;Interferon lambda receptor 1,4778,-0.0751089096819449,2.01722255945531e-07
Primary analysis,Right ventricle,RV stroke volume,VGF;Neurosecretory protein VGF,3444,-0.0884007673780454,2.03464513993991e-07
Primary analysis,Left ventricle,LV stroke volume,RTBDN;Retbindin,4832,-0.0746520145685422,2.04541427433662e-07
Primary analysis,Right atrium,RA maximum volume,PRRT3;Proline-rich transmembrane protein 3,3288,-0.0904394643710531,2.05190433580571e-07
Primary analysis,Left ventricle,LV cardiac output,IGSF3;Immunoglobulin superfamily member 3,4830,-0.0746550245954837,2.05495537421044e-07
Primary analysis,Right atrium,RA maximum volume,"ATRN;Attractin, Isoform 2",3382,-0.0891568000457652,2.06556022295593e-07
Primary analysis,Right ventricle,RV end systolic volume,AOC3;Membrane primary amine oxidase,4864,-0.0743699492818351,2.07381814047373e-07
Primary analysis,Right ventricle,RV end diastolic volume,ATRAID;All-trans retinoic acid-induced differentiation factor,3428,-0.0885433539574232,2.07549187257598e-07
Primary analysis,Right atrium,RA maximum volume,GUSB;Beta-glucuronidase,4781,-0.075005778597703,2.07805219486361e-07
Primary analysis,Left ventricle,LV cardiac output,FUOM;Fucose mutarotase,3374,-0.089241744083662,2.0787944372063e-07
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4137,-0.122119782933821,3.22628745010806e-15
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,CDON;Cell adhesion molecule-related/down-regulated by oncogenes,4147,-0.082060956278972,1.21098657484514e-07
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,CKB;Creatine kinase B-type,2968,0.0966450462373297,1.32543416395851e-07
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,CLMP;CXADR-like membrane protein,4183,-0.0817229796078694,1.2045771858709e-07
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,"FABP4;Fatty acid-binding protein, adipocyte",4202,-0.106967136938942,3.60647055784178e-12
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,IGFBP2;Insulin-like growth factor-binding protein 2,4196,0.0814057229299206,1.28919658267139e-07
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,LEP;Leptin,4166,-0.170253103754148,1.82390092086202e-28
sensitivity analysis,Ascending aorta,Ascending aorta maximum area,REN;Renin,4166,-0.093461552483304,1.50473111111173e-09
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4137,-0.127618663787124,1.72787206985524e-16
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,CDON;Cell adhesion molecule-related/down-regulated by oncogenes,4147,-0.0839213535687433,6.22479612753301e-08
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,CLMP;CXADR-like membrane protein,4183,-0.0806064045459113,1.78684776169458e-07
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,CRLF1;Cytokine receptor-like factor 1,4159,-0.0836992359856817,6.45723083242537e-08
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,"FABP4;Fatty acid-binding protein, adipocyte",4202,-0.10178848678727,3.75495495775948e-11
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,LEP;Leptin,4166,-0.16925144484014,3.80308499376016e-28
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,MFAP5;Microfibrillar-associated protein 5,4202,-0.0821225433454779,9.77605072572672e-08
sensitivity analysis,Ascending aorta,Ascending aorta minimum area,REN;Renin,4166,-0.105874190116709,7.34309651253207e-12
sensitivity analysis,Descending aorta,Descending aorta maximum area,ACVRL1;Serine/threonine-protein kinase receptor R3,4126,-0.0967270603534203,4.78857162657851e-10
sensitivity analysis,Descending aorta,Descending aorta maximum area,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4131,-0.0818227110641889,1.39261759085694e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4134,-0.104037096883039,2.00899084456565e-11
sensitivity analysis,Descending aorta,Descending aorta maximum area,ADM;Pro-adrenomedullin,4180,-0.0821150617785457,1.05857537868468e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,CALB2;Calretinin,4055,-0.0838454628768334,8.94456882587146e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,CBLN4;Cerebellin-4,4180,-0.0825031581719316,9.21385468291571e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,CCN5;CCN family member 5,4135,-0.104358094404471,1.7321511055831e-11
sensitivity analysis,Descending aorta,Descending aorta maximum area,CD59;CD59 glycoprotein,3997,-0.0840912868070013,1.01412648823973e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,CHRDL1;Chordin-like protein 1,4149,-0.0892818978345435,8.37831589308486e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,CLMP;CXADR-like membrane protein,4180,-0.132418619094149,8.21342845594076e-18
sensitivity analysis,Descending aorta,Descending aorta maximum area,COL15A1;Collagen alpha-1(XV) chain,2966,-0.117233928810343,1.51280064335767e-10
sensitivity analysis,Descending aorta,Descending aorta maximum area,COL6A3;Collagen alpha-3(VI) chain,4199,-0.0873625790359791,1.42609119029384e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,COLEC12;Collectin-12,4137,-0.0887730399885416,1.0689596024666e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,CRLF1;Cytokine receptor-like factor 1,4156,-0.114463250826959,1.34934783806075e-13
sensitivity analysis,Descending aorta,Descending aorta maximum area,DKK4;Dickkopf-related protein 4,4121,-0.098508687803948,2.33877248098635e-10
sensitivity analysis,Descending aorta,Descending aorta maximum area,DLL1;Delta-like protein 1,4166,-0.0806448521455573,1.86699743316581e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,"FABP4;Fatty acid-binding protein, adipocyte",4199,-0.143861283265264,7.3808560488858e-21
sensitivity analysis,Descending aorta,Descending aorta maximum area,FSTL3;Follistatin-related protein 3,4130,-0.0894867603782744,8.37694516074493e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,GFRA1;GDNF family receptor alpha-1,4176,-0.1045975783147,1.23658286572293e-11
sensitivity analysis,Descending aorta,Descending aorta maximum area,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4126,-0.0937863042339049,1.58229899324612e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,IGFBP6;Insulin-like growth factor-binding protein 6,4135,-0.105472895787776,1.05167654263006e-11
sensitivity analysis,Descending aorta,Descending aorta maximum area,IL1RN;Interleukin-1 receptor antagonist protein,4133,-0.0810308477317166,1.82485106181474e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,LEP;Leptin,4163,-0.171410634610374,8.1159132936972e-29
sensitivity analysis,Descending aorta,Descending aorta maximum area,MFAP5;Microfibrillar-associated protein 5,4199,-0.109420889210386,1.16308128790234e-12
sensitivity analysis,Descending aorta,Descending aorta maximum area,MIA;Melanoma-derived growth regulatory protein,4166,-0.0880126780149114,1.26980550477572e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,NOTCH1;Neurogenic locus notch homolog protein 1,4199,-0.0917417895847646,2.59068192086868e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,NPDC1;Neural proliferation differentiation and control protein 1,4163,-0.0920220395812661,2.71067679826586e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,OGN;Mimecan,4135,-0.0827720807881569,9.81523517375436e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,PALM;Paralemmin-1,2916,-0.10484721695553,1.38713680401928e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,PRELP;Prolargin,4137,-0.0924797098200432,2.53434929054914e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,PRND;Prion-like protein doppel,2956,-0.0973892053991674,1.12463195744092e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,PTGDS;Prostaglandin-H2 D-isomerase,4121,-0.0902502353999702,6.48657303086809e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,REN;Renin,4163,-0.116853749311306,3.93223908993317e-14
sensitivity analysis,Descending aorta,Descending aorta maximum area,SEMA3F;Semaphorin-3F,4163,-0.0992257604265128,1.39816431762518e-10
sensitivity analysis,Descending aorta,Descending aorta maximum area,SEZ6L;Seizure 6-like protein,4166,-0.0823080896203841,1.03782482476051e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,SMOC1;SPARC-related modular calcium-binding protein 1,4180,-0.0818898102828737,1.14705541424678e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,SMOC2;SPARC-related modular calcium-binding protein 2,4156,-0.0945686302325382,1.00622514282288e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,SOST;Sclerostin,4162,-0.0815221763568731,1.39069180336971e-07
sensitivity analysis,Descending aorta,Descending aorta maximum area,STC2;Stanniocalcin-2,4125,-0.106103908452799,8.38125311648376e-12
sensitivity analysis,Descending aorta,Descending aorta maximum area,TAFA5;Chemokine-like protein TAFA-5,4134,-0.0911500656557875,4.33032696977582e-09
sensitivity analysis,Descending aorta,Descending aorta maximum area,TGFBR2;TGF-beta receptor type-2,4166,-0.0850796657631564,3.80318504409277e-08
sensitivity analysis,Descending aorta,Descending aorta maximum area,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4180,-0.0872856115836558,1.58248558784974e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,ACVRL1;Serine/threonine-protein kinase receptor R3,4127,-0.0966984008778018,4.82224904645857e-10
sensitivity analysis,Descending aorta,Descending aorta minimum area,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4135,-0.110077708281421,1.26692975264112e-12
sensitivity analysis,Descending aorta,Descending aorta minimum area,CALB2;Calretinin,4056,-0.0832618681227301,1.0946641706725e-07
sensitivity analysis,Descending aorta,Descending aorta minimum area,CBLN4;Cerebellin-4,4181,-0.0817429182680708,1.20438520267227e-07
sensitivity analysis,Descending aorta,Descending aorta minimum area,CCN5;CCN family member 5,4136,-0.105437906481063,1.0622824614087e-11
sensitivity analysis,Descending aorta,Descending aorta minimum area,CHRDL1;Chordin-like protein 1,4150,-0.0845627830744061,4.87778091291781e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,CLMP;CXADR-like membrane protein,4181,-0.1262367425124,2.54999542052524e-16
sensitivity analysis,Descending aorta,Descending aorta minimum area,COL15A1;Collagen alpha-1(XV) chain,2966,-0.107408889496742,4.51575130751811e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,COL6A3;Collagen alpha-3(VI) chain,4200,-0.0878614167177006,1.17435538923431e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,COLEC12;Collectin-12,4138,-0.0829160781078093,9.22547859201917e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,CRLF1;Cytokine receptor-like factor 1,4157,-0.127193601308192,1.84468962583724e-16
sensitivity analysis,Descending aorta,Descending aorta minimum area,DKK4;Dickkopf-related protein 4,4122,-0.0905247165435316,5.81007765776903e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,"FABP4;Fatty acid-binding protein, adipocyte",4200,-0.132397695709353,6.9485445144558e-18
sensitivity analysis,Descending aorta,Descending aorta minimum area,FSTL3;Follistatin-related protein 3,4131,-0.0879333043879692,1.50508985548769e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,GFRA1;GDNF family receptor alpha-1,4177,-0.0980428418759162,2.15473005575952e-10
sensitivity analysis,Descending aorta,Descending aorta minimum area,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4127,-0.0940517138487546,1.41611716034686e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,IGFBP6;Insulin-like growth factor-binding protein 6,4136,-0.103989499910381,2.02921043048523e-11
sensitivity analysis,Descending aorta,Descending aorta minimum area,LEP;Leptin,4164,-0.171483970361153,7.57203590559639e-29
sensitivity analysis,Descending aorta,Descending aorta minimum area,MEPE;Matrix extracellular phosphoglycoprotein,4138,-0.0829981576773308,8.95920836750688e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,MFAP5;Microfibrillar-associated protein 5,4200,-0.113997624403699,1.26435339187218e-13
sensitivity analysis,Descending aorta,Descending aorta minimum area,MIA;Melanoma-derived growth regulatory protein,4167,-0.087750951107877,1.39685520890375e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,NOTCH1;Neurogenic locus notch homolog protein 1,4200,-0.0898722370494774,5.39642969248805e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,NPDC1;Neural proliferation differentiation and control protein 1,4164,-0.0838175279953203,6.07512317318009e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,PALM;Paralemmin-1,2916,-0.0983411754341669,1.03170946164759e-07
sensitivity analysis,Descending aorta,Descending aorta minimum area,PRELP;Prolargin,4138,-0.0882738514035479,1.28680636602662e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,PRND;Prion-like protein doppel,2956,-0.096976639982355,1.27253126384794e-07
sensitivity analysis,Descending aorta,Descending aorta minimum area,PTGDS;Prostaglandin-H2 D-isomerase,4122,-0.091251458375375,4.38245511476078e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,REN;Renin,4164,-0.129386374880035,5.20674515257397e-17
sensitivity analysis,Descending aorta,Descending aorta minimum area,SEMA3F;Semaphorin-3F,4164,-0.0980719712301766,2.26970792923792e-10
sensitivity analysis,Descending aorta,Descending aorta minimum area,SMOC2;SPARC-related modular calcium-binding protein 2,4157,-0.093331573363944,1.65091850641084e-09
sensitivity analysis,Descending aorta,Descending aorta minimum area,STC2;Stanniocalcin-2,4126,-0.118301954012672,2.46921639295413e-14
sensitivity analysis,Descending aorta,Descending aorta minimum area,TAFA5;Chemokine-like protein TAFA-5,4135,-0.0848283579191754,4.681565806706e-08
sensitivity analysis,Descending aorta,Descending aorta minimum area,TGFBR2;TGF-beta receptor type-2,4167,-0.0808396470271304,1.73803995139314e-07
sensitivity analysis,Descending aorta,Descending aorta minimum area,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4181,-0.0839388032594965,5.4640192836239e-08
sensitivity analysis,Left atrium,LA ejection fraction,NPPB;Natriuretic peptides B,4207,-0.0983622216321427,1.62106267284827e-10
sensitivity analysis,Left atrium,LA ejection fraction,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4304,-0.121264272863372,1.4317718539436e-15
sensitivity analysis,Left atrium,LA maximum volume,APCS;Serum amyloid P-component,3038,-0.11095402102136,8.67842391817648e-10
sensitivity analysis,Left atrium,LA maximum volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4281,-0.0837118485314236,4.12903671988676e-08
sensitivity analysis,Left atrium,LA maximum volume,CDHR5;Cadherin-related family member 5,4313,-0.086047967109182,1.51437120220518e-08
sensitivity analysis,Left atrium,LA maximum volume,CNTN3;Contactin-3,4284,-0.100926416629658,3.57147648650634e-11
sensitivity analysis,Left atrium,LA maximum volume,COL4A1;Collagen alpha-1(IV) chain,4313,0.0985416156603725,8.84498181042714e-11
sensitivity analysis,Left atrium,LA maximum volume,"FABP4;Fatty acid-binding protein, adipocyte",4350,-0.0995683253130317,4.65868435208188e-11
sensitivity analysis,Left atrium,LA maximum volume,LDLR;Low-density lipoprotein receptor,4303,-0.0995004176742654,6.09881315533486e-11
sensitivity analysis,Left atrium,LA maximum volume,LEP;Leptin,4313,-0.111277111033987,2.32566824690407e-13
sensitivity analysis,Left atrium,LA maximum volume,NOTCH3;Neurogenic locus notch homolog protein 3,4350,0.0879129660272002,6.32842073688603e-09
sensitivity analysis,Left atrium,LA maximum volume,NPPB;Natriuretic peptides B,4216,0.131518087944026,9.96908218249858e-18
sensitivity analysis,Left atrium,LA maximum volume,NPPC;C-type natriuretic peptide,4301,-0.0819606883575128,7.3400524470064e-08
sensitivity analysis,Left atrium,LA maximum volume,NPY;Pro-neuropeptide Y,4329,-0.0790095966586316,1.93908711325514e-07
sensitivity analysis,Left atrium,LA maximum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4313,0.159600907152323,5.29113238094761e-26
sensitivity analysis,Left atrium,LA maximum volume,PAMR1;Inactive serine protease PAMR1,4284,-0.0798401240966518,1.67190161983396e-07
sensitivity analysis,Left atrium,LA maximum volume,PLAT;Tissue-type plasminogen activator,4339,-0.0812827287576747,8.25282451612377e-08
sensitivity analysis,Left atrium,LA maximum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4312,-0.0895976213082749,3.77752858318232e-09
sensitivity analysis,Left atrium,LA minimum volume,LEP;Leptin,4285,-0.086897894216693,1.21613656243195e-08
sensitivity analysis,Left atrium,LA minimum volume,NPPB;Natriuretic peptides B,4188,0.116595445707082,3.76046641334877e-14
sensitivity analysis,Left atrium,LA minimum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4285,0.141413313696073,1.39161115840281e-20
sensitivity analysis,Left atrium,LA stroke volume,AGRN;Agrin,4310,-0.0887594576760328,5.31671061784051e-09
sensitivity analysis,Left atrium,LA stroke volume,APCS;Serum amyloid P-component,3041,-0.097958242233465,6.2069692297129e-08
sensitivity analysis,Left atrium,LA stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4285,-0.102436943152109,1.80180164326174e-11
sensitivity analysis,Left atrium,LA stroke volume,CDHR5;Cadherin-related family member 5,4317,-0.0810248704827321,9.77417058024576e-08
sensitivity analysis,Left atrium,LA stroke volume,CNTN3;Contactin-3,4288,-0.0886684503246378,6.02632301249131e-09
sensitivity analysis,Left atrium,LA stroke volume,COL4A1;Collagen alpha-1(IV) chain,4317,0.0842822755658389,2.92381547068199e-08
sensitivity analysis,Left atrium,LA stroke volume,CPM;Carboxypeptidase M,4330,-0.0924865706477069,1.07953491455012e-09
sensitivity analysis,Left atrium,LA stroke volume,CST3;Cystatin-C,4302,-0.0850927590015941,2.27434625353855e-08
sensitivity analysis,Left atrium,LA stroke volume,CXCL17;C-X-C motif chemokine 17,4350,-0.0837707017448494,3.14446230644665e-08
sensitivity analysis,Left atrium,LA stroke volume,CYTL1;Cytokine-like protein 1,3063,-0.0972997728346342,6.82936459204403e-08
sensitivity analysis,Left atrium,LA stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4354,-0.104764757946962,4.20904706846645e-12
sensitivity analysis,Left atrium,LA stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4347,0.0863755776765482,1.17082808918993e-08
sensitivity analysis,Left atrium,LA stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4285,-0.090229962944802,3.28277581273148e-09
sensitivity analysis,Left atrium,LA stroke volume,INHBC;Inhibin beta C chain,4288,-0.0872532602694737,1.04757538592727e-08
sensitivity analysis,Left atrium,LA stroke volume,LDLR;Low-density lipoprotein receptor,4307,-0.0938940394546533,6.66224629990264e-10
sensitivity analysis,Left atrium,LA stroke volume,LEP;Leptin,4317,-0.103369556568474,9.89249482735108e-12
sensitivity analysis,Left atrium,LA stroke volume,LPL;Lipoprotein lipase,4317,0.0999217764246405,4.71019687851345e-11
sensitivity analysis,Left atrium,LA stroke volume,NPPC;C-type natriuretic peptide,4305,-0.0947708387776732,4.65327587526869e-10
sensitivity analysis,Left atrium,LA stroke volume,NPY;Pro-neuropeptide Y,4333,-0.083000446639155,4.46458440675461e-08
sensitivity analysis,Left atrium,LA stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3044,-0.0985436037650593,5.09612141056414e-08
sensitivity analysis,Left atrium,LA stroke volume,PLAT;Tissue-type plasminogen activator,4343,-0.0961132258553202,2.19733190541115e-10
sensitivity analysis,Left atrium,LA stroke volume,PRSS2;Trypsin-2,4308,-0.0855182982571227,1.89092121151746e-08
sensitivity analysis,Left atrium,LA stroke volume,PRSS8;Prostasin,4280,-0.0886791033590512,6.19912615962926e-09
sensitivity analysis,Left atrium,LA stroke volume,SMOC1;SPARC-related modular calcium-binding protein 1,4333,-0.0797513183691362,1.46797343311361e-07
sensitivity analysis,Left atrium,LA stroke volume,SOST;Sclerostin,4316,-0.0820104949653982,6.8404221568549e-08
sensitivity analysis,Left atrium,LA stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4316,-0.084192968897113,3.03511520726217e-08
sensitivity analysis,Left ventricle,LV cardiac output,ACY1;Aminoacylase-1,4371,-0.0878407499063346,5.98957814969275e-09
sensitivity analysis,Left ventricle,LV cardiac output,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4343,-0.0959795583687937,2.32756639563269e-10
sensitivity analysis,Left ventricle,LV cardiac output,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4276,-0.0933802720251426,9.48597698264268e-10
sensitivity analysis,Left ventricle,LV cardiac output,ADM;Pro-adrenomedullin,4392,-0.101856308507287,1.32465541912241e-11
sensitivity analysis,Left ventricle,LV cardiac output,AFM;Afamin,3101,-0.121963452048607,9.46267546349486e-12
sensitivity analysis,Left ventricle,LV cardiac output,AGR3;Anterior gradient protein 3,4261,-0.0937623176429587,8.6684395277925e-10
sensitivity analysis,Left ventricle,LV cardiac output,AGRN;Agrin,4367,-0.108061672041795,8.06770871582206e-13
sensitivity analysis,Left ventricle,LV cardiac output,AHNAK;Neuroblast differentiation-associated protein AHNAK,3010,-0.132087108375151,3.44768830686822e-13
sensitivity analysis,Left ventricle,LV cardiac output,APCS;Serum amyloid P-component,3084,-0.11177131054559,4.84398383877372e-10
sensitivity analysis,Left ventricle,LV cardiac output,"ATRN;Attractin, Isoform 2",3101,-0.0959434505325133,8.65245878719673e-08
sensitivity analysis,Left ventricle,LV cardiac output,C19orf12;Protein C19orf12,4262,-0.095828543462125,3.64155347357003e-10
sensitivity analysis,Left ventricle,LV cardiac output,CALB1;Calbindin,4343,-0.0843285654453164,2.61117212414306e-08
sensitivity analysis,Left ventricle,LV cardiac output,CALB2;Calretinin,4262,-0.0865121761051141,1.54210885155483e-08
sensitivity analysis,Left ventricle,LV cardiac output,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4343,-0.101848705556816,1.72550297485972e-11
sensitivity analysis,Left ventricle,LV cardiac output,CDCP1;CUB domain-containing protein 1,4336,-0.0899815383781766,2.93010167146459e-09
sensitivity analysis,Left ventricle,LV cardiac output,CDHR5;Cadherin-related family member 5,4371,-0.0886961106156313,4.25619300777085e-09
sensitivity analysis,Left ventricle,LV cardiac output,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3038,-0.102661917454702,1.41812340853262e-08
sensitivity analysis,Left ventricle,LV cardiac output,CES1;Liver carboxylesterase 1,4375,-0.106412570697355,1.70672591429301e-12
sensitivity analysis,Left ventricle,LV cardiac output,CES2;Cocaine esterase,4343,-0.0799683762404758,1.31339755836846e-07
sensitivity analysis,Left ventricle,LV cardiac output,CFB;Complement factor B,3057,-0.0952999662284452,1.29882137542478e-07
sensitivity analysis,Left ventricle,LV cardiac output,CFD;Complement factor D,3101,-0.0977381678677656,4.93670632944021e-08
sensitivity analysis,Left ventricle,LV cardiac output,CFH;Complement factor H,2929,-0.12711950981675,5.02638819620821e-12
sensitivity analysis,Left ventricle,LV cardiac output,CFI;Complement factor I,3101,-0.108152369654522,1.56104222177924e-09
sensitivity analysis,Left ventricle,LV cardiac output,CFP;Properdin,3101,-0.108039534102612,1.62351264639508e-09
sensitivity analysis,Left ventricle,LV cardiac output,CKB;Creatine kinase B-type,3107,0.118549744941898,3.38549438120409e-11
sensitivity analysis,Left ventricle,LV cardiac output,CLMP;CXADR-like membrane protein,4392,-0.10074453323158,2.20610681200798e-11
sensitivity analysis,Left ventricle,LV cardiac output,CNTN3;Contactin-3,4345,-0.100835479558082,2.70483404940567e-11
sensitivity analysis,Left ventricle,LV cardiac output,COL15A1;Collagen alpha-1(XV) chain,3107,-0.101529710431711,1.41389501536931e-08
sensitivity analysis,Left ventricle,LV cardiac output,COL4A1;Collagen alpha-1(IV) chain,4371,0.08868285838465,4.27888566386442e-09
sensitivity analysis,Left ventricle,LV cardiac output,COLEC12;Collectin-12,4346,-0.0876988929575587,6.99784929394967e-09
sensitivity analysis,Left ventricle,LV cardiac output,CPM;Carboxypeptidase M,4388,-0.115264923003972,1.87766498777945e-14
sensitivity analysis,Left ventricle,LV cardiac output,CRIP2;Cysteine-rich protein 2,4336,-0.0907677449953043,2.13036068383055e-09
sensitivity analysis,Left ventricle,LV cardiac output,CRLF1;Cytokine receptor-like factor 1,4367,-0.0833005840087137,3.53203823531351e-08
sensitivity analysis,Left ventricle,LV cardiac output,CST3;Cystatin-C,4358,-0.0960076885471216,2.1417264788721e-10
sensitivity analysis,Left ventricle,LV cardiac output,CXCL17;C-X-C motif chemokine 17,4407,-0.0898118844979918,2.33552418537248e-09
sensitivity analysis,Left ventricle,LV cardiac output,DCXR;L-xylulose reductase,4376,-0.0847515979109478,1.9663682272672e-08
sensitivity analysis,Left ventricle,LV cardiac output,DPT;Dermatopontin,4412,-0.0942750801858472,3.51377232311944e-10
sensitivity analysis,Left ventricle,LV cardiac output,ELOA;Elongin-A,4343,-0.0879416272701548,6.43425480430126e-09
sensitivity analysis,Left ventricle,LV cardiac output,ERBB2;Receptor tyrosine-protein kinase erbB-2,4376,-0.0871711075082893,7.65722523726478e-09
sensitivity analysis,Left ventricle,LV cardiac output,EZR;Ezrin,4403,-0.0791472918421087,1.4516705922531e-07
sensitivity analysis,Left ventricle,LV cardiac output,F7;Coagulation factor VII,4356,-0.0927032885763736,8.79540333125348e-10
sensitivity analysis,Left ventricle,LV cardiac output,"FABP4;Fatty acid-binding protein, adipocyte",4412,-0.179414305733512,3.09465197173026e-33
sensitivity analysis,Left ventricle,LV cardiac output,FSTL3;Follistatin-related protein 3,4339,-0.0796019589976556,1.51860433953519e-07
sensitivity analysis,Left ventricle,LV cardiac output,FUOM;Fucose mutarotase,3038,-0.100472665701218,2.86280881621003e-08
sensitivity analysis,Left ventricle,LV cardiac output,FURIN;Furin,4376,-0.089554223654139,2.94982916891647e-09
sensitivity analysis,Left ventricle,LV cardiac output,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,2956,-0.0990635374358421,6.77652611098742e-08
sensitivity analysis,Left ventricle,LV cardiac output,GHR;Growth hormone receptor,3038,-0.120925908532119,2.27776525708341e-11
sensitivity analysis,Left ventricle,LV cardiac output,GPD1;Glycerol-3-phosphate dehydrogenase,3090,-0.129565766219039,4.83524729488012e-13
sensitivity analysis,Left ventricle,LV cardiac output,GSTA1;Glutathione S-transferase A1,4347,-0.0995583359226904,4.75154431741373e-11
sensitivity analysis,Left ventricle,LV cardiac output,GSTA3;Glutathione S-transferase A3,4269,-0.0959071219157181,3.40795631701727e-10
sensitivity analysis,Left ventricle,LV cardiac output,HGF;Hepatocyte growth factor,4407,-0.0783695430049506,1.89740558165371e-07
sensitivity analysis,Left ventricle,LV cardiac output,HNMT;Histamine N-methyltransferase,4325,-0.107048585293059,1.68581119553547e-12
sensitivity analysis,Left ventricle,LV cardiac output,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3014,-0.0967205819138591,1.03638719647426e-07
sensitivity analysis,Left ventricle,LV cardiac output,HSPB6;Heat shock protein beta-6,4392,-0.0957233395018022,2.0628429675659e-10
sensitivity analysis,Left ventricle,LV cardiac output,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4331,-0.0863066341789247,1.27900753750223e-08
sensitivity analysis,Left ventricle,LV cardiac output,IGFBP1;Insulin-like growth factor-binding protein 1,4407,0.0871401219531942,6.86472353538831e-09
sensitivity analysis,Left ventricle,LV cardiac output,IGFBP2;Insulin-like growth factor-binding protein 2,4405,0.139913734862969,1.0648649846302e-20
sensitivity analysis,Left ventricle,LV cardiac output,IGFBP6;Insulin-like growth factor-binding protein 6,4341,-0.114129003831241,4.62738717009894e-14
sensitivity analysis,Left ventricle,LV cardiac output,IGSF3;Immunoglobulin superfamily member 3,4343,-0.0812510851946565,8.23561396810687e-08
sensitivity analysis,Left ventricle,LV cardiac output,IGSF9;Protein turtle homolog A,3113,-0.130310638877757,2.90330329960137e-13
sensitivity analysis,Left ventricle,LV cardiac output,IL16;Pro-interleukin-16,4407,-0.0803084831570798,9.37655548432931e-08
sensitivity analysis,Left ventricle,LV cardiac output,IL18R1;Interleukin-18 receptor 1,4407,-0.0789533950472289,1.53720201242088e-07
sensitivity analysis,Left ventricle,LV cardiac output,IL1RN;Interleukin-1 receptor antagonist protein,4341,-0.134996154843965,4.15556330408578e-19
sensitivity analysis,Left ventricle,LV cardiac output,INHBC;Inhibin beta C chain,4345,-0.0997636954106216,4.37934929792129e-11
sensitivity analysis,Left ventricle,LV cardiac output,KLK6;Kallikrein-6,4369,-0.0822594607139168,5.18364915344376e-08
sensitivity analysis,Left ventricle,LV cardiac output,"KRT18;Keratin, type I cytoskeletal 18",4343,-0.101446785647982,2.07199736810689e-11
sensitivity analysis,Left ventricle,LV cardiac output,KYNU;Kynureninase,4407,-0.0903430051079336,1.87791797961472e-09
sensitivity analysis,Left ventricle,LV cardiac output,LCAT;Phosphatidylcholine-sterol acyltransferase,3107,-0.0990684500607069,3.13873249527496e-08
sensitivity analysis,Left ventricle,LV cardiac output,LDLR;Low-density lipoprotein receptor,4364,-0.126019680546264,6.49474927514157e-17
sensitivity analysis,Left ventricle,LV cardiac output,LEP;Leptin,4371,-0.19780995453113,8.22563210069138e-40
sensitivity analysis,Left ventricle,LV cardiac output,LGALS9;Galectin-9,4348,-0.0796241635211711,1.46260807809739e-07
sensitivity analysis,Left ventricle,LV cardiac output,LPL;Lipoprotein lipase,4371,0.108130315310379,7.61806147471217e-13
sensitivity analysis,Left ventricle,LV cardiac output,MIA;Melanoma-derived growth regulatory protein,4376,-0.0808880587088768,8.40987815593168e-08
sensitivity analysis,Left ventricle,LV cardiac output,MOG;Myelin-oligodendrocyte glycoprotein,4392,-0.0884007697712567,4.40195363796788e-09
sensitivity analysis,Left ventricle,LV cardiac output,NPC2;NPC intracellular cholesterol transporter 2,3050,-0.0948144093865528,1.55460607345817e-07
sensitivity analysis,Left ventricle,LV cardiac output,NPPC;C-type natriuretic peptide,4362,-0.107966292346346,8.7066493966992e-13
sensitivity analysis,Left ventricle,LV cardiac output,NPY;Pro-neuropeptide Y,4392,-0.110341228833154,2.25274207161215e-13
sensitivity analysis,Left ventricle,LV cardiac output,NRCAM;Neuronal cell adhesion molecule,4371,-0.0899770710009519,2.53644828732557e-09
sensitivity analysis,Left ventricle,LV cardiac output,NT5C1A;Cytosolic 5'-nucleotidase 1A,3098,-0.0990044656050136,3.3534653471475e-08
sensitivity analysis,Left ventricle,LV cardiac output,OXT;Oxytocin-neurophysin 1,4403,-0.0893751049717914,2.83804003126168e-09
sensitivity analysis,Left ventricle,LV cardiac output,PALM;Paralemmin-1,3059,-0.123037732419863,8.60015998256742e-12
sensitivity analysis,Left ventricle,LV cardiac output,PALM2;Paralemmin-2,3098,-0.107561606128729,1.95084831600236e-09
sensitivity analysis,Left ventricle,LV cardiac output,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3086,-0.110408939223144,7.76114746902237e-10
sensitivity analysis,Left ventricle,LV cardiac output,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3029,-0.0983976674388586,5.75066161235456e-08
sensitivity analysis,Left ventricle,LV cardiac output,PENK;Proenkephalin-A,3038,-0.101393221970244,2.13443824259308e-08
sensitivity analysis,Left ventricle,LV cardiac output,PLAT;Tissue-type plasminogen activator,4401,-0.123216647664196,2.3416899374214e-16
sensitivity analysis,Left ventricle,LV cardiac output,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4343,-0.0926744775029738,9.42857055841958e-10
sensitivity analysis,Left ventricle,LV cardiac output,PON3;Serum paraoxonase/lactonase 3,4367,0.0916267946196861,1.3111134344846e-09
sensitivity analysis,Left ventricle,LV cardiac output,PRAP1;Proline-rich acidic protein 1,3107,-0.116650389044205,6.94656110355561e-11
sensitivity analysis,Left ventricle,LV cardiac output,PRSS2;Trypsin-2,4364,-0.0818956666816361,6.03952005505565e-08
sensitivity analysis,Left ventricle,LV cardiac output,PRSS8;Prostasin,4335,-0.105405274979233,3.46744292779987e-12
sensitivity analysis,Left ventricle,LV cardiac output,PTGDS;Prostaglandin-H2 D-isomerase,4328,-0.0871504093934622,9.31879149252644e-09
sensitivity analysis,Left ventricle,LV cardiac output,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4322,-0.0970251390582618,1.63881319790548e-10
sensitivity analysis,Left ventricle,LV cardiac output,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4250,-0.0827866971438348,6.49082467341401e-08
sensitivity analysis,Left ventricle,LV cardiac output,RARRES2;Retinoic acid receptor responder protein 2,4368,-0.082709803284038,4.39548545879023e-08
sensitivity analysis,Left ventricle,LV cardiac output,RBP5;Retinol-binding protein 5,4343,-0.088711363924298,4.73942638398179e-09
sensitivity analysis,Left ventricle,LV cardiac output,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3038,-0.115920298662196,1.4716519422372e-10
sensitivity analysis,Left ventricle,LV cardiac output,RTBDN;Retbindin,4343,-0.0800613806604811,1.26999620374611e-07
sensitivity analysis,Left ventricle,LV cardiac output,RTN4R;Reticulon-4 receptor,4392,-0.10080706321612,2.14402854419718e-11
sensitivity analysis,Left ventricle,LV cardiac output,SCARB2;Lysosome membrane protein 2,4240,-0.0872503808532689,1.26658760325623e-08
sensitivity analysis,Left ventricle,LV cardiac output,SCG2;Secretogranin-2,4384,-0.0866394509827753,9.15291212975484e-09
sensitivity analysis,Left ventricle,LV cardiac output,SCLY;Selenocysteine lyase,4387,-0.0862958333902915,1.03550620976697e-08
sensitivity analysis,Left ventricle,LV cardiac output,SELE;E-selectin,4412,-0.0878028030371485,5.16559722752606e-09
sensitivity analysis,Left ventricle,LV cardiac output,SERPINF1;Pigment epithelium-derived factor,3068,-0.0991857012321437,3.68770907086286e-08
sensitivity analysis,Left ventricle,LV cardiac output,SERPINF2;Alpha-2-antiplasmin,3051,-0.0953419846945753,1.3191836227729e-07
sensitivity analysis,Left ventricle,LV cardiac output,SEZ6L;Seizure 6-like protein,4376,-0.0987154051585282,5.97827654949928e-11
sensitivity analysis,Left ventricle,LV cardiac output,SFRP1;Secreted frizzled-related protein 1,4321,-0.0887733998122621,5.05615740228359e-09
sensitivity analysis,Left ventricle,LV cardiac output,SMNDC1;Survival of motor neuron-related-splicing factor 30,3086,-0.0988366285992977,3.75930692614768e-08
sensitivity analysis,Left ventricle,LV cardiac output,SMOC2;SPARC-related modular calcium-binding protein 2,4367,-0.0840525274818062,2.65598678510492e-08
sensitivity analysis,Left ventricle,LV cardiac output,SNCG;Gamma-synuclein,4336,-0.0904990172087151,2.37629152560645e-09
sensitivity analysis,Left ventricle,LV cardiac output,SORCS2;VPS10 domain-containing receptor SorCS2,4269,-0.104598133357137,7.3342015810872e-12
sensitivity analysis,Left ventricle,LV cardiac output,SORD;Sorbitol dehydrogenase,4384,-0.0909569310176576,1.60732352832766e-09
sensitivity analysis,Left ventricle,LV cardiac output,SOST;Sclerostin,4370,-0.091555517473988,1.33295863797814e-09
sensitivity analysis,Left ventricle,LV cardiac output,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4370,-0.0847637489867759,2.00129908833248e-08
sensitivity analysis,Left ventricle,LV cardiac output,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4364,-0.102579383442874,1.10255719434767e-11
sensitivity analysis,Left ventricle,LV cardiac output,TAFA5;Chemokine-like protein TAFA-5,4343,-0.101011845519582,2.52374141461758e-11
sensitivity analysis,Left ventricle,LV cardiac output,TREM2;Triggering receptor expressed on myeloid cells 2,4346,-0.0834952024948456,3.53977131409282e-08
sensitivity analysis,Left ventricle,LV cardiac output,UPB1;Beta-ureidopropionase,3113,-0.101469208526207,1.39684587543618e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4331,-0.0815542259436766,7.67887776012921e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,ACY1;Aminoacylase-1,4371,-0.10636167066326,1.78994414161476e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4336,-0.106388795926437,2.16466703361541e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4343,-0.134329181377812,6.09677132159589e-19
sensitivity analysis,Left ventricle,LV end diastolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4276,-0.116998553457911,1.65675003396948e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,ADIPOQ;Adiponectin,3101,0.100181944139951,2.26267982941352e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,ADM;Pro-adrenomedullin,4392,-0.146536457904071,1.65094561491437e-22
sensitivity analysis,Left ventricle,LV end diastolic volume,AFM;Afamin,3101,-0.15282949459326,1.15399317762331e-17
sensitivity analysis,Left ventricle,LV end diastolic volume,AGR3;Anterior gradient protein 3,4262,-0.0815530887911827,9.74413799934134e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,AGRN;Agrin,4367,-0.1308203482161,3.96160259609121e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3010,-0.163807180989766,1.5041713175927e-19
sensitivity analysis,Left ventricle,LV end diastolic volume,ALDH1A1;Retinal dehydrogenase 1,4345,-0.08010293847379,1.24275822313466e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,ANXA2;Annexin A2,2962,-0.096223238472758,1.54724831105358e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,APCS;Serum amyloid P-component,3084,-0.139728138014274,6.45355410301256e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,ASGR1;Asialoglycoprotein receptor 1,4336,-0.103818863942021,7.23929376652041e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,"ATRN;Attractin, Isoform 2",3101,-0.10332722810211,8.06633436923512e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,B2M;Beta-2-microglobulin,3101,-0.10201288611605,1.24592182684926e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,BCAN;Brevican core protein,4336,-0.0874532007642374,8.0199406352988e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,BCHE;Cholinesterase,3049,-0.105846543686705,4.66573936194982e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,C19orf12;Protein C19orf12,4262,-0.107485945477445,1.98628303884333e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,C1R;Complement C1r subcomponent,3101,-0.110500685280876,6.83629347696781e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,C1RL;Complement C1r subcomponent-like protein,3096,-0.104197891978525,6.2014813659352e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4276,-0.0871727862288407,1.13287490986312e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CALB1;Calbindin,4343,-0.104458018721977,5.16967946311888e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,CALB2;Calretinin,4262,-0.109810845126548,6.54899348074411e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,CALCB;Calcitonin gene-related peptide 2,3098,-0.108867854912415,1.23857405714871e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,CBLN4;Cerebellin-4,4392,-0.114329185336503,2.97011161896109e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,CD300E;CMRF35-like molecule 2,4377,-0.0798121608991929,1.24194473473105e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,CD302;CD302 antigen,4343,-0.09861985149304,7.35656445267289e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4343,-0.135807849611372,2.49420446926786e-19
sensitivity analysis,Left ventricle,LV end diastolic volume,CD4;T-cell surface glycoprotein CD4,4358,-0.099579488234803,4.45043128832637e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,CD59;CD59 glycoprotein,4200,-0.110422496820859,7.1770663578602e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,CD83;CD83 antigen,4361,-0.0821652898232083,5.52115234131716e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CD99L2;CD99 antigen-like protein 2,4345,-0.0847395943663881,2.21636245060732e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CDCP1;CUB domain-containing protein 1,4336,-0.0845051564567815,2.505512798888e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CDHR2;Cadherin-related family member 2,4343,-0.105680023626776,2.9096641603126e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,CDHR5;Cadherin-related family member 5,4371,-0.11709686200164,8.08736622271692e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,CDON;Cell adhesion molecule-related/down-regulated by oncogenes,4354,-0.0833580570060843,3.62155560706721e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3039,-0.112528998453663,4.95211447115941e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,CES1;Liver carboxylesterase 1,4375,-0.123640003407488,2.26429329793811e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,CFB;Complement factor B,3057,-0.119990507008395,2.82074369797533e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,CFC1;Cryptic protein,4269,-0.0863472540822499,1.59865849726289e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CFD;Complement factor D,3101,-0.129986089554376,3.69151802704504e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,CFH;Complement factor H,2929,-0.15211365884823,1.26188000634449e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,CFI;Complement factor I,3101,-0.132376049135877,1.34964481677851e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,CFP;Properdin,3101,-0.116812121116073,6.81846220568285e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,CKB;Creatine kinase B-type,3107,0.119819242305404,2.08072111012197e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,CLEC4A;C-type lectin domain family 4 member A,4361,0.103695521566756,6.67809230023273e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,CLMP;CXADR-like membrane protein,4392,-0.151319862211685,6.5319489856352e-24
sensitivity analysis,Left ventricle,LV end diastolic volume,CNTN3;Contactin-3,4345,-0.119129175382369,3.31595197130347e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,COL15A1;Collagen alpha-1(XV) chain,3107,-0.144679525073875,5.32113592491507e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4386,-0.0859225821427954,1.20296973527852e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,COL4A1;Collagen alpha-1(IV) chain,4371,0.102717120404794,9.96127663277723e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,COL6A3;Collagen alpha-3(VI) chain,4412,-0.109270855390902,3.39231852447939e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,COLEC12;Collectin-12,4346,-0.131150220431335,3.92286869380311e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,CPM;Carboxypeptidase M,4388,-0.146791389169504,1.45631803385324e-22
sensitivity analysis,Left ventricle,LV end diastolic volume,CRIP2;Cysteine-rich protein 2,4336,-0.106699803612906,1.86674244468564e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,CRLF1;Cytokine receptor-like factor 1,4367,-0.0837111548118248,3.02385728012334e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CST3;Cystatin-C,4358,-0.131185132526868,3.45845387013669e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,CSTB;Cystatin-B,4322,-0.0843832409458984,2.76307540170287e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CTSD;Cathepsin D,4082,-0.0872166162303062,2.38800256401368e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,CTSO;Cathepsin O,4407,-0.0866584041768353,8.30989945648474e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,CXCL10;C-X-C motif chemokine 10,4367,-0.0916838555947991,1.28051476407204e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,CXCL17;C-X-C motif chemokine 17,4407,-0.0954940837563716,2.12367988825707e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,CYTL1;Cytokine-like protein 1,3107,-0.12760516073183,9.39363118167973e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,DCXR;L-xylulose reductase,4376,-0.0952221243260559,2.76134438395932e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,DLK1;Protein delta homolog 1,4412,-0.0901801176064672,1.96643478369702e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,DPT;Dermatopontin,4412,-0.111454531543542,1.13485355754468e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3086,-0.109488586166306,1.07294918334249e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,EFNA4;Ephrin-A4,4331,-0.0951025918460833,3.58404079355695e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,EGLN1;Egl nine homolog 1,4361,-0.0979339029062008,9.10706413410553e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,ELOA;Elongin-A,4343,-0.104465838681769,5.15080733151303e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,EPHA1;Ephrin type-A receptor 1,4359,-0.091268562168216,1.57324029677016e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4376,-0.112755478124465,7.39495004521072e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,ESM1;Endothelial cell-specific molecule 1,4346,0.0816175103281426,7.12413625035984e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,F7;Coagulation factor VII,4356,-0.122366608135349,5.30281476764911e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,F9;Coagulation factor IX,4363,-0.0938361889549382,5.29534263177246e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4412,-0.229345116214181,9.42717687950828e-54
sensitivity analysis,Left ventricle,LV end diastolic volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3113,-0.0932133011219441,1.88815048740601e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,FGF21;Fibroblast growth factor 21,4388,-0.109771037619518,3.06699939695505e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,FGFR2;Fibroblast growth factor receptor 2,4376,-0.0838696325086949,2.75561146070324e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,FSTL3;Follistatin-related protein 3,4339,-0.10587664948468,2.71265977945625e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,FTCD;Formimidoyltransferase-cyclodeaminase,3089,-0.110006885110565,8.77765972968132e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,FURIN;Furin,4376,-0.107896464324847,8.28496441088973e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,GCHFR;GTP cyclohydrolase 1 feedback regulatory protein,2957,-0.0965467174006334,1.43962501390357e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,GFRA1;GDNF family receptor alpha-1,4388,-0.0823234171505168,4.73503944895475e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,GGH;Gamma-glutamyl hydrolase,4269,-0.0885115368623054,6.92190721958571e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,GHR;Growth hormone receptor,3039,-0.157806271155394,2.12016155544533e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,GM2A;Ganglioside GM2 activator,3026,-0.0960952026964865,1.18246595839571e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3090,-0.144625779566549,6.54726582322618e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,GPKOW;G-patch domain and KOW motifs-containing protein,4262,-0.0866739506093047,1.44955612555777e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,GPR37;Prosaposin receptor GPR37,4276,-0.101807615143961,2.51119051002196e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,GSTA1;Glutathione S-transferase A1,4347,-0.118771073373482,3.95462111017971e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,GSTA3;Glutathione S-transferase A3,4269,-0.126398371592479,1.13810503443807e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,GUSB;Beta-glucuronidase,4366,-0.0925223746098766,9.07563144568438e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,HAO1;Hydroxyacid oxidase 1,4392,-0.0808866980783865,7.96994405196816e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,HGF;Hepatocyte growth factor,4407,-0.108244745440565,5.80468551647415e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,HNMT;Histamine N-methyltransferase,4325,-0.125568055411153,1.14795384166854e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3015,-0.115864164209561,1.76108833403076e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4361,0.0901310574612786,2.48415429129685e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,HSPB6;Heat shock protein beta-6,4392,-0.0878857360601129,5.41104716910987e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4331,-0.119202246961247,3.53082647449048e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,ICAM1;Intercellular adhesion molecule 1,4340,-0.079278485913402,1.69978777683365e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,3015,-0.096600963141009,1.06952399254539e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,IGFBP1;Insulin-like growth factor-binding protein 1,4407,0.10732982354621,9.08263459723722e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4405,0.149215470155191,2.36394706781789e-23
sensitivity analysis,Left ventricle,LV end diastolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4341,-0.144070892175567,1.43710703524086e-21
sensitivity analysis,Left ventricle,LV end diastolic volume,IGSF8;Immunoglobulin superfamily member 8,4371,-0.0825978024126009,4.53560086284066e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,IGSF9;Protein turtle homolog A,3113,-0.177395070708229,2.00402337923252e-23
sensitivity analysis,Left ventricle,LV end diastolic volume,IL16;Pro-interleukin-16,4407,-0.0885386680463663,3.91942914832382e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,IL18R1;Interleukin-18 receptor 1,4407,-0.0831358925926377,3.25752792156445e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4341,-0.166560073745109,2.23861909122851e-28
sensitivity analysis,Left ventricle,LV end diastolic volume,INHBC;Inhibin beta C chain,4345,-0.143158087968813,2.47880008865542e-21
sensitivity analysis,Left ventricle,LV end diastolic volume,ISM1;Isthmin-1,4361,-0.0799858768272528,1.22947862009349e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,ITGA5;Integrin alpha-5,4345,-0.0881264369983097,5.93254655110226e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,KLK6;Kallikrein-6,4369,-0.116424074069969,1.1677990056703e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,KLRD1;Natural killer cells antigen CD94,4407,-0.0842073516840944,2.16233430080287e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,"KRT18;Keratin, type I cytoskeletal 18",4343,-0.119513747454891,2.74027925530823e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,KYNU;Kynureninase,4407,-0.0993072433923585,3.92181197730273e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,LCAT;Phosphatidylcholine-sterol acyltransferase,3107,-0.118993522337344,2.85741377426733e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,LDLR;Low-density lipoprotein receptor,4364,-0.145042595705883,5.98373282140601e-22
sensitivity analysis,Left ventricle,LV end diastolic volume,LEP;Leptin,4371,-0.255139519139725,6.51485658545814e-66
sensitivity analysis,Left ventricle,LV end diastolic volume,LGALS1;Galectin-1,4371,-0.0958382247765489,2.16704481135998e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,LGALS3BP;Galectin-3-binding protein,3101,-0.097728931777897,4.95110968383257e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,LGALS9;Galectin-9,4348,-0.101082620149295,2.38089721532898e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,LPL;Lipoprotein lipase,4371,0.134288059751992,4.82864142591373e-19
sensitivity analysis,Left ventricle,LV end diastolic volume,LSP1;Lymphocyte-specific protein 1,4361,-0.0875782289701491,6.91587873357773e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4325,-0.0903926018648766,2.59879751023298e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,MFAP5;Microfibrillar-associated protein 5,4412,-0.0991295940533712,4.14313483388543e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,MIA;Melanoma-derived growth regulatory protein,4376,-0.107032974171481,1.25888711124155e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4392,-0.129836434220737,5.68659803769118e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4376,-0.0829879533401554,3.84818252501014e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NCAN;Neurocan core protein,4403,-0.0948278429995789,2.88685390310595e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,NCS1;Neuronal calcium sensor 1,4392,-0.0805218648273793,9.11599902359415e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NEFL;Neurofilament light polypeptide,4256,-0.0839805842804551,4.09250863394506e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NELL2;Protein kinase C-binding protein NELL2,4367,-0.0824919292534075,4.78601156480375e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NOMO1;Nodal modulator 1,4345,-0.092451600519331,1.02529301305814e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,"NOS3;Nitric oxide synthase, endothelial",4262,-0.0820454363085039,8.1522046514521e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NPC2;NPC intracellular cholesterol transporter 2,3050,-0.125383493502255,3.67545216115003e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4371,-0.120203339686553,1.53967126742649e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,NPPC;C-type natriuretic peptide,4361,-0.145865428317832,3.60655735597713e-22
sensitivity analysis,Left ventricle,LV end diastolic volume,NPTXR;Neuronal pentraxin receptor,4371,-0.0804094522556254,1.01927260890902e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,NPY;Pro-neuropeptide Y,4392,-0.117550099659194,5.48801774819364e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,NRCAM;Neuronal cell adhesion molecule,4371,-0.0963218952705786,1.75703874051806e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3098,-0.0982027613948902,4.32668518474589e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4371,0.078600461936957,1.95970931718086e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,OGN;Mimecan,4345,-0.0984537436348665,7.83808774761924e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,OXT;Oxytocin-neurophysin 1,4403,-0.117153169529101,6.27119166503596e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,PALM;Paralemmin-1,3059,-0.15115715722518,4.27300441698969e-17
sensitivity analysis,Left ventricle,LV end diastolic volume,PALM2;Paralemmin-2,3098,-0.112948678787275,2.89437827933456e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,PAMR1;Inactive serine protease PAMR1,4345,-0.089157016345742,3.93354385979377e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,PARP1;Poly [ADP-ribose] polymerase 1,4361,-0.0885646327162942,4.67186143013322e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3086,-0.133126139548635,1.12380316043429e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,3030,-0.097201288123685,8.27727274121937e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,PENK;Proenkephalin-A,3039,-0.133845545411101,1.27406639235412e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,PGF;Placenta growth factor,4407,-0.103282005371571,6.29353536329065e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4345,-0.080370864409326,1.12775628154571e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,PLAT;Tissue-type plasminogen activator,4401,-0.163263273778373,1.13959717336053e-27
sensitivity analysis,Left ventricle,LV end diastolic volume,PLIN1;Perilipin-1,4262,-0.101464433577678,3.15389824444088e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,PLTP;Phospholipid transfer protein,4401,0.0811529408856951,7.00460655525304e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4343,-0.100728082529763,2.86902143867314e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,PON3;Serum paraoxonase/lactonase 3,4367,0.116165344479475,1.35565355047624e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,PRAP1;Proline-rich acidic protein 1,3107,-0.152288175237548,1.40125832571589e-17
sensitivity analysis,Left ventricle,LV end diastolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4371,-0.0792190245262868,1.56966107362163e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,PRND;Prion-like protein doppel,3098,-0.128292249118731,7.64021968911311e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,PROC;Vitamin K-dependent protein C,4363,-0.0792171864569371,1.61213864736858e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,PROS1;Vitamin K-dependent protein S,3101,-0.113171352389098,2.61728852832208e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,PRRT3;Proline-rich transmembrane protein 3,3010,-0.107495536231272,3.37432924060804e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,PRSS8;Prostasin,4335,-0.114275125572532,4.47047714658232e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,PSPN;Persephin,4361,-0.097912210641115,9.19455360176078e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4328,-0.140466573684798,1.62705003657359e-20
sensitivity analysis,Left ventricle,LV end diastolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4322,-0.137382749293347,1.16595521818406e-19
sensitivity analysis,Left ventricle,LV end diastolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3098,-0.123808873644652,4.67860511566903e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4250,-0.103314889032778,1.46427003470885e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,RARRES2;Retinoic acid receptor responder protein 2,4368,-0.0990985836276624,5.24547944080359e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,RBKS;Ribokinase,4270,-0.0835133561715098,4.62512690208166e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,RBP5;Retinol-binding protein 5,4343,-0.126212186152904,6.90918374681669e-17
sensitivity analysis,Left ventricle,LV end diastolic volume,RBP7;Retinoid-binding protein 7,3086,-0.0993513726338992,3.19142822046008e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4345,-0.0966293142378502,1.74123864379708e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3039,-0.110599516767725,9.75992175764882e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,RNASE1;Ribonuclease pancreatic,3107,-0.10676031188731,2.43839555583618e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,RNASE4;Ribonuclease 4,2986,-0.125731449548306,5.3861715246938e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,RTBDN;Retbindin,4343,-0.121878581807928,7.64668784443019e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,RTN4R;Reticulon-4 receptor,4392,-0.126620172977298,3.67199748127833e-17
sensitivity analysis,Left ventricle,LV end diastolic volume,SCARB2;Lysosome membrane protein 2,4240,-0.126324600380223,1.50219435171813e-16
sensitivity analysis,Left ventricle,LV end diastolic volume,SCG2;Secretogranin-2,4384,-0.102104048141087,1.23310891664949e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,SCLY;Selenocysteine lyase,4387,-0.0995720511348615,3.85230241162004e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,SELE;E-selectin,4412,-0.0899702800118871,2.14356988942809e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,SEMA3F;Semaphorin-3F,4371,-0.106928277685044,1.36346488672354e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,SERPIND1;Heparin cofactor 2,3099,-0.0961759313957824,8.12799121942937e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,SERPINF1;Pigment epithelium-derived factor,3068,-0.135625574391436,4.55574266910944e-14
sensitivity analysis,Left ventricle,LV end diastolic volume,SERPINF2;Alpha-2-antiplasmin,3051,-0.0999203328730419,3.18829304688736e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,SEZ6L;Seizure 6-like protein,4376,-0.1325431555242,1.31705672060548e-18
sensitivity analysis,Left ventricle,LV end diastolic volume,SFRP1;Secreted frizzled-related protein 1,4321,-0.0957659174685329,2.83053289174342e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,SHISA5;Protein shisa-5,3107,-0.117293091857601,5.45383426950712e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4278,-0.0824517819552139,6.64565077258737e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,SKAP1;Src kinase-associated phosphoprotein 1,4332,-0.0827045657187665,5.00274244387837e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,SLC39A5;Zinc transporter ZIP5,4361,-0.110302477232017,2.7861150848134e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,SMAD5;Mothers against decapentaplegic homolog 5,4343,-0.0893449905271959,3.67784874048031e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3086,-0.106478637155048,3.03776330198968e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4392,-0.110848237118311,1.74807373885841e-13
sensitivity analysis,Left ventricle,LV end diastolic volume,SMOC2;SPARC-related modular calcium-binding protein 2,4367,-0.0842270784631583,2.48505272866408e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,SNCG;Gamma-synuclein,4336,-0.104868680770587,4.43651656003206e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,SNRPB2;U2 small nuclear ribonucleoprotein B'',3098,-0.0951372185858568,1.12545313988196e-07
sensitivity analysis,Left ventricle,LV end diastolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4269,-0.142022351412383,1.12058811444673e-20
sensitivity analysis,Left ventricle,LV end diastolic volume,SORD;Sorbitol dehydrogenase,4384,-0.102767829980124,9.06830042359857e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,SOST;Sclerostin,4370,-0.118343981621244,4.2070570334016e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4370,-0.118959074797794,3.02950566832991e-15
sensitivity analysis,Left ventricle,LV end diastolic volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4364,-0.106051571343159,2.16168613510089e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4343,0.0822222714513115,5.75678328671337e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,STC1;Stanniocalcin-1,4403,-0.0838705549553892,2.49698816172545e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,TAFA5;Chemokine-like protein TAFA-5,4343,-0.143201331344301,2.46199377982153e-21
sensitivity analysis,Left ventricle,LV end diastolic volume,TCTN3;Tectonic-3,3113,-0.0971836612304061,5.54214646152865e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,TFPI;Tissue factor pathway inhibitor,4344,-0.0828585916046842,4.52674978264687e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,TGFBR2;TGF-beta receptor type-2,4376,-0.103791958967625,5.87653614817283e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,THY1;Thy-1 membrane glycoprotein,4403,-0.0915568206567423,1.1553256400457e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4336,-0.0941003581673545,5.35463448821447e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4407,-0.0993610900443592,3.82759962425772e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4392,-0.0894366102813885,2.89627144657874e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4345,-0.0965842104314091,1.77561199313169e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,TREM2;Triggering receptor expressed on myeloid cells 2,4346,-0.0918929328444933,1.28653404194337e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,UPB1;Beta-ureidopropionase,3113,-0.122940789599771,5.87040119174841e-12
sensitivity analysis,Left ventricle,LV end diastolic volume,VGF;Neurosecretory protein VGF,3098,-0.120485309734281,1.72023473848413e-11
sensitivity analysis,Left ventricle,LV end diastolic volume,VNN1;Pantetheinase,3107,-0.101528605446909,1.41440730929235e-08
sensitivity analysis,Left ventricle,LV end diastolic volume,VSNL1;Visinin-like protein 1,3098,-0.103704388665376,7.23278583540861e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,VWC2;Brorin,4327,-0.0877030649327323,7.5337131984085e-09
sensitivity analysis,Left ventricle,LV end diastolic volume,VWC2L;von Willebrand factor C domain-containing protein 2-like,3098,-0.110613498175653,6.69306120035775e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,XG;Glycoprotein Xg,4393,-0.0932032133490377,6.04704718687415e-10
sensitivity analysis,Left ventricle,LV end diastolic volume,ZHX2;Zinc fingers and homeoboxes protein 2,3098,-0.0990990505175678,3.25372544747558e-08
sensitivity analysis,Left ventricle,LV end systolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4323,-0.0804282537387618,1.18905878570882e-07
sensitivity analysis,Left ventricle,LV end systolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4328,-0.0799121991661822,1.40856167496143e-07
sensitivity analysis,Left ventricle,LV end systolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4335,-0.102207618312962,1.52866779986379e-11
sensitivity analysis,Left ventricle,LV end systolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4268,-0.086420556053446,1.5604895399491e-08
sensitivity analysis,Left ventricle,LV end systolic volume,ADM;Pro-adrenomedullin,4384,-0.121542263010498,6.73729329470769e-16
sensitivity analysis,Left ventricle,LV end systolic volume,AFM;Afamin,3094,-0.0963127778478781,7.97941120598727e-08
sensitivity analysis,Left ventricle,LV end systolic volume,AGRN;Agrin,4359,-0.0870531903992555,8.573793495078e-09
sensitivity analysis,Left ventricle,LV end systolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3003,-0.117768606963218,9.57406708993561e-11
sensitivity analysis,Left ventricle,LV end systolic volume,CALB2;Calretinin,4254,-0.0883857810905387,7.72423808715729e-09
sensitivity analysis,Left ventricle,LV end systolic volume,CBLN4;Cerebellin-4,4384,-0.104473167659065,4.08051497092317e-12
sensitivity analysis,Left ventricle,LV end systolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4335,-0.110141428329369,3.54644163052112e-13
sensitivity analysis,Left ventricle,LV end systolic volume,CD59;CD59 glycoprotein,4192,-0.0935951800703178,1.26795970452006e-09
sensitivity analysis,Left ventricle,LV end systolic volume,CDHR2;Cadherin-related family member 2,4335,-0.0860609804321588,1.38515468788996e-08
sensitivity analysis,Left ventricle,LV end systolic volume,CDHR5;Cadherin-related family member 5,4363,-0.0857498006769391,1.40432808929002e-08
sensitivity analysis,Left ventricle,LV end systolic volume,CFH;Complement factor H,2923,-0.0974134387878433,1.31361051440582e-07
sensitivity analysis,Left ventricle,LV end systolic volume,CLEC4A;C-type lectin domain family 4 member A,4353,0.0985943990163517,7.07734069043845e-11
sensitivity analysis,Left ventricle,LV end systolic volume,CLMP;CXADR-like membrane protein,4384,-0.123325074649643,2.51548816428721e-16
sensitivity analysis,Left ventricle,LV end systolic volume,COL15A1;Collagen alpha-1(XV) chain,3100,-0.107319911853457,2.09561364058885e-09
sensitivity analysis,Left ventricle,LV end systolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4378,-0.0789528028968088,1.68867588636255e-07
sensitivity analysis,Left ventricle,LV end systolic volume,COL6A3;Collagen alpha-3(VI) chain,4404,-0.101177825915502,1.69900175876913e-11
sensitivity analysis,Left ventricle,LV end systolic volume,COLEC12;Collectin-12,4338,-0.104724488190214,4.69341734939256e-12
sensitivity analysis,Left ventricle,LV end systolic volume,CPM;Carboxypeptidase M,4380,-0.105339158196765,2.76906976000825e-12
sensitivity analysis,Left ventricle,LV end systolic volume,CST3;Cystatin-C,4350,-0.0998780375162871,4.05567782130393e-11
sensitivity analysis,Left ventricle,LV end systolic volume,CYTL1;Cytokine-like protein 1,3100,-0.105315461980938,4.15997639176984e-09
sensitivity analysis,Left ventricle,LV end systolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4368,-0.089036533579382,3.75760145968593e-09
sensitivity analysis,Left ventricle,LV end systolic volume,F7;Coagulation factor VII,4348,-0.0795084035605679,1.52481007819676e-07
sensitivity analysis,Left ventricle,LV end systolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4404,-0.169968560987775,6.68269446978976e-30
sensitivity analysis,Left ventricle,LV end systolic volume,FGF21;Fibroblast growth factor 21,4380,-0.0939624222073054,4.64670632815851e-10
sensitivity analysis,Left ventricle,LV end systolic volume,GHR;Growth hormone receptor,3033,-0.115701065163306,1.65005219787838e-10
sensitivity analysis,Left ventricle,LV end systolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3083,-0.100018658220416,2.61821456645923e-08
sensitivity analysis,Left ventricle,LV end systolic volume,GSTA1;Glutathione S-transferase A1,4339,-0.0859867467721785,1.40385956913934e-08
sensitivity analysis,Left ventricle,LV end systolic volume,GSTA3;Glutathione S-transferase A3,4262,-0.102401880063992,2.0719110240297e-11
sensitivity analysis,Left ventricle,LV end systolic volume,HGF;Hepatocyte growth factor,4399,-0.0929659170639883,6.50874949820275e-10
sensitivity analysis,Left ventricle,LV end systolic volume,HNMT;Histamine N-methyltransferase,4317,-0.0844972985562061,2.69561099781829e-08
sensitivity analysis,Left ventricle,LV end systolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4323,-0.098504772097145,8.55185524911734e-11
sensitivity analysis,Left ventricle,LV end systolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4397,0.0889681754294182,3.43120927151258e-09
sensitivity analysis,Left ventricle,LV end systolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4333,-0.100048678391244,4.09986929141043e-11
sensitivity analysis,Left ventricle,LV end systolic volume,IGSF9;Protein turtle homolog A,3106,-0.142554992560245,1.43510327224938e-15
sensitivity analysis,Left ventricle,LV end systolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4333,-0.115273180625204,2.71748250607065e-14
sensitivity analysis,Left ventricle,LV end systolic volume,INHBC;Inhibin beta C chain,4337,-0.11824537368266,5.61395010008424e-15
sensitivity analysis,Left ventricle,LV end systolic volume,KLK6;Kallikrein-6,4361,-0.0876956448873782,6.60184592122536e-09
sensitivity analysis,Left ventricle,LV end systolic volume,"KRT18;Keratin, type I cytoskeletal 18",4335,-0.0841496782537656,2.87767393471522e-08
sensitivity analysis,Left ventricle,LV end systolic volume,LDLR;Low-density lipoprotein receptor,4356,-0.0822950304799358,5.35381542064752e-08
sensitivity analysis,Left ventricle,LV end systolic volume,LEP;Leptin,4363,-0.185645926143601,3.96223836447953e-35
sensitivity analysis,Left ventricle,LV end systolic volume,LPL;Lipoprotein lipase,4363,0.10118819660894,2.09750744453786e-11
sensitivity analysis,Left ventricle,LV end systolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4384,-0.108302849502985,6.4773962258203e-13
sensitivity analysis,Left ventricle,LV end systolic volume,NCAN;Neurocan core protein,4395,-0.0845826231764978,1.95588973771462e-08
sensitivity analysis,Left ventricle,LV end systolic volume,NPC2;NPC intracellular cholesterol transporter 2,3043,-0.0969758051674813,8.32434301899231e-08
sensitivity analysis,Left ventricle,LV end systolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4363,-0.113721934229801,4.92184872460522e-14
sensitivity analysis,Left ventricle,LV end systolic volume,NPPC;C-type natriuretic peptide,4353,-0.113873272319193,4.8679749088374e-14
sensitivity analysis,Left ventricle,LV end systolic volume,OGN;Mimecan,4337,-0.0831435778151784,4.17197619302598e-08
sensitivity analysis,Left ventricle,LV end systolic volume,OXT;Oxytocin-neurophysin 1,4395,-0.0905343480625141,1.82572011126007e-09
sensitivity analysis,Left ventricle,LV end systolic volume,PALM;Paralemmin-1,3052,-0.0987346928213476,4.61047647357545e-08
sensitivity analysis,Left ventricle,LV end systolic volume,PENK;Proenkephalin-A,3033,-0.0997942947365702,3.64118191505598e-08
sensitivity analysis,Left ventricle,LV end systolic volume,PGF;Placenta growth factor,4399,-0.0960375338517956,1.74069530972381e-10
sensitivity analysis,Left ventricle,LV end systolic volume,PLAT;Tissue-type plasminogen activator,4393,-0.127724116974555,1.92996409137239e-17
sensitivity analysis,Left ventricle,LV end systolic volume,PON3;Serum paraoxonase/lactonase 3,4359,0.0972476978480035,1.24312918858468e-10
sensitivity analysis,Left ventricle,LV end systolic volume,PRAP1;Proline-rich acidic protein 1,3100,-0.109501754718461,9.79411831562834e-10
sensitivity analysis,Left ventricle,LV end systolic volume,PRND;Prion-like protein doppel,3091,-0.109493236287308,1.03858258418993e-09
sensitivity analysis,Left ventricle,LV end systolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4320,-0.120660505638473,1.75677735449035e-15
sensitivity analysis,Left ventricle,LV end systolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4314,-0.11165637190117,1.9151510745353e-13
sensitivity analysis,Left ventricle,LV end systolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3091,-0.0996583931599125,2.81984459118452e-08
sensitivity analysis,Left ventricle,LV end systolic volume,RBP5;Retinol-binding protein 5,4335,-0.107198052688147,1.47990646129234e-12
sensitivity analysis,Left ventricle,LV end systolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4337,-0.0840227535433502,2.99719676109108e-08
sensitivity analysis,Left ventricle,LV end systolic volume,REN;Renin,4363,-0.0793924588539353,1.51359563161461e-07
sensitivity analysis,Left ventricle,LV end systolic volume,RNASE1;Ribonuclease pancreatic,3100,-0.0975056574240241,5.33819433197105e-08
sensitivity analysis,Left ventricle,LV end systolic volume,RTBDN;Retbindin,4335,-0.100220441176578,3.75748440286164e-11
sensitivity analysis,Left ventricle,LV end systolic volume,RTN4R;Reticulon-4 receptor,4384,-0.0881044543521848,5.11906392892741e-09
sensitivity analysis,Left ventricle,LV end systolic volume,SCARB2;Lysosome membrane protein 2,4232,-0.103511056140611,1.47907733478478e-11
sensitivity analysis,Left ventricle,LV end systolic volume,SEMA3F;Semaphorin-3F,4363,-0.0881445089794622,5.48012645324619e-09
sensitivity analysis,Left ventricle,LV end systolic volume,SEZ6L;Seizure 6-like protein,4368,-0.104335054104232,4.76216525132102e-12
sensitivity analysis,Left ventricle,LV end systolic volume,SHISA5;Protein shisa-5,3100,-0.106333867796981,2.94089499117625e-09
sensitivity analysis,Left ventricle,LV end systolic volume,SLC39A5;Zinc transporter ZIP5,4353,-0.0859053539215577,1.37343054111368e-08
sensitivity analysis,Left ventricle,LV end systolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4384,-0.0873690291126316,6.86100743851894e-09
sensitivity analysis,Left ventricle,LV end systolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4262,-0.109965975867432,6.07657810106153e-13
sensitivity analysis,Left ventricle,LV end systolic volume,SOST;Sclerostin,4362,-0.0892981002221785,3.46607354707062e-09
sensitivity analysis,Left ventricle,LV end systolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4362,-0.0981600909141247,8.20122381466369e-11
sensitivity analysis,Left ventricle,LV end systolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4335,0.0804455001210767,1.13504271450062e-07
sensitivity analysis,Left ventricle,LV end systolic volume,TAFA5;Chemokine-like protein TAFA-5,4335,-0.1164957637399,1.42424427071005e-14
sensitivity analysis,Left ventricle,LV end systolic volume,TGFBR2;TGF-beta receptor type-2,4368,-0.0872586201127366,7.63314029235319e-09
sensitivity analysis,Left ventricle,LV end systolic volume,THY1;Thy-1 membrane glycoprotein,4395,-0.0830628220730194,3.49578507510641e-08
sensitivity analysis,Left ventricle,LV end systolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4328,-0.084255268629659,2.83685891320633e-08
sensitivity analysis,Left ventricle,LV end systolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4399,-0.0825768609944616,4.1412683774616e-08
sensitivity analysis,Left ventricle,LV end systolic volume,VGF;Neurosecretory protein VGF,3091,-0.0953628612990246,1.08529263110007e-07
sensitivity analysis,Left ventricle,LV longitudinal strain Segment 2,ADIPOQ;Adiponectin,3018,0.0973429943205232,8.40645136699672e-08
sensitivity analysis,Left ventricle,LV longitudinal strain Segment 2,ANGPT2;Angiopoietin-2,4281,0.10783676357082,1.5024199554248e-12
sensitivity analysis,Left ventricle,LV longitudinal strain Segment 2,ITGBL1;Integrin beta-like protein 1,3022,0.0959668141723981,1.25309127608145e-07
sensitivity analysis,Left ventricle,LV longitudinal strain Segment 2,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4263,0.0998242012734601,6.48553379532962e-11
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 1,LEP;Leptin,4371,-0.0851670304412583,1.70711769851091e-08
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,"FABP4;Fatty acid-binding protein, adipocyte",4412,-0.0903759304017674,1.81404851766024e-09
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,LEP;Leptin,4371,-0.122370192729648,4.7182666169096e-16
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 10,REN;Renin,4371,-0.0938923500694901,4.98667799148922e-10
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,CLMP;CXADR-like membrane protein,4392,-0.0796522172600458,1.25278512467304e-07
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,"FABP4;Fatty acid-binding protein, adipocyte",4412,-0.0861107052424526,1.01176956585127e-08
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,LEP;Leptin,4371,-0.119140076212786,2.72969567970044e-15
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 4,REN;Renin,4371,-0.0831869011357201,3.63437943784873e-08
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 5,LEP;Leptin,4370,-0.0936616425395342,5.52339691518303e-10
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 6,LEP;Leptin,4369,-0.0852665156347325,1.65517373775958e-08
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,LEP;Leptin,4371,-0.0808863424772247,8.55902295036475e-08
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 7,REN;Renin,4371,-0.0933134073520133,6.36948922421691e-10
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,LEP;Leptin,4371,-0.0961922353798758,1.85884500479862e-10
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 8,REN;Renin,4371,-0.0960244813318771,1.99914494300797e-10
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,LEP;Leptin,4371,-0.103322660365614,7.52013282015688e-12
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness AHA 9,REN;Renin,4371,-0.0915664705325959,1.32121366137376e-09
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness global,"FABP4;Fatty acid-binding protein, adipocyte",4412,-0.0781437416619168,2.02519094904028e-07
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness global,LEP;Leptin,4371,-0.112651902514438,8.05170832378619e-14
sensitivity analysis,Left ventricle,LV mean myocardial wall thickness global,REN;Renin,4371,-0.10062436826945,2.59916321733493e-11
sensitivity analysis,Left ventricle,LV myocardial mass,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4344,-0.10937130683023,4.89530150124965e-13
sensitivity analysis,Left ventricle,LV myocardial mass,ADM;Pro-adrenomedullin,4393,-0.126782054753501,3.31934826261202e-17
sensitivity analysis,Left ventricle,LV myocardial mass,AGRN;Agrin,4368,-0.0829742232995197,3.97996081159131e-08
sensitivity analysis,Left ventricle,LV myocardial mass,AHNAK;Neuroblast differentiation-associated protein AHNAK,3011,-0.119912807710574,4.08330007080153e-11
sensitivity analysis,Left ventricle,LV myocardial mass,APCS;Serum amyloid P-component,3085,-0.108912282952087,1.32046144260968e-09
sensitivity analysis,Left ventricle,LV myocardial mass,CALB2;Calretinin,4263,-0.0953470434268496,4.43893840244739e-10
sensitivity analysis,Left ventricle,LV myocardial mass,CFB;Complement factor B,3058,-0.117068352705471,8.38779300785198e-11
sensitivity analysis,Left ventricle,LV myocardial mass,CFD;Complement factor D,3102,-0.105749052600313,3.5491351851089e-09
sensitivity analysis,Left ventricle,LV myocardial mass,CFH;Complement factor H,2930,-0.120364614074943,6.30726547685011e-11
sensitivity analysis,Left ventricle,LV myocardial mass,CFI;Complement factor I,3102,-0.105993235962453,3.26566995088056e-09
sensitivity analysis,Left ventricle,LV myocardial mass,CHGB;Secretogranin-1,4397,-0.0864912568069483,9.22688398541758e-09
sensitivity analysis,Left ventricle,LV myocardial mass,CLEC4A;C-type lectin domain family 4 member A,4362,0.108329942312935,7.29614057742391e-13
sensitivity analysis,Left ventricle,LV myocardial mass,CLMP;CXADR-like membrane protein,4393,-0.147770904065842,7.16675411199621e-23
sensitivity analysis,Left ventricle,LV myocardial mass,COLEC12;Collectin-12,4347,-0.0984632418195686,7.72791078963071e-11
sensitivity analysis,Left ventricle,LV myocardial mass,CST3;Cystatin-C,4359,-0.0800033618849515,1.22984155323061e-07
sensitivity analysis,Left ventricle,LV myocardial mass,CYTL1;Cytokine-like protein 1,3108,-0.0971976653467704,5.65454495411963e-08
sensitivity analysis,Left ventricle,LV myocardial mass,DPT;Dermatopontin,4413,-0.092119302810769,8.74223464851083e-10
sensitivity analysis,Left ventricle,LV myocardial mass,F7;Coagulation factor VII,4357,-0.0932214790968824,7.04892036604448e-10
sensitivity analysis,Left ventricle,LV myocardial mass,"FABP4;Fatty acid-binding protein, adipocyte",4413,-0.218482600766779,7.74499159631129e-49
sensitivity analysis,Left ventricle,LV myocardial mass,GHR;Growth hormone receptor,3040,-0.10758595876508,2.73589370032937e-09
sensitivity analysis,Left ventricle,LV myocardial mass,HGF;Hepatocyte growth factor,4408,-0.0802016019655693,9.71975456890082e-08
sensitivity analysis,Left ventricle,LV myocardial mass,IGFBP6;Insulin-like growth factor-binding protein 6,4342,-0.104179931015493,5.919537075258e-12
sensitivity analysis,Left ventricle,LV myocardial mass,IGSF9;Protein turtle homolog A,3114,-0.104302222519009,5.41200851753166e-09
sensitivity analysis,Left ventricle,LV myocardial mass,IL1RN;Interleukin-1 receptor antagonist protein,4342,-0.113610482237108,5.98554121153986e-14
sensitivity analysis,Left ventricle,LV myocardial mass,INHBB;Inhibin beta B chain,3040,-0.0986319632301036,5.05838846600529e-08
sensitivity analysis,Left ventricle,LV myocardial mass,INHBC;Inhibin beta C chain,4346,-0.102955759315537,1.02172193849086e-11
sensitivity analysis,Left ventricle,LV myocardial mass,ITGAM;Integrin alpha-M,4346,0.086039151067233,1.33935197782999e-08
sensitivity analysis,Left ventricle,LV myocardial mass,LEP;Leptin,4372,-0.250475570504088,1.57663731734868e-63
sensitivity analysis,Left ventricle,LV myocardial mass,LGALS9;Galectin-9,4349,-0.0804985896907748,1.06225704943071e-07
sensitivity analysis,Left ventricle,LV myocardial mass,MEGF10;Multiple epidermal growth factor-like domains protein 10,4347,0.0858924501413691,1.41224343239382e-08
sensitivity analysis,Left ventricle,LV myocardial mass,MFAP5;Microfibrillar-associated protein 5,4413,-0.0819168175727628,5.05438569457493e-08
sensitivity analysis,Left ventricle,LV myocardial mass,MOG;Myelin-oligodendrocyte glycoprotein,4393,-0.0901699564153254,2.13830339710363e-09
sensitivity analysis,Left ventricle,LV myocardial mass,NPDC1;Neural proliferation differentiation and control protein 1,4372,-0.121209606805909,8.84658517885636e-16
sensitivity analysis,Left ventricle,LV myocardial mass,OXT;Oxytocin-neurophysin 1,4404,-0.0876352980559133,5.70208011562341e-09
sensitivity analysis,Left ventricle,LV myocardial mass,PALM;Paralemmin-1,3060,-0.156951380663706,2.48560203198378e-18
sensitivity analysis,Left ventricle,LV myocardial mass,PLAT;Tissue-type plasminogen activator,4402,-0.119959988813013,1.39789925562575e-15
sensitivity analysis,Left ventricle,LV myocardial mass,PRND;Prion-like protein doppel,3099,-0.1154421600261,1.1523724557102e-10
sensitivity analysis,Left ventricle,LV myocardial mass,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4323,-0.0873659489324738,8.73563991489897e-09
sensitivity analysis,Left ventricle,LV myocardial mass,RBP7;Retinoid-binding protein 7,3087,-0.0950665839234249,1.21103379220736e-07
sensitivity analysis,Left ventricle,LV myocardial mass,REN;Renin,4372,-0.114445438215961,3.19797443181316e-14
sensitivity analysis,Left ventricle,LV myocardial mass,RTBDN;Retbindin,4344,-0.0831243834746694,4.09818716650682e-08
sensitivity analysis,Left ventricle,LV myocardial mass,SCGB1A1;Uteroglobin,4355,-0.0944112190382852,4.30400399848672e-10
sensitivity analysis,Left ventricle,LV myocardial mass,SEZ6L;Seizure 6-like protein,4377,-0.0895187882536999,2.98017314956478e-09
sensitivity analysis,Left ventricle,LV myocardial mass,SMOC1;SPARC-related modular calcium-binding protein 1,4393,-0.0928223869642823,7.1019319440246e-10
sensitivity analysis,Left ventricle,LV myocardial mass,SNCG;Gamma-synuclein,4337,-0.103114394110649,9.97348842572075e-12
sensitivity analysis,Left ventricle,LV myocardial mass,SORCS2;VPS10 domain-containing receptor SorCS2,4270,-0.0846278037875911,3.05348506496421e-08
sensitivity analysis,Left ventricle,LV myocardial mass,SOST;Sclerostin,4371,-0.0945430444249297,3.78078693702008e-10
sensitivity analysis,Left ventricle,LV myocardial mass,TAFA5;Chemokine-like protein TAFA-5,4344,-0.113208783559026,7.24231795949373e-14
sensitivity analysis,Left ventricle,LV myocardial mass,TGFBR2;TGF-beta receptor type-2,4377,-0.086237072414484,1.10112618990161e-08
sensitivity analysis,Left ventricle,LV myocardial mass,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4401,-0.0823910154581278,4.41039280474071e-08
sensitivity analysis,Left ventricle,LV myocardial mass,XG;Glycoprotein Xg,4394,-0.0800459573757651,1.07809115720143e-07
sensitivity analysis,Left ventricle,LV myocardial mass,YAP1;Transcriptional coactivator YAP1,3099,-0.0964558771698865,7.45059862351644e-08
sensitivity analysis,Left ventricle,LV radial strain AHA 16,LEP;Leptin,4367,-0.0788350961952512,1.82522517631554e-07
sensitivity analysis,Left ventricle,LV radial strain AHA 2,LEP;Leptin,4367,0.0785826524679047,1.99766602919682e-07
sensitivity analysis,Left ventricle,LV stroke volume,ACY1;Aminoacylase-1,4373,-0.0894592115391405,3.10381445992266e-09
sensitivity analysis,Left ventricle,LV stroke volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4338,-0.0845833324271027,2.41420898375353e-08
sensitivity analysis,Left ventricle,LV stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4345,-0.10264590210334,1.18487946018289e-11
sensitivity analysis,Left ventricle,LV stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4278,-0.095684347986305,3.58888516334033e-10
sensitivity analysis,Left ventricle,LV stroke volume,ADM;Pro-adrenomedullin,4394,-0.109319297724374,3.69741281727767e-13
sensitivity analysis,Left ventricle,LV stroke volume,AFM;Afamin,3103,-0.129007531299211,5.45011869104354e-13
sensitivity analysis,Left ventricle,LV stroke volume,AGR3;Anterior gradient protein 3,4263,-0.0903059248211095,3.4931394861767e-09
sensitivity analysis,Left ventricle,LV stroke volume,AGRN;Agrin,4369,-0.111759632984824,1.27988146950275e-13
sensitivity analysis,Left ventricle,LV stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3012,-0.132414291905772,2.95894357964998e-13
sensitivity analysis,Left ventricle,LV stroke volume,APCS;Serum amyloid P-component,3086,-0.121703643242458,1.17426308168502e-11
sensitivity analysis,Left ventricle,LV stroke volume,ASGR1;Asialoglycoprotein receptor 1,4338,-0.0821231485574814,6.07737512492703e-08
sensitivity analysis,Left ventricle,LV stroke volume,C19orf12;Protein C19orf12,4264,-0.0938098906375232,8.3849654736956e-10
sensitivity analysis,Left ventricle,LV stroke volume,C1R;Complement C1r subcomponent,3103,-0.0986592225315814,3.65009733160551e-08
sensitivity analysis,Left ventricle,LV stroke volume,CALB1;Calbindin,4345,-0.0826752409264623,4.83025302547996e-08
sensitivity analysis,Left ventricle,LV stroke volume,CALB2;Calretinin,4264,-0.0877253642840538,9.59196366281087e-09
sensitivity analysis,Left ventricle,LV stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4345,-0.0996893112265857,4.52743355450451e-11
sensitivity analysis,Left ventricle,LV stroke volume,CDCP1;CUB domain-containing protein 1,4338,-0.0928480205301157,8.96805415465283e-10
sensitivity analysis,Left ventricle,LV stroke volume,CDHR2;Cadherin-related family member 2,4345,-0.0791671605114872,1.74030998165503e-07
sensitivity analysis,Left ventricle,LV stroke volume,CDHR5;Cadherin-related family member 5,4373,-0.0917820224811185,1.19789981116728e-09
sensitivity analysis,Left ventricle,LV stroke volume,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3040,-0.0979865196114723,6.18346685958387e-08
sensitivity analysis,Left ventricle,LV stroke volume,CES1;Liver carboxylesterase 1,4377,-0.106296626188376,1.78351241683221e-12
sensitivity analysis,Left ventricle,LV stroke volume,CFB;Complement factor B,3059,-0.0967822482721691,8.17328591699628e-08
sensitivity analysis,Left ventricle,LV stroke volume,CFD;Complement factor D,3103,-0.104565278200235,5.2695441546379e-09
sensitivity analysis,Left ventricle,LV stroke volume,CFH;Complement factor H,2931,-0.131802217082297,7.8453363299444e-13
sensitivity analysis,Left ventricle,LV stroke volume,CFI;Complement factor I,3103,-0.111617376230262,4.52981526926087e-10
sensitivity analysis,Left ventricle,LV stroke volume,CFP;Properdin,3103,-0.107648865005353,1.83707679348039e-09
sensitivity analysis,Left ventricle,LV stroke volume,CKB;Creatine kinase B-type,3109,0.117325792089781,5.31113345342548e-11
sensitivity analysis,Left ventricle,LV stroke volume,CLMP;CXADR-like membrane protein,4394,-0.108425559103759,5.74331664853534e-13
sensitivity analysis,Left ventricle,LV stroke volume,CNTN3;Contactin-3,4347,-0.100515020214175,3.09339007798776e-11
sensitivity analysis,Left ventricle,LV stroke volume,COL15A1;Collagen alpha-1(XV) chain,3109,-0.104764761268871,4.76190556384558e-09
sensitivity analysis,Left ventricle,LV stroke volume,COL4A1;Collagen alpha-1(IV) chain,4373,0.0952317156553348,2.78872162600461e-10
sensitivity analysis,Left ventricle,LV stroke volume,COLEC12;Collectin-12,4348,-0.0951730416286092,3.21327278410505e-10
sensitivity analysis,Left ventricle,LV stroke volume,CPM;Carboxypeptidase M,4390,-0.116839369368323,8.11053489218901e-15
sensitivity analysis,Left ventricle,LV stroke volume,CRIP2;Cysteine-rich protein 2,4338,-0.0929157119530294,8.7187470969267e-10
sensitivity analysis,Left ventricle,LV stroke volume,CRLF1;Cytokine receptor-like factor 1,4369,-0.0852981722727025,1.63505911543872e-08
sensitivity analysis,Left ventricle,LV stroke volume,CST3;Cystatin-C,4360,-0.0970103125966858,1.37238164558133e-10
sensitivity analysis,Left ventricle,LV stroke volume,CXCL17;C-X-C motif chemokine 17,4409,-0.0900597338117793,2.09230653460091e-09
sensitivity analysis,Left ventricle,LV stroke volume,CYTL1;Cytokine-like protein 1,3109,-0.0946418470304092,1.24456506187967e-07
sensitivity analysis,Left ventricle,LV stroke volume,DCXR;L-xylulose reductase,4378,-0.0834979892446573,3.15065353335188e-08
sensitivity analysis,Left ventricle,LV stroke volume,DPT;Dermatopontin,4414,-0.0898232431206256,2.2579958003212e-09
sensitivity analysis,Left ventricle,LV stroke volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3088,-0.0946187349858486,1.38193071812176e-07
sensitivity analysis,Left ventricle,LV stroke volume,ELOA;Elongin-A,4345,-0.085264338035559,1.81286834108834e-08
sensitivity analysis,Left ventricle,LV stroke volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4378,-0.0865700874738654,9.62697896715461e-09
sensitivity analysis,Left ventricle,LV stroke volume,EZR;Ezrin,4405,-0.0783876229016923,1.8971768752558e-07
sensitivity analysis,Left ventricle,LV stroke volume,F7;Coagulation factor VII,4358,-0.101486789578995,1.87954186783023e-11
sensitivity analysis,Left ventricle,LV stroke volume,F9;Coagulation factor IX,4365,-0.0826033950523004,4.62302482643608e-08
sensitivity analysis,Left ventricle,LV stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4414,-0.185858322084286,1.34354035069928e-35
sensitivity analysis,Left ventricle,LV stroke volume,FSTL3;Follistatin-related protein 3,4341,-0.085406549382199,1.7425007973569e-08
sensitivity analysis,Left ventricle,LV stroke volume,FUOM;Fucose mutarotase,3040,-0.0979059789452689,6.33982147259167e-08
sensitivity analysis,Left ventricle,LV stroke volume,FURIN;Furin,4378,-0.0963401830541282,1.68586274001062e-10
sensitivity analysis,Left ventricle,LV stroke volume,GHR;Growth hormone receptor,3040,-0.125386350681091,3.98030880736545e-12
sensitivity analysis,Left ventricle,LV stroke volume,GPD1;Glycerol-3-phosphate dehydrogenase,3092,-0.130849971817132,2.78311517341541e-13
sensitivity analysis,Left ventricle,LV stroke volume,GSTA1;Glutathione S-transferase A1,4349,-0.0983684763566994,7.97838625006102e-11
sensitivity analysis,Left ventricle,LV stroke volume,GSTA3;Glutathione S-transferase A3,4271,-0.0951759928478589,4.5946888798774e-10
sensitivity analysis,Left ventricle,LV stroke volume,GUSB;Beta-glucuronidase,4368,-0.0794782465627479,1.44367006959542e-07
sensitivity analysis,Left ventricle,LV stroke volume,HGF;Hepatocyte growth factor,4409,-0.0823055271791536,4.42856765365675e-08
sensitivity analysis,Left ventricle,LV stroke volume,HNMT;Histamine N-methyltransferase,4327,-0.101685470076702,2.02353881951417e-11
sensitivity analysis,Left ventricle,LV stroke volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3016,-0.104512938297006,8.76549623667123e-09
sensitivity analysis,Left ventricle,LV stroke volume,HSPB6;Heat shock protein beta-6,4394,-0.0968950892814456,1.22476836529223e-10
sensitivity analysis,Left ventricle,LV stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4333,-0.0835804653696744,3.59276158329091e-08
sensitivity analysis,Left ventricle,LV stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4409,0.0995902734138699,3.41580867138567e-11
sensitivity analysis,Left ventricle,LV stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4407,0.144522563058635,5.30892590022374e-22
sensitivity analysis,Left ventricle,LV stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4343,-0.117115220429853,9.74833558638224e-15
sensitivity analysis,Left ventricle,LV stroke volume,IGSF3;Immunoglobulin superfamily member 3,4345,-0.0794239211601607,1.5873167652e-07
sensitivity analysis,Left ventricle,LV stroke volume,IGSF9;Protein turtle homolog A,3115,-0.13499855994643,3.84302338190954e-14
sensitivity analysis,Left ventricle,LV stroke volume,IL18R1;Interleukin-18 receptor 1,4409,-0.086566471994581,8.55106208971055e-09
sensitivity analysis,Left ventricle,LV stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4343,-0.144110312825516,1.37160757428347e-21
sensitivity analysis,Left ventricle,LV stroke volume,INHBC;Inhibin beta C chain,4347,-0.104866115367399,4.17466642192168e-12
sensitivity analysis,Left ventricle,LV stroke volume,ITGA5;Integrin alpha-5,4347,-0.080584618401365,1.03645632371038e-07
sensitivity analysis,Left ventricle,LV stroke volume,KLK6;Kallikrein-6,4371,-0.0817258273587608,6.27821074434698e-08
sensitivity analysis,Left ventricle,LV stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4345,-0.100342619437573,3.37788527801551e-11
sensitivity analysis,Left ventricle,LV stroke volume,KYNU;Kynureninase,4409,-0.0896760629447069,2.44859322003431e-09
sensitivity analysis,Left ventricle,LV stroke volume,LCAT;Phosphatidylcholine-sterol acyltransferase,3109,-0.104560245346104,5.1025653676487e-09
sensitivity analysis,Left ventricle,LV stroke volume,LDLR;Low-density lipoprotein receptor,4366,-0.130691460065541,4.31103317733233e-18
sensitivity analysis,Left ventricle,LV stroke volume,LEP;Leptin,4373,-0.208830265692468,2.73811177539933e-44
sensitivity analysis,Left ventricle,LV stroke volume,LGALS9;Galectin-9,4350,-0.0836812938056875,3.25251294233096e-08
sensitivity analysis,Left ventricle,LV stroke volume,LPL;Lipoprotein lipase,4373,0.107203991611896,1.1797484866624e-12
sensitivity analysis,Left ventricle,LV stroke volume,MFAP5;Microfibrillar-associated protein 5,4414,-0.0800957827153076,9.90523405244315e-08
sensitivity analysis,Left ventricle,LV stroke volume,MIA;Melanoma-derived growth regulatory protein,4378,-0.0798199079017422,1.23437127613253e-07
sensitivity analysis,Left ventricle,LV stroke volume,MOG;Myelin-oligodendrocyte glycoprotein,4394,-0.0847143787065372,1.86588458335258e-08
sensitivity analysis,Left ventricle,LV stroke volume,NELL2;Protein kinase C-binding protein NELL2,4369,-0.0812306593347557,7.59191665290367e-08
sensitivity analysis,Left ventricle,LV stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3052,-0.0974416073877464,6.89880346483114e-08
sensitivity analysis,Left ventricle,LV stroke volume,NPPC;C-type natriuretic peptide,4363,-0.108641984795893,6.22872086744023e-13
sensitivity analysis,Left ventricle,LV stroke volume,NPY;Pro-neuropeptide Y,4394,-0.111005342068458,1.59531188107801e-13
sensitivity analysis,Left ventricle,LV stroke volume,NRCAM;Neuronal cell adhesion molecule,4373,-0.0868801920020186,8.6892620753225e-09
sensitivity analysis,Left ventricle,LV stroke volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3100,-0.0972412981943481,5.80055483455414e-08
sensitivity analysis,Left ventricle,LV stroke volume,OXT;Oxytocin-neurophysin 1,4405,-0.0960701718104313,1.66792097819811e-10
sensitivity analysis,Left ventricle,LV stroke volume,PALM;Paralemmin-1,3061,-0.131019305613949,3.407127634664e-13
sensitivity analysis,Left ventricle,LV stroke volume,PALM2;Paralemmin-2,3100,-0.111759188101555,4.38876862963564e-10
sensitivity analysis,Left ventricle,LV stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3088,-0.113300809539109,2.72104875359019e-10
sensitivity analysis,Left ventricle,LV stroke volume,PENK;Proenkephalin-A,3040,-0.100532232631513,2.779898233491e-08
sensitivity analysis,Left ventricle,LV stroke volume,PLAT;Tissue-type plasminogen activator,4403,-0.129688969276132,5.64150375460994e-18
sensitivity analysis,Left ventricle,LV stroke volume,PLIN1;Perilipin-1,4264,-0.0810282742572858,1.16916166356231e-07
sensitivity analysis,Left ventricle,LV stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4345,-0.092455135609502,1.02378891257154e-09
sensitivity analysis,Left ventricle,LV stroke volume,PON3;Serum paraoxonase/lactonase 3,4369,0.0923455733222696,9.64243724047653e-10
sensitivity analysis,Left ventricle,LV stroke volume,PRAP1;Proline-rich acidic protein 1,3109,-0.127441176802146,9.88077175457942e-13
sensitivity analysis,Left ventricle,LV stroke volume,PRSS8;Prostasin,4337,-0.112385750838091,1.14793666048657e-13
sensitivity analysis,Left ventricle,LV stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4330,-0.0926876952559534,9.93194276675159e-10
sensitivity analysis,Left ventricle,LV stroke volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4324,-0.0966661219853116,1.8955921299503e-10
sensitivity analysis,Left ventricle,LV stroke volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4252,-0.0836963522666867,4.61330021986222e-08
sensitivity analysis,Left ventricle,LV stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4370,-0.0864342282138964,1.04722930786539e-08
sensitivity analysis,Left ventricle,LV stroke volume,RBP5;Retinol-binding protein 5,4345,-0.0882491784825444,5.65056581486176e-09
sensitivity analysis,Left ventricle,LV stroke volume,RIDA;2-iminobutanoate/2-iminopropanoate deaminase,3040,-0.108630821205164,1.91563295602686e-09
sensitivity analysis,Left ventricle,LV stroke volume,RNASE4;Ribonuclease 4,2988,-0.100227073444337,4.01458152292951e-08
sensitivity analysis,Left ventricle,LV stroke volume,RTBDN;Retbindin,4345,-0.0813767895794466,7.81064023408326e-08
sensitivity analysis,Left ventricle,LV stroke volume,RTN4R;Reticulon-4 receptor,4394,-0.109186288704133,3.94876166621645e-13
sensitivity analysis,Left ventricle,LV stroke volume,SCARB2;Lysosome membrane protein 2,4242,-0.0906763108477703,3.29352177495678e-09
sensitivity analysis,Left ventricle,LV stroke volume,SCG2;Secretogranin-2,4386,-0.0878779098055547,5.55932138945725e-09
sensitivity analysis,Left ventricle,LV stroke volume,SCLY;Selenocysteine lyase,4389,-0.0849268463756698,1.7511609250472e-08
sensitivity analysis,Left ventricle,LV stroke volume,SELE;E-selectin,4414,-0.0862294608366785,9.58153219541001e-09
sensitivity analysis,Left ventricle,LV stroke volume,SERPINF1;Pigment epithelium-derived factor,3070,-0.111000189310463,6.96805519683221e-10
sensitivity analysis,Left ventricle,LV stroke volume,SERPINF2;Alpha-2-antiplasmin,3053,-0.094540916998705,1.66469046364451e-07
sensitivity analysis,Left ventricle,LV stroke volume,SEZ6L;Seizure 6-like protein,4378,-0.100590907333069,2.54467664654524e-11
sensitivity analysis,Left ventricle,LV stroke volume,SFRP1;Secreted frizzled-related protein 1,4323,-0.0878833387065193,7.13067145393711e-09
sensitivity analysis,Left ventricle,LV stroke volume,SLC39A5;Zinc transporter ZIP5,4363,-0.0813004778830098,7.55247693260352e-08
sensitivity analysis,Left ventricle,LV stroke volume,SMNDC1;Survival of motor neuron-related-splicing factor 30,3088,-0.0948827922946655,1.27501379873699e-07
sensitivity analysis,Left ventricle,LV stroke volume,SMOC1;SPARC-related modular calcium-binding protein 1,4394,-0.0785608189046253,1.84652873659397e-07
sensitivity analysis,Left ventricle,LV stroke volume,SMOC2;SPARC-related modular calcium-binding protein 2,4369,-0.0872356029486177,7.67260448149465e-09
sensitivity analysis,Left ventricle,LV stroke volume,SNCG;Gamma-synuclein,4338,-0.0960514671157752,2.31076710255693e-10
sensitivity analysis,Left ventricle,LV stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4271,-0.104761982148768,6.72469044125389e-12
sensitivity analysis,Left ventricle,LV stroke volume,SORD;Sorbitol dehydrogenase,4386,-0.0912198495937799,1.4296501201778e-09
sensitivity analysis,Left ventricle,LV stroke volume,SOST;Sclerostin,4372,-0.0905886491572912,1.96773072045545e-09
sensitivity analysis,Left ventricle,LV stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4372,-0.0863986492323473,1.05375407003167e-08
sensitivity analysis,Left ventricle,LV stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4366,-0.100722880858264,2.55108524958477e-11
sensitivity analysis,Left ventricle,LV stroke volume,TAFA5;Chemokine-like protein TAFA-5,4345,-0.101097751637109,2.40213679856593e-11
sensitivity analysis,Left ventricle,LV stroke volume,TREM2;Triggering receptor expressed on myeloid cells 2,4348,-0.0864179561429349,1.14724335302008e-08
sensitivity analysis,Left ventricle,LV stroke volume,UPB1;Beta-ureidopropionase,3115,-0.101109367744278,1.55513251900642e-08
sensitivity analysis,Right atrium,RA maximum volume,ACP5;Tartrate-resistant acid phosphatase type 5,4297,-0.0996331029770568,5.9300106651904e-11
sensitivity analysis,Right atrium,RA maximum volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4266,-0.0887407372655918,6.40494728948718e-09
sensitivity analysis,Right atrium,RA maximum volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4273,-0.106002859724795,3.73752750199881e-12
sensitivity analysis,Right atrium,RA maximum volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4208,-0.113655460634656,1.41933066537668e-13
sensitivity analysis,Right atrium,RA maximum volume,ADIPOQ;Adiponectin,3051,0.112769104786177,4.2034669141037e-10
sensitivity analysis,Right atrium,RA maximum volume,ADM;Pro-adrenomedullin,4321,-0.0815159927397471,8.06006958284413e-08
sensitivity analysis,Right atrium,RA maximum volume,AGRN;Agrin,4298,-0.119203600890288,4.48465774202568e-15
sensitivity analysis,Right atrium,RA maximum volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,2957,-0.126547091790829,4.97501482522637e-12
sensitivity analysis,Right atrium,RA maximum volume,APCS;Serum amyloid P-component,3034,-0.0996534645349378,3.78667750624428e-08
sensitivity analysis,Right atrium,RA maximum volume,APOF;Apolipoprotein F,3055,0.105853244706406,4.49633508437641e-09
sensitivity analysis,Right atrium,RA maximum volume,ASGR1;Asialoglycoprotein receptor 1,4266,-0.124151955960569,4.01648289469931e-16
sensitivity analysis,Right atrium,RA maximum volume,BCHE;Cholinesterase,2998,-0.107858196360335,3.20998531008798e-09
sensitivity analysis,Right atrium,RA maximum volume,BPIFB2;BPI fold-containing family B member 2,3054,-0.112450646187583,4.61723331921501e-10
sensitivity analysis,Right atrium,RA maximum volume,BTN2A1;Butyrophilin subfamily 2 member A1,4298,-0.0938342245722541,7.11527681467573e-10
sensitivity analysis,Right atrium,RA maximum volume,CCL22;C-C motif chemokine 22,4224,-0.088212947526604,9.31988148662579e-09
sensitivity analysis,Right atrium,RA maximum volume,CCL27;C-C motif chemokine 27,4305,-0.0859269410607506,1.63566552344823e-08
sensitivity analysis,Right atrium,RA maximum volume,CCL7;C-C motif chemokine 7,4293,-0.0792845811400863,1.9770693358315e-07
sensitivity analysis,Right atrium,RA maximum volume,CCN1;CCN family member 1,4271,-0.0793644272732828,2.0652176299555e-07
sensitivity analysis,Right atrium,RA maximum volume,CD300E;CMRF35-like molecule 2,4307,-0.0837093278383726,3.7610996668111e-08
sensitivity analysis,Right atrium,RA maximum volume,CD302;CD302 antigen,4273,-0.0976519225766559,1.58714440443373e-10
sensitivity analysis,Right atrium,RA maximum volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4273,-0.0996542099346269,6.64025773472823e-11
sensitivity analysis,Right atrium,RA maximum volume,CD4;T-cell surface glycoprotein CD4,4290,-0.0888612694598881,5.53996926502449e-09
sensitivity analysis,Right atrium,RA maximum volume,CD80;T-lymphocyte activation antigen CD80,3061,-0.0940511084377513,1.85877979666431e-07
sensitivity analysis,Right atrium,RA maximum volume,CD83;CD83 antigen,4293,-0.102551996356508,1.63800763883154e-11
sensitivity analysis,Right atrium,RA maximum volume,CDHR2;Cadherin-related family member 2,4273,-0.0878535964046881,8.80504719964507e-09
sensitivity analysis,Right atrium,RA maximum volume,CDHR5;Cadherin-related family member 5,4305,-0.0990249272366686,7.44561124337009e-11
sensitivity analysis,Right atrium,RA maximum volume,CES1;Liver carboxylesterase 1,4308,-0.0947397557972879,4.64976176615677e-10
sensitivity analysis,Right atrium,RA maximum volume,CFC1;Cryptic protein,4200,-0.0898471267087645,5.44965351800795e-09
sensitivity analysis,Right atrium,RA maximum volume,CFH;Complement factor H,2881,-0.106625151698197,9.63816251836532e-09
sensitivity analysis,Right atrium,RA maximum volume,CFI;Complement factor I,3051,-0.0995348767356646,3.60208432475829e-08
sensitivity analysis,Right atrium,RA maximum volume,CHRDL1;Chordin-like protein 1,4290,-0.0874982464314049,9.45035127575288e-09
sensitivity analysis,Right atrium,RA maximum volume,CKB;Creatine kinase B-type,3055,0.0954206958791728,1.26393397017238e-07
sensitivity analysis,Right atrium,RA maximum volume,CLMP;CXADR-like membrane protein,4321,-0.110021712303985,4.10255424889775e-13
sensitivity analysis,Right atrium,RA maximum volume,CNTN3;Contactin-3,4276,-0.101102859065872,3.44248221960272e-11
sensitivity analysis,Right atrium,RA maximum volume,COL18A1;Collagen alpha-1(XVIII) chain,4316,-0.0858604224092182,1.60905426508332e-08
sensitivity analysis,Right atrium,RA maximum volume,COL4A1;Collagen alpha-1(IV) chain,4305,0.0922219321263204,1.34375755701973e-09
sensitivity analysis,Right atrium,RA maximum volume,COL6A3;Collagen alpha-3(VI) chain,4342,-0.0986587741684535,7.26730852887327e-11
sensitivity analysis,Right atrium,RA maximum volume,COLEC12;Collectin-12,4277,-0.106308419434586,3.16564110085721e-12
sensitivity analysis,Right atrium,RA maximum volume,CPM;Carboxypeptidase M,4318,-0.110288143060922,3.66802850818451e-13
sensitivity analysis,Right atrium,RA maximum volume,CRHBP;Corticotropin-releasing factor-binding protein,4277,-0.0947115521250193,5.42936049880347e-10
sensitivity analysis,Right atrium,RA maximum volume,CRIP2;Cysteine-rich protein 2,4266,-0.092946052025366,1.18598828500366e-09
sensitivity analysis,Right atrium,RA maximum volume,CST3;Cystatin-C,4290,-0.119916050284153,3.26246505628198e-15
sensitivity analysis,Right atrium,RA maximum volume,CSTB;Cystatin-B,4254,-0.0838101207490491,4.39123799678879e-08
sensitivity analysis,Right atrium,RA maximum volume,CYTL1;Cytokine-like protein 1,3055,-0.107869676709166,2.27025002750954e-09
sensitivity analysis,Right atrium,RA maximum volume,DPT;Dermatopontin,4342,-0.081287279350745,8.1548966275739e-08
sensitivity analysis,Right atrium,RA maximum volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3036,-0.105188704347138,6.26131944850215e-09
sensitivity analysis,Right atrium,RA maximum volume,EFNA4;Ephrin-A4,4261,-0.0957104725554404,3.84554980339161e-10
sensitivity analysis,Right atrium,RA maximum volume,EPHA1;Ephrin type-A receptor 1,4290,-0.0957357558531845,3.31849702316189e-10
sensitivity analysis,Right atrium,RA maximum volume,EPHB6;Ephrin type-B receptor 6,4262,-0.0800211042239192,1.68636754212538e-07
sensitivity analysis,Right atrium,RA maximum volume,F7;Coagulation factor VII,4288,-0.128371861477643,3.21062214188167e-17
sensitivity analysis,Right atrium,RA maximum volume,F9;Coagulation factor IX,4295,-0.0844971455082999,2.92388771764206e-08
sensitivity analysis,Right atrium,RA maximum volume,"FABP4;Fatty acid-binding protein, adipocyte",4342,-0.153174792760898,3.30267978082543e-24
sensitivity analysis,Right atrium,RA maximum volume,FAS;Tumor necrosis factor receptor superfamily member 6,4331,-0.0858917241887386,1.50146744758583e-08
sensitivity analysis,Right atrium,RA maximum volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3061,-0.103823345988178,8.54291845198494e-09
sensitivity analysis,Right atrium,RA maximum volume,FGF21;Fibroblast growth factor 21,4317,-0.0812487152155207,9.00934822994985e-08
sensitivity analysis,Right atrium,RA maximum volume,FSTL3;Follistatin-related protein 3,4270,-0.107560627766601,1.82857560037657e-12
sensitivity analysis,Right atrium,RA maximum volume,FTCD;Formimidoyltransferase-cyclodeaminase,3038,-0.0940885098204865,2.04313276080866e-07
sensitivity analysis,Right atrium,RA maximum volume,FURIN;Furin,4306,-0.0957043466681782,3.11879197343036e-10
sensitivity analysis,Right atrium,RA maximum volume,GCG;Pro-glucagon,4200,-0.0825417215718253,8.46781964164339e-08
sensitivity analysis,Right atrium,RA maximum volume,GFRA1;GDNF family receptor alpha-1,4317,-0.100464508532462,3.69698514290145e-11
sensitivity analysis,Right atrium,RA maximum volume,GHR;Growth hormone receptor,2985,-0.112696598706462,6.64593726533317e-10
sensitivity analysis,Right atrium,RA maximum volume,GLA;Alpha-galactosidase A,2979,-0.0965575569348631,1.28999313024309e-07
sensitivity analysis,Right atrium,RA maximum volume,GM2A;Ganglioside GM2 activator,2977,-0.111318665610821,1.12810315678053e-09
sensitivity analysis,Right atrium,RA maximum volume,GPD1;Glycerol-3-phosphate dehydrogenase,3040,-0.105753004227884,5.07128466687107e-09
sensitivity analysis,Right atrium,RA maximum volume,GSTA1;Glutathione S-transferase A1,4282,-0.0880892833324814,7.74843886429661e-09
sensitivity analysis,Right atrium,RA maximum volume,GSTA3;Glutathione S-transferase A3,4200,-0.101068755631807,5.20783725734059e-11
sensitivity analysis,Right atrium,RA maximum volume,HAVCR2;Hepatitis A virus cellular receptor 2,4276,-0.0874433164966763,1.02030464766508e-08
sensitivity analysis,Right atrium,RA maximum volume,HGF;Hepatocyte growth factor,4338,-0.109548307321507,4.65740943856579e-13
sensitivity analysis,Right atrium,RA maximum volume,HIP1R;Huntingtin-interacting protein 1-related protein,3042,-0.106403485218766,4.03120556963402e-09
sensitivity analysis,Right atrium,RA maximum volume,HNMT;Histamine N-methyltransferase,4255,-0.101736010595873,2.8994184698151e-11
sensitivity analysis,Right atrium,RA maximum volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4261,-0.0936509425757579,9.07627676939626e-10
sensitivity analysis,Right atrium,RA maximum volume,IFI30;Gamma-interferon-inducible lysosomal thiol reductase,2967,-0.0971577271374777,1.14216944088276e-07
sensitivity analysis,Right atrium,RA maximum volume,IGFBP1;Insulin-like growth factor-binding protein 1,4337,0.118100902238923,6.05871535385326e-15
sensitivity analysis,Right atrium,RA maximum volume,IGFBP2;Insulin-like growth factor-binding protein 2,4335,0.110230110186071,3.39501364589655e-13
sensitivity analysis,Right atrium,RA maximum volume,IGFBP6;Insulin-like growth factor-binding protein 6,4273,-0.130701450609924,9.65062172546533e-18
sensitivity analysis,Right atrium,RA maximum volume,IGSF9;Protein turtle homolog A,3061,-0.115614924440896,1.40400799035879e-10
sensitivity analysis,Right atrium,RA maximum volume,IL10RB;Interleukin-10 receptor subunit beta,4298,-0.096162036819192,2.66500346069385e-10
sensitivity analysis,Right atrium,RA maximum volume,IL12A_IL12B;Interleukin-12,4273,-0.0806050619316464,1.31996942646309e-07
sensitivity analysis,Right atrium,RA maximum volume,IL12B;Interleukin-12 subunit beta,4338,-0.0870591720878528,9.28623208705369e-09
sensitivity analysis,Right atrium,RA maximum volume,IL16;Pro-interleukin-16,4338,-0.0867635385510243,1.04229433861477e-08
sensitivity analysis,Right atrium,RA maximum volume,IL1RN;Interleukin-1 receptor antagonist protein,4273,-0.150570555437922,4.32777281402764e-23
sensitivity analysis,Right atrium,RA maximum volume,INHBC;Inhibin beta C chain,4276,-0.118899177409362,6.17298094408979e-15
sensitivity analysis,Right atrium,RA maximum volume,ITGA5;Integrin alpha-5,4276,-0.0806958056524946,1.26486012309591e-07
sensitivity analysis,Right atrium,RA maximum volume,"KRT18;Keratin, type I cytoskeletal 18",4273,-0.111204764939066,3.10538493281814e-13
sensitivity analysis,Right atrium,RA maximum volume,KYNU;Kynureninase,4338,-0.081221516960444,8.46885407137338e-08
sensitivity analysis,Right atrium,RA maximum volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4277,-0.0900749954248969,3.61149631996341e-09
sensitivity analysis,Right atrium,RA maximum volume,LDLR;Low-density lipoprotein receptor,4295,-0.11938229059961,4.17111414357521e-15
sensitivity analysis,Right atrium,RA maximum volume,LEP;Leptin,4305,-0.187534747512541,2.26888211632634e-35
sensitivity analysis,Right atrium,RA maximum volume,LEPR;Leptin receptor,4305,0.0859374283095488,1.62910004973386e-08
sensitivity analysis,Right atrium,RA maximum volume,LGALS1;Galectin-1,4305,-0.089129597810171,4.6853460902148e-09
sensitivity analysis,Right atrium,RA maximum volume,LGALS9;Galectin-9,4279,-0.0990779520104472,8.29318678005408e-11
sensitivity analysis,Right atrium,RA maximum volume,LPL;Lipoprotein lipase,4305,0.0938826752399997,6.75498513612683e-10
sensitivity analysis,Right atrium,RA maximum volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4306,-0.0827474724118905,5.39880652755288e-08
sensitivity analysis,Right atrium,RA maximum volume,NPC2;NPC intracellular cholesterol transporter 2,3000,-0.132276400468633,3.48890432234363e-13
sensitivity analysis,Right atrium,RA maximum volume,NPDC1;Neural proliferation differentiation and control protein 1,4305,-0.0819761245085003,7.19775884039055e-08
sensitivity analysis,Right atrium,RA maximum volume,NPPB;Natriuretic peptides B,4208,0.0921455250677837,2.11961342710087e-09
sensitivity analysis,Right atrium,RA maximum volume,NPPC;C-type natriuretic peptide,4293,-0.101864752504148,2.23563219171563e-11
sensitivity analysis,Right atrium,RA maximum volume,NPY;Pro-neuropeptide Y,4321,-0.0851095489077302,2.1046943850375e-08
sensitivity analysis,Right atrium,RA maximum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4305,0.114355418397949,5.24529028709102e-14
sensitivity analysis,Right atrium,RA maximum volume,NTRK3;NT-3 growth factor receptor,4333,0.085057806254205,2.05242101793263e-08
sensitivity analysis,Right atrium,RA maximum volume,OCLN;Occludin,3047,-0.10137035551327,2.04960787069344e-08
sensitivity analysis,Right atrium,RA maximum volume,OXT;Oxytocin-neurophysin 1,4333,-0.101920387227307,1.76142820733786e-11
sensitivity analysis,Right atrium,RA maximum volume,PALM;Paralemmin-1,3009,-0.130762796404474,5.98314441850014e-13
sensitivity analysis,Right atrium,RA maximum volume,PAMR1;Inactive serine protease PAMR1,4276,-0.0891044040976311,5.32939424760943e-09
sensitivity analysis,Right atrium,RA maximum volume,PGF;Placenta growth factor,4338,-0.0962733641594739,2.10010886361568e-10
sensitivity analysis,Right atrium,RA maximum volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4276,-0.0887151236648044,6.21206744040195e-09
sensitivity analysis,Right atrium,RA maximum volume,PLAT;Tissue-type plasminogen activator,4331,-0.124962541502892,1.53405882593032e-16
sensitivity analysis,Right atrium,RA maximum volume,PLAUR;Urokinase plasminogen activator surface receptor,4254,-0.0815531819801045,1.00162409551141e-07
sensitivity analysis,Right atrium,RA maximum volume,PLTP;Phospholipid transfer protein,4331,0.0965853246341789,1.89802401864725e-10
sensitivity analysis,Right atrium,RA maximum volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4273,-0.0845868692459815,3.06646570130419e-08
sensitivity analysis,Right atrium,RA maximum volume,PON3;Serum paraoxonase/lactonase 3,4298,0.109294830354987,6.73441296383818e-13
sensitivity analysis,Right atrium,RA maximum volume,PRAP1;Proline-rich acidic protein 1,3055,-0.122885446384321,9.41358683367556e-12
sensitivity analysis,Right atrium,RA maximum volume,PRCP;Lysosomal Pro-X carboxypeptidase,4302,-0.0958245552832064,3.01963464365708e-10
sensitivity analysis,Right atrium,RA maximum volume,PRND;Prion-like protein doppel,3047,-0.112708822638769,4.40880512947748e-10
sensitivity analysis,Right atrium,RA maximum volume,PRRT3;Proline-rich transmembrane protein 3,2957,-0.108477259586689,3.34358044636618e-09
sensitivity analysis,Right atrium,RA maximum volume,PRSS8;Prostasin,4268,-0.128699731227125,3.1570026969951e-17
sensitivity analysis,Right atrium,RA maximum volume,PTGDS;Prostaglandin-H2 D-isomerase,4260,-0.113368038401479,1.16111735722069e-13
sensitivity analysis,Right atrium,RA maximum volume,RARRES2;Retinoic acid receptor responder protein 2,4300,-0.107297940784565,1.73442172392857e-12
sensitivity analysis,Right atrium,RA maximum volume,RBP5;Retinol-binding protein 5,4273,-0.0931926410967895,1.03876222608091e-09
sensitivity analysis,Right atrium,RA maximum volume,RNASE6;Ribonuclease K6,3028,-0.10814505256538,2.43179931295854e-09
sensitivity analysis,Right atrium,RA maximum volume,RTN4R;Reticulon-4 receptor,4321,-0.141618422476261,8.46552889567256e-21
sensitivity analysis,Right atrium,RA maximum volume,SCARA5;Scavenger receptor class A member 5,4333,-0.0800555469736086,1.31567881828928e-07
sensitivity analysis,Right atrium,RA maximum volume,SCARB2;Lysosome membrane protein 2,4172,-0.0897487389247068,6.36223003560524e-09
sensitivity analysis,Right atrium,RA maximum volume,SCG2;Secretogranin-2,4313,-0.0893064112833526,4.2258634828205e-09
sensitivity analysis,Right atrium,RA maximum volume,SCLY;Selenocysteine lyase,4316,-0.0813991740557469,8.55749520808665e-08
sensitivity analysis,Right atrium,RA maximum volume,SELE;E-selectin,4342,-0.0848969739039134,2.11044451386008e-08
sensitivity analysis,Right atrium,RA maximum volume,SEMA3F;Semaphorin-3F,4305,-0.0925607868497015,1.16894810357964e-09
sensitivity analysis,Right atrium,RA maximum volume,SERPINF1;Pigment epithelium-derived factor,3019,-0.117911199281523,8.10283171925878e-11
sensitivity analysis,Right atrium,RA maximum volume,SHBG;Sex hormone-binding globulin,3055,0.0943776306765566,1.73236423201217e-07
sensitivity analysis,Right atrium,RA maximum volume,SHISA5;Protein shisa-5,3055,-0.124042028609688,5.99213085690387e-12
sensitivity analysis,Right atrium,RA maximum volume,SIT1;Signaling threshold-regulating transmembrane adapter 1,4209,-0.0807429946463632,1.5597967530356e-07
sensitivity analysis,Right atrium,RA maximum volume,SLC39A5;Zinc transporter ZIP5,4293,-0.0956541626393477,3.38716942947229e-10
sensitivity analysis,Right atrium,RA maximum volume,SMOC1;SPARC-related modular calcium-binding protein 1,4321,-0.0993272290863102,6.00936457992171e-11
sensitivity analysis,Right atrium,RA maximum volume,SNCG;Gamma-synuclein,4266,-0.0906067578788774,3.05884006015954e-09
sensitivity analysis,Right atrium,RA maximum volume,SORCS2;VPS10 domain-containing receptor SorCS2,4200,-0.0843964906370011,4.30976947558334e-08
sensitivity analysis,Right atrium,RA maximum volume,SOST;Sclerostin,4304,-0.0885487656306969,5.92090692434393e-09
sensitivity analysis,Right atrium,RA maximum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4304,-0.110025007441811,4.55134971824108e-13
sensitivity analysis,Right atrium,RA maximum volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4296,-0.111418737737631,2.41580086761993e-13
sensitivity analysis,Right atrium,RA maximum volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4273,0.0850468279233188,2.57946093175592e-08
sensitivity analysis,Right atrium,RA maximum volume,STC1;Stanniocalcin-1,4333,-0.0941586390475617,5.29663494864252e-10
sensitivity analysis,Right atrium,RA maximum volume,TAFA5;Chemokine-like protein TAFA-5,4273,-0.117091987666403,1.61243133534658e-14
sensitivity analysis,Right atrium,RA maximum volume,TGFBR2;TGF-beta receptor type-2,4306,-0.104862535794224,5.26955959775261e-12
sensitivity analysis,Right atrium,RA maximum volume,THY1;Thy-1 membrane glycoprotein,4333,-0.0853618547086132,1.82690182920723e-08
sensitivity analysis,Right atrium,RA maximum volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4266,-0.109245376473259,8.38856606975799e-13
sensitivity analysis,Right atrium,RA maximum volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4338,-0.113819504276945,5.52667028869132e-14
sensitivity analysis,Right atrium,RA maximum volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4276,-0.112280244499894,1.79446948017861e-13
sensitivity analysis,Right atrium,RA maximum volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4276,-0.0960616793757032,3.08778985457841e-10
sensitivity analysis,Right atrium,RA maximum volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4331,-0.0880846067025036,6.37949934626301e-09
sensitivity analysis,Right atrium,RA maximum volume,VMO1;Vitelline membrane outer layer protein 1 homolog,4273,-0.0832764808522298,4.99436647624607e-08
sensitivity analysis,Right atrium,RA maximum volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4266,-0.0922366357750394,1.58466524133993e-09
sensitivity analysis,Right atrium,RA maximum volume,VWC2;Brorin,4257,-0.0974264203055903,1.89095654738601e-10
sensitivity analysis,Right atrium,RA maximum volume,WFDC2;WAP four-disulfide core domain protein 2,4026,-0.0885502127422523,1.82425078348791e-08
sensitivity analysis,Right atrium,RA maximum volume,XCL1;Lymphotactin,4321,-0.0804878029362044,1.17157186115185e-07
sensitivity analysis,Right atrium,RA maximum volume,XG;Glycoprotein Xg,4323,-0.0883645873942823,5.89759138390329e-09
sensitivity analysis,Right atrium,RA minimum volume,ACP5;Tartrate-resistant acid phosphatase type 5,4292,-0.0851368532316547,2.3219803584152e-08
sensitivity analysis,Right atrium,RA minimum volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4269,-0.0888772338343357,5.99715429281071e-09
sensitivity analysis,Right atrium,RA minimum volume,AGRN;Agrin,4293,-0.0912040825337887,2.1437651833823e-09
sensitivity analysis,Right atrium,RA minimum volume,ASGR1;Asialoglycoprotein receptor 1,4261,-0.0963906480948967,2.88440947919491e-10
sensitivity analysis,Right atrium,RA minimum volume,BPIFB2;BPI fold-containing family B member 2,3049,-0.0967965470251951,8.54264351714456e-08
sensitivity analysis,Right atrium,RA minimum volume,BTN2A1;Butyrophilin subfamily 2 member A1,4293,-0.0870100495844519,1.12872646849813e-08
sensitivity analysis,Right atrium,RA minimum volume,CD302;CD302 antigen,4269,-0.0881170057458978,8.07494456367483e-09
sensitivity analysis,Right atrium,RA minimum volume,CD83;CD83 antigen,4288,-0.0921585864227131,1.48564989885169e-09
sensitivity analysis,Right atrium,RA minimum volume,CLMP;CXADR-like membrane protein,4316,-0.0989759996107902,7.19783119010666e-11
sensitivity analysis,Right atrium,RA minimum volume,COL6A3;Collagen alpha-3(VI) chain,4337,-0.0911842274210072,1.78973808991582e-09
sensitivity analysis,Right atrium,RA minimum volume,COLEC12;Collectin-12,4272,-0.0916562357001423,1.95402181993997e-09
sensitivity analysis,Right atrium,RA minimum volume,CPM;Carboxypeptidase M,4313,-0.0805499323046951,1.17678133454941e-07
sensitivity analysis,Right atrium,RA minimum volume,CRHBP;Corticotropin-releasing factor-binding protein,4272,-0.089945516985408,3.88289203848175e-09
sensitivity analysis,Right atrium,RA minimum volume,CST3;Cystatin-C,4285,-0.0951448407499781,4.36128028608883e-10
sensitivity analysis,Right atrium,RA minimum volume,EPHB6;Ephrin type-B receptor 6,4257,-0.0819490541387677,8.59074983246092e-08
sensitivity analysis,Right atrium,RA minimum volume,F7;Coagulation factor VII,4283,-0.0980615180951516,1.26574209436044e-10
sensitivity analysis,Right atrium,RA minimum volume,"FABP4;Fatty acid-binding protein, adipocyte",4337,-0.126141007903956,7.55197631772152e-17
sensitivity analysis,Right atrium,RA minimum volume,FSTL3;Follistatin-related protein 3,4265,-0.0908934414595285,2.73857848502556e-09
sensitivity analysis,Right atrium,RA minimum volume,GFRA1;GDNF family receptor alpha-1,4312,-0.0863585733877597,1.34871677232476e-08
sensitivity analysis,Right atrium,RA minimum volume,HGF;Hepatocyte growth factor,4334,-0.106238683509231,2.3517415536545e-12
sensitivity analysis,Right atrium,RA minimum volume,HNMT;Histamine N-methyltransferase,4250,-0.0796625816535324,1.99178241496972e-07
sensitivity analysis,Right atrium,RA minimum volume,IGFBP1;Insulin-like growth factor-binding protein 1,4332,0.0822103653503907,6.00916520485483e-08
sensitivity analysis,Right atrium,RA minimum volume,IGFBP6;Insulin-like growth factor-binding protein 6,4268,-0.105702097036458,4.42524268375592e-12
sensitivity analysis,Right atrium,RA minimum volume,IL10RB;Interleukin-10 receptor subunit beta,4293,-0.101042138447425,3.23535714892018e-11
sensitivity analysis,Right atrium,RA minimum volume,IL1RN;Interleukin-1 receptor antagonist protein,4268,-0.124200639002409,3.84999171031741e-16
sensitivity analysis,Right atrium,RA minimum volume,INHBC;Inhibin beta C chain,4271,-0.0969895354284757,2.12990020231916e-10
sensitivity analysis,Right atrium,RA minimum volume,"KRT18;Keratin, type I cytoskeletal 18",4269,-0.080629168355822,1.32638577815096e-07
sensitivity analysis,Right atrium,RA minimum volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4272,-0.0803064350876455,1.47361700800761e-07
sensitivity analysis,Right atrium,RA minimum volume,LDLR;Low-density lipoprotein receptor,4290,-0.0870897950266757,1.1073387430332e-08
sensitivity analysis,Right atrium,RA minimum volume,LEP;Leptin,4300,-0.17034368294518,2.33589183133012e-29
sensitivity analysis,Right atrium,RA minimum volume,LGALS9;Galectin-9,4274,-0.0818785813694924,8.30761196575802e-08
sensitivity analysis,Right atrium,RA minimum volume,NPC2;NPC intracellular cholesterol transporter 2,2995,-0.0987873604205295,6.05078623364833e-08
sensitivity analysis,Right atrium,RA minimum volume,NPPB;Natriuretic peptides B,4204,0.092216196864875,2.09677940138174e-09
sensitivity analysis,Right atrium,RA minimum volume,NPPC;C-type natriuretic peptide,4288,-0.0896062148578409,4.15795782505495e-09
sensitivity analysis,Right atrium,RA minimum volume,NTproBNP;N-terminal prohormone of brain natriuretic peptide,4300,0.116442605698157,1.86658615363327e-14
sensitivity analysis,Right atrium,RA minimum volume,OXT;Oxytocin-neurophysin 1,4328,-0.0820884504566185,6.37446703776206e-08
sensitivity analysis,Right atrium,RA minimum volume,PLAT;Tissue-type plasminogen activator,4326,-0.0899861379587077,3.04935392483841e-09
sensitivity analysis,Right atrium,RA minimum volume,PON3;Serum paraoxonase/lactonase 3,4293,0.0831455523206731,4.87966037666481e-08
sensitivity analysis,Right atrium,RA minimum volume,PRRT3;Proline-rich transmembrane protein 3,2952,-0.102676560302868,2.25669344715234e-08
sensitivity analysis,Right atrium,RA minimum volume,PRSS8;Prostasin,4263,-0.0904791119984288,3.25999997612272e-09
sensitivity analysis,Right atrium,RA minimum volume,PTGDS;Prostaglandin-H2 D-isomerase,4255,-0.0935088159006549,9.88753674111617e-10
sensitivity analysis,Right atrium,RA minimum volume,RARRES2;Retinoic acid receptor responder protein 2,4295,-0.0919293694026696,1.58239494171293e-09
sensitivity analysis,Right atrium,RA minimum volume,RTN4R;Reticulon-4 receptor,4316,-0.110715518013179,3.01058069692046e-13
sensitivity analysis,Right atrium,RA minimum volume,SEMA3F;Semaphorin-3F,4300,-0.0841099112623562,3.32044029384221e-08
sensitivity analysis,Right atrium,RA minimum volume,SMOC1;SPARC-related modular calcium-binding protein 1,4316,-0.0843286389176303,2.88366380072157e-08
sensitivity analysis,Right atrium,RA minimum volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4299,-0.0887342572643614,5.61546706294641e-09
sensitivity analysis,Right atrium,RA minimum volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4291,-0.0918003788242264,1.69714635633262e-09
sensitivity analysis,Right atrium,RA minimum volume,TAFA5;Chemokine-like protein TAFA-5,4269,-0.0980917890332027,1.33880474252928e-10
sensitivity analysis,Right atrium,RA minimum volume,TGFBR2;TGF-beta receptor type-2,4301,-0.0985150381359001,9.50062887730214e-11
sensitivity analysis,Right atrium,RA minimum volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4334,-0.101180490772769,2.45142274146685e-11
sensitivity analysis,Right atrium,RA minimum volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4271,-0.0924020819652904,1.44916281554447e-09
sensitivity analysis,Right atrium,RA minimum volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4271,-0.0877347664630631,9.294838423377e-09
sensitivity analysis,Right atrium,RA minimum volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4261,-0.0862092897287404,1.73772144968021e-08
sensitivity analysis,Right atrium,RA minimum volume,VWC2;Brorin,4252,-0.0875473858187446,1.0776173867245e-08
sensitivity analysis,Right atrium,RA minimum volume,WFDC2;WAP four-disulfide core domain protein 2,4021,-0.089168045892061,1.48062796426216e-08
sensitivity analysis,Right atrium,RA stroke volume,ACY1;Aminoacylase-1,4313,-0.0836187578288701,3.80713167074666e-08
sensitivity analysis,Right atrium,RA stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4281,-0.0856913787424142,1.96079808999179e-08
sensitivity analysis,Right atrium,RA stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4216,-0.108799248649912,1.40705367281041e-12
sensitivity analysis,Right atrium,RA stroke volume,ADIPOQ;Adiponectin,3056,0.100783992099418,2.35873050306572e-08
sensitivity analysis,Right atrium,RA stroke volume,AGR3;Anterior gradient protein 3,4201,-0.0809255268836243,1.50250054931346e-07
sensitivity analysis,Right atrium,RA stroke volume,AGRN;Agrin,4306,-0.108168067602736,1.10437648229796e-12
sensitivity analysis,Right atrium,RA stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,2962,-0.115901960508262,2.50708243297542e-10
sensitivity analysis,Right atrium,RA stroke volume,ASGR1;Asialoglycoprotein receptor 1,4274,-0.110666082664088,4.01469136387126e-13
sensitivity analysis,Right atrium,RA stroke volume,BCHE;Cholinesterase,3004,-0.0977558769509541,7.93896646418734e-08
sensitivity analysis,Right atrium,RA stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4281,-0.0976029179069512,1.55871762517198e-10
sensitivity analysis,Right atrium,RA stroke volume,CD4;T-cell surface glycoprotein CD4,4298,-0.0885739784030867,6.00641803001117e-09
sensitivity analysis,Right atrium,RA stroke volume,CDHR5;Cadherin-related family member 5,4313,-0.0852352001537853,2.06733274298007e-08
sensitivity analysis,Right atrium,RA stroke volume,CES1;Liver carboxylesterase 1,4316,-0.0816985840565223,7.67001076981133e-08
sensitivity analysis,Right atrium,RA stroke volume,CFC1;Cryptic protein,4208,-0.0834408144263565,5.94070461071407e-08
sensitivity analysis,Right atrium,RA stroke volume,CFH;Complement factor H,2885,-0.100122317511565,7.08489942676689e-08
sensitivity analysis,Right atrium,RA stroke volume,CKB;Creatine kinase B-type,3061,0.0975219858594958,6.43696025830983e-08
sensitivity analysis,Right atrium,RA stroke volume,CLMP;CXADR-like membrane protein,4329,-0.0840658133370305,3.03628452986793e-08
sensitivity analysis,Right atrium,RA stroke volume,CNTN3;Contactin-3,4284,-0.0941450986918495,6.66136311758905e-10
sensitivity analysis,Right atrium,RA stroke volume,COL15A1;Collagen alpha-1(XV) chain,3061,-0.0956918176993214,1.13113649799239e-07
sensitivity analysis,Right atrium,RA stroke volume,COL4A1;Collagen alpha-1(IV) chain,4313,0.0814041993822913,8.63024641767581e-08
sensitivity analysis,Right atrium,RA stroke volume,COLEC12;Collectin-12,4285,-0.086536147180032,1.3979384418481e-08
sensitivity analysis,Right atrium,RA stroke volume,CPM;Carboxypeptidase M,4326,-0.108230878165344,9.50334746746834e-13
sensitivity analysis,Right atrium,RA stroke volume,CST3;Cystatin-C,4298,-0.101614870791622,2.43660108288216e-11
sensitivity analysis,Right atrium,RA stroke volume,CTSD;Cathepsin D,4022,-0.0824434318228618,1.64281294755356e-07
sensitivity analysis,Right atrium,RA stroke volume,CXCL17;C-X-C motif chemokine 17,4346,-0.0786942344317111,2.05360451802788e-07
sensitivity analysis,Right atrium,RA stroke volume,CYTL1;Cytokine-like protein 1,3061,-0.0979801223028313,5.5808018989423e-08
sensitivity analysis,Right atrium,RA stroke volume,EPHA1;Ephrin type-A receptor 1,4298,-0.0864599228546575,1.36899679877897e-08
sensitivity analysis,Right atrium,RA stroke volume,F7;Coagulation factor VII,4296,-0.107767796633694,1.4198920336766e-12
sensitivity analysis,Right atrium,RA stroke volume,F9;Coagulation factor IX,4303,-0.0894399152433095,4.17542067527489e-09
sensitivity analysis,Right atrium,RA stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4350,-0.129549505769302,9.646037709728e-18
sensitivity analysis,Right atrium,RA stroke volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3067,-0.0957815041731703,1.06957927068042e-07
sensitivity analysis,Right atrium,RA stroke volume,FSTL3;Follistatin-related protein 3,4278,-0.0912266056779338,2.2654704434138e-09
sensitivity analysis,Right atrium,RA stroke volume,FURIN;Furin,4314,-0.107076529213083,1.77457937862013e-12
sensitivity analysis,Right atrium,RA stroke volume,GCG;Pro-glucagon,4208,-0.0869559778002578,1.60649621834259e-08
sensitivity analysis,Right atrium,RA stroke volume,GLA;Alpha-galactosidase A,2984,-0.0973551703430801,9.89961623799963e-08
sensitivity analysis,Right atrium,RA stroke volume,GM2A;Ganglioside GM2 activator,2982,-0.0973518444680792,1.00075582998498e-07
sensitivity analysis,Right atrium,RA stroke volume,GSTA1;Glutathione S-transferase A1,4290,-0.0875725439772774,9.18108419792218e-09
sensitivity analysis,Right atrium,RA stroke volume,GSTA3;Glutathione S-transferase A3,4208,-0.0970574959598603,2.80733080641587e-10
sensitivity analysis,Right atrium,RA stroke volume,HAO1;Hydroxyacid oxidase 1,4329,-0.0796042153475127,1.56807506665179e-07
sensitivity analysis,Right atrium,RA stroke volume,HIP1R;Huntingtin-interacting protein 1-related protein,3048,-0.101291435878033,2.0910699614162e-08
sensitivity analysis,Right atrium,RA stroke volume,HNMT;Histamine N-methyltransferase,4263,-0.0905862754636162,3.12340031554349e-09
sensitivity analysis,Right atrium,RA stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4269,-0.0914430183704345,2.15779749081616e-09
sensitivity analysis,Right atrium,RA stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4345,0.111938286588985,1.36455959558419e-13
sensitivity analysis,Right atrium,RA stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4343,0.109877181005114,3.84313537115357e-13
sensitivity analysis,Right atrium,RA stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4281,-0.106692615935821,2.58211456872203e-12
sensitivity analysis,Right atrium,RA stroke volume,IGSF9;Protein turtle homolog A,3067,-0.105298348351238,5.05491083317484e-09
sensitivity analysis,Right atrium,RA stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4281,-0.131944128812184,4.38159938767435e-18
sensitivity analysis,Right atrium,RA stroke volume,INHBC;Inhibin beta C chain,4284,-0.10399228521532,8.91271286515981e-12
sensitivity analysis,Right atrium,RA stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4281,-0.104145760160381,8.44534984567592e-12
sensitivity analysis,Right atrium,RA stroke volume,KYNU;Kynureninase,4346,-0.0865686750244586,1.09021081170386e-08
sensitivity analysis,Right atrium,RA stroke volume,LDLR;Low-density lipoprotein receptor,4303,-0.102075703678566,1.92664259611325e-11
sensitivity analysis,Right atrium,RA stroke volume,LEP;Leptin,4313,-0.143848219235633,2.23017776524262e-21
sensitivity analysis,Right atrium,RA stroke volume,LGALS1;Galectin-1,4313,-0.0878490783371395,7.5211458600999e-09
sensitivity analysis,Right atrium,RA stroke volume,LGALS9;Galectin-9,4287,-0.0840584868249976,3.54986771375706e-08
sensitivity analysis,Right atrium,RA stroke volume,LPL;Lipoprotein lipase,4313,0.0938822319897987,6.51540029440975e-10
sensitivity analysis,Right atrium,RA stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3005,-0.116450305483681,1.52656650616417e-10
sensitivity analysis,Right atrium,RA stroke volume,OCLN;Occludin,3053,-0.107038742333574,3.04910822113577e-09
sensitivity analysis,Right atrium,RA stroke volume,OXT;Oxytocin-neurophysin 1,4341,-0.087873141976921,6.66374975617481e-09
sensitivity analysis,Right atrium,RA stroke volume,PALM;Paralemmin-1,3015,-0.129631829171181,8.98836552081264e-13
sensitivity analysis,Right atrium,RA stroke volume,PAMR1;Inactive serine protease PAMR1,4284,-0.0850940515746066,2.43169536292012e-08
sensitivity analysis,Right atrium,RA stroke volume,PCBD1;Pterin-4-alpha-carbinolamine dehydratase,2981,-0.0965437541232855,1.28286530472342e-07
sensitivity analysis,Right atrium,RA stroke volume,PLAT;Tissue-type plasminogen activator,4339,-0.121082051513179,1.21455674629992e-15
sensitivity analysis,Right atrium,RA stroke volume,PLTP;Phospholipid transfer protein,4339,0.0881214425537569,6.0889537451006e-09
sensitivity analysis,Right atrium,RA stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4281,-0.0802189106499968,1.47534901497026e-07
sensitivity analysis,Right atrium,RA stroke volume,PON3;Serum paraoxonase/lactonase 3,4306,0.0918209084335553,1.57683669189558e-09
sensitivity analysis,Right atrium,RA stroke volume,PRAP1;Proline-rich acidic protein 1,3061,-0.120295286936519,2.43825536104071e-11
sensitivity analysis,Right atrium,RA stroke volume,PRCP;Lysosomal Pro-X carboxypeptidase,4310,-0.0830014286925424,4.84437576492407e-08
sensitivity analysis,Right atrium,RA stroke volume,PRND;Prion-like protein doppel,3053,-0.0974463286086923,6.85488126954502e-08
sensitivity analysis,Right atrium,RA stroke volume,PRSS8;Prostasin,4276,-0.117903462873566,1.03747458958043e-14
sensitivity analysis,Right atrium,RA stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4268,-0.0888484120741171,6.0902057732882e-09
sensitivity analysis,Right atrium,RA stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4308,-0.0889039388838915,5.06187592954436e-09
sensitivity analysis,Right atrium,RA stroke volume,RBP5;Retinol-binding protein 5,4281,-0.0897193696871575,4.09207659272428e-09
sensitivity analysis,Right atrium,RA stroke volume,RTN4R;Reticulon-4 receptor,4329,-0.116552839079803,1.44146108941072e-14
sensitivity analysis,Right atrium,RA stroke volume,SCARA5;Scavenger receptor class A member 5,4341,-0.0861321196213705,1.31692515981335e-08
sensitivity analysis,Right atrium,RA stroke volume,SCLY;Selenocysteine lyase,4324,-0.0911232954781819,1.93984883235972e-09
sensitivity analysis,Right atrium,RA stroke volume,SERPINF1;Pigment epithelium-derived factor,3024,-0.102271236941805,1.7359428877276e-08
sensitivity analysis,Right atrium,RA stroke volume,SHISA5;Protein shisa-5,3061,-0.109781609185489,1.13091521003654e-09
sensitivity analysis,Right atrium,RA stroke volume,SLC39A5;Zinc transporter ZIP5,4301,-0.0981685864358248,1.10521948259857e-10
sensitivity analysis,Right atrium,RA stroke volume,SNCG;Gamma-synuclein,4274,-0.0868725868223825,1.28187723001472e-08
sensitivity analysis,Right atrium,RA stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4208,-0.0801273028480659,1.94402901571663e-07
sensitivity analysis,Right atrium,RA stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4312,-0.0939640617408695,6.32465213677733e-10
sensitivity analysis,Right atrium,RA stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4304,-0.0934340208286984,8.18050200293699e-10
sensitivity analysis,Right atrium,RA stroke volume,STC1;Stanniocalcin-1,4341,-0.0837417430200268,3.28456773823378e-08
sensitivity analysis,Right atrium,RA stroke volume,TAFA5;Chemokine-like protein TAFA-5,4281,-0.0986108757627776,1.00680736170921e-10
sensitivity analysis,Right atrium,RA stroke volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4274,-0.10098494749825,3.66648324131845e-11
sensitivity analysis,Right atrium,RA stroke volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4346,-0.0838660505705472,3.07752557354713e-08
sensitivity analysis,Right atrium,RA stroke volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4284,-0.088083858586351,7.70292817654304e-09
sensitivity analysis,Right atrium,RA stroke volume,VMO1;Vitelline membrane outer layer protein 1 homolog,4281,-0.0840681862180104,3.61546773498349e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,ACP5;Tartrate-resistant acid phosphatase type 5,4368,-0.101527086190362,1.75021194844858e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4333,-0.0933660031362917,7.38803985623031e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,ACY1;Aminoacylase-1,4373,-0.0918185024860702,1.17989951268835e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4338,-0.11512719211605,2.83157944185457e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4345,-0.126726427376547,5.08132310256539e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4278,-0.124703842902308,2.70006759887162e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,ADIPOQ;Adiponectin,3103,0.0991496155620941,3.12110870434782e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,ADM;Pro-adrenomedullin,4394,-0.156680637011043,1.50344290868133e-25
sensitivity analysis,Right ventricle,RV end diastolic volume,AFM;Afamin,3103,-0.128174315014291,7.68850121560704e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,AGER;Advanced glycosylation end product-specific receptor,4339,-0.10871962401403,6.93506785610225e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,AGRN;Agrin,4369,-0.148727673112461,4.94024882537842e-23
sensitivity analysis,Right ventricle,RV end diastolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3012,-0.142320036449554,4.24418102433243e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,ALDH1A1;Retinal dehydrogenase 1,4347,-0.0814219972669831,7.62939340453688e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,AMBP;Protein AMBP,4393,-0.0957119786861489,2.06329894939826e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,APCS;Serum amyloid P-component,3086,-0.122125308592512,9.96393895024335e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,ASGR1;Asialoglycoprotein receptor 1,4338,-0.1396340851801,2.4780210316692e-20
sensitivity analysis,Right ventricle,RV end diastolic volume,B2M;Beta-2-microglobulin,3103,-0.0978954995173866,4.65106693573743e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,BCHE;Cholinesterase,3051,-0.111464721030832,6.67638133907453e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,BPIFB2;BPI fold-containing family B member 2,3108,-0.112264798734182,3.47326105955124e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,BSG;Basigin,4402,-0.0843753832085617,2.06445592729189e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,BTN2A1;Butyrophilin subfamily 2 member A1,4369,-0.095375972936252,2.67034314238735e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,C19orf12;Protein C19orf12,4264,-0.106065527860529,3.82316587879415e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,C1R;Complement C1r subcomponent,3103,-0.0980538270137561,4.42382778033663e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,C1RL;Complement C1r subcomponent-like protein,3098,-0.0955978544771216,9.76671804542053e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,"CA5A;Carbonic anhydrase 5A, mitochondrial",4278,-0.0925779392667628,1.30765552214048e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CALB1;Calbindin,4345,-0.118973736907646,3.60216289548929e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,CALB2;Calretinin,4264,-0.120684940202349,2.63139580652775e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,CALCB;Calcitonin gene-related peptide 2,3100,-0.0937504803991409,1.70226060696974e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,CBLN4;Cerebellin-4,4394,-0.0917336230847595,1.11587021332355e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CCDC80;Coiled-coil domain-containing protein 80,4373,-0.0854415607253849,1.52372084972115e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CCL16;C-C motif chemokine 16,4414,-0.083185366154056,3.11773112141503e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CCL22;C-C motif chemokine 22,4295,-0.0793713871385178,1.90468536979497e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,CCL7;C-C motif chemokine 7,4363,-0.0826067070352154,4.65002620050311e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CCN5;CCN family member 5,4347,-0.089977153725983,2.80357236299072e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CD300E;CMRF35-like molecule 2,4379,-0.102880979362923,8.84056901737076e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,CD302;CD302 antigen,4345,-0.110221339736155,3.2039882202152e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4345,-0.138412815362259,4.94438215872856e-20
sensitivity analysis,Right ventricle,RV end diastolic volume,CD4;T-cell surface glycoprotein CD4,4360,-0.102622564063278,1.10441114910536e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,CD5;T-cell surface glycoprotein CD5,4393,-0.0877596426707668,5.66792027881086e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CD59;CD59 glycoprotein,4202,-0.129443396866643,3.64301430771866e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,CD74;HLA class II histocompatibility antigen gamma chain,4405,-0.0853575485350013,1.3954615848943e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CD83;CD83 antigen,4363,-0.123003149858695,3.5389838877381e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,CD99L2;CD99 antigen-like protein 2,4347,-0.103426432289157,8.17391890245578e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,CDCP1;CUB domain-containing protein 1,4338,-0.0847285025618091,2.28434842813784e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CDHR2;Cadherin-related family member 2,4345,-0.10829222147018,8.23061088331235e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,CDHR5;Cadherin-related family member 5,4373,-0.102378099218885,1.15262894995437e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,CES1;Liver carboxylesterase 1,4377,-0.117633264885523,5.83873140443524e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,CFB;Complement factor B,3059,-0.122965041207048,8.84720412063079e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,CFC1;Cryptic protein,4271,-0.0883127523500677,7.42129051882259e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CFD;Complement factor D,3103,-0.117249850675015,5.70270358579108e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,CFH;Complement factor H,2931,-0.151919717368216,1.34783156866943e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,CFI;Complement factor I,3103,-0.126741077604652,1.38239094205295e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,CFP;Properdin,3103,-0.0961172249665536,8.12025699374588e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CHRDL1;Chordin-like protein 1,4361,-0.0969605445109146,1.39576207998874e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,CKAP4;Cytoskeleton-associated protein 4,4391,-0.0879627464902961,5.26798155241157e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CKB;Creatine kinase B-type,3109,0.107327893641616,1.98094497176319e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CLEC4A;C-type lectin domain family 4 member A,4363,0.104491781199623,4.54952086358905e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,CLMP;CXADR-like membrane protein,4394,-0.17341706045278,5.21007353296993e-31
sensitivity analysis,Right ventricle,RV end diastolic volume,CNTN3;Contactin-3,4347,-0.090982308294142,1.86248975019798e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,COL15A1;Collagen alpha-1(XV) chain,3109,-0.136500994465315,2.10870598474417e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4388,-0.100781158446255,2.21525670931407e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,COL4A1;Collagen alpha-1(IV) chain,4373,0.0949136070653425,3.1968877958196e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,COL6A3;Collagen alpha-3(VI) chain,4414,-0.122677118102003,2.86170256214621e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,COLEC12;Collectin-12,4348,-0.154525519559024,1.20825488598971e-24
sensitivity analysis,Right ventricle,RV end diastolic volume,CPM;Carboxypeptidase M,4390,-0.129362678019898,7.63633232456315e-18
sensitivity analysis,Right ventricle,RV end diastolic volume,CRHBP;Corticotropin-releasing factor-binding protein,4348,-0.087907486042541,6.39295487273201e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CRIP2;Cysteine-rich protein 2,4338,-0.0938094431913217,5.99767139849094e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,CSF1;Macrophage colony-stimulating factor 1,4369,-0.0800845660566285,1.15509563417927e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,CST3;Cystatin-C,4360,-0.144128672376391,1.13177166283429e-21
sensitivity analysis,Right ventricle,RV end diastolic volume,CSTB;Cystatin-B,4324,-0.0889166445711856,4.71825194846232e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,CTSD;Cathepsin D,4084,-0.0876486435965599,2.01888597657272e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,CTSZ;Cathepsin Z,4357,-0.0792454959121575,1.62730896075688e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,CXCL10;C-X-C motif chemokine 10,4369,-0.0785512323893567,2.00730367149403e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,CXCL17;C-X-C motif chemokine 17,4409,-0.116124066879155,1.03675271825475e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,CYTL1;Cytokine-like protein 1,3109,-0.135282391678392,3.59285297357652e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,DCXR;L-xylulose reductase,4378,-0.0873695422821873,7.02368675730863e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,"DDAH1;N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4345,-0.0911603780122783,1.7464172673538e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,DLK1;Protein delta homolog 1,4414,-0.0855387842752828,1.25673722118617e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,DPT;Dermatopontin,4414,-0.107321335350841,8.75117679263139e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3088,-0.121237537193889,1.38601357477391e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,EFNA1;Ephrin-A1,4344,-0.0972371011959881,1.34335258947461e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,EFNA4;Ephrin-A4,4333,-0.116988296093807,1.11736410014162e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,EGLN1;Egl nine homolog 1,4363,-0.0821449677904883,5.52431838651819e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,ELOA;Elongin-A,4345,-0.0946913455651513,4.00088667695516e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,EPHA1;Ephrin type-A receptor 1,4361,-0.111159218937852,1.81941479114608e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,EPHA2;Ephrin type-A receptor 2,4153,-0.0818591655987677,1.27368392585654e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,EPHB6;Ephrin type-B receptor 6,4334,-0.0946421682506465,4.29782723771096e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4378,-0.0805926908944466,9.31019063858007e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,F7;Coagulation factor VII,4358,-0.12803815207461,2.15762024157126e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,F9;Coagulation factor IX,4365,-0.0932239582819134,6.79402925039437e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4414,-0.241997475392736,7.55041522296258e-60
sensitivity analysis,Right ventricle,RV end diastolic volume,FAM3C;Protein FAM3C,4372,-0.0807282894492049,9.03959408229773e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,FAS;Tumor necrosis factor receptor superfamily member 6,4403,-0.0999991611808533,2.92605065431495e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,FCAMR;High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,3115,-0.096509424818897,6.7824334361897e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,FGF21;Fibroblast growth factor 21,4390,-0.110929087034835,1.69989097007354e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,FGFR2;Fibroblast growth factor receptor 2,4378,-0.0822423491235867,5.05502723163587e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,FSTL3;Follistatin-related protein 3,4341,-0.136984638739529,1.2395284162041e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,FTCD;Formimidoyltransferase-cyclodeaminase,3091,-0.104751995241828,5.29637994097492e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,FURIN;Furin,4378,-0.111848551733223,1.15533381194898e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,GDF15;Growth/differentiation factor 15,4414,-0.0925072115588469,7.39234872852385e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,GFRA1;GDNF family receptor alpha-1,4390,-0.128525926987522,1.24371104274489e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,GGH;Gamma-glutamyl hydrolase,4271,-0.112928721422342,1.3440631253451e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,GHR;Growth hormone receptor,3040,-0.136411201049017,4.23930666702803e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,GM2A;Ganglioside GM2 activator,3028,-0.113433851305453,3.8599089272837e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,GPD1;Glycerol-3-phosphate dehydrogenase,3092,-0.12528920605863,2.71868395503251e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,GPKOW;G-patch domain and KOW motifs-containing protein,4264,-0.0830722401371647,5.5613303954905e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,GSTA1;Glutathione S-transferase A1,4349,-0.108406490197157,7.60151197641834e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,GSTA3;Glutathione S-transferase A3,4271,-0.118352233628726,8.51428582641244e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,GUSB;Beta-glucuronidase,4368,-0.0904157165545068,2.14793879955596e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,HAO1;Hydroxyacid oxidase 1,4394,-0.0883757644336623,4.4107240667539e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,HAVCR2;Hepatitis A virus cellular receptor 2,4347,-0.0799843330848686,1.28863853767418e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,HGF;Hepatocyte growth factor,4409,-0.120173786953105,1.18170136309322e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,HIP1R;Huntingtin-interacting protein 1-related protein,3095,-0.098304253222102,4.25322485306239e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,HNMT;Histamine N-methyltransferase,4327,-0.134647212553605,5.838844331015e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3016,-0.119224429450581,5.08905961180346e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,HSD11B1;Corticosteroid 11-beta-dehydrogenase isozyme 1,4363,0.0806131689142836,9.71928230576487e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,HSPB6;Heat shock protein beta-6,4394,-0.0896906613765816,2.59021201149543e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4333,-0.138950423250966,3.98542647536318e-20
sensitivity analysis,Right ventricle,RV end diastolic volume,ICAM1;Intercellular adhesion molecule 1,4342,-0.0898252902026291,3.04378991327074e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,IGFBP1;Insulin-like growth factor-binding protein 1,4409,0.103271049568065,6.25713490664799e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,IGFBP2;Insulin-like growth factor-binding protein 2,4407,0.126141386454147,4.27341657301424e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,IGFBP4;Insulin-like growth factor-binding protein 4,4292,-0.0903497138823925,3.03823484318627e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4343,-0.158413381116157,8.36349918433885e-26
sensitivity analysis,Right ventricle,RV end diastolic volume,IGSF8;Immunoglobulin superfamily member 8,4373,-0.0804350597071973,1.00303281884743e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,IGSF9;Protein turtle homolog A,3115,-0.151525357821325,1.85223725602121e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,IL16;Pro-interleukin-16,4409,-0.0819534820567369,5.05510995911279e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,IL18BP;Interleukin-18-binding protein,4366,-0.0866407837040709,9.80910662917886e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4343,-0.169621431177725,2.14552077338364e-29
sensitivity analysis,Right ventricle,RV end diastolic volume,INHBB;Inhibin beta B chain,3040,-0.0977406606278772,6.67283991305948e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,INHBC;Inhibin beta C chain,4347,-0.154209103394657,1.52317222980609e-24
sensitivity analysis,Right ventricle,RV end diastolic volume,ISM1;Isthmin-1,4363,-0.0939548430889058,5.03595956503473e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,ITGA5;Integrin alpha-5,4347,-0.0834673395875603,3.56422931726548e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,KHK;Ketohexokinase,3012,-0.104334504121073,9.50424681918138e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,KIAA0319;Dyslexia-associated protein KIAA0319,3100,-0.099499419894101,2.83327167956734e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,KLK6;Kallikrein-6,4371,-0.104429390290956,4.47984754406971e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,"KRT18;Keratin, type I cytoskeletal 18",4345,-0.128857314905322,1.50239239476306e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,KYNU;Kynureninase,4409,-0.0869800058074752,7.25871182669409e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4348,-0.106723032438225,1.72125827839136e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,LAYN;Layilin,4334,-0.0892265915451425,4.00202427809413e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,LDLR;Low-density lipoprotein receptor,4366,-0.124737418182414,1.3164302498357e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,LEP;Leptin,4373,-0.262508777687749,7.79026603279607e-70
sensitivity analysis,Right ventricle,RV end diastolic volume,LGALS1;Galectin-1,4373,-0.118375512832463,4.04900483316711e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,LGALS9;Galectin-9,4350,-0.109665098953836,4.08499614529162e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,LPL;Lipoprotein lipase,4373,0.109722400965613,3.44635936289642e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,LY6D;Lymphocyte antigen 6D,4333,-0.0843517807004588,2.68524190258351e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,MAD1L1;Mitotic spindle assembly checkpoint protein MAD1,4327,-0.0984459406892412,8.60271599068419e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,MEGF10;Multiple epidermal growth factor-like domains protein 10,4348,0.0924137913484925,1.02786343103014e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,MFAP5;Microfibrillar-associated protein 5,4414,-0.0999292721572991,2.85475474149486e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,MIA;Melanoma-derived growth regulatory protein,4378,-0.0936924875260715,5.25828671931373e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4394,-0.11396486068296,3.5373220475243e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4378,-0.107316816075692,1.08465881729171e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,NCAN;Neurocan core protein,4405,-0.0922585589160188,8.53923012121138e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,NECTIN4;Nectin-4,4378,-0.0959782427746588,1.97308457994216e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,NOMO1;Nodal modulator 1,4347,-0.0927947251210779,8.81052938077259e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,NPC2;NPC intracellular cholesterol transporter 2,3052,-0.126676309853527,2.16122261966263e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4373,-0.127399118943459,2.74805255036108e-17
sensitivity analysis,Right ventricle,RV end diastolic volume,NPPC;C-type natriuretic peptide,4363,-0.150739147974152,1.36128604584773e-23
sensitivity analysis,Right ventricle,RV end diastolic volume,NPY;Pro-neuropeptide Y,4394,-0.0868940803709114,7.96271274885497e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,NRCAM;Neuronal cell adhesion molecule,4373,-0.087693142374828,6.30106312662378e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3100,-0.116292237244728,8.3414089848658e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,OCLN;Occludin,3100,-0.113479636718258,2.35490151376642e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,OGN;Mimecan,4347,-0.115254631291488,2.49446765543479e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,OPTC;Opticin,4345,-0.0885753681069936,4.96305741853465e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,OXT;Oxytocin-neurophysin 1,4405,-0.118992037724009,2.31018296736865e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,PALM;Paralemmin-1,3061,-0.161840139773841,2.06403885919502e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,PALM2;Paralemmin-2,3100,-0.120398085001586,1.75285826226424e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,PAMR1;Inactive serine protease PAMR1,4347,-0.0867522754961092,1.01089885312408e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,PARP1;Poly [ADP-ribose] polymerase 1,4363,-0.084624416264209,2.16664565038634e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3088,-0.111612132807207,4.99727829824772e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,PENK;Proenkephalin-A,3040,-0.117593082836654,7.84496618946898e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,PGF;Placenta growth factor,4409,-0.11438332019497,2.57742059654977e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,PI3;Elafin,4302,-0.0809542271293261,1.05524995694074e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4347,-0.106795221631518,1.67258511024495e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,PLAT;Tissue-type plasminogen activator,4403,-0.150824916043316,8.06916740226236e-24
sensitivity analysis,Right ventricle,RV end diastolic volume,PLIN1;Perilipin-1,4264,-0.103991577965936,9.9620687094791e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,PLTP;Phospholipid transfer protein,4403,0.0836310488796092,2.73651873711851e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4345,-0.104159124158077,5.87828632057005e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,PON3;Serum paraoxonase/lactonase 3,4369,0.11214756175104,1.05269405819409e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,PRAP1;Proline-rich acidic protein 1,3109,-0.13961696788095,5.28158118799227e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,PRCP;Lysosomal Pro-X carboxypeptidase,4373,-0.0877741250082572,6.10157574522422e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,PRND;Prion-like protein doppel,3100,-0.15779352424167,9.79322318988365e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,PRRT3;Proline-rich transmembrane protein 3,3012,-0.118582612793012,6.64943538924804e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,PRSS2;Trypsin-2,4366,-0.0862273022398036,1.15302823622838e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,PRSS8;Prostasin,4337,-0.115774195653403,2.04215750449616e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,PSPN;Persephin,4363,-0.0910077597488508,1.72153776652361e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4330,-0.161083526149864,1.46178583741503e-26
sensitivity analysis,Right ventricle,RV end diastolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4324,-0.134642458449047,6.02048651767592e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,PTPRR;Receptor-type tyrosine-protein phosphatase R,3100,-0.0981254032305037,4.38988769698795e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4252,-0.0910760611475727,2.69043052259557e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,RARRES2;Retinoic acid receptor responder protein 2,4370,-0.123778403854659,2.17993490835867e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,RBP5;Retinol-binding protein 5,4345,-0.13163682525068,2.97262254280733e-18
sensitivity analysis,Right ventricle,RV end diastolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4347,-0.10849530017125,7.36879401640711e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,RGMB;RGM domain family member B,4405,-0.0935271903796728,4.99409919132521e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,RNASE1;Ribonuclease pancreatic,3109,-0.0951576050806848,1.06208020233779e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,RNASE4;Ribonuclease 4,2988,-0.115571194086138,2.35777001530534e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,ROBO2;Roundabout homolog 2,4405,-0.0892111604936711,3.00896367153723e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,RSPO3;R-spondin-3,4394,-0.083610838303214,2.8489195315652e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,RTBDN;Retbindin,4345,-0.11434258652138,4.03962019249473e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,RTN4R;Reticulon-4 receptor,4394,-0.15806829323429,5.57442919152678e-26
sensitivity analysis,Right ventricle,RV end diastolic volume,SCARB2;Lysosome membrane protein 2,4242,-0.141408693829737,2.16531052289618e-20
sensitivity analysis,Right ventricle,RV end diastolic volume,SCG2;Secretogranin-2,4386,-0.1139878681132,3.68658954757417e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,SCGB1A1;Uteroglobin,4356,-0.0882467691378831,5.41143214101037e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,SCLY;Selenocysteine lyase,4389,-0.0890423631023023,3.44035539688307e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,SEMA3F;Semaphorin-3F,4373,-0.108166087908401,7.39726868797823e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,SERPIND1;Heparin cofactor 2,3101,-0.102381119517039,1.10363965770697e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,SERPINF1;Pigment epithelium-derived factor,3070,-0.128793321896026,7.88895716335058e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,SEZ6L;Seizure 6-like protein,4378,-0.124442407810087,1.41224070746571e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,SFRP1;Secreted frizzled-related protein 1,4323,-0.089094752539118,4.41307846067599e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,SHISA5;Protein shisa-5,3109,-0.124419611772511,3.36154369060192e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,SLC39A5;Zinc transporter ZIP5,4363,-0.0951242752858289,3.05967999356644e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,SLITRK2;SLIT and NTRK-like protein 2,4394,-0.0860131937629243,1.12617391528268e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,SMAD5;Mothers against decapentaplegic homolog 5,4345,-0.0850672066996863,1.95530012954014e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4394,-0.112822759545326,6.35548289314788e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,SNCG;Gamma-synuclein,4338,-0.124504202023174,1.87278380210211e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4271,-0.131072241470195,7.93218125212119e-18
sensitivity analysis,Right ventricle,RV end diastolic volume,SORD;Sorbitol dehydrogenase,4386,-0.101632174945984,1.51623566894643e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,SOST;Sclerostin,4372,-0.114319458448092,3.41230972761589e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4372,-0.105020973066981,3.36969496898916e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4366,-0.104713215054708,4.03089092884931e-12
sensitivity analysis,Right ventricle,RV end diastolic volume,"ST3GAL1;CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4345,0.0842648692310697,2.65553006136177e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,STC1;Stanniocalcin-1,4405,-0.0987129450713625,5.17623715210185e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,TAFA5;Chemokine-like protein TAFA-5,4345,-0.153674786395901,2.25780886875711e-24
sensitivity analysis,Right ventricle,RV end diastolic volume,TFF3;Trefoil factor 3,4337,-0.085883788633028,1.4720230658989e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,TGFBR2;TGF-beta receptor type-2,4378,-0.13374450762995,6.28803483471354e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,THY1;Thy-1 membrane glycoprotein,4405,-0.122678995684132,3.0636380840662e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4338,-0.124343632981779,2.04760359868188e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4409,-0.124359604113874,1.15788040514974e-16
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4394,-0.115302724169997,1.76743032388321e-14
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4347,-0.137872167442016,6.77563686446257e-20
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4347,-0.101304318191164,2.16438259532909e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4402,-0.135738284802848,1.4933820999207e-19
sensitivity analysis,Right ventricle,RV end diastolic volume,TNFRSF6B;Tumor necrosis factor receptor superfamily member 6B,4338,-0.0914595349091669,1.59199350008586e-09
sensitivity analysis,Right ventricle,RV end diastolic volume,TREM2;Triggering receptor expressed on myeloid cells 2,4348,-0.10189849689569,1.64239004512868e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,UPB1;Beta-ureidopropionase,3115,-0.0932443604804364,1.85366479537865e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,VEGFB;Vascular endothelial growth factor B,3016,-0.0984684555063447,6.00563271044842e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,VGF;Neurosecretory protein VGF,3100,-0.100605550094915,1.98311777916784e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4337,-0.0958237798317059,2.56039989325814e-10
sensitivity analysis,Right ventricle,RV end diastolic volume,VWC2;Brorin,4329,-0.119803492050142,2.6007131447902e-15
sensitivity analysis,Right ventricle,RV end diastolic volume,VWC2L;von Willebrand factor C domain-containing protein 2-like,3100,-0.0940212332458427,1.56800289234044e-07
sensitivity analysis,Right ventricle,RV end diastolic volume,WFDC2;WAP four-disulfide core domain protein 2,4094,-0.100845035367874,9.99495854974743e-11
sensitivity analysis,Right ventricle,RV end diastolic volume,XCL1;Lymphotactin,4394,-0.0808822354545713,7.92915746968959e-08
sensitivity analysis,Right ventricle,RV end diastolic volume,XG;Glycoprotein Xg,4395,-0.109442490784943,3.45738589720061e-13
sensitivity analysis,Right ventricle,RV end diastolic volume,YAP1;Transcriptional coactivator YAP1,3100,-0.106888203521733,2.43168273296808e-09
sensitivity analysis,Right ventricle,RV end systolic volume,ACP5;Tartrate-resistant acid phosphatase type 5,4367,-0.0808237840789266,8.87728755636702e-08
sensitivity analysis,Right ventricle,RV end systolic volume,ACVRL1;Serine/threonine-protein kinase receptor R3,4332,-0.0997824490755083,4.64128250159447e-11
sensitivity analysis,Right ventricle,RV end systolic volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4337,-0.0947850776582749,3.98938054062408e-10
sensitivity analysis,Right ventricle,RV end systolic volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4344,-0.102368611278778,1.35306774488427e-11
sensitivity analysis,Right ventricle,RV end systolic volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4277,-0.0963707438488228,2.69481012323415e-10
sensitivity analysis,Right ventricle,RV end systolic volume,ADM;Pro-adrenomedullin,4393,-0.13198553104749,1.57867564913364e-18
sensitivity analysis,Right ventricle,RV end systolic volume,AGER;Advanced glycosylation end product-specific receptor,4338,-0.123277631192782,3.69220249370682e-16
sensitivity analysis,Right ventricle,RV end systolic volume,AGRN;Agrin,4368,-0.10071860287851,2.52955493622769e-11
sensitivity analysis,Right ventricle,RV end systolic volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3011,-0.118149890470905,7.85839112351376e-11
sensitivity analysis,Right ventricle,RV end systolic volume,ASGR1;Asialoglycoprotein receptor 1,4337,-0.110105946548621,3.56432279771169e-13
sensitivity analysis,Right ventricle,RV end systolic volume,CALB1;Calbindin,4344,-0.0815972103170266,7.22728943434934e-08
sensitivity analysis,Right ventricle,RV end systolic volume,CALB2;Calretinin,4263,-0.098470261220153,1.17085263661678e-10
sensitivity analysis,Right ventricle,RV end systolic volume,CCN5;CCN family member 5,4346,-0.0801397902890503,1.2222163832967e-07
sensitivity analysis,Right ventricle,RV end systolic volume,CD300E;CMRF35-like molecule 2,4378,-0.0956716141516296,2.25336719975707e-10
sensitivity analysis,Right ventricle,RV end systolic volume,CD302;CD302 antigen,4344,-0.0883170579762868,5.52244549586445e-09
sensitivity analysis,Right ventricle,RV end systolic volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4344,-0.112555726367833,1.00719212795057e-13
sensitivity analysis,Right ventricle,RV end systolic volume,CD59;CD59 glycoprotein,4201,-0.108832427293937,1.51723566661772e-12
sensitivity analysis,Right ventricle,RV end systolic volume,CD83;CD83 antigen,4362,-0.106716748296315,1.5909549095293e-12
sensitivity analysis,Right ventricle,RV end systolic volume,CDHR2;Cadherin-related family member 2,4344,-0.0870797840557266,8.997775882622e-09
sensitivity analysis,Right ventricle,RV end systolic volume,CFB;Complement factor B,3058,-0.0959335660478676,1.06574369695766e-07
sensitivity analysis,Right ventricle,RV end systolic volume,CFH;Complement factor H,2931,-0.0979267991435663,1.08344860395075e-07
sensitivity analysis,Right ventricle,RV end systolic volume,CFI;Complement factor I,3102,-0.0966055198187064,7.00874927395864e-08
sensitivity analysis,Right ventricle,RV end systolic volume,CHRDL1;Chordin-like protein 1,4360,-0.0951340418066398,3.08974861948869e-10
sensitivity analysis,Right ventricle,RV end systolic volume,CLEC4A;C-type lectin domain family 4 member A,4362,0.0827603097122077,4.40570206448359e-08
sensitivity analysis,Right ventricle,RV end systolic volume,CLMP;CXADR-like membrane protein,4393,-0.142370283439959,2.49666286787864e-21
sensitivity analysis,Right ventricle,RV end systolic volume,COL15A1;Collagen alpha-1(XV) chain,3108,-0.108535159347694,1.30916994578569e-09
sensitivity analysis,Right ventricle,RV end systolic volume,COL18A1;Collagen alpha-1(XVIII) chain,4387,-0.0796507509070461,1.27423816987508e-07
sensitivity analysis,Right ventricle,RV end systolic volume,COL6A3;Collagen alpha-3(VI) chain,4413,-0.110828348662807,1.54714367615697e-13
sensitivity analysis,Right ventricle,RV end systolic volume,COLEC12;Collectin-12,4347,-0.135206781846123,3.4595379589852e-19
sensitivity analysis,Right ventricle,RV end systolic volume,CST3;Cystatin-C,4359,-0.109792811062077,3.62897651489278e-13
sensitivity analysis,Right ventricle,RV end systolic volume,CXCL17;C-X-C motif chemokine 17,4408,-0.0866396199212412,8.33948869115377e-09
sensitivity analysis,Right ventricle,RV end systolic volume,CYTL1;Cytokine-like protein 1,3108,-0.101607747542747,1.37082601111483e-08
sensitivity analysis,Right ventricle,RV end systolic volume,DPT;Dermatopontin,4413,-0.0917100595840463,1.03785549143409e-09
sensitivity analysis,Right ventricle,RV end systolic volume,EFNA1;Ephrin-A1,4343,-0.0813381303636374,7.97681178967601e-08
sensitivity analysis,Right ventricle,RV end systolic volume,EFNA4;Ephrin-A4,4332,-0.0994745553422818,5.32336664407004e-11
sensitivity analysis,Right ventricle,RV end systolic volume,EPHA1;Ephrin type-A receptor 1,4360,-0.0836631946572019,3.15837797727539e-08
sensitivity analysis,Right ventricle,RV end systolic volume,EPHB6;Ephrin type-B receptor 6,4333,-0.087176523591058,9.0449638667751e-09
sensitivity analysis,Right ventricle,RV end systolic volume,"FABP4;Fatty acid-binding protein, adipocyte",4413,-0.177780081323358,1.1612441493947e-32
sensitivity analysis,Right ventricle,RV end systolic volume,FSTL3;Follistatin-related protein 3,4340,-0.126113939910999,7.48328307456962e-17
sensitivity analysis,Right ventricle,RV end systolic volume,GFRA1;GDNF family receptor alpha-1,4389,-0.112854885081409,6.45924358877144e-14
sensitivity analysis,Right ventricle,RV end systolic volume,GSTA3;Glutathione S-transferase A3,4270,-0.0861803455832889,1.69732401587771e-08
sensitivity analysis,Right ventricle,RV end systolic volume,HGF;Hepatocyte growth factor,4408,-0.0815394368591056,5.92260235122032e-08
sensitivity analysis,Right ventricle,RV end systolic volume,HNMT;Histamine N-methyltransferase,4326,-0.115870828826271,2.09508590980872e-14
sensitivity analysis,Right ventricle,RV end systolic volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4332,-0.119034042674966,3.83296713565069e-15
sensitivity analysis,Right ventricle,RV end systolic volume,IGFBP4;Insulin-like growth factor-binding protein 4,4291,-0.0828712445070334,5.43946826548288e-08
sensitivity analysis,Right ventricle,RV end systolic volume,IGFBP6;Insulin-like growth factor-binding protein 6,4342,-0.113202054454499,7.36301627670873e-14
sensitivity analysis,Right ventricle,RV end systolic volume,IGSF9;Protein turtle homolog A,3114,-0.109021152960679,1.06415943612093e-09
sensitivity analysis,Right ventricle,RV end systolic volume,IL1RN;Interleukin-1 receptor antagonist protein,4342,-0.116746430568102,1.19045062628615e-14
sensitivity analysis,Right ventricle,RV end systolic volume,INHBC;Inhibin beta C chain,4346,-0.115544208853909,2.16262083389645e-14
sensitivity analysis,Right ventricle,RV end systolic volume,KLK6;Kallikrein-6,4370,-0.0803095033188889,1.06068964898591e-07
sensitivity analysis,Right ventricle,RV end systolic volume,"KRT18;Keratin, type I cytoskeletal 18",4344,-0.0969563149214687,1.51806733955674e-10
sensitivity analysis,Right ventricle,RV end systolic volume,LAIR1;Leukocyte-associated immunoglobulin-like receptor 1,4347,-0.0922920852221665,1.0858821558621e-09
sensitivity analysis,Right ventricle,RV end systolic volume,LAYN;Layilin,4333,-0.0836309486413153,3.52522196985731e-08
sensitivity analysis,Right ventricle,RV end systolic volume,LEP;Leptin,4372,-0.207579248902017,9.25760448588693e-44
sensitivity analysis,Right ventricle,RV end systolic volume,LGALS1;Galectin-1,4372,-0.0911893275779577,1.53730093146849e-09
sensitivity analysis,Right ventricle,RV end systolic volume,LGALS9;Galectin-9,4349,-0.0832202299181091,3.88330835261358e-08
sensitivity analysis,Right ventricle,RV end systolic volume,MEGF10;Multiple epidermal growth factor-like domains protein 10,4347,0.0883853866305757,5.30992346664202e-09
sensitivity analysis,Right ventricle,RV end systolic volume,MFAP5;Microfibrillar-associated protein 5,4413,-0.078988407830733,1.48866139848482e-07
sensitivity analysis,Right ventricle,RV end systolic volume,MOG;Myelin-oligodendrocyte glycoprotein,4393,-0.0847906133189784,1.81851163932101e-08
sensitivity analysis,Right ventricle,RV end systolic volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4377,-0.0799860111895109,1.16587850965477e-07
sensitivity analysis,Right ventricle,RV end systolic volume,NPC2;NPC intracellular cholesterol transporter 2,3051,-0.0947182027649754,1.59289800151723e-07
sensitivity analysis,Right ventricle,RV end systolic volume,NPDC1;Neural proliferation differentiation and control protein 1,4372,-0.118285784914863,4.27776634891769e-15
sensitivity analysis,Right ventricle,RV end systolic volume,NPPC;C-type natriuretic peptide,4362,-0.111664094666283,1.40421925212088e-13
sensitivity analysis,Right ventricle,RV end systolic volume,OGN;Mimecan,4346,-0.0926351983202286,9.45768048369861e-10
sensitivity analysis,Right ventricle,RV end systolic volume,OXT;Oxytocin-neurophysin 1,4404,-0.0787623906161523,1.66304906789382e-07
sensitivity analysis,Right ventricle,RV end systolic volume,PALM;Paralemmin-1,3060,-0.129814161682141,5.65502951400114e-13
sensitivity analysis,Right ventricle,RV end systolic volume,PAMR1;Inactive serine protease PAMR1,4346,-0.0826083030583305,4.93483645089723e-08
sensitivity analysis,Right ventricle,RV end systolic volume,PGF;Placenta growth factor,4408,-0.0793246029143924,1.33921056838532e-07
sensitivity analysis,Right ventricle,RV end systolic volume,PIK3IP1;Phosphoinositide-3-kinase-interacting protein 1,4346,-0.0913705160245096,1.59533556167814e-09
sensitivity analysis,Right ventricle,RV end systolic volume,PLAT;Tissue-type plasminogen activator,4402,-0.101394059819718,1.55446930078818e-11
sensitivity analysis,Right ventricle,RV end systolic volume,PON3;Serum paraoxonase/lactonase 3,4368,0.0808177812334475,8.86679447820489e-08
sensitivity analysis,Right ventricle,RV end systolic volume,PRND;Prion-like protein doppel,3099,-0.141749964068791,2.22867552897848e-15
sensitivity analysis,Right ventricle,RV end systolic volume,PRRT3;Proline-rich transmembrane protein 3,3011,-0.104201277122784,9.98252925701745e-09
sensitivity analysis,Right ventricle,RV end systolic volume,PTGDS;Prostaglandin-H2 D-isomerase,4329,-0.13253630250435,2.01623305191657e-18
sensitivity analysis,Right ventricle,RV end systolic volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4323,-0.107222611845402,1.56977564494783e-12
sensitivity analysis,Right ventricle,RV end systolic volume,RBP5;Retinol-binding protein 5,4344,-0.10628097480014,2.17531450712552e-12
sensitivity analysis,Right ventricle,RV end systolic volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4346,-0.0901888362630005,2.58395857517093e-09
sensitivity analysis,Right ventricle,RV end systolic volume,RGMB;RGM domain family member B,4404,-0.0859663742786683,1.10405572783065e-08
sensitivity analysis,Right ventricle,RV end systolic volume,ROBO2;Roundabout homolog 2,4404,-0.0910069444611767,1.44571977897745e-09
sensitivity analysis,Right ventricle,RV end systolic volume,RTBDN;Retbindin,4344,-0.0881272383518433,5.95447701129885e-09
sensitivity analysis,Right ventricle,RV end systolic volume,RTN4R;Reticulon-4 receptor,4393,-0.104898153621797,3.17219578424096e-12
sensitivity analysis,Right ventricle,RV end systolic volume,SCARB2;Lysosome membrane protein 2,4241,-0.123436481291371,7.20192424421479e-16
sensitivity analysis,Right ventricle,RV end systolic volume,SEMA3F;Semaphorin-3F,4372,-0.0997789893715801,3.78865543442692e-11
sensitivity analysis,Right ventricle,RV end systolic volume,SEZ6L;Seizure 6-like protein,4377,-0.0923036825826363,9.47392325269248e-10
sensitivity analysis,Right ventricle,RV end systolic volume,SHISA5;Protein shisa-5,3108,-0.0949666079973976,1.13170316146735e-07
sensitivity analysis,Right ventricle,RV end systolic volume,SMOC1;SPARC-related modular calcium-binding protein 1,4393,-0.089501967898949,2.80870371331472e-09
sensitivity analysis,Right ventricle,RV end systolic volume,SORCS2;VPS10 domain-containing receptor SorCS2,4270,-0.0878833439472529,8.80849681624115e-09
sensitivity analysis,Right ventricle,RV end systolic volume,SOST;Sclerostin,4371,-0.0844461281786411,2.25213746158717e-08
sensitivity analysis,Right ventricle,RV end systolic volume,TAFA5;Chemokine-like protein TAFA-5,4344,-0.128738874419453,1.62221507904795e-17
sensitivity analysis,Right ventricle,RV end systolic volume,TGFBR2;TGF-beta receptor type-2,4377,-0.121549281103763,7.07579916345802e-16
sensitivity analysis,Right ventricle,RV end systolic volume,THY1;Thy-1 membrane glycoprotein,4404,-0.105450185085654,2.29074149661316e-12
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4337,-0.108869889276208,6.52508503032973e-13
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4408,-0.106796816877256,1.17001980404893e-12
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4393,-0.0967968587251302,1.28494434497348e-10
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4346,-0.118785248888695,3.95335810674683e-15
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF1B;Tumor necrosis factor receptor superfamily member 1B,4346,-0.0927417603657401,9.04719141220349e-10
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF21;Tumor necrosis factor receptor superfamily member 21,4404,-0.0840706839734439,2.30411777383519e-08
sensitivity analysis,Right ventricle,RV end systolic volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4401,-0.131096738716691,2.49764479211234e-18
sensitivity analysis,Right ventricle,RV end systolic volume,VSIG4;V-set and immunoglobulin domain-containing protein 4,4336,-0.0809192358560631,9.5223945389196e-08
sensitivity analysis,Right ventricle,RV end systolic volume,VWC2;Brorin,4328,-0.0892867979649711,4.00428052465691e-09
sensitivity analysis,Right ventricle,RV end systolic volume,XG;Glycoprotein Xg,4394,-0.0898853476710916,2.3923622045032e-09
sensitivity analysis,Right ventricle,RV stroke volume,ACY1;Aminoacylase-1,4373,-0.0788206245272638,1.79956682068308e-07
sensitivity analysis,Right ventricle,RV stroke volume,ADAM22;Disintegrin and metalloproteinase domain-containing protein 22,4338,-0.084486883323999,2.50441695905103e-08
sensitivity analysis,Right ventricle,RV stroke volume,ADAMTS15;A disintegrin and metalloproteinase with thrombospondin motifs 15,4345,-0.0946667146351234,4.04298736687534e-10
sensitivity analysis,Right ventricle,RV stroke volume,ADH4;All-trans-retinol dehydrogenase [NAD(+)] ADH4,4278,-0.0969780857354545,2.0691088781489e-10
sensitivity analysis,Right ventricle,RV stroke volume,ADM;Pro-adrenomedullin,4394,-0.115067002405007,1.99842908565561e-14
sensitivity analysis,Right ventricle,RV stroke volume,AFM;Afamin,3103,-0.119615772797125,2.31757237825367e-11
sensitivity analysis,Right ventricle,RV stroke volume,AGR3;Anterior gradient protein 3,4263,-0.0861851394087268,1.7403639968421e-08
sensitivity analysis,Right ventricle,RV stroke volume,AGRN;Agrin,4369,-0.131385620002186,2.78895329366494e-18
sensitivity analysis,Right ventricle,RV stroke volume,AHNAK;Neuroblast differentiation-associated protein AHNAK,3012,-0.103133383972246,1.4038581677037e-08
sensitivity analysis,Right ventricle,RV stroke volume,AMBP;Protein AMBP,4393,-0.0825041022123892,4.34729699186152e-08
sensitivity analysis,Right ventricle,RV stroke volume,APCS;Serum amyloid P-component,3086,-0.110354037677885,7.91313438821443e-10
sensitivity analysis,Right ventricle,RV stroke volume,ASGR1;Asialoglycoprotein receptor 1,4338,-0.106321489191837,2.20927539625405e-12
sensitivity analysis,Right ventricle,RV stroke volume,BCHE;Cholinesterase,3051,-0.0955149161721523,1.25173921372554e-07
sensitivity analysis,Right ventricle,RV stroke volume,C19orf12;Protein C19orf12,4264,-0.0922140928257282,1.61334508975461e-09
sensitivity analysis,Right ventricle,RV stroke volume,C1R;Complement C1r subcomponent,3103,-0.0988012113257944,3.48859325523964e-08
sensitivity analysis,Right ventricle,RV stroke volume,CALB1;Calbindin,4345,-0.0998884171212951,4.1416162474174e-11
sensitivity analysis,Right ventricle,RV stroke volume,CALB2;Calretinin,4264,-0.091849481592505,1.87070230747985e-09
sensitivity analysis,Right ventricle,RV stroke volume,CCL7;C-C motif chemokine 7,4363,-0.0810978471943854,8.13724258442259e-08
sensitivity analysis,Right ventricle,RV stroke volume,CD302;CD302 antigen,4345,-0.0870153585791034,9.19173838354454e-09
sensitivity analysis,Right ventricle,RV stroke volume,CD38;ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4345,-0.106006977309621,2.46357895356139e-12
sensitivity analysis,Right ventricle,RV stroke volume,CD4;T-cell surface glycoprotein CD4,4360,-0.086358232704841,1.12118748010118e-08
sensitivity analysis,Right ventricle,RV stroke volume,CD59;CD59 glycoprotein,4202,-0.0953253723561673,5.95846151721749e-10
sensitivity analysis,Right ventricle,RV stroke volume,CD83;CD83 antigen,4363,-0.0854467007880216,1.57915061808507e-08
sensitivity analysis,Right ventricle,RV stroke volume,CD99L2;CD99 antigen-like protein 2,4347,-0.0825885672025675,4.95374583615946e-08
sensitivity analysis,Right ventricle,RV stroke volume,CDCP1;CUB domain-containing protein 1,4338,-0.089607796043167,3.37818962271709e-09
sensitivity analysis,Right ventricle,RV stroke volume,CDHR2;Cadherin-related family member 2,4345,-0.0809177411148918,9.24104627238444e-08
sensitivity analysis,Right ventricle,RV stroke volume,CDHR5;Cadherin-related family member 5,4373,-0.100126040667718,3.22333237777078e-11
sensitivity analysis,Right ventricle,RV stroke volume,CELSR2;Cadherin EGF LAG seven-pass G-type receptor 2,3040,-0.099862698018973,3.43696766138736e-08
sensitivity analysis,Right ventricle,RV stroke volume,CES1;Liver carboxylesterase 1,4377,-0.112527519782841,8.24847891319884e-14
sensitivity analysis,Right ventricle,RV stroke volume,CFB;Complement factor B,3059,-0.0938182788564216,2.01151403381574e-07
sensitivity analysis,Right ventricle,RV stroke volume,CFC1;Cryptic protein,4271,-0.0799147826175113,1.699706863691e-07
sensitivity analysis,Right ventricle,RV stroke volume,CFD;Complement factor D,3103,-0.0992261960663724,3.04551896564426e-08
sensitivity analysis,Right ventricle,RV stroke volume,CFH;Complement factor H,2931,-0.136924986641883,9.70407524313899e-14
sensitivity analysis,Right ventricle,RV stroke volume,CFI;Complement factor I,3103,-0.102249828071568,1.14006114330737e-08
sensitivity analysis,Right ventricle,RV stroke volume,CFP;Properdin,3103,-0.0942766203638736,1.43083410896814e-07
sensitivity analysis,Right ventricle,RV stroke volume,CKB;Creatine kinase B-type,3109,0.105997819810863,3.13078060490325e-09
sensitivity analysis,Right ventricle,RV stroke volume,CLEC4A;C-type lectin domain family 4 member A,4363,0.0808610754600381,8.87614733251218e-08
sensitivity analysis,Right ventricle,RV stroke volume,CLMP;CXADR-like membrane protein,4394,-0.128559545628174,1.17914383917798e-17
sensitivity analysis,Right ventricle,RV stroke volume,CNTN3;Contactin-3,4347,-0.0846513493463968,2.27535459937643e-08
sensitivity analysis,Right ventricle,RV stroke volume,COL15A1;Collagen alpha-1(XV) chain,3109,-0.105653661154816,3.52123218472775e-09
sensitivity analysis,Right ventricle,RV stroke volume,COL4A1;Collagen alpha-1(IV) chain,4373,0.0914291698729279,1.38640807540512e-09
sensitivity analysis,Right ventricle,RV stroke volume,COL6A3;Collagen alpha-3(VI) chain,4414,-0.0830064944095821,3.3373243092026e-08
sensitivity analysis,Right ventricle,RV stroke volume,COLEC12;Collectin-12,4348,-0.105835083807302,2.62720165425748e-12
sensitivity analysis,Right ventricle,RV stroke volume,CPM;Carboxypeptidase M,4390,-0.11985565468361,1.61576301774591e-15
sensitivity analysis,Right ventricle,RV stroke volume,CST3;Cystatin-C,4360,-0.116290009569621,1.33317606787163e-14
sensitivity analysis,Right ventricle,RV stroke volume,CTSD;Cathepsin D,4084,-0.093393679334382,2.23577457538797e-09
sensitivity analysis,Right ventricle,RV stroke volume,CXCL17;C-X-C motif chemokine 17,4409,-0.0965196752364578,1.34392430278703e-10
sensitivity analysis,Right ventricle,RV stroke volume,CYTL1;Cytokine-like protein 1,3109,-0.113484655334582,2.21433523044179e-10
sensitivity analysis,Right ventricle,RV stroke volume,EFCAB14;EF-hand calcium-binding domain-containing protein 14,3088,-0.0984606125683331,4.19250970358737e-08
sensitivity analysis,Right ventricle,RV stroke volume,EFNA4;Ephrin-A4,4333,-0.0838500241196201,3.24612242537825e-08
sensitivity analysis,Right ventricle,RV stroke volume,ELOA;Elongin-A,4345,-0.0805669875252798,1.05017246560944e-07
sensitivity analysis,Right ventricle,RV stroke volume,EPHA1;Ephrin type-A receptor 1,4361,-0.0887495002126823,4.33868043153589e-09
sensitivity analysis,Right ventricle,RV stroke volume,ERBB2;Receptor tyrosine-protein kinase erbB-2,4378,-0.0807749609444795,8.70772541272657e-08
sensitivity analysis,Right ventricle,RV stroke volume,F7;Coagulation factor VII,4358,-0.119760405096051,2.15131083023843e-15
sensitivity analysis,Right ventricle,RV stroke volume,F9;Coagulation factor IX,4365,-0.0974816719705524,1.0896148468613e-10
sensitivity analysis,Right ventricle,RV stroke volume,"FABP4;Fatty acid-binding protein, adipocyte",4414,-0.202186683424015,6.0790053871809e-42
sensitivity analysis,Right ventricle,RV stroke volume,FAS;Tumor necrosis factor receptor superfamily member 6,4403,-0.092927573247847,6.4984791052134e-10
sensitivity analysis,Right ventricle,RV stroke volume,FGF21;Fibroblast growth factor 21,4390,-0.0923467555874408,8.78871366616503e-10
sensitivity analysis,Right ventricle,RV stroke volume,FSTL3;Follistatin-related protein 3,4341,-0.0889326759981341,4.37409784154503e-09
sensitivity analysis,Right ventricle,RV stroke volume,FURIN;Furin,4378,-0.105750700987357,2.30232152884683e-12
sensitivity analysis,Right ventricle,RV stroke volume,GFRA1;GDNF family receptor alpha-1,4390,-0.0902484348323927,2.0968514077686e-09
sensitivity analysis,Right ventricle,RV stroke volume,GGH;Gamma-glutamyl hydrolase,4271,-0.10379275866917,1.04952232562564e-11
sensitivity analysis,Right ventricle,RV stroke volume,GHR;Growth hormone receptor,3040,-0.11517034650165,1.90705710390654e-10
sensitivity analysis,Right ventricle,RV stroke volume,GPD1;Glycerol-3-phosphate dehydrogenase,3092,-0.105237904326072,4.47077274492034e-09
sensitivity analysis,Right ventricle,RV stroke volume,GSTA1;Glutathione S-transferase A1,4349,-0.0862379746142261,1.22571684076014e-08
sensitivity analysis,Right ventricle,RV stroke volume,GSTA3;Glutathione S-transferase A3,4271,-0.0975714131188827,1.65931002216773e-10
sensitivity analysis,Right ventricle,RV stroke volume,GUSB;Beta-glucuronidase,4368,-0.102351809905278,1.19848360628349e-11
sensitivity analysis,Right ventricle,RV stroke volume,HGF;Hepatocyte growth factor,4409,-0.10665493961063,1.24602223648324e-12
sensitivity analysis,Right ventricle,RV stroke volume,HNMT;Histamine N-methyltransferase,4327,-0.0930008873182932,8.83710749756706e-10
sensitivity analysis,Right ventricle,RV stroke volume,HS6ST2;Heparan-sulfate 6-O-sulfotransferase 2,3016,-0.107794729712083,2.94330865069628e-09
sensitivity analysis,Right ventricle,RV stroke volume,HSPB6;Heat shock protein beta-6,4394,-0.0799894912123727,1.10056849927958e-07
sensitivity analysis,Right ventricle,RV stroke volume,HSPG2;Basement membrane-specific heparan sulfate proteoglycan core protein,4333,-0.100297888386201,3.66692963999088e-11
sensitivity analysis,Right ventricle,RV stroke volume,ICAM1;Intercellular adhesion molecule 1,4342,-0.0846395946282026,2.32830199245672e-08
sensitivity analysis,Right ventricle,RV stroke volume,IGFBP1;Insulin-like growth factor-binding protein 1,4409,0.0993346019025847,3.83460693572424e-11
sensitivity analysis,Right ventricle,RV stroke volume,IGFBP2;Insulin-like growth factor-binding protein 2,4407,0.120732958126759,8.83514851626462e-16
sensitivity analysis,Right ventricle,RV stroke volume,IGFBP6;Insulin-like growth factor-binding protein 6,4343,-0.129648909790636,9.66919749302413e-18
sensitivity analysis,Right ventricle,RV stroke volume,IGSF9;Protein turtle homolog A,3115,-0.126789643754162,1.22745585548534e-12
sensitivity analysis,Right ventricle,RV stroke volume,IL18R1;Interleukin-18 receptor 1,4409,-0.0907209052823186,1.59323146329228e-09
sensitivity analysis,Right ventricle,RV stroke volume,IL1RN;Interleukin-1 receptor antagonist protein,4343,-0.148203449193552,9.39391945029581e-23
sensitivity analysis,Right ventricle,RV stroke volume,INHBC;Inhibin beta C chain,4347,-0.128005892727598,2.4100297226962e-17
sensitivity analysis,Right ventricle,RV stroke volume,ISM1;Isthmin-1,4363,-0.0840951219033302,2.65175700011244e-08
sensitivity analysis,Right ventricle,RV stroke volume,KLK6;Kallikrein-6,4371,-0.0800573336148098,1.15886541297779e-07
sensitivity analysis,Right ventricle,RV stroke volume,"KRT18;Keratin, type I cytoskeletal 18",4345,-0.103304524668391,8.74406360013045e-12
sensitivity analysis,Right ventricle,RV stroke volume,LDLR;Low-density lipoprotein receptor,4366,-0.120466739468751,1.3854585588004e-15
sensitivity analysis,Right ventricle,RV stroke volume,LEP;Leptin,4373,-0.201747822359386,2.15666986551288e-41
sensitivity analysis,Right ventricle,RV stroke volume,LGALS1;Galectin-1,4373,-0.0908354376584572,1.77074646217053e-09
sensitivity analysis,Right ventricle,RV stroke volume,LGALS9;Galectin-9,4350,-0.088177152894398,5.69894056741177e-09
sensitivity analysis,Right ventricle,RV stroke volume,LPL;Lipoprotein lipase,4373,0.103425911583349,7.08877778212167e-12
sensitivity analysis,Right ventricle,RV stroke volume,MFAP5;Microfibrillar-associated protein 5,4414,-0.0784184703691102,1.82315525312012e-07
sensitivity analysis,Right ventricle,RV stroke volume,MIA;Melanoma-derived growth regulatory protein,4378,-0.0789349585550495,1.69954358186091e-07
sensitivity analysis,Right ventricle,RV stroke volume,MOG;Myelin-oligodendrocyte glycoprotein,4394,-0.0902647860972596,2.04815670677445e-09
sensitivity analysis,Right ventricle,RV stroke volume,NBL1;Neuroblastoma suppressor of tumorigenicity 1,4378,-0.08805022807317,5.35830108498145e-09
sensitivity analysis,Right ventricle,RV stroke volume,NOMO1;Nodal modulator 1,4347,-0.088901674570286,4.32160411649415e-09
sensitivity analysis,Right ventricle,RV stroke volume,NPC2;NPC intracellular cholesterol transporter 2,3052,-0.105932549985868,4.45495520317338e-09
sensitivity analysis,Right ventricle,RV stroke volume,NPDC1;Neural proliferation differentiation and control protein 1,4373,-0.0813087213562529,7.27610275005693e-08
sensitivity analysis,Right ventricle,RV stroke volume,NPPC;C-type natriuretic peptide,4363,-0.12393168612074,2.11452065570013e-16
sensitivity analysis,Right ventricle,RV stroke volume,NPY;Pro-neuropeptide Y,4394,-0.0896716928916514,2.61031929819419e-09
sensitivity analysis,Right ventricle,RV stroke volume,NRCAM;Neuronal cell adhesion molecule,4373,-0.0853617659961056,1.57152105817471e-08
sensitivity analysis,Right ventricle,RV stroke volume,NT5C1A;Cytosolic 5'-nucleotidase 1A,3100,-0.116682864931987,7.20744048822145e-11
sensitivity analysis,Right ventricle,RV stroke volume,OCLN;Occludin,3100,-0.0940030961699179,1.57666705576675e-07
sensitivity analysis,Right ventricle,RV stroke volume,OGN;Mimecan,4347,-0.090604631262011,2.17298050965254e-09
sensitivity analysis,Right ventricle,RV stroke volume,OXT;Oxytocin-neurophysin 1,4405,-0.103545812053466,5.62148164347639e-12
sensitivity analysis,Right ventricle,RV stroke volume,PALM;Paralemmin-1,3061,-0.123329666980955,7.55518217249917e-12
sensitivity analysis,Right ventricle,RV stroke volume,PALM2;Paralemmin-2,3100,-0.100280780237746,2.20298477540763e-08
sensitivity analysis,Right ventricle,RV stroke volume,PBXIP1;Pre-B-cell leukemia transcription factor-interacting protein 1,3088,-0.110321435204119,7.90489163328177e-10
sensitivity analysis,Right ventricle,RV stroke volume,PGF;Placenta growth factor,4409,-0.100324944533453,2.44603221774884e-11
sensitivity analysis,Right ventricle,RV stroke volume,PLAT;Tissue-type plasminogen activator,4403,-0.132279063492247,1.21132466842914e-18
sensitivity analysis,Right ventricle,RV stroke volume,PLIN1;Perilipin-1,4264,-0.0902043196810745,3.62215440592202e-09
sensitivity analysis,Right ventricle,RV stroke volume,"POLR2F;DNA-directed RNA polymerases I, II, and III subunit RPABC2",4345,-0.0898678873706101,2.9547561726813e-09
sensitivity analysis,Right ventricle,RV stroke volume,PON3;Serum paraoxonase/lactonase 3,4369,0.0955972860286989,2.42749233855783e-10
sensitivity analysis,Right ventricle,RV stroke volume,PRAP1;Proline-rich acidic protein 1,3109,-0.12332366963332,5.20321974498788e-12
sensitivity analysis,Right ventricle,RV stroke volume,PRND;Prion-like protein doppel,3100,-0.103165243217404,8.55978374963624e-09
sensitivity analysis,Right ventricle,RV stroke volume,PRSS2;Trypsin-2,4366,-0.0790999032203949,1.6652182463514e-07
sensitivity analysis,Right ventricle,RV stroke volume,PRSS8;Prostasin,4337,-0.115216447760509,2.72292310501095e-14
sensitivity analysis,Right ventricle,RV stroke volume,PTGDS;Prostaglandin-H2 D-isomerase,4330,-0.118335179253172,5.62913096450565e-15
sensitivity analysis,Right ventricle,RV stroke volume,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4324,-0.101850573264907,1.90758022495757e-11
sensitivity analysis,Right ventricle,RV stroke volume,PTS;6-pyruvoyl tetrahydrobiopterin synthase,4252,-0.0823448465902758,7.57183722299847e-08
sensitivity analysis,Right ventricle,RV stroke volume,RARRES2;Retinoic acid receptor responder protein 2,4370,-0.117711222935216,5.88722650473298e-15
sensitivity analysis,Right ventricle,RV stroke volume,RBP5;Retinol-binding protein 5,4345,-0.0996621223733073,4.58277427951627e-11
sensitivity analysis,Right ventricle,RV stroke volume,RELT;Tumor necrosis factor receptor superfamily member 19L,4347,-0.0817952508471407,6.6490084542591e-08
sensitivity analysis,Right ventricle,RV stroke volume,RNASE4;Ribonuclease 4,2988,-0.0966079724855776,1.21640721761757e-07
sensitivity analysis,Right ventricle,RV stroke volume,RTBDN;Retbindin,4345,-0.0880878073868172,6.02408981983079e-09
sensitivity analysis,Right ventricle,RV stroke volume,RTN4R;Reticulon-4 receptor,4394,-0.136437606301669,1.0464772365447e-19
sensitivity analysis,Right ventricle,RV stroke volume,SCARB2;Lysosome membrane protein 2,4242,-0.100796093053676,4.71266853167747e-11
sensitivity analysis,Right ventricle,RV stroke volume,SCG2;Secretogranin-2,4386,-0.103606130613054,6.06682343527953e-12
sensitivity analysis,Right ventricle,RV stroke volume,SELE;E-selectin,4414,-0.0833071505361583,2.97630975447569e-08
sensitivity analysis,Right ventricle,RV stroke volume,SERPINF1;Pigment epithelium-derived factor,3070,-0.110997649131322,6.97431283381893e-10
sensitivity analysis,Right ventricle,RV stroke volume,SEZ6L;Seizure 6-like protein,4378,-0.102806470724909,9.20151580033622e-12
sensitivity analysis,Right ventricle,RV stroke volume,SFRP1;Secreted frizzled-related protein 1,4323,-0.0900131451473877,3.05439512209732e-09
sensitivity analysis,Right ventricle,RV stroke volume,SHISA5;Protein shisa-5,3109,-0.100371901548683,2.0409401007981e-08
sensitivity analysis,Right ventricle,RV stroke volume,SLC39A5;Zinc transporter ZIP5,4363,-0.0851155152961134,1.79432886630669e-08
sensitivity analysis,Right ventricle,RV stroke volume,SMOC1;SPARC-related modular calcium-binding protein 1,4394,-0.0849804141963102,1.68356843007466e-08
sensitivity analysis,Right ventricle,RV stroke volume,SNCG;Gamma-synuclein,4338,-0.115391250549611,2.47161918137593e-14
sensitivity analysis,Right ventricle,RV stroke volume,SORCS2;VPS10 domain-containing receptor SorCS2,4271,-0.113945787221623,8.09031846869065e-14
sensitivity analysis,Right ventricle,RV stroke volume,SORD;Sorbitol dehydrogenase,4386,-0.0877662171732374,5.81254807514736e-09
sensitivity analysis,Right ventricle,RV stroke volume,SOST;Sclerostin,4372,-0.0905201371652398,2.02371741921177e-09
sensitivity analysis,Right ventricle,RV stroke volume,SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4372,-0.0923536275522144,9.4843107569809e-10
sensitivity analysis,Right ventricle,RV stroke volume,SSC5D;Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,4366,-0.0994605995973616,4.50665220275163e-11
sensitivity analysis,Right ventricle,RV stroke volume,STC1;Stanniocalcin-1,4405,-0.0890397983241998,3.2258800607224e-09
sensitivity analysis,Right ventricle,RV stroke volume,TAFA5;Chemokine-like protein TAFA-5,4345,-0.112120689372747,1.24530878561423e-13
sensitivity analysis,Right ventricle,RV stroke volume,TFF3;Trefoil factor 3,4337,-0.0819614179218963,6.47422940144107e-08
sensitivity analysis,Right ventricle,RV stroke volume,TGFBR2;TGF-beta receptor type-2,4378,-0.0878910002520514,5.70953396219399e-09
sensitivity analysis,Right ventricle,RV stroke volume,THY1;Thy-1 membrane glycoprotein,4405,-0.0864053376638222,9.25455226095263e-09
sensitivity analysis,Right ventricle,RV stroke volume,TNFRSF10B;Tumor necrosis factor receptor superfamily member 10B,4338,-0.0877651071153055,7.03755615394703e-09
sensitivity analysis,Right ventricle,RV stroke volume,TNFRSF11A;Tumor necrosis factor receptor superfamily member 11A,4409,-0.0890789725187724,3.12345358596578e-09
sensitivity analysis,Right ventricle,RV stroke volume,TNFRSF19;Tumor necrosis factor receptor superfamily member 19,4394,-0.0839081038783102,2.54330039343102e-08
sensitivity analysis,Right ventricle,RV stroke volume,TNFRSF1A;Tumor necrosis factor receptor superfamily member 1A,4347,-0.0955336304315153,2.76647067451237e-10
sensitivity analysis,Right ventricle,RV stroke volume,TNFRSF4;Tumor necrosis factor receptor superfamily member 4,4402,-0.0833865959677252,3.014750760052e-08
sensitivity analysis,Right ventricle,RV stroke volume,TREM2;Triggering receptor expressed on myeloid cells 2,4348,-0.0949132440727568,3.59013095037321e-10
sensitivity analysis,Right ventricle,RV stroke volume,VWC2;Brorin,4329,-0.0950883632646664,3.63950652082203e-10
sensitivity analysis,Right ventricle,RV stroke volume,XG;Glycoprotein Xg,4395,-0.0814952473116112,6.29633595570351e-08
Primary analysis,Volume of global and regional brain,Volume of grey matter,ANGPT2;Angiopoietin-2,5615,-0.0945357615831968,1.2639153470415e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),ANGPT2;Angiopoietin-2,5614,-0.0933208492462509,2.45311549319952e-12
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,ANGPT2;Angiopoietin-2,5615,-0.0888592044415414,2.55404747935275e-11
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),ANGPT2;Angiopoietin-2,5615,-0.0877053326962973,4.60194198601629e-11
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),ANGPT2;Angiopoietin-2,5464,-0.0868644011193645,1.26260197874848e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.157273736662892,3.9178409303364e-31
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.157165572757765,4.30585059813335e-31
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),ANGPT2;Angiopoietin-2,5464,-0.0855542163691774,2.38513394223676e-10
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",BCAN;Brevican core protein,5544,0.134713748173062,7.18348141472464e-24
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",BCAN;Brevican core protein,5544,0.132620559258396,3.53731238986266e-23
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),BCAN;Brevican core protein,5394,0.132611275299159,1.36603704120879e-22
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),BCAN;Brevican core protein,5394,0.128930903146948,1.96826015004985e-21
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),BCAN;Brevican core protein,5394,0.124374087014036,4.81821714396519e-20
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),NCAN;Neurocan core protein,5485,0.14647997689062,1.09314984531197e-27
Primary analysis,Volume of global and regional brain,Volume of grey matter,BCAN;Brevican core protein,5544,0.122172403783632,6.9210715068958e-20
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),NCAN;Neurocan core protein,5485,0.143274534475487,1.50548441446935e-26
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,BCAN;Brevican core protein,5544,0.119796366836447,3.5535882399109e-19
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),BCAN;Brevican core protein,5394,0.119364650750038,1.41739902248488e-18
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),BCAN;Brevican core protein,5394,0.118408768301854,2.6596820032994e-18
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),BCAN;Brevican core protein,5543,0.116106176208735,4.2590197081025e-18
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),BCAN;Brevican core protein,5394,0.117679082688645,4.28549597786275e-18
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),BCAN;Brevican core protein,5544,0.115019175967084,8.64449872668175e-18
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),BCAN;Brevican core protein,5394,0.107950539488051,1.86954534272942e-15
Primary analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),BCAN;Brevican core protein,5543,0.106156367682815,2.298073104325e-15
Primary analysis,Volume of global and regional brain,Volume of white matter,BCAN;Brevican core protein,5544,0.10478958511281,5.1903480422405e-15
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),BCAN;Brevican core protein,5389,0.0980402772746113,5.4800909033963e-13
Primary analysis,Volume of global and regional brain,Volume of thalamus (right),BCAN;Brevican core protein,5540,0.0943635246198637,1.95423302032979e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),BCAN;Brevican core protein,5541,0.0935046437075805,3.08051253905332e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),BCAN;Brevican core protein,5079,-0.1422833594532,2.20883320958852e-24
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampus (left hemisphere),BCAN;Brevican core protein,5394,0.0937316730397825,5.28849749281668e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),BCAN;Brevican core protein,5539,0.0919433992884624,7.09053735062157e-12
Primary analysis,Volume of global and regional brain,Volume of MDm (left hemisphere),BCAN;Brevican core protein,5394,0.0918465165026007,1.39632467538886e-11
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampus (right hemisphere),BCAN;Brevican core protein,5394,0.0904724067835199,2.79935191432721e-11
Primary analysis,Volume of global and regional brain,Volume of thalamus (left),BCAN;Brevican core protein,5540,0.0887503367514192,3.65664798245652e-11
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampal-head (left hemisphere),BCAN;Brevican core protein,5394,0.089892750449205,3.74240523408571e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),TF;Serotransferrin,3661,-0.164690633714034,1.1256286208608e-23
Primary analysis,Volume of global and regional brain,Volume of SubCortGray (whole brain),BCAN;Brevican core protein,5394,0.0887849205246054,6.48545508343664e-11
Primary analysis,Volume of global and regional brain,Volume of MDm (right hemisphere),BCAN;Brevican core protein,5394,0.0873425725739042,1.31375498446325e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),BCAN;Brevican core protein,5079,-0.139047727724493,2.38655971957552e-23
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),TF;Serotransferrin,3725,0.161638340060064,3.16807687800533e-23
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (right),BCAN;Brevican core protein,5540,0.0845172772410679,2.9654146981062e-10
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampal-body (left hemisphere),BCAN;Brevican core protein,5394,0.0842838455471107,5.6560319914094e-10
Primary analysis,Volume of global and regional brain,Volume of 3rd-Ventricle (whole brain),BCAN;Brevican core protein,5389,-0.0842195167919087,5.9365075236695e-10
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Lateral Occipital Cortex, superior division (left)",BCAN;Brevican core protein,5542,0.0825271345662906,7.6121098261395e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.15594261972621,1.62690016173972e-22
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.155214415063763,2.56206585981097e-22
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (right),BCAN;Brevican core protein,5540,0.082473988653465,7.86017153893298e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),TF;Serotransferrin,3661,-0.159057634091084,3.58258491322106e-22
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5371,-0.130878329677856,5.92014024657504e-22
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,5373,-0.130010777695904,1.08672827753327e-21
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.128688829422094,1.29584126687977e-21
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5372,-0.129574907777456,1.49791713291731e-21
Primary analysis,NODDI dMRI,Mean ICVF in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.129321475344054,1.79528652781432e-21
Primary analysis,Volume of global and regional brain,Volume of hippocampus (right),BCAN;Brevican core protein,5541,0.0822543722282953,8.68612392324943e-10
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampal-head (right hemisphere),BCAN;Brevican core protein,5394,0.0830908234916584,9.85960643910786e-10
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,5371,-0.128858034105034,2.51896721044793e-21
Primary analysis,Volume of global and regional brain,Volume of Whole-hippocampal-body (right hemisphere),BCAN;Brevican core protein,5394,0.0828062210110923,1.12445771012449e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),TF;Serotransferrin,3659,-0.15495664948707,4.21719466076681e-21
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),NCAN;Neurocan core protein,5485,0.126786930965616,4.26597922201595e-21
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),BCAN;Brevican core protein,5082,-0.131472363493065,4.91483143110877e-21
Primary analysis,Volume of global and regional brain,Volume of presubiculum-head (left hemisphere),BCAN;Brevican core protein,5393,0.0814077135657722,2.1388496294027e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),NCAN;Neurocan core protein,5485,0.125799653533729,8.61114339225256e-21
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),BCAN;Brevican core protein,5394,0.0813143171559068,2.22374413623207e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.126211389877747,1.52016997427311e-20
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),TF;Serotransferrin,3661,-0.15246239270552,1.75885119947978e-20
Primary analysis,NODDI dMRI,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5370,-0.125954892316578,1.95481425938464e-20
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),TF;Serotransferrin,3725,0.150436759837581,2.679427766579e-20
Primary analysis,Volume of global and regional brain,Volume of Inf-Lat-Vent (left hemisphere),BCAN;Brevican core protein,5326,-0.0810143558029908,3.20517603273436e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.125044466252338,3.41713567694221e-20
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),TF;Serotransferrin,3662,-0.151223385838946,3.54510287930325e-20
Primary analysis,Volume of global and regional brain,Volume of MV(Re) (right hemisphere),BCAN;Brevican core protein,5392,0.0797538814926258,4.50945551376366e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Paracingulate Gyrus (left),BCAN;Brevican core protein,5540,0.0780852165330286,5.90063202366403e-09
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),BCAN;Brevican core protein,5394,0.0790661776190447,6.07487250331331e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.122583938259459,9.58951728147692e-20
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5372,-0.122951162141618,1.51307098922475e-19
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5372,-0.122778356115936,1.70110357271539e-19
Primary analysis,NODDI dMRI,Mean ICVF in sagittal stratum on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5368,-0.122564154354776,2.02765202594959e-19
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.121456785645128,2.07442070671451e-19
Primary analysis,NODDI dMRI,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.121914829030081,3.0469143753009e-19
Primary analysis,Volume of global and regional brain,Volume of grey matter in Central Opercular Cortex (right),BCAN;Brevican core protein,5542,0.077765988513911,6.76194378405696e-09
Primary analysis,NODDI dMRI,Mean ICVF in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.121548125255193,3.8977115365826e-19
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.121231966500634,4.60500185410516e-19
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.119914470482461,5.89354083015526e-19
Primary analysis,Volume of global and regional brain,Volume of Hippocampus (right hemisphere),BCAN;Brevican core protein,5394,0.078657726074628,7.27060548687685e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),BCAN;Brevican core protein,5082,-0.124025373748749,7.07910012914152e-19
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),BGLAP;Osteocalcin,3874,-0.117067621303216,2.6863103926561e-13
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,5373,-0.120180512467049,9.62982184812515e-19
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),C7;Complement component C7,3781,-0.0952132597512685,4.46319972424336e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CCN5;CCN family member 5,5414,-0.0926130356565582,8.63706176417897e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),BCAN;Brevican core protein,5172,0.122148740239417,1.19228672479108e-18
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CDH3;Cadherin-3,5485,0.0799656812694289,3.02068973519247e-09
Primary analysis,NODDI dMRI,Mean ICVF in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.119221310093578,1.82758345744096e-18
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.118643739518982,2.5386853215914e-18
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),TF;Serotransferrin,3659,-0.143579940013915,2.60618969099213e-18
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),CDH3;Cadherin-3,5638,0.0786695494684324,3.32099682549582e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),BCAN;Brevican core protein,5172,0.120416156254739,3.64154329471152e-18
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CHAD;Chondroadherin,3784,-0.175004077890765,2.09534709301768e-27
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CHAD;Chondroadherin,3781,0.107393336834594,3.57817432555155e-11
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",CHAD;Chondroadherin,3891,-0.104456799325998,6.50818279837298e-11
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",CHAD;Chondroadherin,3891,-0.102420443533378,1.51792401197333e-10
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),CHAD;Chondroadherin,3891,-0.0991708167670617,5.66915923539151e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),OMG;Oligodendrocyte-myelin glycoprotein,5085,-0.120431487635966,6.8647812405894e-18
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract posterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5368,-0.117085460437134,7.56051417073589e-18
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left)",CHAD;Chondroadherin,3890,-0.097147936836867,1.26703889526598e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (vermis),CHAD;Chondroadherin,3891,0.0960816869489518,1.90926665958297e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),CHAD;Chondroadherin,3890,-0.0957905819220635,2.14674770705981e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,CHAD;Chondroadherin,3891,-0.0924955083302379,7.4605543270905e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter,CHI3L1;Chitinase-3-like protein 1,5465,-0.0791955820314057,4.56076100809162e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),CHI3L1;Chitinase-3-like protein 1,5464,-0.0780806368855436,7.50850458002357e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CHRDL2;Chordin-like protein 2,5433,-0.0966562267340234,9.36679202331776e-13
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (vermis),CHRDL2;Chordin-like protein 2,5588,-0.0815890414111118,1.00988683671487e-09
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CHRDL2;Chordin-like protein 2,5439,0.0783894717929484,7.09034772650179e-09
Primary analysis,NODDI dMRI,Mean ICVF in cingulum cingulate gyrus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5373,-0.114589564344427,3.5979162532903e-17
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),OMG;Oligodendrocyte-myelin glycoprotein,5085,-0.117764901381292,3.60796986453832e-17
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),TFRC;Transferrin receptor protein 1,5118,-0.116989556278626,4.60937422719276e-17
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),COL1A1;Collagen alpha-1(I) chain,5497,-0.140590151956628,1.14595559687435e-25
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract acoustic radiation (right),GFAP;Glial fibrillary acidic protein,5372,-0.114167090066302,4.72835794261266e-17
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5367,-0.113799290773521,6.15859280302378e-17
Primary analysis,NODDI dMRI,Mean ICVF in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5364,-0.113648895827732,6.90240815797215e-17
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",COL1A1;Collagen alpha-1(I) chain,5649,-0.0980544135617008,1.51396318130272e-13
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",COL1A1;Collagen alpha-1(I) chain,5649,-0.0975472196047296,2.01891310184932e-13
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5370,-0.112645114891528,1.24103624266767e-16
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (left),TF;Serotransferrin,3725,0.134904004329954,1.35512021468122e-16
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),COL1A1;Collagen alpha-1(I) chain,5648,-0.0973199833121735,2.30684488967238e-13
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),COL1A1;Collagen alpha-1(I) chain,5649,-0.0960679591111142,4.63498083179654e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.111199328902579,1.67350396092954e-16
Primary analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5361,-0.112090653203271,1.85369661184093e-16
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,COL1A1;Collagen alpha-1(I) chain,5649,-0.0918447284729479,4.64155250041072e-12
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left)",COL1A1;Collagen alpha-1(I) chain,5647,-0.0913657067165683,6.04071879128123e-12
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract posterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5368,-0.111625707826416,2.3606691321057e-16
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (right),COL1A1;Collagen alpha-1(I) chain,5646,-0.0898531308788471,1.34472443060852e-11
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.110442838473211,2.67823206652395e-16
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.132763494581667,3.00023682924929e-16
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract corticospinal tract (right),GFAP;Glial fibrillary acidic protein,5369,-0.111180503351937,3.0833069417723e-16
Primary analysis,Volume of global and regional brain,Volume of grey matter,COL1A1;Collagen alpha-1(I) chain,5649,-0.0890928220388773,1.97226184170097e-11
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.132540860015215,3.36445153498437e-16
Primary analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5362,-0.110721016057231,4.26676505288494e-16
Primary analysis,NODDI dMRI,Mean ICVF in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5366,-0.110519482248366,4.7051549514204e-16
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,5484,0.109304271270252,4.78216988829794e-16
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),COL1A1;Collagen alpha-1(I) chain,5491,0.0880816989195867,6.22672538023714e-11
Primary analysis,NODDI dMRI,Mean ICVF in cingulum hippocampus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.109757969731373,7.19859607873587e-16
Primary analysis,NODDI dMRI,Mean ICVF in cingulum cingulate gyrus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5373,-0.109671144317006,7.54052470359932e-16
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),COL5A1;Collagen alpha-1(V) chain,3784,-0.107640961277605,3.16766435631722e-11
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.128769519488218,8.57304850623284e-16
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",COL5A1;Collagen alpha-1(V) chain,3891,-0.0977379133742311,1.0003370903103e-09
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",COL5A1;Collagen alpha-1(V) chain,3891,-0.0965680658723881,1.58092462374619e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),BCAN;Brevican core protein,5083,-0.11219810872586,1.035667862725e-15
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.128440750493801,1.0499665906802e-15
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract forceps minor,GFAP;Glial fibrillary acidic protein,5373,-0.109001607869665,1.12929374247437e-15
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),COL5A1;Collagen alpha-1(V) chain,3890,-0.0948182073676784,3.11820255090334e-09
Primary analysis,DTI dMRI,Mean L2 in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5366,0.108945247271235,1.2188430351515e-15
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract acoustic radiation (left),GFAP;Glial fibrillary acidic protein,5373,-0.108778313393972,1.29142148876841e-15
Primary analysis,NODDI dMRI,Mean ICVF in external capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5371,-0.108513575103383,1.53183238250416e-15
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),COL9A1;Collagen alpha-1(IX) chain,5414,-0.0961717787996976,1.33034818096281e-12
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CRLF1;Cytokine receptor-like factor 1,5429,-0.0909108381434021,1.9352485833794e-11
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CST6;Cystatin-M,5292,0.0833167749796867,1.27832832764802e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),TF;Serotransferrin,3725,0.129399710631121,2.22119519755571e-15
Primary analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.107799812793265,2.23619059784043e-15
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),DMP1;Dentin matrix acidic phosphoprotein 1,3777,-0.129779658390045,1.17396144553307e-15
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),OMG;Oligodendrocyte-myelin glycoprotein,5088,-0.110620417561597,2.51391592452742e-15
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),DMP1;Dentin matrix acidic phosphoprotein 1,3773,0.112288889693539,4.6158052695964e-12
Primary analysis,DTI dMRI,Mean L2 in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5366,0.10770643052275,2.55326916719768e-15
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.126552142563354,2.74533603799863e-15
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.12632762994475,2.97586817208817e-15
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (right),DMP1;Dentin matrix acidic phosphoprotein 1,3883,-0.0974609588102437,1.15989378512393e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SEZ6L;Seizure 6-like protein,5447,0.106365174245049,3.52698114101896e-15
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),DPP4;Dipeptidyl peptidase 4,5306,0.0959910252597997,2.43928745406614e-12
Primary analysis,NODDI dMRI,Mean ICVF in cingulum hippocampus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.106889695187843,3.9959698545834e-15
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),DPP4;Dipeptidyl peptidase 4,5312,-0.0918617073073558,1.97566257196577e-11
Primary analysis,DTI dMRI,Mean MD in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5365,0.106323741079692,5.80418430658927e-15
Primary analysis,NODDI dMRI,Mean ICVF in middle cerebellar peduncle on FA skeleton,GFAP;Glial fibrillary acidic protein,5372,-0.1061395430406,6.20970455514828e-15
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (right),TF;Serotransferrin,3724,0.127317235002886,6.25839056333183e-15
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract middle cerebellar peduncle,GFAP;Glial fibrillary acidic protein,5367,-0.106028565514726,6.81948234504145e-15
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),BCAN;Brevican core protein,5394,0.105697324778891,7.09205437177131e-15
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.105579860945313,8.27417046068475e-15
Primary analysis,NODDI dMRI,Mean ICVF in external capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5369,-0.105598567527987,8.6641794113235e-15
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),BCAN;Brevican core protein,5082,-0.108426699197534,9.15346724697963e-15
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),CDHR2;Cadherin-related family member 2,5180,-0.107366927665176,9.33689495012297e-15
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),ACAN;Aggrecan core protein,5063,-0.108521412798008,9.72630439830893e-15
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.10500325543959,1.15715714719123e-14
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),FSHB;Follitropin subunit beta,3773,0.104139796977895,1.43545490523044e-10
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),FSHB;Follitropin subunit beta,3777,-0.103162911607096,2.08457584985617e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),BCAN;Brevican core protein,5394,0.104598116043428,1.34539856948021e-14
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (vermis),FSHB;Follitropin subunit beta,3884,0.0964291380626019,1.72557578451999e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SEZ6L;Seizure 6-like protein,5447,0.103652744401006,1.73513206774593e-14
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract corticospinal tract (left),GFAP;Glial fibrillary acidic protein,5371,-0.104298791207105,1.81803537609805e-14
Primary analysis,NODDI dMRI,Mean ICVF in anterior limb of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5366,-0.104344695626723,1.82058207382707e-14
Primary analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (right),GDF15;Growth/differentiation factor 15,5548,0.0974812079512918,3.42397452508769e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.103823716912315,2.28516057121524e-14
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract uncinate fasciculus (left),GFAP;Glial fibrillary acidic protein,5373,-0.103589491179914,2.70083485405456e-14
Primary analysis,NODDI dMRI,Mean ICVF in posterior thalamic radiation on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5371,-0.103550804709677,2.79166203647763e-14
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (left),GFAP;Glial fibrillary acidic protein,5373,-0.10350099443069,2.84094945070501e-14
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),TFRC;Transferrin receptor protein 1,5118,-0.105971001600321,2.94432692727324e-14
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.102375112243727,3.3080197026484e-14
Primary analysis,Volume of global and regional brain,Volume of grey matter,GDF15;Growth/differentiation factor 15,5649,-0.0961290324502165,4.47975063045853e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.12085578902136,4.4371736899887e-14
Primary analysis,DTI dMRI,Mean MD in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5355,0.102882016740217,4.45529483932701e-14
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),GDF15;Growth/differentiation factor 15,5648,-0.0937180452526372,1.69908195435277e-12
Primary analysis,NODDI dMRI,Weighted-mean ISOVF in tract posterior thalamic radiation (left),GDF15;Growth/differentiation factor 15,5541,0.0903304374294463,1.62510015268714e-11
Primary analysis,NODDI dMRI,Mean ICVF in posterior thalamic radiation on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5370,-0.102462780238279,5.2090784985286e-14
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",GDF15;Growth/differentiation factor 15,5649,-0.0864565971498712,7.57460242154666e-11
Primary analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5363,-0.102370366212856,5.69805378025054e-14
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),TFRC;Transferrin receptor protein 1,5215,0.103601613546541,6.38270166168544e-14
Primary analysis,DTI dMRI,Weighted-mean MD in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,5368,0.101718485168158,8.00623579022802e-14
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),DPP10;Inactive dipeptidyl peptidase 10,5095,-0.104018139027027,9.83388892207758e-14
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (right),GFAP;Glial fibrillary acidic protein,5373,-0.101118494513641,1.09103361414911e-13
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),DPP10;Inactive dipeptidyl peptidase 10,5095,-0.10362588219778,1.21722402253228e-13
Primary analysis,DTI dMRI,Mean MD in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5365,0.1009965646711,1.21760610080903e-13
Primary analysis,NODDI dMRI,Mean ICVF in anterior limb of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.100889308419867,1.24624734753993e-13
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),FLT3LG;Fms-related tyrosine kinase 3 ligand,5161,0.102616620188782,1.47141953641434e-13
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",GDF15;Growth/differentiation factor 15,5649,-0.0858614241876595,1.0207816858355e-10
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,GDF15;Growth/differentiation factor 15,5649,-0.0850850029827096,1.50195657051314e-10
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (right),GDF15;Growth/differentiation factor 15,5529,0.0857812593325739,1.67198727980995e-10
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),GDF15;Growth/differentiation factor 15,5649,-0.0839366058040315,2.64256368197954e-10
Primary analysis,NODDI dMRI,Mean ICVF in splenium of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,5373,-0.099930634852339,2.10946743235122e-13
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),CDHR2;Cadherin-related family member 2,5088,0.102667632159558,2.12146715945589e-13
Primary analysis,DTI dMRI,Mean FA in fornix cres+stria terminalis on FA skeleton (left),GDF15;Growth/differentiation factor 15,5565,-0.0843264560202803,2.96736550465412e-10
Primary analysis,DTI dMRI,Mean L2 in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5467,-0.0989905374139325,2.2068668078964e-13
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),ITGA11;Integrin alpha-11,5408,0.0940864142183362,4.12550241972973e-12
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5463,0.0989116403897602,2.35242704354205e-13
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),RTBDN;Retbindin,5402,0.0992687297616817,2.62292558754228e-13
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),KLK4;Kallikrein-4,5458,-0.0942138716189651,3.07438494903216e-12
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),KLK6;Kallikrein-6,5439,0.165176383649908,1.42731221656543e-34
Primary analysis,DTI dMRI,Weighted-mean L1 in tract superior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5466,-0.0983982471293467,3.07998313985373e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.098308135267762,3.26936594827492e-13
Primary analysis,NODDI dMRI,Mean ISOVF in fornix on FA skeleton,GDF15;Growth/differentiation factor 15,5568,0.0842645406692357,3.02427605753317e-10
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),KLK6;Kallikrein-6,5439,0.162834704839915,1.23749363376239e-33
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),KLK6;Kallikrein-6,5439,0.152978123603048,7.73491603170184e-30
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),KLK6;Kallikrein-6,5439,0.149964434001836,1.00037361213905e-28
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),BCAN;Brevican core protein,5394,0.0980932616760472,5.19511096611145e-13
Primary analysis,DTI dMRI,Weighted-mean MD in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5365,0.0983548365612732,5.20081866696631e-13
Primary analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),KLK6;Kallikrein-6,5589,0.141146204133807,2.89207092355084e-26
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),ACAN;Aggrecan core protein,5062,-0.101167747731329,5.40950320357619e-13
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),KLK6;Kallikrein-6,5439,0.142972296263747,3.10336894777226e-26
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),TFRC;Transferrin receptor protein 1,5121,-0.100434705522538,5.86045556901447e-13
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),KLK6;Kallikrein-6,5439,0.0972280773994488,6.6760348539119e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0970014439513851,6.69388214270483e-13
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract parahippocampal part of cingulum (right),GFAP;Glial fibrillary acidic protein,5372,-0.0978034937017175,6.77196151902195e-13
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,5485,0.096756056840759,6.91782824507348e-13
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract parahippocampal part of cingulum (left),GFAP;Glial fibrillary acidic protein,5370,-0.0976391070960628,7.47278326893471e-13
Primary analysis,DTI dMRI,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,5366,0.0976518405250331,7.56797804955003e-13
Primary analysis,DTI dMRI,Mean MD in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5346,0.0976166617588212,8.50302919764443e-13
Primary analysis,DTI dMRI,Weighted-mean L3 in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5365,0.0973796379129857,8.80412462586923e-13
Primary analysis,Susceptibility weighted MRI,Median T2star in pallidum (left),BCAN;Brevican core protein,5168,0.0990927882225446,9.36602049522937e-13
Primary analysis,Volume of global and regional brain,Volume of white matter,KLK6;Kallikrein-6,5590,0.140296090521689,5.6959282440903e-26
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),KLK6;Kallikrein-6,5439,0.141706324544953,8.50983461491103e-26
Primary analysis,NODDI dMRI,Mean ICVF in posterior limb of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5373,-0.0968289301020955,1.13794626396272e-12
Primary analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5366,0.0968400375133387,1.16986618752633e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),DPP10;Inactive dipeptidyl peptidase 10,5095,-0.0993578844813971,1.17782252613154e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),TFRC;Transferrin receptor protein 1,5121,-0.0990276205358509,1.22729427838509e-12
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),KLK6;Kallikrein-6,5439,0.140190070222862,2.81430748327766e-25
Primary analysis,DTI dMRI,Mean MD in superior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5349,0.0968747627239484,1.24608724918046e-12
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",KLK6;Kallikrein-6,5590,0.134758494874239,4.53514121382969e-24
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),BCAN;Brevican core protein,5394,0.0964332064919795,1.27189658623273e-12
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",KLK6;Kallikrein-6,5590,0.133688072213366,1.03529279312456e-23
Primary analysis,Volume of global and regional brain,Volume of thalamus (right),KLK6;Kallikrein-6,5588,0.0852671227137965,1.72329727684842e-10
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract superior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5366,-0.0961461408843543,1.69273643661963e-12
Primary analysis,DTI dMRI,Mean MD in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5357,0.0962205773382348,1.6980905035153e-12
Primary analysis,Volume of global and regional brain,Volume of VentralDC (right hemisphere),KLK6;Kallikrein-6,5439,0.085883101328708,2.23714417983316e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),OMD;Osteomodulin,5121,-0.0983264896142032,1.76703026016072e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),DPP6;Dipeptidyl aminopeptidase-like protein 6,5089,-0.0986038048499169,1.79460634927171e-12
Primary analysis,Volume of global and regional brain,Volume of VentralDC (left hemisphere),KLK6;Kallikrein-6,5439,0.0849866786541228,3.43727434188338e-10
Primary analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5364,-0.0959702675366958,1.87574556603229e-12
Primary analysis,Volume of global and regional brain,Volume of Pallidum (right hemisphere),KLK6;Kallikrein-6,5439,0.0834226124108372,7.19632941828404e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),CDHR2;Cadherin-related family member 2,5085,0.0984155044619183,2.01729309084724e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),FLT3LG;Fms-related tyrosine kinase 3 ligand,5161,0.0975510755012955,2.16941632132335e-12
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0955276838188591,2.20931783770677e-12
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),KLK6;Kallikrein-6,5439,0.0811986928935253,2.01123850011332e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter,KLK6;Kallikrein-6,5590,0.077917469523041,5.43848816403301e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3874,0.0999314668947311,4.56179916646879e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),DPP10;Inactive dipeptidyl peptidase 10,5096,-0.0979118229214987,2.47549346595509e-12
Primary analysis,DTI dMRI,Weighted-mean L3 in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5360,0.0954389353987026,2.52993878893892e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),DPP6;Dipeptidyl aminopeptidase-like protein 6,5088,-0.0977582096122574,2.78546469767014e-12
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract superior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5371,-0.0950232262727477,2.99091191886262e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),BCAN;Brevican core protein,5170,0.0968287731114118,3.01621019615155e-12
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.166336599234917,3.39849988614367e-35
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.162654981168521,1.04092152341002e-33
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.157466499151952,1.13003194334495e-31
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.15281282748277,6.61863451018144e-30
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.15192331523405,1.42038931167984e-29
Primary analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (left),TF;Serotransferrin,3662,0.114345231696159,3.92238549404621e-12
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.151914989110664,1.43054724038406e-29
Primary analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left),BCAN;Brevican core protein,5435,-0.0938605795731273,4.10988134588443e-12
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.150832622592931,3.60019887504355e-29
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),OMD;Osteomodulin,5121,-0.0966488919156365,4.18323794170008e-12
Primary analysis,NODDI dMRI,Mean ICVF in posterior limb of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5370,-0.0943415192222266,4.29197130586557e-12
Primary analysis,DTI dMRI,Weighted-mean MD in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,5363,0.0943924173412211,4.3152914817358e-12
Primary analysis,NODDI dMRI,Mean ICVF in body of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,5373,-0.0942048481150933,4.54616655745053e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),CDHR2;Cadherin-related family member 2,5180,-0.0959204230698426,4.58403953648146e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in pallidum (left),TF;Serotransferrin,3723,0.113038959192932,4.61005515349652e-12
Primary analysis,Volume of global and regional brain,Volume of white matter,MOG;Myelin-oligodendrocyte glycoprotein,5615,0.140661552488014,3.29543901624785e-26
Primary analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),MOG;Myelin-oligodendrocyte glycoprotein,5614,0.140637272872875,3.39512266647047e-26
Primary analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5364,0.0942269915197163,4.68184415052837e-12
Primary analysis,DTI dMRI,Mean MD in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5367,0.0941827879814969,4.7258038812655e-12
Primary analysis,DTI dMRI,Weighted-mean MD in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5360,0.0941787286720384,4.88885830568509e-12
Primary analysis,DTI dMRI,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,5371,0.0939846689423379,5.1441244616406e-12
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",MOG;Myelin-oligodendrocyte glycoprotein,5615,0.135468011252482,2.06954981200195e-24
Primary analysis,DTI dMRI,Weighted-mean L1 in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5467,-0.0930958594379861,5.31728951494207e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),DPP6;Dipeptidyl aminopeptidase-like protein 6,5088,-0.0964322938863977,5.46605261485704e-12
Primary analysis,DTI dMRI,Mean FA in anterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5475,0.0929284996169988,5.60192846312434e-12
Primary analysis,DTI dMRI,Weighted-mean L3 in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5452,-0.093065614406296,5.77396853148981e-12
Primary analysis,DTI dMRI,Weighted-mean L2 in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5365,0.0937946186681413,5.83283740803672e-12
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),OMG;Oligodendrocyte-myelin glycoprotein,5088,-0.0962417630886102,6.0175925067588e-12
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",MOG;Myelin-oligodendrocyte glycoprotein,5615,0.132944540824088,1.46081390104306e-23
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,5485,0.0926690401611084,6.13935133460731e-12
Primary analysis,DTI dMRI,Weighted-mean L2 in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5364,0.0936557980583799,6.2953965359089e-12
Primary analysis,DTI dMRI,Weighted-mean L2 in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5441,-0.0927905445235224,6.99546541975246e-12
Primary analysis,DTI dMRI,Weighted-mean MD in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5363,0.0934419896393945,7.06169709017366e-12
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5458,0.116744797990378,5.03702107753489e-18
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0859173293746861,2.00152187114605e-10
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0850451747522928,3.04609035192414e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SCG3;Secretogranin-3,5421,0.0928680003041298,7.34046780121031e-12
Primary analysis,DTI dMRI,Weighted-mean L2 in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,5367,0.0932290025597025,7.74130393645517e-12
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),RTBDN;Retbindin,5402,0.0929235111539903,7.75793097012478e-12
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SCG3;Secretogranin-3,5421,0.0927154428235523,7.94355340580596e-12
Primary analysis,NODDI dMRI,Mean ICVF in genu of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,5373,-0.0930889782220113,8.1008096469279e-12
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.109497877457379,8.27721694503063e-12
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0849162207196214,3.24008305919422e-10
Primary analysis,DTI dMRI,Weighted-mean L2 in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5365,0.092963860393715,8.95088481880591e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (left),BCAN;Brevican core protein,5172,0.0946152564324522,9.22756885512031e-12
Primary analysis,Volume of global and regional brain,Volume of CC-Anterior (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0836052010940573,6.03835109306742e-10
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),TFRC;Transferrin receptor protein 1,5215,0.0940079926175963,1.03016565578399e-11
Primary analysis,DTI dMRI,Mean L2 in posterior thalamic radiation on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5447,-0.0919571666527879,1.04880438222477e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),OMD;Osteomodulin,5122,-0.0947292231420636,1.09657381496522e-11
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),KLK6;Kallikrein-6,5439,0.0919329255281078,1.09943933797542e-11
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0835635732607929,6.15795150652556e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter,MOG;Myelin-oligodendrocyte glycoprotein,5615,0.0804665275638559,1.55965610275275e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),MOG;Myelin-oligodendrocyte glycoprotein,5612,0.0804789011097841,1.56626660887518e-09
Primary analysis,DTI dMRI,Weighted-mean MD in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5362,0.0922685830604781,1.29408647530539e-11
Primary analysis,NODDI dMRI,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5453,0.0914367564042113,1.33565809828564e-11
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0786017853117565,5.96170067471625e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,NCAN;Neurocan core protein,5638,0.140763093085403,2.40572185037464e-26
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),NCAN;Neurocan core protein,5638,0.136690878013791,6.36311546347165e-25
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3873,0.108275148980102,1.41825414634035e-11
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),NCAN;Neurocan core protein,5485,0.136527738440267,3.09570234594526e-24
Primary analysis,Regional and tissue intensity,Mean intensity of Pallidum (right hemisphere),ESM1;Endothelial cell-specific molecule 1,5385,-0.09182280485313,1.46937502908906e-11
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3874,0.108097534869424,1.52236586642227e-11
Primary analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5462,0.0909898032945909,1.61610105547911e-11
Primary analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left),GDF15;Growth/differentiation factor 15,5538,0.0841998730457082,3.4807342894136e-10
Primary analysis,DTI dMRI,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,5374,0.091666296001219,1.66831959191406e-11
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.0916548546532111,1.69254451975095e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter,NCAN;Neurocan core protein,5638,0.134043596589451,5.07599125798864e-24
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),NCAN;Neurocan core protein,5485,0.135071045992332,9.44564441774389e-24
Primary analysis,DTI dMRI,Mean L1 in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5373,0.0915767672443131,1.75328876296595e-11
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",NCAN;Neurocan core protein,5638,0.130746097027799,6.36483796212067e-23
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",NCAN;Neurocan core protein,5638,0.129773949292278,1.32516256442538e-22
Primary analysis,NODDI dMRI,Mean ICVF in uncinate fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.091536024398502,1.7975444350817e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),NCAN;Neurocan core protein,5637,0.128635319104844,3.1324758069927e-22
Primary analysis,DTI dMRI,Weighted-mean L1 in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5367,0.0914798737292991,1.88946242109326e-11
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.090467030407451,1.91581244701223e-11
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),NCAN;Neurocan core protein,5485,0.126987388952879,3.69647857493213e-21
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),NCAN;Neurocan core protein,5485,0.124137953411649,2.77359228731917e-20
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),NCAN;Neurocan core protein,5485,0.118776095596169,1.08579102220592e-18
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract forceps major,GFAP;Glial fibrillary acidic protein,5367,-0.0913180017855949,2.05040098635489e-11
Primary analysis,DTI dMRI,Weighted-mean MD in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5367,0.0912477331879784,2.12437154322055e-11
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),NCAN;Neurocan core protein,5485,0.115598033894722,8.83934257265694e-18
Primary analysis,DTI dMRI,Mean L1 in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5373,0.0910481835984147,2.28980405480882e-11
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),NCAN;Neurocan core protein,5485,0.115372710616799,1.0234027844487e-17
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),NCAN;Neurocan core protein,5485,0.11362330549623,3.16093405346532e-17
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),OMD;Osteomodulin,5121,-0.0932227627759158,2.32411770420823e-11
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,5485,0.111022624837954,1.63714265261076e-16
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),NCAN;Neurocan core protein,5633,0.107672410134085,5.36453245641386e-16
Primary analysis,NODDI dMRI,Mean ICVF in fornix cres+stria terminalis on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.0909556357174548,2.40920641645564e-11
Primary analysis,DTI dMRI,Weighted-mean L3 in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,5375,0.0908622072031103,2.49320771687314e-11
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,5484,0.103904149073615,1.22266692553055e-14
Primary analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.106759102681072,2.70596472661115e-11
Primary analysis,DTI dMRI,Weighted-mean L1 in tract corticospinal tract (right),PAEP;Glycodelin,5461,0.0899844640116087,2.70642572544312e-11
Primary analysis,DTI dMRI,Mean MD in cingulum hippocampus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5368,0.0907254284718637,2.7506815234734e-11
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5431,-0.0901779367983195,2.78089451037762e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),NCAN;Neurocan core protein,5635,0.100071655453943,5.10201219323971e-14
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),NCAN;Neurocan core protein,5479,0.101392998229514,5.36081606563009e-14
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (right),NCAN;Neurocan core protein,5634,0.0971727159704312,2.68205488379796e-13
Primary analysis,NODDI dMRI,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5351,-0.0907525521052015,2.91556569877831e-11
Primary analysis,Cortical surface area,Area of G-front-middle (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.090465961799261,2.9909633726374e-11
Primary analysis,DTI dMRI,Mean FA in posterior thalamic radiation on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5465,0.0896845147056241,3.09758208678313e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (right),NCAN;Neurocan core protein,5634,0.0949135981864086,9.41821998017878e-13
Primary analysis,Volume of global and regional brain,Volume of grey matter in Paracingulate Gyrus (left),NCAN;Neurocan core protein,5634,0.0922141978189599,4.06683697091517e-12
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),NCAN;Neurocan core protein,5484,0.0913847831208746,1.20126490568455e-11
Primary analysis,Volume of global and regional brain,Volume of precuneus (left hemisphere),NCAN;Neurocan core protein,5485,0.0910683231791307,1.40782471329853e-11
Primary analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0895456243066169,3.33598422454224e-11
Primary analysis,Volume of global and regional brain,Volume of white matter,NCAN;Neurocan core protein,5638,0.0888708671974894,2.31298723853945e-11
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),KLK6;Kallikrein-6,5439,0.089643696119098,3.51975842669542e-11
Primary analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),NCAN;Neurocan core protein,5637,0.0888096445717709,2.39682180970204e-11
Primary analysis,Volume of global and regional brain,Volume of Lateral-nucleus (right hemisphere),NCAN;Neurocan core protein,5484,0.0895256119187727,3.10379036013929e-11
Primary analysis,Volume of global and regional brain,Volume of precuneus (left hemisphere),NCAN;Neurocan core protein,5485,0.0893626011316436,3.35633412771421e-11
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),NCAN;Neurocan core protein,5485,0.0890503548560085,3.9280992171969e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),CDHR2;Cadherin-related family member 2,5088,0.0925268085431515,3.77821001270174e-11
Primary analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),NCAN;Neurocan core protein,5485,0.0884534101557869,5.29835572350177e-11
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Lateral Occipital Cortex, superior division (left)",NCAN;Neurocan core protein,5636,0.0870521169430217,5.8992042657749e-11
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3874,0.10586842257196,3.95242026708508e-11
Primary analysis,Volume of global and regional brain,Volume of insula (left hemisphere),NCAN;Neurocan core protein,5485,0.0879872933644776,6.68383653390429e-11
Primary analysis,DTI dMRI,Weighted-mean L1 in tract corticospinal tract (right),OXT;Oxytocin-neurophysin 1,5554,0.0884176405352348,4.08982486060555e-11
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),NCAN;Neurocan core protein,5484,0.087602609817276,8.1209234745491e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),EDA2R;Tumor necrosis factor receptor superfamily member 27,5138,0.0918526325224147,4.21465513951718e-11
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (left),TF;Serotransferrin,3928,-0.104964939977868,4.261825234443e-11
Primary analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5465,-0.0890478774212013,4.26637543868762e-11
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.0869376649626391,1.12280575259586e-10
Primary analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),OMD;Osteomodulin,5504,0.0887001332641734,4.33732695743176e-11
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.0845778208219758,3.52532419375225e-10
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.107141680355828,4.52719797397284e-11
Primary analysis,Volume of global and regional brain,Volume of G-front-middle (left hemisphere),NCAN;Neurocan core protein,5485,0.0845471532089301,3.57741400049455e-10
Primary analysis,Volume of global and regional brain,Volume of superiorparietal (left hemisphere),NCAN;Neurocan core protein,5484,0.0837278644717747,5.30255569752796e-10
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (left hemisphere),NCAN;Neurocan core protein,5485,0.0835193164004162,5.83139841176922e-10
Primary analysis,DTI dMRI,Weighted-mean MD in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5361,0.0897084271832713,4.70175940601003e-11
Primary analysis,NODDI dMRI,Mean ICVF in fornix cres+stria terminalis on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5371,-0.0896003380339722,4.76000433676378e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),DPP10;Inactive dipeptidyl peptidase 10,5092,-0.091895792412952,5.0376834483814e-11
Primary analysis,DTI dMRI,Weighted-mean MD in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5448,-0.0888497967215005,5.04693130896989e-11
Primary analysis,Cortical surface area,Area of G-front-middle (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0886381168960553,5.25760141530875e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Paracingulate Gyrus (right),NCAN;Neurocan core protein,5636,0.0821480589431368,6.56635534120707e-10
Primary analysis,Cortical surface area,Area of G-cuneus (left hemisphere),NCAN;Neurocan core protein,5485,0.0883662330880971,5.53412376597587e-11
Primary analysis,Cortical surface area,Area of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0891596556983971,5.72883454605866e-11
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (left hemisphere),NCAN;Neurocan core protein,5485,0.0821939454277429,1.08566768879279e-09
Primary analysis,DTI dMRI,Mean L3 in posterior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5421,-0.0886556620607263,6.19884627602149e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),OMD;Osteomodulin,5118,-0.091232037525256,6.20130175735127e-11
Primary analysis,Volume of global and regional brain,Volume of Amygdala (right hemisphere),NCAN;Neurocan core protein,5485,0.0821626441236512,1.10159328679524e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Occipital Pole (left),NCAN;Neurocan core protein,5637,0.0806014560262598,1.36059665819868e-09
Primary analysis,Volume of global and regional brain,Volume of supramarginal (left hemisphere),NCAN;Neurocan core protein,5485,0.0816059595782996,1.42596809877363e-09
Primary analysis,Volume of global and regional brain,Volume of Whole-amygdala (right hemisphere),NCAN;Neurocan core protein,5485,0.0811585473206448,1.7525213291668e-09
Primary analysis,DTI dMRI,Mean L3 in posterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5425,-0.088487697835115,6.62837280326268e-11
Primary analysis,DTI dMRI,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,5363,0.088988130227393,6.65385479162058e-11
Primary analysis,Volume of global and regional brain,Volume of G-front-middle (right hemisphere),NCAN;Neurocan core protein,5485,0.0807683972140477,2.09588646233498e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (right),BCAN;Brevican core protein,5083,0.0912838269103414,7.0255622650073e-11
Primary analysis,DTI dMRI,Weighted-mean MD in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5463,-0.0880061520021229,7.22660866158879e-11
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),OMG;Oligodendrocyte-myelin glycoprotein,5180,0.0903521184772367,7.28834313235642e-11
Primary analysis,Volume of global and regional brain,Volume of SubCortGray (whole brain),NCAN;Neurocan core protein,5485,0.0802291424307722,2.68024562628142e-09
Primary analysis,DTI dMRI,Mean L1 in posterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5437,-0.088113992676194,7.59844785887934e-11
Primary analysis,DTI dMRI,Mean MD in genu of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5467,-0.0878369083963247,7.73430282337133e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Precuneous Cortex (right),NCAN;Neurocan core protein,5635,0.0784710198692827,3.6716497273066e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),CSF1R;Macrophage colony-stimulating factor 1 receptor,3670,-0.106957363509134,8.25017327720227e-11
Primary analysis,Volume of global and regional brain,Volume of insula (left hemisphere),NCAN;Neurocan core protein,5485,0.0794041578073209,3.89260947657397e-09
Primary analysis,DTI dMRI,Weighted-mean MD in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,5374,0.0884348356463357,8.34971691949154e-11
Primary analysis,DTI dMRI,Mean L3 in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5367,0.0884827841586491,8.38863811697165e-11
Primary analysis,DTI dMRI,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (right),GSN;Gelsolin,3921,-0.103314446180528,8.89507554718542e-11
Primary analysis,Volume of global and regional brain,Volume of supramarginal (left hemisphere),NCAN;Neurocan core protein,5485,0.0789876653911253,4.69296785142483e-09
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.0788915573855227,4.89923417278226e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Intracalcarine Cortex (left),NCAN;Neurocan core protein,5636,0.0772669800285842,6.3191649848142e-09
Primary analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5464,-0.0873211767242723,1.0092503632155e-10
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.0780970646121552,6.97778618155862e-09
Primary analysis,DTI dMRI,Mean L3 in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5356,0.0881664517080892,1.02295937448403e-10
Primary analysis,DTI dMRI,Mean L3 in superior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5454,-0.0873388884316747,1.04046112107963e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),CDHR2;Cadherin-related family member 2,5085,0.09038451743375,1.06883068309847e-10
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract forceps major,OMG;Oligodendrocyte-myelin glycoprotein,5465,0.0871962193665112,1.06896065727652e-10
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.103407169666548,1.10794095793426e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Middle Frontal Gyrus (left),NCAN;Neurocan core protein,5634,0.0769109973964428,7.46032167531961e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,NPTXR;Neuronal pentraxin receptor,5589,0.0797251151136703,2.39609880882802e-09
Primary analysis,DTI dMRI,Mean L2 in superior cerebellar peduncle on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5470,-0.0870075740610046,1.15001400647376e-10
Primary analysis,DTI dMRI,Weighted-mean L3 in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5363,0.0878471135823119,1.16192070154e-10
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),NPTXR;Neuronal pentraxin receptor,5439,0.0804239789738194,2.85903810518848e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),NPTXR;Neuronal pentraxin receptor,5439,0.0795663337870428,4.20420360003873e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),OGN;Mimecan,5414,-0.0785146311600794,7.26439845264886e-09
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),OMD;Osteomodulin,5435,-0.113518836011869,4.69446443749085e-17
Primary analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),CDHR2;Cadherin-related family member 2,5178,-0.0892089687392339,1.27099643777776e-10
Primary analysis,Volume of global and regional brain,Volume of 3rd-Ventricle (whole brain),OMG;Oligodendrocyte-myelin glycoprotein,5397,-0.0930753376145881,7.33334532902369e-12
Primary analysis,DTI dMRI,Mean L2 in posterior thalamic radiation on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5456,-0.086668137083694,1.43320951843452e-10
Primary analysis,Volume of global and regional brain,Volume of Inf-Lat-Vent (left hemisphere),OMG;Oligodendrocyte-myelin glycoprotein,5333,-0.0828314209967296,1.37861487820827e-09
Primary analysis,DTI dMRI,Weighted-mean L1 in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5366,0.0872943320891691,1.50063401888578e-10
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),PAEP;Glycodelin,5389,-0.117765477795122,4.19660939137857e-18
Primary analysis,Cortical surface area,Area of precuneus (left hemisphere),NCAN;Neurocan core protein,5485,0.0863324068144089,1.51013112555005e-10
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),PAEP;Glycodelin,5394,0.117137487447203,6.09452167558165e-18
Primary analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (left),BCAN;Brevican core protein,5083,0.0896114707533889,1.55201956462126e-10
Primary analysis,DTI dMRI,Weighted-mean L2 in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,5374,0.0870676872691881,1.62258673871222e-10
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.102468705238308,1.6311361645564e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (vermis),PAEP;Glycodelin,5543,-0.090788873452816,1.2717593138838e-11
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (left),GDF15;Growth/differentiation factor 15,5523,0.0838883995929597,4.26734010458343e-10
Primary analysis,DTI dMRI,Mean FA in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5377,-0.0869726367280783,1.67897239486245e-10
Primary analysis,DTI dMRI,Mean L3 in posterior thalamic radiation on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5447,-0.0863759544765032,1.71010119222651e-10
Primary analysis,NODDI dMRI,Mean ICVF in uncinate fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5372,-0.0869639609003575,1.71907676450783e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter,PLA2G15;Phospholipase A2 group XV,5599,-0.0791842301942845,2.97320794256691e-09
Primary analysis,DTI dMRI,Mean L3 in genu of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5468,-0.0861394374665653,1.77012684931851e-10
Primary analysis,DTI dMRI,Mean L3 in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5468,-0.0861185128803373,1.78819716889688e-10
Primary analysis,DTI dMRI,Weighted-mean L2 in tract forceps minor,GFAP;Glial fibrillary acidic protein,5371,0.086863392276879,1.81133594366856e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter,PODXL2;Podocalyxin-like protein 2,5599,0.0798023995772159,2.23773818251754e-09
Primary analysis,DTI dMRI,Weighted-mean L1 in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5369,0.0867451528854353,1.93212776624532e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),PODXL2;Podocalyxin-like protein 2,5598,0.0771484624131708,7.48975155088418e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),PRRT3;Proline-rich transmembrane protein 3,3777,0.0948118181974263,5.27979406715172e-09
Primary analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (right),BCAN;Brevican core protein,5445,-0.0859145408672436,2.15395339049579e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Supracalcarine Cortex (right),PTGDS;Prostaglandin-H2 D-isomerase,5539,0.0811427996928971,1.47001275487821e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),NPTXR;Neuronal pentraxin receptor,5119,-0.0885439598823804,2.20997995142721e-10
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.140465762768517,4.14335150381096e-25
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (right),TF;Serotransferrin,3928,-0.100975467843084,2.25751979730918e-10
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.136005729391932,1.25572919377636e-23
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),DPP6;Dipeptidyl aminopeptidase-like protein 6,5085,-0.0886958711901625,2.36166310717621e-10
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.1290447131125,2.06081467674289e-21
Primary analysis,DTI dMRI,Weighted-mean FA in tract superior thalamic radiation (right),RBKS;Ribokinase,5373,0.086209593444893,2.45887070183617e-10
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3874,0.101378825365169,2.54499657393948e-10
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5528,0.125338685336678,8.45572580093137e-21
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5528,0.124849530488765,1.19673494500877e-20
Primary analysis,Regional and tissue intensity,Mean intensity of Lateral-Ventricle (left hemisphere),MMP10;Stromelysin-2,5402,-0.085809875867991,2.66561384462818e-10
Primary analysis,DTI dMRI,Mean MD in genu of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,5368,0.0860324939669972,2.72703383124436e-10
Primary analysis,DTI dMRI,Weighted-mean L3 in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5363,0.0860223988702209,2.79277330634372e-10
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),EDA2R;Tumor necrosis factor receptor superfamily member 27,5234,-0.0869947602509482,2.89671583906039e-10
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.124043381592208,6.80474565956202e-20
Primary analysis,Volume of global and regional brain,Volume of ventricular cerebrospinal fluid (normalised for head size),GDF15;Growth/differentiation factor 15,5635,0.0825830844379732,5.35043649277563e-10
Primary analysis,NODDI dMRI,Weighted-mean ISOVF in tract anterior thalamic radiation (right),PTPRB;Receptor-type tyrosine-protein phosphatase beta,3936,0.100192857557106,2.98194042391727e-10
Primary analysis,DTI dMRI,Weighted-mean MD in tract superior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5466,-0.0850576667185658,3.00548007916583e-10
Primary analysis,Volume of global and regional brain,Volume of thalamus (left),GDF15;Growth/differentiation factor 15,5644,-0.0822665447121138,6.03450903895395e-10
Primary analysis,DTI dMRI,Weighted-mean L3 in tract posterior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5452,-0.0851491148273543,3.03053710070319e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5527,0.119224781072351,5.92914213040758e-19
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),OMG;Oligodendrocyte-myelin glycoprotein,5088,-0.0881204916125903,3.04715004486839e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5528,0.118636369090062,8.75583203800832e-19
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.120025566900001,1.02109437905112e-18
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.115510757866533,1.92484289452604e-17
Primary analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.11544940081621,2.00165742531382e-17
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),DPP6;Dipeptidyl aminopeptidase-like protein 6,5088,-0.0879700949900939,3.26647381204208e-10
Primary analysis,DTI dMRI,Weighted-mean L1 in tract posterior thalamic radiation (right),GSN;Gelsolin,3907,-0.100241112737029,3.39691186035116e-10
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.11222100663816,1.52350433160877e-16
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),KLK6;Kallikrein-6,5439,0.084998769426221,3.4175200551697e-10
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.110957451346369,3.34015701868046e-16
Primary analysis,Volume of global and regional brain,Volume of ventricular cerebrospinal fluid,GDF15;Growth/differentiation factor 15,5631,0.0821929429203007,6.53967722851825e-10
Primary analysis,DTI dMRI,Mean L3 in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5358,0.0855792235766073,3.51188061046026e-10
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.109462926447234,8.24373409878684e-16
Primary analysis,NODDI dMRI,Mean ICVF in fornix on FA skeleton,GFAP;Glial fibrillary acidic protein,5370,-0.0854686732095585,3.53721401498577e-10
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.109392834826518,8.60046885450911e-16
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.108237286518169,1.7224580182394e-15
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5528,0.105715483784444,3.26560758135227e-15
Primary analysis,DTI dMRI,Weighted-mean L3 in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,5363,0.0854319817030653,3.69494279951112e-10
Primary analysis,Cortical surface area,Area of V2 (left hemisphere),NCAN;Neurocan core protein,5485,0.0842957894800379,4.03363885021585e-10
Primary analysis,NODDI dMRI,Mean ISOVF in genu of corpus callosum on FA skeleton,BCAN;Brevican core protein,5451,-0.0845192946378542,4.10745798883684e-10
Primary analysis,DTI dMRI,Mean MD in posterior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5409,-0.0848313937005978,4.13550243849705e-10
Primary analysis,DTI dMRI,Mean L3 in fornix cres+stria terminalis on FA skeleton (left),GDF15;Growth/differentiation factor 15,5499,0.0822179692161095,1.022572258306e-09
Primary analysis,Cortical surface area,Area of G-front-middle (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0843019890428217,4.34242088809603e-10
Primary analysis,DTI dMRI,Mean FA in superior fronto-occipital fasciculus on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5476,0.0841082079832938,4.55737237250708e-10
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5528,0.105440512350222,3.85050816674105e-15
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),FLT3LG;Fms-related tyrosine kinase 3 ligand,5164,0.0865866692867841,4.59332102872426e-10
Primary analysis,DTI dMRI,Weighted-mean MD in tract forceps minor,GFAP;Glial fibrillary acidic protein,5372,0.0848516846621962,4.69716677866815e-10
Primary analysis,DTI dMRI,Weighted-mean FA in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,5377,-0.0847339777212392,4.87348759125092e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),OMD;Osteomodulin,5118,-0.0868185759175627,4.9320888637986e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3874,0.0995968922001769,5.21457077303367e-10
Primary analysis,Volume of global and regional brain,Volume of G-front-middle (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.104949541270991,1.19377338673009e-14
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.100207134680193,1.75564648569281e-13
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (right),CDHR2;Cadherin-related family member 2,5179,-0.0861071623407351,5.40883044786722e-10
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5435,-0.0840346010083359,5.47703492048175e-10
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0982258748521133,5.23066255968265e-13
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0958672995410215,1.85447708978382e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5525,0.0932845965464868,3.71920913952928e-12
Primary analysis,Cortical surface area,Area of V1 (left hemisphere),NCAN;Neurocan core protein,5485,0.0835814840090473,5.66251286341095e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5524,0.0907193719399862,1.42837171844733e-11
Primary analysis,DTI dMRI,Mean FA in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5376,-0.0843964468711529,5.73051129869969e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Supracalcarine Cortex (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5527,0.0897643723536026,2.30272862931395e-11
Primary analysis,Volume of global and regional brain,Volume of G-front-middle (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.090076986575251,3.63308741667053e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Supracalcarine Cortex (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5527,0.0887369417213446,3.88001445312108e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter in Paracingulate Gyrus (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5524,0.0869216716100657,9.72784016585462e-11
Primary analysis,NODDI dMRI,Mean ISOVF in superior cerebellar peduncle on FA skeleton (left),BCAN;Brevican core protein,5458,-0.0836395660256044,6.07096259714066e-10
Primary analysis,Volume of global and regional brain,Volume of S-parieto-occipital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0880705043199243,9.7800999627733e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),DPP10;Inactive dipeptidyl peptidase 10,5092,-0.0865689611028649,6.1121481269267e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5523,0.0866623712558296,1.10997604783332e-10
Primary analysis,DTI dMRI,Weighted-mean MD in tract middle cerebellar peduncle,MMP10;Stromelysin-2,5467,0.0834886850424529,6.31072436397607e-10
Primary analysis,DTI dMRI,Weighted-mean L3 in tract middle cerebellar peduncle,MMP10;Stromelysin-2,5463,0.0835111642179461,6.33449525168533e-10
Primary analysis,NODDI dMRI,Mean ISOVF in superior cerebellar peduncle on FA skeleton (right),BCAN;Brevican core protein,5461,-0.083463082441337,6.52603582983643e-10
Primary analysis,DTI dMRI,Weighted-mean L2 in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5361,0.0842351217477726,6.52727689082326e-10
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),OMG;Oligodendrocyte-myelin glycoprotein,5180,0.0856891420131722,6.52844573161387e-10
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Middle Temporal Gyrus, posterior division (right)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5526,0.0858244185269177,1.65576309735858e-10
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5374,0.08644093822614,2.19291995925252e-10
Primary analysis,DTI dMRI,Mean FA in posterior thalamic radiation on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5466,0.0833922565310271,6.62737306031579e-10
Primary analysis,DTI dMRI,Mean MD in splenium of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,5358,0.0841207754794114,6.95982637665212e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Precuneous Cortex (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5525,0.0851658489869908,2.29026159016909e-10
Primary analysis,DTI dMRI,Mean L3 in fornix cres+stria terminalis on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5408,-0.083687599104867,7.10632418391857e-10
Primary analysis,Volume of global and regional brain,Volume of lateralorbitofrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0853609039760825,3.59883737549258e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Cuneal Cortex (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5527,0.0833131376547934,5.53263787285287e-10
Primary analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),CHAD;Chondroadherin,3839,0.0991259101150534,7.50909971649607e-10
Primary analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0839284892288732,7.05260963216255e-10
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.100129464521504,7.6304248516148e-10
Primary analysis,DTI dMRI,Mean L3 in superior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5452,-0.0831795512889601,7.69782822948956e-10
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.0986000314498005,7.74729569333094e-10
Primary analysis,Volume of global and regional brain,Volume of BA44 (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0835251165283463,8.50682079035321e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),AHSP;Alpha-hemoglobin-stabilizing protein,5100,0.0859324490056555,7.91254505772395e-10
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),NCAN;Neurocan core protein,5484,0.082831047748768,8.09093474837848e-10
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),OMG;Oligodendrocyte-myelin glycoprotein,5089,-0.0858922590713327,8.40128188603804e-10
Primary analysis,Volume of global and regional brain,Volume of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0829832580118079,1.09279856489603e-09
Primary analysis,NODDI dMRI,Mean ICVF in inferior cerebellar peduncle on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5370,-0.083583238438128,8.55277451807164e-10
Primary analysis,DTI dMRI,Mean FA in fornix cres+stria terminalis on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5473,0.0827793059734071,8.61723527986797e-10
Primary analysis,DTI dMRI,Weighted-mean FA in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5373,-0.0835359073344731,8.64866190034886e-10
Primary analysis,DTI dMRI,Mean FA in fornix on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5476,0.0827437614296826,8.66951016288968e-10
Primary analysis,Volume of global and regional brain,Volume of lateraloccipital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0829194869845468,1.12537312960614e-09
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),BCAN;Brevican core protein,5394,0.0833407462307364,8.78164350733804e-10
Primary analysis,DTI dMRI,Mean L2 in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5356,0.0836313382217957,8.79641239876008e-10
Primary analysis,DTI dMRI,Weighted-mean MO in tract cingulate gyrus part of cingulum (left),BCAN;Brevican core protein,5462,0.0827717146106428,8.98973265057738e-10
Primary analysis,DTI dMRI,Weighted-mean MD in tract posterior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5450,-0.0827902476849408,9.2975457380292e-10
Primary analysis,Volume of global and regional brain,Volume of lateraloccipital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0822000988785781,1.56510406554665e-09
Primary analysis,DTI dMRI,Weighted-mean MD in tract posterior thalamic radiation (right),GSN;Gelsolin,3901,-0.0976993019164253,9.66909870650612e-10
Primary analysis,Volume of global and regional brain,Volume of G-temp-sup-Lateral (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0814087820334208,2.25010971402088e-09
Primary analysis,DTI dMRI,Mean L2 in posterior thalamic radiation on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5357,0.083373027911731,9.87501180675749e-10
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.081165449654508,2.50295965669457e-09
Primary analysis,DTI dMRI,Weighted-mean L1 in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5367,0.0832541890030267,1.00652633682937e-09
Primary analysis,Volume of global and regional brain,Volume of lateraloccipital (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.080888238940395,2.83572548398991e-09
Primary analysis,DTI dMRI,Mean L1 in fornix on FA skeleton,GDF15;Growth/differentiation factor 15,5568,0.0801380579151438,2.12288195797395e-09
Primary analysis,DTI dMRI,Mean MD in sagittal stratum on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5363,0.0832156149775566,1.03929759803198e-09
Primary analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5459,0.0824781792877108,1.04155575490601e-09
Primary analysis,DTI dMRI,Mean MD in posterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5410,-0.0828230686722218,1.0544875161829e-09
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (right),BCAN;Brevican core protein,5458,-0.0824251165733334,1.071288888534e-09
Primary analysis,Volume of global and regional brain,Volume of lateraloccipital (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.080619219522775,3.19964561996264e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Middle Frontal Gyrus (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5524,0.0794570328021545,3.34814590490478e-09
Primary analysis,Grey white matter intensity contrast,Grey-white contrast in rostralanteriorcingulate (left hemisphere),KLK6;Kallikrein-6,5439,0.0825267073227533,1.09225643043945e-09
Primary analysis,Volume of global and regional brain,Volume of G-orbital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0803367987361951,3.63053679417105e-09
Primary analysis,Volume of global and regional brain,Volume of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.07969735796747,4.82522255417216e-09
Primary analysis,rfMRI component amplitude,d100_component_amplitudes_46,NCAN;Neurocan core protein,5633,0.0810868722128165,1.09762663245962e-09
Primary analysis,Volume of global and regional brain,Volume of superiorparietal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0796813800462498,4.87543866167332e-09
Primary analysis,DTI dMRI,Mean FA in anterior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5476,0.0822289254947795,1.10211134068201e-09
Primary analysis,DTI dMRI,Weighted-mean L1 in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,5369,0.0830011596394567,1.12293306983382e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Central Opercular Cortex (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5526,0.0785110215714701,5.09678678343573e-09
Primary analysis,Volume of global and regional brain,Volume of G-temp-sup-Lateral (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0792731765193087,5.83924929127418e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),NELL2;Protein kinase C-binding protein NELL2,5121,-0.0849527480604375,1.13729949147182e-09
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0828865495671265,1.14661312782187e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Middle Frontal Gyrus (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5526,0.0781063583988607,6.10823613340737e-09
Primary analysis,DTI dMRI,Mean FA in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5466,0.0821842703510024,1.16501364969535e-09
Primary analysis,DTI dMRI,Mean MO in body of corpus callosum on FA skeleton,BCAN;Brevican core protein,5428,0.0824446329461028,1.17907402554395e-09
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.079148779060837,6.14825523364332e-09
Primary analysis,Cortical surface area,Area of S-front-middle (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0827611729786426,1.2103860465798e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),KLK6;Kallikrein-6,5439,0.082284094150007,1.22200328952112e-09
Primary analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5461,0.0820955483065052,1.23515081471861e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),EDA2R;Tumor necrosis factor receptor superfamily member 27,5141,0.0845972996361191,1.23903785186715e-09
Primary analysis,Volume of global and regional brain,Volume of G-occipital-middle (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0788970997977432,6.86749162353648e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),EDA2R;Tumor necrosis factor receptor superfamily member 27,5138,0.0845665414533149,1.27022101090031e-09
Primary analysis,Volume of global and regional brain,Volume of superiorfrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0787050891786474,7.47058607730503e-09
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Cingulate Gyrus, anterior division (right)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5517,0.0776775220728412,7.60272139760307e-09
Primary analysis,Grey white matter intensity contrast,Grey-white contrast in parahippocampal (left hemisphere),GFAP;Glial fibrillary acidic protein,5307,-0.0831876857722068,1.28511415538093e-09
Primary analysis,DTI dMRI,Weighted-mean FA in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,5470,0.0819262864485156,1.29480369965769e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3874,0.0972890274149052,1.29629115104709e-09
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.09729944553591,1.31647750085769e-09
Primary analysis,DTI dMRI,Mean L2 in superior cerebellar peduncle on FA skeleton (left),BCAN;Brevican core protein,5455,-0.0819403559686628,1.35484045286911e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.131467229518595,2.18427768252257e-16
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),NCAN;Neurocan core protein,5485,0.0816870339727397,1.37350810362774e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.122931622068206,1.66525150045197e-14
Primary analysis,DTI dMRI,Mean FA in posterior thalamic radiation on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5367,-0.0825465315860439,1.39312153742297e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SEZ6L;Seizure 6-like protein,5447,0.0819347347955287,1.39643140507952e-09
Primary analysis,DTI dMRI,Mean L3 in body of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5467,-0.0817823079018604,1.39827156380839e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),FLT3LG;Fms-related tyrosine kinase 3 ligand,5164,0.0841398906251899,1.3985078453437e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.097134521856923,1.40379977406863e-09
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.122650500352137,1.9112498874533e-14
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,PTPRR;Receptor-type tyrosine-protein phosphatase R,3982,0.119383853050338,4.08782889323379e-14
Primary analysis,DTI dMRI,Weighted-mean L2 in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,5362,0.082529231752996,1.42902045172448e-09
Primary analysis,rfMRI component amplitude,d100_component_amplitudes_17,IGFBP2;Insulin-like growth factor-binding protein 2,5633,-0.0805061433556355,1.44186693315546e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),DPP6;Dipeptidyl aminopeptidase-like protein 6,5085,-0.0847114973712062,1.4475618839338e-09
Primary analysis,DTI dMRI,Mean MD in body of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5464,-0.0817189074125259,1.45470405567569e-09
Primary analysis,NODDI dMRI,Mean ICVF in inferior cerebellar peduncle on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5372,-0.0824072557290757,1.45896190366726e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),PTPRR;Receptor-type tyrosine-protein phosphatase R,3982,0.116030044686691,2.06725581523171e-13
Primary analysis,DTI dMRI,Weighted-mean L2 in tract posterior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5446,-0.0818099596823068,1.48410902442713e-09
Primary analysis,NODDI dMRI,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5354,-0.0825049191525583,1.48606042290645e-09
Primary analysis,DTI dMRI,Weighted-mean FA in tract forceps minor,GFAP;Glial fibrillary acidic protein,5374,-0.0822821794804976,1.53400945714186e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),NPTXR;Neuronal pentraxin receptor,5119,-0.0842819588551882,1.54676764676726e-09
Primary analysis,DTI dMRI,Mean L3 in superior fronto-occipital fasciculus on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5381,-0.082201306331153,1.553396943809e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter,PTPRR;Receptor-type tyrosine-protein phosphatase R,3982,0.109971574349282,3.43960823666129e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),PTPRR;Receptor-type tyrosine-protein phosphatase R,3981,0.105182286424358,2.87430978100868e-11
Primary analysis,DTI dMRI,Mean L2 in superior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5363,0.0823216995851938,1.56550878732234e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),PTPRR;Receptor-type tyrosine-protein phosphatase R,3980,0.099421750341417,3.26059420567314e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (right),PTPRR;Receptor-type tyrosine-protein phosphatase R,3981,0.0964191856616615,1.08836483984532e-09
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5371,-0.082160757334829,1.63838621477293e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (right),BCAN;Brevican core protein,5171,0.0837127225440903,1.65097036551759e-09
Primary analysis,DTI dMRI,Mean L3 in body of corpus callosum on FA skeleton,NCAN;Neurocan core protein,5549,-0.080758124771168,1.69854867967404e-09
Primary analysis,Cortical surface area,Area of pericalcarine (left hemisphere),NCAN;Neurocan core protein,5485,0.0811972426953812,1.72161822477622e-09
Primary analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.0963392602647016,1.91053298856903e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),PTPRR;Receptor-type tyrosine-protein phosphatase R,3981,0.0949604003223474,1.93430033088236e-09
Primary analysis,Volume of global and regional brain,Volume of superiortemporal (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.0957728224492489,2.37596619310116e-09
Primary analysis,DTI dMRI,Mean L2 in fornix on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5471,-0.0811195097421425,1.8709121945283e-09
Primary analysis,Volume of global and regional brain,Volume of G-temp-sup-Lateral (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3869,0.0948618308097657,3.3806742573767e-09
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),PTPRZ1;Receptor-type tyrosine-protein phosphatase zeta,3881,-0.0973958003668881,1.20155366699965e-09
Primary analysis,Cortical surface area,Area of S-front-inf (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5463,0.0811088294655953,1.93173435519224e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),RTBDN;Retbindin,5402,0.0912998864835612,1.78169986098367e-11
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in pallidum (right),BCAN;Brevican core protein,5081,-0.0840759610677404,1.94680410267321e-09
Primary analysis,DTI dMRI,Mean L1 in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5371,0.0817787316208937,1.94918026160482e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),RTBDN;Retbindin,5402,0.0893803293319779,4.6743151483518e-11
Primary analysis,Grey white matter intensity contrast,Grey-white contrast in entorhinal (right hemisphere),GFAP;Glial fibrillary acidic protein,5307,-0.0822144722621008,1.99762528745263e-09
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),RTBDN;Retbindin,5402,0.087361285812995,1.26168553279741e-10
Primary analysis,NODDI dMRI,Weighted-mean ICVF in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5465,0.0809875542632589,2.02813768125798e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),SEZ6L;Seizure 6-like protein,5447,0.106926176741345,2.52395147813129e-15
Primary analysis,Volume of global and regional brain,Volume of thalamus (right),GDF15;Growth/differentiation factor 15,5644,-0.0790208852501416,2.77218494986504e-09
Primary analysis,DTI dMRI,Mean L2 in superior fronto-occipital fasciculus on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5326,-0.0819271143208448,2.12882096798341e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),SEZ6L;Seizure 6-like protein,5447,0.101758251423662,5.15358579032742e-14
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SEZ6L;Seizure 6-like protein,5599,0.0978808180288147,2.13481041660951e-13
Primary analysis,DTI dMRI,Mean L2 in anterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5465,-0.080832362205348,2.17709171177006e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SEZ6L;Seizure 6-like protein,5599,0.0947146257975504,1.23367883631111e-12
Primary analysis,Volume of global and regional brain,Volume of grey matter,SEZ6L;Seizure 6-like protein,5599,0.0914440405929562,7.11765008851936e-12
Primary analysis,DTI dMRI,Mean MD in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5467,-0.080756940833239,2.23819208532881e-09
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),SEZ6L;Seizure 6-like protein,5446,0.0917030639036727,1.20052044370438e-11
Primary analysis,Cortical surface area,Area of cuneus (right hemisphere),NCAN;Neurocan core protein,5485,0.0806039191299328,2.25952921738688e-09
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),SEZ6L;Seizure 6-like protein,5447,0.0903485385965361,2.38616802643385e-11
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),SEZ6L;Seizure 6-like protein,5447,0.0899785327347657,2.87704779420192e-11
Primary analysis,DTI dMRI,Mean L3 in posterior thalamic radiation on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5358,0.0813970256082546,2.42187522889207e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Supracalcarine Cortex (left),SEZ6L;Seizure 6-like protein,5598,0.088523021049495,3.24893563082587e-11
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3874,0.0955463512055041,2.5431186375622e-09
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),NCAN;Neurocan core protein,5485,0.0803128340028191,2.58014140869569e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PRRT3;Proline-rich transmembrane protein 3,3777,0.0966475956536572,2.65418356624783e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SEZ6L;Seizure 6-like protein,5598,0.0879776433785217,4.28748300681639e-11
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),SEZ6L;Seizure 6-like protein,5446,0.0883209676749916,6.61705130717486e-11
Primary analysis,NODDI dMRI,Mean ISOVF in genu of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5463,-0.0803549962421795,2.72323492613251e-09
Primary analysis,DTI dMRI,Mean L2 in cerebral peduncle on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5374,0.0810056458181984,2.73568614572554e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),C1QA;Complement C1q subcomponent subunit A,5139,-0.0828098722846085,2.76212244964887e-09
Primary analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),SEZ6L;Seizure 6-like protein,5447,0.0855024477813288,2.6066184041905e-10
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),FLT3LG;Fms-related tyrosine kinase 3 ligand,5258,-0.0818582023600711,2.77685209398411e-09
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),SEZ6L;Seizure 6-like protein,5447,0.0849476132480167,3.39948809536112e-10
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (right),TFRC;Transferrin receptor protein 1,5214,0.0821712804611929,2.81472257938235e-09
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),SEZ6L;Seizure 6-like protein,5446,0.080196126068233,3.09603687255069e-09
Primary analysis,Volume of global and regional brain,Volume of G-front-middle (left hemisphere),SEZ6L;Seizure 6-like protein,5447,0.0782580244695876,7.32561434756719e-09
Primary analysis,DTI dMRI,Mean L3 in posterior thalamic radiation on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5457,-0.0802960849934993,2.85323690952846e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SLITRK1;SLIT and NTRK-like protein 1,3868,0.135491864548189,2.60569233519533e-17
Primary analysis,DTI dMRI,Mean L2 in fornix on FA skeleton,BCAN;Brevican core protein,5460,-0.0802138174881411,2.93214262896595e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.137161704987921,2.9983331007333e-17
Primary analysis,Cortical surface area,Area of V2 (right hemisphere),NCAN;Neurocan core protein,5485,0.0799731543632773,3.0104772159497e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter,SLITRK1;SLIT and NTRK-like protein 1,3868,0.135202797608515,3.04607928097883e-17
Primary analysis,DTI dMRI,Mean FA in fornix on FA skeleton,BCAN;Brevican core protein,5465,0.080090267181534,3.04979291419354e-09
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.135089810943274,8.95751001886635e-17
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.13477301962696,1.05734626676494e-16
Primary analysis,Cortical surface area,Area of S-front-inf (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0806351667520008,3.18752045416076e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SYT1;Synaptotagmin-1,3870,0.0950010856274285,3.19134114185633e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SLITRK1;SLIT and NTRK-like protein 1,3868,0.131467296456589,2.22317485655528e-16
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SLITRK1;SLIT and NTRK-like protein 1,3867,0.128740686856533,9.23344161253611e-16
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3874,0.0949142176665182,3.2378725589044e-09
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.115116620852044,1.45118845182807e-12
Primary analysis,DTI dMRI,Weighted-mean L1 in tract corticospinal tract (left),OXT;Oxytocin-neurophysin 1,5555,0.0792595572495017,3.31188396207207e-09
Primary analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.113993625987479,2.3906586516586e-12
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.11079018073597,9.66939140403713e-12
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.107462234231914,3.96104981686645e-11
Primary analysis,Cortical surface area,Area of inferiortemporal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0798304346349954,3.4406970994865e-09
Primary analysis,Cortical surface area,Area of superiortemporal (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.0947963151259484,3.44987384770978e-09
Primary analysis,NODDI dMRI,Mean ICVF in anterior corona radiata on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,5470,0.0797343053766864,3.52303150819829e-09
Primary analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.107379151858632,4.10075923329826e-11
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),NCAN;Neurocan core protein,5484,0.0796140179955401,3.55292085229735e-09
Primary analysis,DTI dMRI,Mean L1 in anterior limb of internal capsule on FA skeleton (right),OCLN;Occludin,3926,0.0940432308283781,3.55323773024084e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),EDA2R;Tumor necrosis factor receptor superfamily member 27,5141,0.0821826785351954,3.61059527224034e-09
Primary analysis,NODDI dMRI,Weighted-mean ISOVF in tract inferior fronto-occipital fasciculus (right),PTPRB;Receptor-type tyrosine-protein phosphatase beta,3939,0.0938413354571829,3.61800350654205e-09
Primary analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.105472968926129,9.01808099620981e-11
Primary analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (right),TF;Serotransferrin,3662,0.0972969006153933,3.63806815791453e-09
Primary analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3759,0.104851501812817,1.16251383815766e-10
Primary analysis,DTI dMRI,Mean L3 in genu of corpus callosum on FA skeleton,NCAN;Neurocan core protein,5550,-0.0790368773870092,3.72389018509951e-09
Primary analysis,DTI dMRI,Mean MD in fornix cres+stria terminalis on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5419,-0.0799667140895158,3.75267727470597e-09
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",SLITRK1;SLIT and NTRK-like protein 1,3868,0.103229736344613,1.23216972142012e-10
Primary analysis,DTI dMRI,Mean L2 in body of corpus callosum on FA skeleton,NCAN;Neurocan core protein,5537,-0.0790907337962167,3.78956367675454e-09
Primary analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",SLITRK1;SLIT and NTRK-like protein 1,3868,0.100559322475858,3.65755954383674e-10
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),SLITRK1;SLIT and NTRK-like protein 1,3867,0.0974061656575648,1.28147851707502e-09
Primary analysis,DTI dMRI,Weighted-mean L3 in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,5465,-0.0794802655794769,4.01450815189134e-09
Primary analysis,NODDI dMRI,Mean ISOVF in genu of corpus callosum on FA skeleton,KLK6;Kallikrein-6,5498,-0.0792395656091244,4.01895283162453e-09
Primary analysis,NODDI dMRI,Mean ISOVF in fornix on FA skeleton,BCAN;Brevican core protein,5465,-0.0794419486507995,4.08414073367689e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in thalamus (right),SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,5121,0.0820225225308177,4.15001383054762e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in caudate (left),CDHR2;Cadherin-related family member 2,5180,-0.0815404150292989,4.17727592651253e-09
Primary analysis,Volume of global and regional brain,Volume of superiorparietal (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0976421648449084,1.98713146973925e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in hippocampus (right),TF;Serotransferrin,3661,-0.0969133355373216,4.21086378624881e-09
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (left),FLT3LG;Fms-related tyrosine kinase 3 ligand,5258,-0.0809083698364938,4.22660395213381e-09
Primary analysis,DTI dMRI,Mean L3 in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5353,0.0801779240363153,4.24782065522262e-09
Primary analysis,Cortical surface area,Area of S-front-middle (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,5464,0.0793488196700569,4.2721579103373e-09
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (right),BCAN;Brevican core protein,5426,-0.079611646695952,4.29854178636736e-09
Primary analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),KLK6;Kallikrein-6,5439,0.079509984153953,4.31147721356352e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Postcentral Gyrus (right),SLITRK1;SLIT and NTRK-like protein 1,3867,0.0954917080472429,2.68384910124297e-09
Primary analysis,DTI dMRI,Weighted-mean L2 in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5361,0.0800749473351181,4.3302410472419e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3870,0.094154080078778,4.39995621792683e-09
Primary analysis,Volume of global and regional brain,Volume of G-front-inf-Opercular (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0961144547996313,3.53595828499584e-09
Primary analysis,Regional and tissue intensity,Mean intensity of Pallidum (right hemisphere),NCAN;Neurocan core protein,5458,-0.0792746226053905,4.503193246111e-09
Primary analysis,Volume of global and regional brain,Volume of G-parietal-sup (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0958091174928778,3.96343143443914e-09
Primary analysis,DTI dMRI,Mean MD in fornix on FA skeleton,GDF15;Growth/differentiation factor 15,5564,0.0784977796420145,4.54422805372623e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),SLITRK1;SLIT and NTRK-like protein 1,3865,0.0929356051440404,7.10656119075307e-09
Primary analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5460,0.0792255642758688,4.57336831381221e-09
Primary analysis,DTI dMRI,Mean FA in body of corpus callosum on FA skeleton,NCAN;Neurocan core protein,5550,0.0785622262244802,4.61489549122485e-09
Primary analysis,Volume of global and regional brain,Volume of G-orbital (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0942286962735687,7.11503765446815e-09
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5378,0.0797615879301849,4.70516182942609e-09
Primary analysis,Regional and tissue intensity,Mean intensity of Putamen (left hemisphere),ESM1;Endothelial cell-specific molecule 1,5410,-0.0795182058653997,4.721467751527e-09
Primary analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),COL1A1;Collagen alpha-1(I) chain,5564,0.0783979955329572,4.75345924645256e-09
Primary analysis,DTI dMRI,Mean L2 in body of corpus callosum on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5455,-0.0791703822787486,4.7639093017837e-09
Primary analysis,Cortical surface area,Area of superiorparietal (left hemisphere),VGF;Neurosecretory protein VGF,3873,0.0939032471911837,4.77080121462157e-09
Primary analysis,Volume of global and regional brain,Volume of superiorparietal (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0941531658462971,7.31507902022712e-09
Primary analysis,DTI dMRI,Mean L2 in fornix on FA skeleton,GDF15;Growth/differentiation factor 15,5563,0.0783588930259879,4.85331708745958e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Precentral Gyrus (right),SLITRK1;SLIT and NTRK-like protein 1,3867,0.092704159150979,7.67688148606686e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),SOST;Sclerostin,5432,-0.0879754398210175,8.29899413099737e-11
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),SPP1;Osteopontin,5490,-0.097670423064925,4.09022379004711e-13
Primary analysis,DTI dMRI,Weighted-mean L1 in tract middle cerebellar peduncle,CLC;Galectin-10,5477,0.0788675309325211,5.0808311554304e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SPP1;Osteopontin,5640,-0.0875012881795631,4.62563886145972e-11
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SPP1;Osteopontin,5640,-0.0835737999418603,3.25761495397757e-10
Primary analysis,DTI dMRI,Weighted-mean L3 in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,5363,0.0796521601405813,5.18729745481434e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SPP1;Osteopontin,5639,-0.0824377006487171,5.6571277060911e-10
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0794860886373118,5.29819688014844e-09
Primary analysis,NODDI dMRI,Mean ISOVF in posterior corona radiata on FA skeleton (right),PTPRB;Receptor-type tyrosine-protein phosphatase beta,3917,0.0930644712205685,5.36823465069138e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Putamen (left),SPP1;Osteopontin,5629,0.0790721135165305,2.84150731555127e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SRPX;Sushi repeat-containing protein SRPX,3994,-0.0950222923166598,1.77715174384089e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),STC2;Stanniocalcin-2,5402,-0.0840645963776593,6.08819357562532e-10
Primary analysis,DTI dMRI,Mean L3 in corticospinal tract on FA skeleton (right),CLC;Galectin-10,5471,-0.0786796481677787,5.63176452019754e-09
Primary analysis,DTI dMRI,Mean L3 in superior cerebellar peduncle on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5470,-0.0786162876067265,5.81125057887316e-09
Primary analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (left),BCAN;Brevican core protein,5420,-0.0789762477479748,5.81347985387293e-09
Primary analysis,Regional and tissue intensity,Mean intensity of Inf-Lat-Vent (left hemisphere),OMG;Oligodendrocyte-myelin glycoprotein,5402,0.0791013439647227,5.82896720866902e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter in Frontal Operculum Cortex (right),STC2;Stanniocalcin-2,5559,0.077681675458038,6.6589586258647e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SUSD2;Sushi domain-containing protein 2,5573,-0.0815262514360233,1.09490180096399e-09
Primary analysis,DTI dMRI,Weighted-mean L1 in tract superior thalamic radiation (right),LILRA5;Leukocyte immunoglobulin-like receptor subfamily A member 5,5500,0.0783612136533382,5.91825506642551e-09
Primary analysis,DTI dMRI,Mean MD in fornix on FA skeleton,BCAN;Brevican core protein,5461,-0.0786281088132644,5.94902732445662e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PRRT3;Proline-rich transmembrane protein 3,3777,0.0944888618332142,5.95099867778367e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SUSD2;Sushi domain-containing protein 2,5573,-0.0791616937351829,3.267073310677e-09
Primary analysis,Cortical surface area,Area of S-parieto-occipital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,5379,0.0791931048440447,6.02940915830588e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SUSD2;Sushi domain-containing protein 2,5572,-0.0781849504884336,5.10177929510474e-09
Primary analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),TFPI;Tissue factor pathway inhibitor,5407,0.089425791555778,4.47700402836311e-11
Primary analysis,Volume of global and regional brain,Volume of grey matter,TIMP4;Metalloproteinase inhibitor 4,5573,-0.0818402782992135,9.44729775187373e-10
Primary analysis,Cortical surface area,Area of insula (left hemisphere),NCAN;Neurocan core protein,5483,0.0783912392555062,6.16275272643406e-09
Primary analysis,DTI dMRI,Mean L3 in fornix cres+stria terminalis on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,5419,-0.0788451896618165,6.18015086772466e-09
Primary analysis,Cortical surface area,Area of precuneus (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3759,0.0946089440437906,6.18603939115615e-09
Primary analysis,DTI dMRI,Mean MD in retrolenticular part of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5368,0.0791997632008629,6.22949235607562e-09
Primary analysis,Cortical surface area,Area of pericalcarine (left hemisphere),NCAN;Neurocan core protein,5485,0.0783402325317483,6.26422802901513e-09
Primary analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),TIMP4;Metalloproteinase inhibitor 4,5572,-0.080965093811952,1.42802339606991e-09
Primary analysis,Cortical surface area,Area of TotalSurface (left hemisphere),APLP1;Amyloid-like protein 1,5439,0.0786478724276777,6.32568644334312e-09
Primary analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),DMP1;Dentin matrix acidic phosphoprotein 1,3833,0.0936238879378459,6.35118665698458e-09
Primary analysis,DTI dMRI,Mean L2 in cerebral peduncle on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5371,0.0791177972884977,6.39571512581907e-09
Primary analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),TIMP4;Metalloproteinase inhibitor 4,5420,-0.0786262317160862,6.78531549398466e-09
Primary analysis,DTI dMRI,Mean MO in fornix on FA skeleton,OMG;Oligodendrocyte-myelin glycoprotein,5278,0.0797643999055207,6.52376330566774e-09
Primary analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),NELL2;Protein kinase C-binding protein NELL2,5121,-0.0809690268301957,6.53912446499251e-09
Primary analysis,Cortical surface area,Area of TotalSurface (right hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3874,0.0930462213366315,6.55073323765397e-09
Primary analysis,NODDI dMRI,Mean ISOVF in superior cerebellar peduncle on FA skeleton (right),MOG;Myelin-oligodendrocyte glycoprotein,5531,-0.0779001383348758,6.59228330056201e-09
Primary analysis,Volume of global and regional brain,Volume of Brain-Stem (whole brain),TMPRSS5;Transmembrane protease serine 5,5370,0.0916660303979091,1.69754908127055e-11
Primary analysis,DTI dMRI,Weighted-mean L3 in tract forceps minor,GFAP;Glial fibrillary acidic protein,5371,0.0790187660752934,6.68001504236161e-09
Primary analysis,DTI dMRI,Mean L3 in fornix cres+stria terminalis on FA skeleton (right),GDF15;Growth/differentiation factor 15,5513,0.0779763118472934,6.74218148650933e-09
Primary analysis,Volume of global and regional brain,Volume of Whole-brainstem (whole brain),TMPRSS5;Transmembrane protease serine 5,5370,0.0914802897513429,1.86490101195633e-11
Primary analysis,Volume of global and regional brain,Volume of Pons (whole brain),TMPRSS5;Transmembrane protease serine 5,5370,0.0868687448819886,1.81369619452287e-10
Primary analysis,DTI dMRI,Mean MD in retrolenticular part of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,5373,0.0789613874621829,6.80640853471861e-09
Primary analysis,Volume of global and regional brain,Volume of Medulla (whole brain),TMPRSS5;Transmembrane protease serine 5,5369,0.0803231293031823,3.77625176596792e-09
Primary analysis,NODDI dMRI,Mean ICVF in cerebral peduncle on FA skeleton (left),AHSP;Alpha-hemoglobin-stabilizing protein,5480,0.0781418240200731,6.94932013237821e-09
Primary analysis,Volume of global and regional brain,Volume of Midbrain (whole brain),TMPRSS5;Transmembrane protease serine 5,5370,0.0797181039722684,4.92411693769749e-09
Primary analysis,DTI dMRI,Mean L2 in sagittal stratum on FA skeleton (right),GSN;Gelsolin,3914,-0.0923671444618434,7.07208808141546e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.131139215357588,2.50435547630292e-16
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.127550021695804,1.60085591261105e-15
Primary analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),VGF;Neurosecretory protein VGF,3874,0.111712593163481,3.1081292200104e-12
Primary analysis,Susceptibility weighted MRI,Median T2star in putamen (right),DPP10;Inactive dipeptidyl peptidase 10,5189,0.0802332117650445,7.14349611323877e-09
Primary analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.107826659953368,1.71128238227492e-11
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,VGF;Neurosecretory protein VGF,3983,0.106290907058354,1.75496889877694e-11
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.107204671675228,2.23615244774493e-11
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),VGF;Neurosecretory protein VGF,3983,0.104903644639416,3.20531882245707e-11
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3874,0.100768717099015,3.25804694234936e-10
Primary analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),VGF;Neurosecretory protein VGF,3874,0.0987529679826557,7.29259312650017e-10
Primary analysis,DTI dMRI,Mean L3 in fornix cres+stria terminalis on FA skeleton (right),GFAP;Glial fibrillary acidic protein,5322,0.0791261786065231,7.46455329855284e-09
Primary analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.0952988987581975,2.79581190089137e-09
Primary analysis,Volume of global and regional brain,"Volume of grey matter in Cingulate Gyrus, anterior division (right)",VGF;Neurosecretory protein VGF,3976,0.092287094729663,5.54851055967729e-09
Primary analysis,Volume of global and regional brain,Volume of caudalanteriorcingulate (left hemisphere),VGF;Neurosecretory protein VGF,3874,0.0931049140386728,6.40860974047676e-09
Primary analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3874,0.0941518548952491,4.32380572369528e-09
Primary analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (left),OMD;Osteomodulin,5505,0.0777603014401906,7.60817179199116e-09
Primary analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,VWC2L;von Willebrand factor C domain-containing protein 2-like,3983,0.0922000082899306,5.56172139530888e-09
sensitivity analysis,Volume of global and regional brain,Volume of MDm (left hemisphere),BCAN;Brevican core protein,4610,0.08641689,4.18e-09
sensitivity analysis,Volume of global and regional brain,Volume of Pons (whole brain),TMPRSS5;Transmembrane protease serine 5,4592,0.09217658,3.9e-10
sensitivity analysis,Volume of global and regional brain,Volume of Whole-brainstem (whole brain),TMPRSS5;Transmembrane protease serine 5,4592,0.09646954,5.73e-11
sensitivity analysis,Volume of global and regional brain,Volume of Whole-hippocampal-head (left hemisphere),BCAN;Brevican core protein,4610,0.08564145,5.75e-09
sensitivity analysis,Volume of global and regional brain,Volume of Whole-hippocampal-head (right hemisphere),BCAN;Brevican core protein,4610,0.08583125,5.32e-09
sensitivity analysis,Volume of global and regional brain,Volume of Whole-hippocampus (left hemisphere),BCAN;Brevican core protein,4610,0.08946033,1.17e-09
sensitivity analysis,Volume of global and regional brain,Volume of Whole-hippocampus (right hemisphere),BCAN;Brevican core protein,4610,0.08997956,9.35e-10
sensitivity analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11681775,1.95e-15
sensitivity analysis,Volume of global and regional brain,Volume of G+S-cingul-Ant (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.1059485,9.33e-10
sensitivity analysis,Volume of global and regional brain,Volume of G-front-middle (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.10698932,3.54e-13
sensitivity analysis,Volume of global and regional brain,Volume of G-front-middle (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.09080419,6.96e-10
sensitivity analysis,Volume of global and regional brain,Volume of G-orbital (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.08791588,2.37e-09
sensitivity analysis,Volume of global and regional brain,Volume of G-temp-sup-Lateral (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4595,0.08594582,5.37e-09
sensitivity analysis,Volume of global and regional brain,Volume of caudalanteriorcingulate (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.10118156,5.11e-09
sensitivity analysis,Volume of global and regional brain,Volume of insula (left hemisphere),NCAN;Neurocan core protein,4684,0.08514544,5.33e-09
sensitivity analysis,Volume of global and regional brain,Volume of lateralorbitofrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.0919648,4.21e-10
sensitivity analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),NCAN;Neurocan core protein,4683,0.08465641,6.55e-09
sensitivity analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4595,0.09342024,2.23e-10
sensitivity analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),NCAN;Neurocan core protein,4683,0.08718585,2.28e-09
sensitivity analysis,Volume of global and regional brain,Volume of precuneus (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4595,0.09386437,1.83e-10
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,4683,0.10501896,5.82e-13
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4595,0.12049067,2.5e-16
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),SEZ6L;Seizure 6-like protein,4654,0.08561556,4.92e-09
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.0878702,1.77e-09
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,4684,0.11458307,3.67e-15
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.1220026,1.04e-16
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11019462,6.82e-14
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.10712338,6.06e-10
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.08695921,2.6e-09
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11601159,3.04e-15
sensitivity analysis,Volume of global and regional brain,Volume of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.10959279,2.41e-10
sensitivity analysis,Volume of global and regional brain,Volume of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.08695326,3.54e-09
sensitivity analysis,Volume of global and regional brain,Volume of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.08630438,4.62e-09
sensitivity analysis,Volume of global and regional brain,Volume of 3rd-Ventricle (whole brain),OMG;Oligodendrocyte-myelin glycoprotein,4618,-0.0921445,3.53e-10
sensitivity analysis,Volume of global and regional brain,Volume of Brain-Stem (whole brain),TMPRSS5;Transmembrane protease serine 5,4592,0.09503661,1.1e-10
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),BCAN;Brevican core protein,4610,0.11309505,1.35e-14
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),KLK6;Kallikrein-6,4647,0.14136445,3.57e-22
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.15288315,7.67e-26
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),NCAN;Neurocan core protein,4684,0.11940431,2.42e-16
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11395827,9.28e-15
sensitivity analysis,Volume of global and regional brain,Volume of BrainSeg (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.12128614,4.68e-12
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),BCAN;Brevican core protein,4610,0.12695106,5.05e-18
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),KLK6;Kallikrein-6,4647,0.13997221,9.12e-22
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.1507253,3.73e-25
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),NCAN;Neurocan core protein,4684,0.12034601,1.41e-16
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11418904,8.19e-15
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVent (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.11752038,2.1e-11
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),BCAN;Brevican core protein,4610,0.13279461,1.38e-19
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),KLK6;Kallikrein-6,4647,0.14439952,4.47e-23
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.15378851,3.93e-26
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),NCAN;Neurocan core protein,4684,0.12695094,2.75e-18
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11622418,2.7e-15
sensitivity analysis,Volume of global and regional brain,Volume of BrainSegNotVentSurf (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.12497935,1.03e-12
sensitivity analysis,Volume of global and regional brain,Volume of CC-Anterior (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.08546393,4.86e-09
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),BCAN;Brevican core protein,4610,0.12963012,9.88e-19
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),KLK6;Kallikrein-6,4647,0.16742268,1.46e-30
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.16204322,7.23e-29
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (left hemisphere),NCAN;Neurocan core protein,4684,0.09855124,1.38e-11
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),BCAN;Brevican core protein,4610,0.13004623,7.65e-19
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),KLK6;Kallikrein-6,4647,0.16488845,1.11e-29
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.15708784,3.3e-27
sensitivity analysis,Volume of global and regional brain,Volume of CerebralWhiteMatter (right hemisphere),NCAN;Neurocan core protein,4684,0.09695069,2.95e-11
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),NCAN;Neurocan core protein,4684,0.12051523,1.27e-16
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.14550346,3.61e-23
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.13093408,3.71e-14
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),SEZ6L;Seizure 6-like protein,4655,0.10020724,7.27e-12
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.1369073,5.56e-15
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.12779966,1.44e-13
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),NCAN;Neurocan core protein,4684,0.10546125,4.62e-13
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.14083493,8.56e-22
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.11524905,2.79e-11
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),SEZ6L;Seizure 6-like protein,4655,0.10504951,6.71e-13
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.13063281,9.18e-14
sensitivity analysis,Volume of global and regional brain,Volume of Cortex (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.12843281,1.09e-13
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),BGLAP;Osteocalcin,3328,-0.118071,8.33e-12
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CDH3;Cadherin-3,4684,0.08539769,4.81e-09
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CHAD;Chondroadherin,3244,-0.1717971,6.56e-23
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),CHRDL2;Chordin-like protein 2,4648,0.09154578,4.03e-10
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),COL1A1;Collagen alpha-1(I) chain,4689,-0.1305159,2.88e-19
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),COL9A1;Collagen alpha-1(IX) chain,4628,-0.0927551,2.58e-10
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),DMP1;Dentin matrix acidic phosphoprotein 1,3230,-0.1197852,8.51e-12
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),DPP4;Dipeptidyl peptidase 4,4541,-0.0881232,2.71e-09
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),FSHB;Follitropin subunit beta,3230,-0.1020021,6.25e-09
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),OMD;Osteomodulin,4643,-0.102948,2.04e-12
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),PAEP;Glycodelin,4610,0.12122592,1.47e-16
sensitivity analysis,Volume of global and regional brain,Volume of EstimatedTotalIntraCranial (whole brain),SPP1;Osteopontin,4683,-0.090084,6.59e-10
sensitivity analysis,Volume of global and regional brain,Volume of Pallidum (right hemisphere),KLK6;Kallikrein-6,4647,0.08919824,1.12e-09
sensitivity analysis,Volume of global and regional brain,Volume of SubCortGray (whole brain),BCAN;Brevican core protein,4610,0.09205742,3.8e-10
sensitivity analysis,Volume of global and regional brain,Volume of SubCortGray (whole brain),NCAN;Neurocan core protein,4684,0.0863634,3.22e-09
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),BCAN;Brevican core protein,4610,0.12406549,2.81e-17
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),KLK6;Kallikrein-6,4647,0.15459042,3.01e-26
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.16804393,5.99e-31
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),NCAN;Neurocan core protein,4684,0.14032155,4.97e-22
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.12716782,4.97e-18
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),SEZ6L;Seizure 6-like protein,4655,0.0962466,4.7e-11
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.13119434,7.18e-14
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorial (whole brain),VGF;Neurosecretory protein VGF,3321,0.10292072,2.77e-09
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),BCAN;Brevican core protein,4610,0.13619812,1.57e-20
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),KLK6;Kallikrein-6,4647,0.15125956,3.46e-25
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.16369977,1.96e-29
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),NCAN;Neurocan core protein,4684,0.1393279,9.73e-22
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.1259711,1.02e-17
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),SEZ6L;Seizure 6-like protein,4655,0.09032101,6.69e-10
sensitivity analysis,Volume of global and regional brain,Volume of SupraTentorialNotVent (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.12614377,6.29e-13
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),NCAN;Neurocan core protein,4684,0.10643697,2.81e-13
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.13870355,3.51e-21
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.12188686,1.87e-12
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),SEZ6L;Seizure 6-like protein,4655,0.0922841,2.82e-10
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),SLITRK1;SLIT and NTRK-like protein 1,3229,0.13672772,6.04e-15
sensitivity analysis,Volume of global and regional brain,Volume of TotalGray (whole brain),VGF;Neurosecretory protein VGF,3321,0.11515614,2.82e-11
sensitivity analysis,Volume of global and regional brain,Volume of VentralDC (left hemisphere),KLK6;Kallikrein-6,4647,0.09004876,7.78e-10
sensitivity analysis,Volume of global and regional brain,Volume of VentralDC (left hemisphere),TMPRSS5;Transmembrane protease serine 5,4592,0.08605797,5.19e-09
sensitivity analysis,Volume of global and regional brain,Volume of VentralDC (right hemisphere),KLK6;Kallikrein-6,4647,0.08689902,2.97e-09
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),BCAN;Brevican core protein,4605,0.09513782,9.87e-11
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CCN5;CCN family member 5,4619,-0.094517,1.22e-10
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CHAD;Chondroadherin,3241,0.10290233,4.32e-09
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CHRDL2;Chordin-like protein 2,4642,-0.0959592,5.7e-11
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),CRLF1;Cytokine receptor-like factor 1,4637,-0.0978395,2.44e-11
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),DPP4;Dipeptidyl peptidase 4,4535,0.09786236,3.99e-11
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),FSHB;Follitropin subunit beta,3226,0.11308716,1.18e-10
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),ITGA11;Integrin alpha-11,4622,0.09424793,1.36e-10
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),KLK4;Kallikrein-4,4668,-0.1003808,6.25e-12
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),MOG;Myelin-oligodendrocyte glycoprotein,4668,0.1113401,2.37e-14
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),NCAN;Neurocan core protein,4678,0.09956414,8.8e-12
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),PAEP;Glycodelin,4605,-0.1167411,1.91e-15
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),PROC;Vitamin K-dependent protein C,4636,0.08582259,4.84e-09
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4591,0.08652877,4.3e-09
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),STC2;Stanniocalcin-2,4608,-0.0928865,2.66e-10
sensitivity analysis,Volume of global and regional brain,Volume-ratio of BrainSegVol-to-eTIV (whole brain),TFPI;Tissue factor pathway inhibitor,4615,0.09457371,1.22e-10
sensitivity analysis,Regional and tissue intensity,Mean intensity of Pallidum (right hemisphere),ESM1;Endothelial cell-specific molecule 1,4600,-0.089273,1.32e-09
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),APLP1;Amyloid-like protein 1,4648,0.08473148,7.23e-09
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),BCAN;Brevican core protein,4610,0.09985198,1.08e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3321,0.11077687,1.54e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.1141015,5.11e-15
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),NCAN;Neurocan core protein,4684,0.14381368,4.54e-23
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.15660903,1.26e-26
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.12051268,3.32e-12
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SCG3;Secretogranin-3,4632,0.09378349,1.6e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SEZ6L;Seizure 6-like protein,4655,0.11076284,3.5e-14
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.13840875,2.79e-15
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.14782698,1.1e-17
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3321,0.11499964,3e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),BCAN;Brevican core protein,4610,0.09681704,4.48e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3321,0.10994171,2.12e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.11164933,1.93e-14
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),NCAN;Neurocan core protein,4684,0.13861883,1.56e-21
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.15748994,6.53e-27
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.1189524,6.3e-12
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),RTBDN;Retbindin,4622,0.09122197,5.2e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SCG3;Secretogranin-3,4632,0.09429124,1.28e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SEZ6L;Seizure 6-like protein,4655,0.10722958,2.21e-13
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.13988239,1.41e-15
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.15001319,3.59e-18
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3321,0.11275998,7.2e-11
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4673,0.09860901,1.42e-11
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,4683,0.11418798,4.59e-15
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4595,0.12407786,3.14e-17
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),SEZ6L;Seizure 6-like protein,4654,0.08640775,3.54e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3320,0.10560465,1.06e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.10058015,5.5e-12
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),NCAN;Neurocan core protein,4684,0.08949935,8.46e-10
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.12268018,7.05e-17
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRR;Receptor-type tyrosine-protein phosphatase R,3317,0.10089438,5.76e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),SEZ6L;Seizure 6-like protein,4655,0.08652671,3.36e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.12133662,2.29e-12
sensitivity analysis,Cortical surface area,Area of superiortemporal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.09019129,9.06e-10
sensitivity analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.09343825,1.55e-10
sensitivity analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11273629,1.79e-14
sensitivity analysis,Cortical surface area,Area of G+S-cingul-Ant (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.1018191,4.08e-09
sensitivity analysis,Cortical surface area,Area of G-cuneus (left hemisphere),NCAN;Neurocan core protein,4684,0.09320067,1.65e-10
sensitivity analysis,Cortical surface area,Area of G-front-middle (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.08641219,3.27e-09
sensitivity analysis,Cortical surface area,Area of G-front-middle (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.09243023,3.43e-10
sensitivity analysis,Cortical surface area,Area of G-front-middle (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.0876941,1.91e-09
sensitivity analysis,Cortical surface area,Area of S-front-inf (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4673,0.08565176,4.51e-09
sensitivity analysis,Cortical surface area,Area of insula (left hemisphere),NCAN;Neurocan core protein,4682,0.08459289,6.75e-09
sensitivity analysis,Cortical surface area,Area of pericalcarine (left hemisphere),NCAN;Neurocan core protein,4684,0.0893082,9.19e-10
sensitivity analysis,Cortical surface area,Area of pericalcarine (left hemisphere),NCAN;Neurocan core protein,4684,0.08643001,3.13e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),BCAN;Brevican core protein,4610,0.08651428,4.02e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),KLK6;Kallikrein-6,4647,0.08946324,1e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.1104709,3.63e-14
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,4684,0.09982895,7.51e-12
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11317455,1.41e-14
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.10500643,1.31e-09
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),BCAN;Brevican core protein,4610,0.09534795,8.76e-11
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),KLK6;Kallikrein-6,4647,0.09699154,3.46e-11
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.11592803,1.86e-15
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),NCAN;Neurocan core protein,4684,0.10434011,8.15e-13
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.11235847,2.18e-14
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.10632756,8.12e-10
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.1030776,1.62e-12
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.1023102,3.59e-12
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.10824327,4e-10
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.11555996,2.28e-15
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.10978241,8.45e-14
sensitivity analysis,Cortical surface area,Area of rostralmiddlefrontal (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.11456953,3.55e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),BCAN;Brevican core protein,4610,0.11513996,4.45e-15
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),KLK6;Kallikrein-6,4647,0.09892328,1.4e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3321,0.11580946,2.17e-11
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.12676008,3.35e-18
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),NCAN;Neurocan core protein,4684,0.12925468,6.62e-19
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.12851564,2.2e-18
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SEZ6L;Seizure 6-like protein,4655,0.08805935,1.76e-09
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.12040323,6.69e-12
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VGF;Neurosecretory protein VGF,3321,0.12468613,5.56e-13
sensitivity analysis,Cortical surface area,Area of TotalSurface (left hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3321,0.10593399,9.37e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),BCAN;Brevican core protein,4610,0.1124148,1.94e-14
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),KLK6;Kallikrein-6,4647,0.0931498,1.99e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),LRTM2;Leucine-rich repeat and transmembrane domain-containing protein 2,3321,0.11182045,1.03e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),MOG;Myelin-oligodendrocyte glycoprotein,4674,0.12019919,1.65e-16
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),NCAN;Neurocan core protein,4684,0.12601101,4.87e-18
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4596,0.12681668,6.14e-18
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),SLITRK1;SLIT and NTRK-like protein 1,3229,0.11333127,1.06e-10
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VGF;Neurosecretory protein VGF,3321,0.12860275,1.01e-13
sensitivity analysis,Cortical surface area,Area of TotalSurface (right hemisphere),VWC2L;von Willebrand factor C domain-containing protein 2-like,3321,0.10646163,7.73e-10
sensitivity analysis,Cortical surface area,Area of BA1 (right hemisphere),NCAN;Neurocan core protein,4684,0.08576441,4.13e-09
sensitivity analysis,Cortical surface area,Area of V1 (left hemisphere),NCAN;Neurocan core protein,4684,0.0934619,1.47e-10
sensitivity analysis,Cortical surface area,Area of V2 (left hemisphere),NCAN;Neurocan core protein,4684,0.08933557,9.08e-10
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",BCAN;Brevican core protein,4752,0.1370204,2.36e-21
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",CHAD;Chondroadherin,3346,-0.1039982,1.64e-09
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",COL1A1;Collagen alpha-1(I) chain,4833,-0.095336,3.11e-11
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",KLK6;Kallikrein-6,4790,0.14073148,1.29e-22
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",MOG;Myelin-oligodendrocyte glycoprotein,4818,0.13848972,4.6e-22
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",NCAN;Neurocan core protein,4829,0.12977302,1.38e-19
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.11673795,7.63e-16
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",SLITRK1;SLIT and NTRK-like protein 1,3334,0.11342987,5.09e-11
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter",THY1;Thy-1 membrane glycoprotein,4829,0.08427854,4.48e-09
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",BCAN;Brevican core protein,4752,0.13680781,2.72e-21
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",CHAD;Chondroadherin,3346,-0.1034491,2e-09
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",COL1A1;Collagen alpha-1(I) chain,4833,-0.0937702,6.51e-11
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",KLK6;Kallikrein-6,4790,0.13925526,3.58e-22
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",MOG;Myelin-oligodendrocyte glycoprotein,4818,0.13674027,1.52e-21
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",NCAN;Neurocan core protein,4829,0.13026311,1e-19
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.11639064,9.29e-16
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",SLITRK1;SLIT and NTRK-like protein 1,3334,0.11074632,1.44e-10
sensitivity analysis,Volume of global and regional brain,"Volume of brain, grey+white matter (normalised for head size)",THY1;Thy-1 membrane glycoprotein,4829,0.08597966,2.17e-09
sensitivity analysis,Volume of global and regional brain,Volume of white matter,BCAN;Brevican core protein,4752,0.11432046,2.69e-15
sensitivity analysis,Volume of global and regional brain,Volume of white matter,KLK6;Kallikrein-6,4790,0.14778038,8.52e-25
sensitivity analysis,Volume of global and regional brain,Volume of white matter,MOG;Myelin-oligodendrocyte glycoprotein,4818,0.14763839,6.92e-25
sensitivity analysis,Volume of global and regional brain,Volume of white matter,NCAN;Neurocan core protein,4829,0.0942549,5.28e-11
sensitivity analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),BCAN;Brevican core protein,4751,0.11715722,5.44e-16
sensitivity analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),KLK6;Kallikrein-6,4789,0.14824571,6.13e-25
sensitivity analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),MOG;Myelin-oligodendrocyte glycoprotein,4817,0.14778736,6.28e-25
sensitivity analysis,Volume of global and regional brain,Volume of white matter (normalised for head size),NCAN;Neurocan core protein,4828,0.09532905,3.2e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,BCAN;Brevican core protein,4752,0.11518922,1.65e-15
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,COL1A1;Collagen alpha-1(I) chain,4833,-0.0960851,2.18e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,NCAN;Neurocan core protein,4829,0.125724,1.8e-18
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.13247423,5.4e-20
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,PTPRR;Receptor-type tyrosine-protein phosphatase R,3425,0.11115552,6.89e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,SEZ6L;Seizure 6-like protein,4799,0.0961305,2.5e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,SLITRK1;SLIT and NTRK-like protein 1,3334,0.12912414,7.19e-14
sensitivity analysis,Volume of global and regional brain,Volume of grey matter,TIMP4;Metalloproteinase inhibitor 4,4771,-0.0941469,7.23e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),BCAN;Brevican core protein,4752,0.1110054,1.67e-14
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),CHAD;Chondroadherin,3346,-0.1010932,4.61e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),COL1A1;Collagen alpha-1(I) chain,4833,-0.1010331,1.92e-12
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),NCAN;Neurocan core protein,4829,0.12265773,1.19e-17
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.13262335,4.91e-20
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),PTPRR;Receptor-type tyrosine-protein phosphatase R,3425,0.10711017,3.29e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SEZ6L;Seizure 6-like protein,4799,0.09314247,1.01e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SLITRK1;SLIT and NTRK-like protein 1,3334,0.12341377,8.63e-13
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),SPP1;Osteopontin,4825,-0.0855206,2.68e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter (normalised for head size),TIMP4;Metalloproteinase inhibitor 4,4771,-0.094946,4.99e-11
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,BCAN;Brevican core protein,4752,0.11189959,1.03e-14
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,CHAD;Chondroadherin,3346,-0.1008893,4.96e-09
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,COL1A1;Collagen alpha-1(I) chain,4833,-0.0995442,4.04e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,NCAN;Neurocan core protein,4829,0.12927219,1.9e-19
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.1390161,7.11e-22
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,PTPRR;Receptor-type tyrosine-protein phosphatase R,3425,0.1203682,1.58e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SEZ6L;Seizure 6-like protein,4799,0.101836,1.54e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SLITRK1;SLIT and NTRK-like protein 1,3334,0.12658018,2.21e-13
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,SPP1;Osteopontin,4825,-0.0918293,1.65e-10
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,TIMP4;Metalloproteinase inhibitor 4,4771,-0.0856097,3.17e-09
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter,VGF;Neurosecretory protein VGF,3426,0.11138284,6.26e-11
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),BCAN;Brevican core protein,4752,0.10855495,6.22e-14
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),CHAD;Chondroadherin,3346,-0.1059832,7.97e-10
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),COL1A1;Collagen alpha-1(I) chain,4833,-0.1026472,8.49e-13
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),NCAN;Neurocan core protein,4829,0.12687526,8.74e-19
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),OMD;Osteomodulin,4787,-0.0837505,6.51e-09
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4737,0.13872818,8.64e-22
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),PTPRR;Receptor-type tyrosine-protein phosphatase R,3425,0.11633307,8.56e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SEZ6L;Seizure 6-like protein,4799,0.09912311,5.91e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SLITRK1;SLIT and NTRK-like protein 1,3334,0.12231667,1.37e-12
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),SPP1;Osteopontin,4825,-0.0947815,4.2e-11
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),TIMP4;Metalloproteinase inhibitor 4,4771,-0.0860657,2.61e-09
sensitivity analysis,Volume of global and regional brain,Volume of peripheral cortical grey matter (normalised for head size),VGF;Neurosecretory protein VGF,3426,0.10973142,1.2e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Operculum Cortex (right),STC2;Stanniocalcin-2,4758,0.09171779,2.32e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),BCAN;Brevican core protein,4749,0.08714847,1.79e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),NCAN;Neurocan core protein,4826,0.08839078,7.7e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4734,0.09755974,1.73e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (right),NCAN;Neurocan core protein,4825,0.08727336,1.26e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Frontal Pole (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4733,0.09573441,4.12e-11
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left)",CHAD;Chondroadherin,3345,-0.1020028,3.37e-09
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left)",COL1A1;Collagen alpha-1(I) chain,4831,-0.0976731,1.02e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),NCAN;Neurocan core protein,4824,0.10467918,3.13e-13
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4732,0.10028985,4.69e-12
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (left),PTPRR;Receptor-type tyrosine-protein phosphatase R,3423,0.10227834,2e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (right),NCAN;Neurocan core protein,4825,0.09489564,3.98e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Insular Cortex (right),PTPRR;Receptor-type tyrosine-protein phosphatase R,3424,0.10241225,1.9e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Intracalcarine Cortex (left),NCAN;Neurocan core protein,4827,0.08574422,2.42e-09
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Lateral Occipital Cortex, superior division (left)",BCAN;Brevican core protein,4750,0.0850866,4.27e-09
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Lateral Occipital Cortex, superior division (left)",NCAN;Neurocan core protein,4827,0.09105194,2.34e-10
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Middle Temporal Gyrus, posterior division (left)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4734,0.08616625,2.88e-09
sensitivity analysis,Volume of global and regional brain,"Volume of grey matter in Middle Temporal Gyrus, posterior division (right)",PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4735,0.0978642,1.49e-11
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Paracingulate Gyrus (left),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4733,0.09125576,3.18e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Planum Polare (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4733,0.08382867,7.66e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Postcentral Gyrus (right),SLITRK1;SLIT and NTRK-like protein 1,3333,0.10426966,1.6e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in Precuneous Cortex (right),PTPRN2;Receptor-type tyrosine-protein phosphatase N2,4734,0.0891567,8e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (vermis),PAEP;Glycodelin,4751,-0.0910285,3.26e-10
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (right),COL1A1;Collagen alpha-1(I) chain,4830,-0.0858214,2.32e-09
sensitivity analysis,Volume of global and regional brain,Volume of grey matter in X Cerebellum (right),DMP1;Dentin matrix acidic phosphoprotein 1,3331,-0.1043422,1.58e-09
sensitivity analysis,Volume of global and regional brain,Volume of hippocampus (right),BCAN;Brevican core protein,4749,0.09136111,2.84e-10
sensitivity analysis,Volume of global and regional brain,Volume of thalamus (left),BCAN;Brevican core protein,4748,0.0909243,3.46e-10
sensitivity analysis,Volume of global and regional brain,Volume of thalamus (right),BCAN;Brevican core protein,4748,0.0985744,9.96e-12
sensitivity analysis,Volume of global and regional brain,Volume of thalamus (right),KLK6;Kallikrein-6,4788,0.08897692,6.94e-10
sensitivity analysis,DTI dMRI,Mean FA in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4596,-0.0858716,5.52e-09
sensitivity analysis,DTI dMRI,Mean FA in posterior thalamic radiation on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4682,0.08637479,3.23e-09
sensitivity analysis,NODDI dMRI,Mean ICVF in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4591,-0.1155446,4.06e-15
sensitivity analysis,NODDI dMRI,Mean ICVF in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4591,-0.114931,5.67e-15
sensitivity analysis,NODDI dMRI,Mean ICVF in anterior limb of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4585,-0.1028208,2.98e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in anterior limb of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4591,-0.0963678,6.03e-11
sensitivity analysis,NODDI dMRI,Mean ICVF in cingulum cingulate gyrus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4592,-0.102267,3.75e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in cingulum cingulate gyrus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4592,-0.1073622,3e-13
sensitivity analysis,NODDI dMRI,Mean ICVF in cingulum hippocampus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4591,-0.0997865,1.23e-11
sensitivity analysis,NODDI dMRI,Mean ICVF in cingulum hippocampus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4591,-0.1010037,6.92e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in external capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4588,-0.0990897,1.74e-11
sensitivity analysis,NODDI dMRI,Mean ICVF in external capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4590,-0.1032117,2.39e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in genu of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,4592,-0.0867727,3.87e-09
sensitivity analysis,NODDI dMRI,Mean ICVF in middle cerebellar peduncle on FA skeleton,GFAP;Glial fibrillary acidic protein,4591,-0.0968994,4.73e-11
sensitivity analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4584,-0.092138,4.11e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in posterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4586,-0.0859451,5.56e-09
sensitivity analysis,NODDI dMRI,Mean ICVF in posterior limb of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4592,-0.0911485,6.1e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in posterior thalamic radiation on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4591,-0.0935827,2.11e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in posterior thalamic radiation on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4590,-0.0917277,4.79e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4592,-0.1079049,2.28e-13
sensitivity analysis,NODDI dMRI,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4589,-0.1162806,2.75e-15
sensitivity analysis,NODDI dMRI,Mean ICVF in sagittal stratum on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4591,-0.1166075,2.27e-15
sensitivity analysis,NODDI dMRI,Mean ICVF in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4591,-0.1252229,1.65e-17
sensitivity analysis,NODDI dMRI,Mean ICVF in splenium of corpus callosum on FA skeleton,GFAP;Glial fibrillary acidic protein,4592,-0.0870998,3.38e-09
sensitivity analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4583,-0.1022245,4.01e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in superior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4584,-0.1024086,3.65e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4674,0.08927628,9.71e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4579,-0.0912825,6.09e-10
sensitivity analysis,NODDI dMRI,Mean ICVF in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4584,-0.1033195,2.35e-12
sensitivity analysis,NODDI dMRI,Mean ICVF in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4586,-0.1003834,9.54e-12
sensitivity analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left),BCAN;Brevican core protein,4652,-0.0889562,1.22e-09
sensitivity analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left),GDF15;Growth/differentiation factor 15,4731,0.08426611,6.44e-09
sensitivity analysis,NODDI dMRI,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (right),GDF15;Growth/differentiation factor 15,4738,0.08658637,2.38e-09
sensitivity analysis,DTI dMRI,Mean L2 in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4586,0.10057609,8.7e-12
sensitivity analysis,DTI dMRI,Mean L2 in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4586,0.11090848,5e-14
sensitivity analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4657,-0.0894654,9.6e-10
sensitivity analysis,DTI dMRI,Mean L2 in fornix cres+stria terminalis on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,4656,-0.0849166,6.51e-09
sensitivity analysis,DTI dMRI,Mean L2 in posterior thalamic radiation on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4668,-0.0908854,4.95e-10
sensitivity analysis,DTI dMRI,Mean L2 in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4681,-0.0985107,1.43e-11
sensitivity analysis,DTI dMRI,Mean L2 in superior cerebellar peduncle on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,4684,-0.0932894,1.59e-10
sensitivity analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4586,0.09150788,5.36e-10
sensitivity analysis,DTI dMRI,Mean L3 in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4584,0.09071681,7.6e-10
sensitivity analysis,DTI dMRI,Mean L3 in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4682,-0.0877403,1.81e-09
sensitivity analysis,DTI dMRI,Mean L3 in superior cerebellar peduncle on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,4684,-0.0879283,1.66e-09
sensitivity analysis,DTI dMRI,Mean MD in anterior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4585,0.10299596,2.73e-12
sensitivity analysis,DTI dMRI,Mean MD in anterior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4585,0.09825536,2.6e-11
sensitivity analysis,DTI dMRI,Mean MD in sagittal stratum on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4590,0.08855745,1.86e-09
sensitivity analysis,DTI dMRI,Mean MD in superior cerebellar peduncle on FA skeleton (left),OMG;Oligodendrocyte-myelin glycoprotein,4681,-0.0848788,6.02e-09
sensitivity analysis,DTI dMRI,Mean MD in superior cerebellar peduncle on FA skeleton (right),OMG;Oligodendrocyte-myelin glycoprotein,4684,-0.0860908,3.6e-09
sensitivity analysis,DTI dMRI,Mean MD in superior corona radiata on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4573,0.09055202,8.55e-10
sensitivity analysis,DTI dMRI,Mean MD in superior corona radiata on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4574,0.09149284,5.68e-10
sensitivity analysis,DTI dMRI,Mean MD in superior longitudinal fasciculus on FA skeleton (left),GFAP;Glial fibrillary acidic protein,4579,0.08754,2.97e-09
sensitivity analysis,DTI dMRI,Mean MD in superior longitudinal fasciculus on FA skeleton (right),GFAP;Glial fibrillary acidic protein,4579,0.09307445,2.79e-10
sensitivity analysis,NODDI dMRI,Mean OD in posterior corona radiata on FA skeleton (right),"WFIKKN1;WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",4661,0.09082994,5.22e-10
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract acoustic radiation (left),GFAP;Glial fibrillary acidic protein,4592,-0.0982367,2.54e-11
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract acoustic radiation (right),GFAP;Glial fibrillary acidic protein,4591,-0.1042052,1.46e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,4591,-0.117641,1.28e-15
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,4591,-0.1171126,1.71e-15
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (left),GFAP;Glial fibrillary acidic protein,4592,-0.1000846,1.07e-11
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (right),GFAP;Glial fibrillary acidic protein,4592,-0.0924479,3.46e-10
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract corticospinal tract (left),GFAP;Glial fibrillary acidic protein,4590,-0.0951465,1.05e-10
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract corticospinal tract (right),GFAP;Glial fibrillary acidic protein,4589,-0.1012499,6.21e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract forceps major,OMG;Oligodendrocyte-myelin glycoprotein,4681,0.08488013,6.02e-09
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract forceps minor,GFAP;Glial fibrillary acidic protein,4592,-0.1032391,2.34e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,4591,-0.1217601,1.25e-16
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,4592,-0.123969,3.43e-17
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,4592,-0.1198787,3.62e-16
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,4590,-0.1235078,4.56e-17
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract middle cerebellar peduncle,GFAP;Glial fibrillary acidic protein,4587,-0.0918248,4.65e-10
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract parahippocampal part of cingulum (left),GFAP;Glial fibrillary acidic protein,4589,-0.0886755,1.77e-09
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract parahippocampal part of cingulum (right),GFAP;Glial fibrillary acidic protein,4591,-0.087021,3.51e-09
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract posterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,4588,-0.1052501,8.87e-13
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract posterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,4587,-0.1036153,2e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract superior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,4587,-0.1018035,4.81e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract superior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,4590,-0.1007965,7.67e-12
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract superior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,4587,-0.086078,5.25e-09
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract uncinate fasciculus (left),GFAP;Glial fibrillary acidic protein,4592,-0.0979642,2.88e-11
sensitivity analysis,NODDI dMRI,Weighted-mean ICVF in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,4592,-0.1160065,3.13e-15
sensitivity analysis,DTI dMRI,Weighted-mean L1 in tract corticospinal tract (right),PAEP;Glycodelin,4671,0.09801719,1.9e-11
sensitivity analysis,DTI dMRI,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,4593,0.09367454,2.01e-10
sensitivity analysis,DTI dMRI,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (right),GSN;Gelsolin,3367,-0.1021337,2.85e-09
sensitivity analysis,DTI dMRI,Weighted-mean L1 in tract superior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,4684,-0.0991396,1.05e-11
sensitivity analysis,DTI dMRI,Weighted-mean L1 in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,4683,-0.0928209,1.97e-10
sensitivity analysis,DTI dMRI,Weighted-mean L2 in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,4583,0.09114781,6.34e-10
sensitivity analysis,DTI dMRI,Weighted-mean L2 in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,4585,0.09339832,2.35e-10
sensitivity analysis,DTI dMRI,Weighted-mean L2 in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,4589,0.08646865,4.44e-09
sensitivity analysis,DTI dMRI,Weighted-mean L2 in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,4588,0.08603823,5.31e-09
sensitivity analysis,DTI dMRI,Weighted-mean L2 in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,4668,-0.0917067,3.45e-10
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,4583,0.08713575,3.45e-09
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,4586,0.08659053,4.27e-09
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,4588,0.09098548,6.66e-10
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract inferior longitudinal fasciculus (left),GFAP;Glial fibrillary acidic protein,4584,0.08693005,3.74e-09
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,4588,0.08997138,1.03e-09
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,4673,-0.0886009,1.3e-09
sensitivity analysis,DTI dMRI,Weighted-mean L3 in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,4595,0.08989659,1.03e-09
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract anterior thalamic radiation (left),GFAP;Glial fibrillary acidic protein,4582,0.09331074,2.48e-10
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract anterior thalamic radiation (right),GFAP;Glial fibrillary acidic protein,4587,0.09136741,5.67e-10
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract inferior fronto-occipital fasciculus (left),GFAP;Glial fibrillary acidic protein,4586,0.09250224,3.47e-10
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract inferior fronto-occipital fasciculus (right),GFAP;Glial fibrillary acidic protein,4589,0.09428316,1.56e-10
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract inferior longitudinal fasciculus (right),GFAP;Glial fibrillary acidic protein,4588,0.08977016,1.12e-09
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract posterior thalamic radiation (left),OMG;Oligodendrocyte-myelin glycoprotein,4670,-0.0861186,3.76e-09
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract superior thalamic radiation (right),OMG;Oligodendrocyte-myelin glycoprotein,4680,-0.0874674,2.05e-09
sensitivity analysis,DTI dMRI,Weighted-mean MD in tract uncinate fasciculus (right),GFAP;Glial fibrillary acidic protein,4595,0.08665268,4.02e-09
sensitivity analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),CHAD;Chondroadherin,3294,0.10412797,2.09e-09
sensitivity analysis,NODDI dMRI,Weighted-mean OD in tract corticospinal tract (right),COL1A1;Collagen alpha-1(I) chain,4750,0.0848325,4.75e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (left),BCAN;Brevican core protein,4412,0.09042976,1.77e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (left),TF;Serotransferrin,3190,0.10674112,1.51e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in substantia nigra (right),BCAN;Brevican core protein,4412,0.0885598,3.81e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),BCAN;Brevican core protein,4411,-0.125125,7.39e-17
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),CDHR2;Cadherin-related family member 2,4419,0.0891845,2.87e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),DPP10;Inactive dipeptidyl peptidase 10,4422,-0.1060561,1.54e-12
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),DPP6;Dipeptidyl aminopeptidase-like protein 6,4419,-0.0879806,4.68e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),OMG;Oligodendrocyte-myelin glycoprotein,4419,-0.1006257,2.02e-11
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),TF;Serotransferrin,3189,-0.1555127,1.03e-18
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (left),TFRC;Transferrin receptor protein 1,4437,-0.0928867,5.69e-10
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),BCAN;Brevican core protein,4411,-0.1184748,2.92e-15
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),CDHR2;Cadherin-related family member 2,4419,0.09935726,3.61e-11
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),DPP10;Inactive dipeptidyl peptidase 10,4422,-0.0990326,4.12e-11
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),OMG;Oligodendrocyte-myelin glycoprotein,4419,-0.0867648,7.6e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),TF;Serotransferrin,3189,-0.1597345,1.13e-19
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in caudate (right),TFRC;Transferrin receptor protein 1,4437,-0.0951786,2.12e-10
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),BCAN;Brevican core protein,4408,-0.1308943,2.65e-18
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),FLT3LG;Fms-related tyrosine kinase 3 ligand,4478,0.09200758,6.9e-10
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),OMG;Oligodendrocyte-myelin glycoprotein,4416,-0.1078325,6.73e-13
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),TF;Serotransferrin,3187,-0.1478108,4.98e-17
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (left),TFRC;Transferrin receptor protein 1,4434,-0.0890368,2.87e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),BCAN;Brevican core protein,4409,-0.1323525,1.1e-18
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),CDHR2;Cadherin-related family member 2,4417,0.09658282,1.26e-10
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),FLT3LG;Fms-related tyrosine kinase 3 ligand,4479,0.08859304,2.87e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),OMG;Oligodendrocyte-myelin glycoprotein,4417,-0.1041362,3.98e-12
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),TF;Serotransferrin,3187,-0.1380156,5.04e-15
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in putamen (right),TFRC;Transferrin receptor protein 1,4435,-0.1000264,2.45e-11
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),BCAN;Brevican core protein,4412,-0.1062547,1.49e-12
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),DPP10;Inactive dipeptidyl peptidase 10,4423,-0.1095319,2.78e-13
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),DPP6;Dipeptidyl aminopeptidase-like protein 6,4420,-0.0889368,3.16e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),OMG;Oligodendrocyte-myelin glycoprotein,4420,-0.0884464,3.86e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (left),TF;Serotransferrin,3190,-0.1373292,6.69e-15
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),ACAN;Aggrecan core protein,4395,-0.0909035,1.57e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),BCAN;Brevican core protein,4412,-0.1050692,2.63e-12
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),DPP10;Inactive dipeptidyl peptidase 10,4423,-0.1053861,2.12e-12
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),DPP6;Dipeptidyl aminopeptidase-like protein 6,4420,-0.0908199,1.46e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),OMG;Oligodendrocyte-myelin glycoprotein,4420,-0.0872041,6.36e-09
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in substantia nigra (right),TF;Serotransferrin,3190,-0.1414786,9.91e-16
sensitivity analysis,Susceptibility weighted MRI,Median magnetic susceptibility in thalamus (right),SSC4D;Scavenger receptor cysteine-rich domain-containing group B protein,4441,0.08724066,5.77e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in caudate (left),BCAN;Brevican core protein,4499,0.08970454,1.67e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in caudate (left),TF;Serotransferrin,3253,0.1248914,8.78e-13
sensitivity analysis,Susceptibility weighted MRI,Median T2star in caudate (right),CDHR2;Cadherin-related family member 2,4507,-0.0920881,5.88e-10
sensitivity analysis,Susceptibility weighted MRI,Median T2star in caudate (right),TF;Serotransferrin,3252,0.12129513,3.92e-12
sensitivity analysis,Susceptibility weighted MRI,Median T2star in pallidum (left),BCAN;Brevican core protein,4495,0.08646663,6.38e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in pallidum (left),TF;Serotransferrin,3251,0.11037475,2.79e-10
sensitivity analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),BCAN;Brevican core protein,4497,0.08729218,4.54e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),CDHR2;Cadherin-related family member 2,4506,-0.0879174,3.39e-09
sensitivity analysis,Susceptibility weighted MRI,Median T2star in pallidum (right),TF;Serotransferrin,3253,0.12088892,4.59e-12
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (left),BCAN;Brevican core protein,4499,0.11290473,3.07e-14
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (left),CDHR2;Cadherin-related family member 2,4508,-0.092246,5.47e-10
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (left),TF;Serotransferrin,3253,0.14241707,3.31e-16
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (right),BCAN;Brevican core protein,4499,0.11295503,2.99e-14
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (right),CDHR2;Cadherin-related family member 2,4508,-0.1086433,2.59e-13
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (right),TF;Serotransferrin,3253,0.14794585,2.22e-17
sensitivity analysis,Susceptibility weighted MRI,Median T2star in putamen (right),TFRC;Transferrin receptor protein 1,4529,0.08831037,2.63e-09
sensitivity analysis,rfMRI component amplitude,component amplitudes dimension 100,IGFBP2;Insulin-like growth factor-binding protein 2,4818,-0.0891491,5.69e-10
